None
[{"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.438Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.439Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.440Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.441Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.441Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.442Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.443Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.443Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.444Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.445Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.445Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.446Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.447Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.447Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.448Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.449Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.449Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.450Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.451Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.451Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.452Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.453Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.453Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.454Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.455Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.455Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.456Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.457Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.457Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.458Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.459Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.459Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.460Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.460Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.461Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.462Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.462Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.463Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.464Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.464Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.465Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.466Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.466Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.467Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.468Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.468Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.469Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.470Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.470Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.471Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.472Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.472Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.473Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.474Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.475Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.475Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.476Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.477Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.478Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.478Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.479Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.479Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.480Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.481Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.481Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.482Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.483Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.483Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.484Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.485Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.485Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.489Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.490Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.490Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.491Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.492Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.492Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.493Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.494Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.494Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.495Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.496Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.496Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.497Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.498Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.498Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.499Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.500Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.500Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:30:45.501Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:35:29.998Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:35:29.999Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:39:53.598Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:39:53.599Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:46:17.563Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:46:17.564Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:47:39.014Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:47:39.015Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:55:27.335Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-06T13:55:27.336Z", "user": 1, "content_type": 38, "object_id": "0", "object_repr": "downloadcount object (0)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.516Z", "user": 1, "content_type": 15, "object_id": "19", "object_repr": "ContactUs object (19)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.517Z", "user": 1, "content_type": 15, "object_id": "18", "object_repr": "ContactUs object (18)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.518Z", "user": 1, "content_type": 15, "object_id": "17", "object_repr": "ContactUs object (17)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.518Z", "user": 1, "content_type": 15, "object_id": "16", "object_repr": "ContactUs object (16)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.519Z", "user": 1, "content_type": 15, "object_id": "15", "object_repr": "ContactUs object (15)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.519Z", "user": 1, "content_type": 15, "object_id": "14", "object_repr": "ContactUs object (14)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.520Z", "user": 1, "content_type": 15, "object_id": "13", "object_repr": "ContactUs object (13)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.521Z", "user": 1, "content_type": 15, "object_id": "12", "object_repr": "ContactUs object (12)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.521Z", "user": 1, "content_type": 15, "object_id": "10", "object_repr": "ContactUs object (10)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.522Z", "user": 1, "content_type": 15, "object_id": "9", "object_repr": "ContactUs object (9)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.522Z", "user": 1, "content_type": 15, "object_id": "8", "object_repr": "ContactUs object (8)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.523Z", "user": 1, "content_type": 15, "object_id": "7", "object_repr": "ContactUs object (7)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.523Z", "user": 1, "content_type": 15, "object_id": "6", "object_repr": "ContactUs object (6)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.524Z", "user": 1, "content_type": 15, "object_id": "5", "object_repr": "ContactUs object (5)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.525Z", "user": 1, "content_type": 15, "object_id": "4", "object_repr": "ContactUs object (4)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T09:39:58.525Z", "user": 1, "content_type": 15, "object_id": "3", "object_repr": "ContactUs object (3)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T10:48:58.839Z", "user": 1, "content_type": 7, "object_id": "0", "object_repr": "fdsf", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 0, "fields": {"action_time": "2021-12-10T10:48:58.840Z", "user": 1, "content_type": 7, "object_id": "0", "object_repr": "dfsdf", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 1, "fields": {"action_time": "2021-10-22T05:40:42.929Z", "user": 1, "content_type": 7, "object_id": "1", "object_repr": "Blogs object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 2, "fields": {"action_time": "2021-10-22T05:43:37.658Z", "user": 1, "content_type": 7, "object_id": "1", "object_repr": "Blogs object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Img\"]}}]"}}, {"model": "admin.logentry", "pk": 3, "fields": {"action_time": "2021-10-24T03:45:51.021Z", "user": 1, "content_type": 12, "object_id": "1", "object_repr": "authors object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 4, "fields": {"action_time": "2021-10-24T03:46:44.253Z", "user": 1, "content_type": 12, "object_id": "2", "object_repr": "authors object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 5, "fields": {"action_time": "2021-10-24T03:47:16.815Z", "user": 1, "content_type": 12, "object_id": "3", "object_repr": "authors object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 6, "fields": {"action_time": "2021-10-24T03:47:27.272Z", "user": 1, "content_type": 9, "object_id": "1", "object_repr": "issue object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 7, "fields": {"action_time": "2021-10-24T03:47:38.952Z", "user": 1, "content_type": 11, "object_id": "1", "object_repr": "year object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 8, "fields": {"action_time": "2021-10-24T03:47:43.919Z", "user": 1, "content_type": 11, "object_id": "2", "object_repr": "year object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 9, "fields": {"action_time": "2021-10-24T03:47:49.040Z", "user": 1, "content_type": 11, "object_id": "3", "object_repr": "year object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 10, "fields": {"action_time": "2021-10-24T03:47:55.341Z", "user": 1, "content_type": 11, "object_id": "4", "object_repr": "year object (4)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 11, "fields": {"action_time": "2021-10-24T03:47:59.107Z", "user": 1, "content_type": 11, "object_id": "5", "object_repr": "year object (5)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 12, "fields": {"action_time": "2021-10-24T03:48:04.329Z", "user": 1, "content_type": 11, "object_id": "6", "object_repr": "year object (6)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 13, "fields": {"action_time": "2021-10-24T03:48:24.855Z", "user": 1, "content_type": 10, "object_id": "1", "object_repr": "vol object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 14, "fields": {"action_time": "2021-10-24T03:48:28.904Z", "user": 1, "content_type": 10, "object_id": "2", "object_repr": "vol object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 15, "fields": {"action_time": "2021-10-24T03:48:33.121Z", "user": 1, "content_type": 10, "object_id": "3", "object_repr": "vol object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 16, "fields": {"action_time": "2021-10-24T03:48:43.142Z", "user": 1, "content_type": 9, "object_id": "2", "object_repr": "issue object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 17, "fields": {"action_time": "2021-10-24T03:48:46.695Z", "user": 1, "content_type": 9, "object_id": "3", "object_repr": "issue object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 18, "fields": {"action_time": "2021-10-24T03:48:50.452Z", "user": 1, "content_type": 9, "object_id": "4", "object_repr": "issue object (4)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 19, "fields": {"action_time": "2021-10-24T03:55:34.440Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 20, "fields": {"action_time": "2021-10-24T04:00:20.516Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Pdf\"]}}]"}}, {"model": "admin.logentry", "pk": 21, "fields": {"action_time": "2021-10-24T21:34:26.018Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Keywords\", \"Do\", \"References\"]}}]"}}, {"model": "admin.logentry", "pk": 22, "fields": {"action_time": "2021-10-24T21:35:09.838Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"References\"]}}]"}}, {"model": "admin.logentry", "pk": 23, "fields": {"action_time": "2021-10-24T21:36:54.772Z", "user": 1, "content_type": 13, "object_id": "2", "object_repr": "artical object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 24, "fields": {"action_time": "2021-10-24T15:26:00.849Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 25, "fields": {"action_time": "2021-10-24T16:00:56.464Z", "user": 1, "content_type": 9, "object_id": "1", "object_repr": "2017 | Vol 1 | issue 1", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Year\"]}}]"}}, {"model": "admin.logentry", "pk": 26, "fields": {"action_time": "2021-10-24T16:01:09.322Z", "user": 1, "content_type": 9, "object_id": "3", "object_repr": "2018 | Vol 1 | issue 3", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Year\"]}}]"}}, {"model": "admin.logentry", "pk": 27, "fields": {"action_time": "2021-10-24T16:01:16.429Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Issue\"]}}]"}}, {"model": "admin.logentry", "pk": 28, "fields": {"action_time": "2021-10-24T17:03:50.555Z", "user": 1, "content_type": 9, "object_id": "5", "object_repr": "2017 | Vol 2 | issue 5", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 29, "fields": {"action_time": "2021-10-24T17:04:42.455Z", "user": 1, "content_type": 13, "object_id": "4", "object_repr": "artical object (4)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 30, "fields": {"action_time": "2021-10-24T17:42:15.057Z", "user": 1, "content_type": 13, "object_id": "5", "object_repr": "artical object (5)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 31, "fields": {"action_time": "2021-10-24T17:51:03.470Z", "user": 1, "content_type": 9, "object_id": "5", "object_repr": "2017 | Vol 2 | issue 5", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 32, "fields": {"action_time": "2021-10-24T17:51:03.494Z", "user": 1, "content_type": 9, "object_id": "4", "object_repr": "2016 | Vol 1 | issue 4", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 33, "fields": {"action_time": "2021-10-24T17:51:03.510Z", "user": 1, "content_type": 9, "object_id": "3", "object_repr": "2018 | Vol 1 | issue 3", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 34, "fields": {"action_time": "2021-10-24T17:51:03.534Z", "user": 1, "content_type": 9, "object_id": "2", "object_repr": "2016 | Vol 1 | issue 2", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 35, "fields": {"action_time": "2021-10-24T17:51:03.550Z", "user": 1, "content_type": 9, "object_id": "1", "object_repr": "2017 | Vol 1 | issue 1", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 36, "fields": {"action_time": "2021-10-24T17:55:51.883Z", "user": 1, "content_type": 9, "object_id": "1", "object_repr": "2017 | Vol 1 | issue 1", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 37, "fields": {"action_time": "2021-10-24T17:55:54.265Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Issue\"]}}]"}}, {"model": "admin.logentry", "pk": 38, "fields": {"action_time": "2021-10-24T17:59:48.657Z", "user": 1, "content_type": 13, "object_id": "5", "object_repr": "artical object (5)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 39, "fields": {"action_time": "2021-10-24T17:59:48.673Z", "user": 1, "content_type": 13, "object_id": "4", "object_repr": "artical object (4)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 40, "fields": {"action_time": "2021-10-24T17:59:48.697Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 41, "fields": {"action_time": "2021-10-24T17:59:48.713Z", "user": 1, "content_type": 13, "object_id": "2", "object_repr": "artical object (2)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 42, "fields": {"action_time": "2021-10-24T17:59:48.729Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 43, "fields": {"action_time": "2021-10-24T18:01:32.621Z", "user": 1, "content_type": 9, "object_id": "2", "object_repr": "2016 | Vol 1 | issue 1", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 44, "fields": {"action_time": "2021-10-24T18:02:37.827Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 45, "fields": {"action_time": "2021-10-24T18:03:01.450Z", "user": 1, "content_type": 9, "object_id": "1", "object_repr": "2017 | Vol 2 | issue 1", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Vol\"]}}]"}}, {"model": "admin.logentry", "pk": 46, "fields": {"action_time": "2021-10-24T18:03:44.480Z", "user": 1, "content_type": 13, "object_id": "2", "object_repr": "artical object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 47, "fields": {"action_time": "2021-10-24T18:04:06.343Z", "user": 1, "content_type": 9, "object_id": "3", "object_repr": "2016 | Vol 2 | issue 1", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 48, "fields": {"action_time": "2021-10-24T18:04:35.622Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 49, "fields": {"action_time": "2021-10-25T07:09:42.004Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Heading\"]}}]"}}, {"model": "admin.logentry", "pk": 50, "fields": {"action_time": "2021-10-25T07:10:02.183Z", "user": 1, "content_type": 13, "object_id": "2", "object_repr": "artical object (2)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Heading\"]}}]"}}, {"model": "admin.logentry", "pk": 51, "fields": {"action_time": "2021-10-25T07:10:15.942Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Heading\"]}}]"}}, {"model": "admin.logentry", "pk": 52, "fields": {"action_time": "2021-10-25T07:11:20.059Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 53, "fields": {"action_time": "2021-10-25T07:11:23.957Z", "user": 1, "content_type": 13, "object_id": "2", "object_repr": "artical object (2)", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 54, "fields": {"action_time": "2021-10-25T07:12:28.059Z", "user": 1, "content_type": 13, "object_id": "4", "object_repr": "artical object (4)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 55, "fields": {"action_time": "2021-10-25T07:12:36.533Z", "user": 1, "content_type": 13, "object_id": "4", "object_repr": "artical object (4)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 56, "fields": {"action_time": "2021-10-25T13:48:34.304Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 57, "fields": {"action_time": "2021-10-25T14:13:26.706Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Slug\"]}}]"}}, {"model": "admin.logentry", "pk": 58, "fields": {"action_time": "2021-10-25T14:13:43.935Z", "user": 1, "content_type": 13, "object_id": "2", "object_repr": "artical object (2)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Slug\"]}}]"}}, {"model": "admin.logentry", "pk": 59, "fields": {"action_time": "2021-10-25T14:13:48.342Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 60, "fields": {"action_time": "2021-10-25T14:15:05.588Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Abstract\", \"Keywords\", \"References\", \"Slug\"]}}]"}}, {"model": "admin.logentry", "pk": 61, "fields": {"action_time": "2021-10-25T14:16:48.241Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Abstract\", \"Keywords\", \"References\"]}}]"}}, {"model": "admin.logentry", "pk": 62, "fields": {"action_time": "2021-10-25T14:17:50.204Z", "user": 1, "content_type": 13, "object_id": "2", "object_repr": "artical object (2)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Abstract\", \"Keywords\", \"References\"]}}]"}}, {"model": "admin.logentry", "pk": 63, "fields": {"action_time": "2021-10-26T10:27:07.429Z", "user": 1, "content_type": 17, "object_id": "1", "object_repr": "TeamModel object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 64, "fields": {"action_time": "2021-10-26T10:30:56.826Z", "user": 1, "content_type": 17, "object_id": "1", "object_repr": "TeamModel object (1)", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 65, "fields": {"action_time": "2021-10-26T10:58:46.812Z", "user": 1, "content_type": 17, "object_id": "1", "object_repr": "TeamModel object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Twiter\", \"Facebook\", \"Google\", \"Linkedin\"]}}]"}}, {"model": "admin.logentry", "pk": 66, "fields": {"action_time": "2021-10-26T11:00:10.449Z", "user": 1, "content_type": 17, "object_id": "1", "object_repr": "TeamModel object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Twiter\", \"Facebook\", \"Google\", \"Linkedin\"]}}]"}}, {"model": "admin.logentry", "pk": 67, "fields": {"action_time": "2021-10-26T11:03:06.205Z", "user": 1, "content_type": 17, "object_id": "1", "object_repr": "TeamModel object (1)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Twiter\", \"Facebook\", \"Google\", \"Linkedin\"]}}]"}}, {"model": "admin.logentry", "pk": 68, "fields": {"action_time": "2021-10-26T11:06:41.320Z", "user": 1, "content_type": 17, "object_id": "2", "object_repr": "TeamModel object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 69, "fields": {"action_time": "2021-10-26T12:39:26.159Z", "user": 1, "content_type": 18, "object_id": "1", "object_repr": "category object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 70, "fields": {"action_time": "2021-10-26T12:39:33.891Z", "user": 1, "content_type": 18, "object_id": "2", "object_repr": "category object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 71, "fields": {"action_time": "2021-10-26T12:39:42.545Z", "user": 1, "content_type": 18, "object_id": "3", "object_repr": "category object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 72, "fields": {"action_time": "2021-10-26T12:39:50.810Z", "user": 1, "content_type": 18, "object_id": "4", "object_repr": "category object (4)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 73, "fields": {"action_time": "2021-10-26T12:40:03.100Z", "user": 1, "content_type": 18, "object_id": "5", "object_repr": "category object (5)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 74, "fields": {"action_time": "2021-10-26T12:40:18.289Z", "user": 1, "content_type": 18, "object_id": "6", "object_repr": "category object (6)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 75, "fields": {"action_time": "2021-10-26T12:40:28.065Z", "user": 1, "content_type": 18, "object_id": "4", "object_repr": "category object (4)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 76, "fields": {"action_time": "2021-10-26T12:42:08.121Z", "user": 1, "content_type": 19, "object_id": "1", "object_repr": "researchModel object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 77, "fields": {"action_time": "2021-10-26T12:42:22.366Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "researchModel object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 78, "fields": {"action_time": "2021-10-26T12:44:35.702Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "researchModel object (2)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Img\"]}}]"}}, {"model": "admin.logentry", "pk": 79, "fields": {"action_time": "2021-10-26T12:45:30.202Z", "user": 1, "content_type": 19, "object_id": "1", "object_repr": "NANOSTRUCTURED MATERIALS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Img\"]}}]"}}, {"model": "admin.logentry", "pk": 80, "fields": {"action_time": "2021-10-26T12:47:10.150Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 81, "fields": {"action_time": "2021-10-26T12:47:16.380Z", "user": 1, "content_type": 19, "object_id": "1", "object_repr": "NANOSTRUCTURED MATERIALS", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 82, "fields": {"action_time": "2021-10-27T08:39:42.680Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 83, "fields": {"action_time": "2021-10-27T08:51:41.879Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Details\"]}}]"}}, {"model": "admin.logentry", "pk": 84, "fields": {"action_time": "2021-10-27T09:35:10.903Z", "user": 1, "content_type": 21, "object_id": "1", "object_repr": "faq object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 85, "fields": {"action_time": "2021-10-27T09:35:43.365Z", "user": 1, "content_type": 21, "object_id": "2", "object_repr": "faq object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 86, "fields": {"action_time": "2021-10-27T09:36:13.902Z", "user": 1, "content_type": 21, "object_id": "3", "object_repr": "faq object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 87, "fields": {"action_time": "2021-10-27T10:53:40.181Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Img1\", \"Img2\"]}}]"}}, {"model": "admin.logentry", "pk": 88, "fields": {"action_time": "2021-10-27T10:53:40.476Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Img1\", \"Img2\"]}}]"}}, {"model": "admin.logentry", "pk": 89, "fields": {"action_time": "2021-10-27T10:53:41.429Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Img1\", \"Img2\"]}}]"}}, {"model": "admin.logentry", "pk": 90, "fields": {"action_time": "2021-10-27T10:53:41.951Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Img1\", \"Img2\"]}}]"}}, {"model": "admin.logentry", "pk": 91, "fields": {"action_time": "2021-10-27T10:53:42.901Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Img1\", \"Img2\"]}}]"}}, {"model": "admin.logentry", "pk": 92, "fields": {"action_time": "2021-10-27T10:57:08.156Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Ourresearch\"]}}]"}}, {"model": "admin.logentry", "pk": 93, "fields": {"action_time": "2021-10-27T11:28:51.222Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProjectDetails\", \"Overview\", \"Content\"]}}]"}}, {"model": "admin.logentry", "pk": 94, "fields": {"action_time": "2021-10-27T11:30:07.399Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProjectDetails\", \"Content\"]}}]"}}, {"model": "admin.logentry", "pk": 95, "fields": {"action_time": "2021-10-27T11:30:20.719Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProjectDetails\"]}}]"}}, {"model": "admin.logentry", "pk": 96, "fields": {"action_time": "2021-10-27T11:32:47.214Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProjectDetails\"]}}]"}}, {"model": "admin.logentry", "pk": 97, "fields": {"action_time": "2021-10-27T11:35:38.615Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProjectDetails\"]}}]"}}, {"model": "admin.logentry", "pk": 98, "fields": {"action_time": "2021-10-27T11:37:30.310Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProjectDetails\"]}}]"}}, {"model": "admin.logentry", "pk": 99, "fields": {"action_time": "2021-10-27T11:39:26.442Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProjectDetails\"]}}]"}}, {"model": "admin.logentry", "pk": 100, "fields": {"action_time": "2021-10-27T11:47:29.136Z", "user": 1, "content_type": 19, "object_id": "1", "object_repr": "NANOSTRUCTURED MATERIALS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProjectDetails\", \"Overview\", \"Content\"]}}]"}}, {"model": "admin.logentry", "pk": 101, "fields": {"action_time": "2021-10-27T11:50:10.231Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Content\"]}}]"}}, {"model": "admin.logentry", "pk": 102, "fields": {"action_time": "2021-10-27T11:57:34.691Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Processoverview\"]}}]"}}, {"model": "admin.logentry", "pk": 103, "fields": {"action_time": "2021-10-27T12:01:33.124Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 104, "fields": {"action_time": "2021-10-27T12:03:03.931Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Processoverview\"]}}]"}}, {"model": "admin.logentry", "pk": 105, "fields": {"action_time": "2021-10-27T12:05:11.783Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"ProcessOverview\"]}}]"}}, {"model": "admin.logentry", "pk": 106, "fields": {"action_time": "2021-10-27T12:11:27.792Z", "user": 1, "content_type": 22, "object_id": "1", "object_repr": "process object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 107, "fields": {"action_time": "2021-10-27T12:11:46.951Z", "user": 1, "content_type": 22, "object_id": "2", "object_repr": "process object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 108, "fields": {"action_time": "2021-10-27T12:12:11.910Z", "user": 1, "content_type": 22, "object_id": "3", "object_repr": "process object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 109, "fields": {"action_time": "2021-10-28T04:23:41.811Z", "user": 1, "content_type": 23, "object_id": "1", "object_repr": "category object (1)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 110, "fields": {"action_time": "2021-10-28T04:23:53.542Z", "user": 1, "content_type": 23, "object_id": "2", "object_repr": "category object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 111, "fields": {"action_time": "2021-10-28T04:24:03.617Z", "user": 1, "content_type": 23, "object_id": "3", "object_repr": "category object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 112, "fields": {"action_time": "2021-10-28T04:24:10.513Z", "user": 1, "content_type": 23, "object_id": "4", "object_repr": "category object (4)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 113, "fields": {"action_time": "2021-10-28T04:26:12.812Z", "user": 1, "content_type": 23, "object_id": "2", "object_repr": "Forensic science", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Slug\"]}}]"}}, {"model": "admin.logentry", "pk": 114, "fields": {"action_time": "2021-10-28T06:57:05.783Z", "user": 1, "content_type": 23, "object_id": "4", "object_repr": "Scientific", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 115, "fields": {"action_time": "2021-10-28T06:57:19.166Z", "user": 1, "content_type": 23, "object_id": "5", "object_repr": "Scientific", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 116, "fields": {"action_time": "2021-10-28T07:04:00.831Z", "user": 1, "content_type": 7, "object_id": "1", "object_repr": "Testing Food quality and safety", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 117, "fields": {"action_time": "2021-10-28T07:05:44.092Z", "user": 1, "content_type": 7, "object_id": "2", "object_repr": "Testing Food quality and safety", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 118, "fields": {"action_time": "2021-10-28T07:09:19.496Z", "user": 1, "content_type": 19, "object_id": "2", "object_repr": "ORGANIC SYNTHESIS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Overview\"]}}]"}}, {"model": "admin.logentry", "pk": 119, "fields": {"action_time": "2021-10-28T07:09:40.453Z", "user": 1, "content_type": 19, "object_id": "1", "object_repr": "NANOSTRUCTURED MATERIALS", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Overview\", \"ProcessOverview\"]}}]"}}, {"model": "admin.logentry", "pk": 120, "fields": {"action_time": "2021-10-28T07:52:59.203Z", "user": 1, "content_type": 20, "object_id": "1", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Type\"]}}]"}}, {"model": "admin.logentry", "pk": 121, "fields": {"action_time": "2021-10-28T08:14:35.014Z", "user": 1, "content_type": 20, "object_id": "2", "object_repr": "Chemical Research", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 122, "fields": {"action_time": "2021-10-28T08:15:08.500Z", "user": 1, "content_type": 20, "object_id": "2", "object_repr": "Chemical Research", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Type\"]}}]"}}, {"model": "admin.logentry", "pk": 123, "fields": {"action_time": "2021-10-28T14:10:35.965Z", "user": 1, "content_type": 13, "object_id": "5", "object_repr": "artical object (5)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 124, "fields": {"action_time": "2021-10-28T14:11:03.865Z", "user": 1, "content_type": 25, "object_id": "2", "object_repr": "subscriber object (2)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 125, "fields": {"action_time": "2021-10-28T14:11:13.400Z", "user": 1, "content_type": 25, "object_id": "3", "object_repr": "subscriber object (3)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 126, "fields": {"action_time": "2021-10-28T14:11:29.717Z", "user": 1, "content_type": 25, "object_id": "4", "object_repr": "subscriber object (4)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 127, "fields": {"action_time": "2021-10-28T14:11:47.247Z", "user": 1, "content_type": 25, "object_id": "5", "object_repr": "subscriber object (5)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 128, "fields": {"action_time": "2021-10-28T14:12:15.772Z", "user": 1, "content_type": 25, "object_id": "6", "object_repr": "subscriber object (6)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 129, "fields": {"action_time": "2021-10-28T14:12:37.076Z", "user": 1, "content_type": 25, "object_id": "7", "object_repr": "subscriber object (7)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 130, "fields": {"action_time": "2021-10-28T14:13:08.362Z", "user": 1, "content_type": 9, "object_id": "4", "object_repr": "2016 | Vol 1 | issue 2", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 131, "fields": {"action_time": "2021-10-28T14:14:06.115Z", "user": 1, "content_type": 13, "object_id": "6", "object_repr": "artical object (6)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 132, "fields": {"action_time": "2021-10-28T14:29:15.818Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 2, "change_message": "[]"}}, {"model": "admin.logentry", "pk": 133, "fields": {"action_time": "2021-10-28T14:30:04.528Z", "user": 1, "content_type": 13, "object_id": "7", "object_repr": "artical object (7)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 134, "fields": {"action_time": "2021-10-28T14:43:09.412Z", "user": 1, "content_type": 13, "object_id": "7", "object_repr": "artical object (7)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 135, "fields": {"action_time": "2021-10-28T14:44:02.731Z", "user": 1, "content_type": 13, "object_id": "8", "object_repr": "artical object (8)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 136, "fields": {"action_time": "2021-10-28T14:44:34.436Z", "user": 1, "content_type": 13, "object_id": "8", "object_repr": "artical object (8)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 137, "fields": {"action_time": "2021-10-28T14:45:07.022Z", "user": 1, "content_type": 13, "object_id": "9", "object_repr": "artical object (9)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 138, "fields": {"action_time": "2021-10-28T14:46:02.283Z", "user": 1, "content_type": 13, "object_id": "9", "object_repr": "artical object (9)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 139, "fields": {"action_time": "2021-10-28T14:46:34.670Z", "user": 1, "content_type": 13, "object_id": "10", "object_repr": "artical object (10)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 140, "fields": {"action_time": "2021-10-28T15:11:12.750Z", "user": 1, "content_type": 13, "object_id": "10", "object_repr": "artical object (10)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 141, "fields": {"action_time": "2021-10-28T15:11:48.584Z", "user": 1, "content_type": 13, "object_id": "11", "object_repr": "artical object (11)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 142, "fields": {"action_time": "2021-10-28T15:13:39.317Z", "user": 1, "content_type": 13, "object_id": "11", "object_repr": "artical object (11)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 143, "fields": {"action_time": "2021-10-28T15:14:10.991Z", "user": 1, "content_type": 13, "object_id": "12", "object_repr": "artical object (12)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 144, "fields": {"action_time": "2021-10-28T15:15:21.470Z", "user": 1, "content_type": 13, "object_id": "12", "object_repr": "artical object (12)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 145, "fields": {"action_time": "2021-10-28T15:15:51.251Z", "user": 1, "content_type": 13, "object_id": "13", "object_repr": "artical object (13)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 146, "fields": {"action_time": "2021-10-28T15:34:24.992Z", "user": 1, "content_type": 13, "object_id": "14", "object_repr": "artical object (14)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 147, "fields": {"action_time": "2021-10-28T16:51:36.006Z", "user": 1, "content_type": 13, "object_id": "15", "object_repr": "artical object (15)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 148, "fields": {"action_time": "2021-10-28T16:53:17.794Z", "user": 1, "content_type": 13, "object_id": "16", "object_repr": "artical object (16)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 149, "fields": {"action_time": "2021-10-28T16:59:18.225Z", "user": 1, "content_type": 13, "object_id": "17", "object_repr": "artical object (17)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 150, "fields": {"action_time": "2021-10-28T17:02:29.932Z", "user": 1, "content_type": 13, "object_id": "18", "object_repr": "artical object (18)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 151, "fields": {"action_time": "2021-10-28T17:04:06.013Z", "user": 1, "content_type": 13, "object_id": "19", "object_repr": "artical object (19)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 152, "fields": {"action_time": "2021-11-10T09:43:54.406Z", "user": 1, "content_type": 9, "object_id": "5", "object_repr": "2017 | Vol 1 | issue 1", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 153, "fields": {"action_time": "2021-11-10T09:43:54.568Z", "user": 1, "content_type": 9, "object_id": "4", "object_repr": "2016 | Vol 1 | issue 2", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 154, "fields": {"action_time": "2021-11-10T09:43:54.721Z", "user": 1, "content_type": 9, "object_id": "3", "object_repr": "2016 | Vol 2 | issue 1", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 155, "fields": {"action_time": "2021-11-10T09:43:54.859Z", "user": 1, "content_type": 9, "object_id": "2", "object_repr": "2016 | Vol 1 | issue 1", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 156, "fields": {"action_time": "2021-11-10T09:43:55.003Z", "user": 1, "content_type": 9, "object_id": "1", "object_repr": "2017 | Vol 2 | issue 1", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 157, "fields": {"action_time": "2021-11-10T09:44:10.244Z", "user": 1, "content_type": 13, "object_id": "20", "object_repr": "artical object (20)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 158, "fields": {"action_time": "2021-11-10T09:44:10.382Z", "user": 1, "content_type": 13, "object_id": "19", "object_repr": "artical object (19)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 159, "fields": {"action_time": "2021-11-10T09:44:10.551Z", "user": 1, "content_type": 13, "object_id": "18", "object_repr": "artical object (18)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 160, "fields": {"action_time": "2021-11-10T09:44:10.693Z", "user": 1, "content_type": 13, "object_id": "16", "object_repr": "artical object (16)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 161, "fields": {"action_time": "2021-11-10T09:44:10.826Z", "user": 1, "content_type": 13, "object_id": "15", "object_repr": "artical object (15)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 162, "fields": {"action_time": "2021-11-10T09:44:10.925Z", "user": 1, "content_type": 13, "object_id": "14", "object_repr": "artical object (14)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 163, "fields": {"action_time": "2021-11-10T09:44:11.081Z", "user": 1, "content_type": 13, "object_id": "13", "object_repr": "artical object (13)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 164, "fields": {"action_time": "2021-11-10T09:44:11.215Z", "user": 1, "content_type": 13, "object_id": "6", "object_repr": "artical object (6)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 165, "fields": {"action_time": "2021-11-10T09:44:11.350Z", "user": 1, "content_type": 13, "object_id": "5", "object_repr": "artical object (5)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 166, "fields": {"action_time": "2021-11-10T09:44:11.471Z", "user": 1, "content_type": 13, "object_id": "3", "object_repr": "artical object (3)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 167, "fields": {"action_time": "2021-11-10T09:44:11.603Z", "user": 1, "content_type": 13, "object_id": "2", "object_repr": "artical object (2)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 168, "fields": {"action_time": "2021-11-10T09:44:11.738Z", "user": 1, "content_type": 13, "object_id": "1", "object_repr": "artical object (1)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 169, "fields": {"action_time": "2021-11-10T10:02:18.603Z", "user": 1, "content_type": 13, "object_id": "78", "object_repr": "artical object (78)", "action_flag": 1, "change_message": "[{\"added\": {}}]"}}, {"model": "admin.logentry", "pk": 170, "fields": {"action_time": "2021-11-10T10:03:01.184Z", "user": 1, "content_type": 13, "object_id": "78", "object_repr": "artical object (78)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 171, "fields": {"action_time": "2021-11-10T10:29:09.451Z", "user": 1, "content_type": 13, "object_id": "77", "object_repr": "artical object (77)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 172, "fields": {"action_time": "2021-11-10T10:29:09.607Z", "user": 1, "content_type": 13, "object_id": "76", "object_repr": "artical object (76)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 173, "fields": {"action_time": "2021-11-10T10:29:09.810Z", "user": 1, "content_type": 13, "object_id": "75", "object_repr": "artical object (75)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 174, "fields": {"action_time": "2021-11-10T10:29:09.988Z", "user": 1, "content_type": 13, "object_id": "74", "object_repr": "artical object (74)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 175, "fields": {"action_time": "2021-11-10T10:29:10.162Z", "user": 1, "content_type": 13, "object_id": "73", "object_repr": "artical object (73)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 176, "fields": {"action_time": "2021-11-10T10:29:10.296Z", "user": 1, "content_type": 13, "object_id": "72", "object_repr": "artical object (72)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 177, "fields": {"action_time": "2021-11-10T10:29:10.453Z", "user": 1, "content_type": 13, "object_id": "71", "object_repr": "artical object (71)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 178, "fields": {"action_time": "2021-11-10T10:29:10.735Z", "user": 1, "content_type": 13, "object_id": "70", "object_repr": "artical object (70)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 179, "fields": {"action_time": "2021-11-10T10:29:10.862Z", "user": 1, "content_type": 13, "object_id": "69", "object_repr": "artical object (69)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 180, "fields": {"action_time": "2021-11-10T10:29:11.074Z", "user": 1, "content_type": 13, "object_id": "68", "object_repr": "artical object (68)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 181, "fields": {"action_time": "2021-11-10T10:29:11.310Z", "user": 1, "content_type": 13, "object_id": "67", "object_repr": "artical object (67)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 182, "fields": {"action_time": "2021-11-10T10:29:11.595Z", "user": 1, "content_type": 13, "object_id": "66", "object_repr": "artical object (66)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 183, "fields": {"action_time": "2021-11-10T10:29:11.758Z", "user": 1, "content_type": 13, "object_id": "65", "object_repr": "artical object (65)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 184, "fields": {"action_time": "2021-11-10T10:29:11.888Z", "user": 1, "content_type": 13, "object_id": "64", "object_repr": "artical object (64)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 185, "fields": {"action_time": "2021-11-10T10:29:12.113Z", "user": 1, "content_type": 13, "object_id": "63", "object_repr": "artical object (63)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 186, "fields": {"action_time": "2021-11-10T10:29:12.234Z", "user": 1, "content_type": 13, "object_id": "62", "object_repr": "artical object (62)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 187, "fields": {"action_time": "2021-11-10T10:29:12.364Z", "user": 1, "content_type": 13, "object_id": "61", "object_repr": "artical object (61)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 188, "fields": {"action_time": "2021-11-10T10:29:12.486Z", "user": 1, "content_type": 13, "object_id": "60", "object_repr": "artical object (60)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 189, "fields": {"action_time": "2021-11-10T10:29:12.629Z", "user": 1, "content_type": 13, "object_id": "59", "object_repr": "artical object (59)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 190, "fields": {"action_time": "2021-11-10T10:29:12.819Z", "user": 1, "content_type": 13, "object_id": "58", "object_repr": "artical object (58)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 191, "fields": {"action_time": "2021-11-10T10:29:12.963Z", "user": 1, "content_type": 13, "object_id": "57", "object_repr": "artical object (57)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 192, "fields": {"action_time": "2021-11-10T10:29:13.098Z", "user": 1, "content_type": 13, "object_id": "56", "object_repr": "artical object (56)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 193, "fields": {"action_time": "2021-11-10T10:29:13.295Z", "user": 1, "content_type": 13, "object_id": "55", "object_repr": "artical object (55)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 194, "fields": {"action_time": "2021-11-10T10:29:13.438Z", "user": 1, "content_type": 13, "object_id": "54", "object_repr": "artical object (54)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 195, "fields": {"action_time": "2021-11-10T10:29:13.616Z", "user": 1, "content_type": 13, "object_id": "53", "object_repr": "artical object (53)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 196, "fields": {"action_time": "2021-11-10T10:29:13.751Z", "user": 1, "content_type": 13, "object_id": "52", "object_repr": "artical object (52)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 197, "fields": {"action_time": "2021-11-10T10:29:13.865Z", "user": 1, "content_type": 13, "object_id": "51", "object_repr": "artical object (51)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 198, "fields": {"action_time": "2021-11-10T10:29:14.135Z", "user": 1, "content_type": 13, "object_id": "50", "object_repr": "artical object (50)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 199, "fields": {"action_time": "2021-11-10T10:29:14.409Z", "user": 1, "content_type": 13, "object_id": "49", "object_repr": "artical object (49)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 200, "fields": {"action_time": "2021-11-10T10:29:14.588Z", "user": 1, "content_type": 13, "object_id": "48", "object_repr": "artical object (48)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 201, "fields": {"action_time": "2021-11-10T10:29:14.764Z", "user": 1, "content_type": 13, "object_id": "47", "object_repr": "artical object (47)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 202, "fields": {"action_time": "2021-11-10T10:29:14.919Z", "user": 1, "content_type": 13, "object_id": "46", "object_repr": "artical object (46)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 203, "fields": {"action_time": "2021-11-10T10:29:15.077Z", "user": 1, "content_type": 13, "object_id": "45", "object_repr": "artical object (45)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 204, "fields": {"action_time": "2021-11-10T10:29:15.231Z", "user": 1, "content_type": 13, "object_id": "44", "object_repr": "artical object (44)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 205, "fields": {"action_time": "2021-11-10T10:29:15.411Z", "user": 1, "content_type": 13, "object_id": "43", "object_repr": "artical object (43)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 206, "fields": {"action_time": "2021-11-10T10:29:15.568Z", "user": 1, "content_type": 13, "object_id": "42", "object_repr": "artical object (42)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 207, "fields": {"action_time": "2021-11-10T10:29:15.697Z", "user": 1, "content_type": 13, "object_id": "41", "object_repr": "artical object (41)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 208, "fields": {"action_time": "2021-11-10T10:29:15.862Z", "user": 1, "content_type": 13, "object_id": "40", "object_repr": "artical object (40)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 209, "fields": {"action_time": "2021-11-10T10:29:16.006Z", "user": 1, "content_type": 13, "object_id": "39", "object_repr": "artical object (39)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 210, "fields": {"action_time": "2021-11-10T10:29:16.140Z", "user": 1, "content_type": 13, "object_id": "38", "object_repr": "artical object (38)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 211, "fields": {"action_time": "2021-11-10T10:29:16.306Z", "user": 1, "content_type": 13, "object_id": "37", "object_repr": "artical object (37)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 212, "fields": {"action_time": "2021-11-10T10:29:16.451Z", "user": 1, "content_type": 13, "object_id": "36", "object_repr": "artical object (36)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 213, "fields": {"action_time": "2021-11-10T10:29:16.596Z", "user": 1, "content_type": 13, "object_id": "35", "object_repr": "artical object (35)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 214, "fields": {"action_time": "2021-11-10T10:29:16.775Z", "user": 1, "content_type": 13, "object_id": "34", "object_repr": "artical object (34)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 215, "fields": {"action_time": "2021-11-10T10:29:16.940Z", "user": 1, "content_type": 13, "object_id": "33", "object_repr": "artical object (33)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 216, "fields": {"action_time": "2021-11-10T10:29:17.130Z", "user": 1, "content_type": 13, "object_id": "32", "object_repr": "artical object (32)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 217, "fields": {"action_time": "2021-11-10T10:29:17.307Z", "user": 1, "content_type": 13, "object_id": "31", "object_repr": "artical object (31)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 218, "fields": {"action_time": "2021-11-10T10:29:17.049Z", "user": 1, "content_type": 13, "object_id": "77", "object_repr": "artical object (77)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 219, "fields": {"action_time": "2021-11-10T10:29:17.640Z", "user": 1, "content_type": 13, "object_id": "76", "object_repr": "artical object (76)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 220, "fields": {"action_time": "2021-11-10T10:29:17.800Z", "user": 1, "content_type": 13, "object_id": "75", "object_repr": "artical object (75)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 221, "fields": {"action_time": "2021-11-10T10:29:17.986Z", "user": 1, "content_type": 13, "object_id": "74", "object_repr": "artical object (74)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 222, "fields": {"action_time": "2021-11-10T10:29:18.130Z", "user": 1, "content_type": 13, "object_id": "73", "object_repr": "artical object (73)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 223, "fields": {"action_time": "2021-11-10T10:29:18.274Z", "user": 1, "content_type": 13, "object_id": "72", "object_repr": "artical object (72)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 224, "fields": {"action_time": "2021-11-10T10:29:18.449Z", "user": 1, "content_type": 13, "object_id": "71", "object_repr": "artical object (71)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 225, "fields": {"action_time": "2021-11-10T10:29:18.641Z", "user": 1, "content_type": 13, "object_id": "70", "object_repr": "artical object (70)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 226, "fields": {"action_time": "2021-11-10T10:29:18.807Z", "user": 1, "content_type": 13, "object_id": "69", "object_repr": "artical object (69)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 227, "fields": {"action_time": "2021-11-10T10:29:18.996Z", "user": 1, "content_type": 13, "object_id": "68", "object_repr": "artical object (68)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 228, "fields": {"action_time": "2021-11-10T10:29:19.310Z", "user": 1, "content_type": 13, "object_id": "67", "object_repr": "artical object (67)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 229, "fields": {"action_time": "2021-11-10T10:29:19.497Z", "user": 1, "content_type": 13, "object_id": "66", "object_repr": "artical object (66)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 230, "fields": {"action_time": "2021-11-10T10:29:19.722Z", "user": 1, "content_type": 13, "object_id": "65", "object_repr": "artical object (65)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 231, "fields": {"action_time": "2021-11-10T10:29:19.942Z", "user": 1, "content_type": 13, "object_id": "64", "object_repr": "artical object (64)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 232, "fields": {"action_time": "2021-11-10T10:29:20.175Z", "user": 1, "content_type": 13, "object_id": "63", "object_repr": "artical object (63)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 233, "fields": {"action_time": "2021-11-10T10:29:20.308Z", "user": 1, "content_type": 13, "object_id": "62", "object_repr": "artical object (62)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 234, "fields": {"action_time": "2021-11-10T10:29:20.463Z", "user": 1, "content_type": 13, "object_id": "61", "object_repr": "artical object (61)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 235, "fields": {"action_time": "2021-11-10T10:29:20.595Z", "user": 1, "content_type": 13, "object_id": "60", "object_repr": "artical object (60)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 236, "fields": {"action_time": "2021-11-10T10:29:20.752Z", "user": 1, "content_type": 13, "object_id": "59", "object_repr": "artical object (59)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 237, "fields": {"action_time": "2021-11-10T10:29:20.909Z", "user": 1, "content_type": 13, "object_id": "58", "object_repr": "artical object (58)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 238, "fields": {"action_time": "2021-11-10T10:29:17.449Z", "user": 1, "content_type": 13, "object_id": "30", "object_repr": "artical object (30)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 239, "fields": {"action_time": "2021-11-10T10:29:21.220Z", "user": 1, "content_type": 13, "object_id": "29", "object_repr": "artical object (29)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 240, "fields": {"action_time": "2021-11-10T10:29:21.398Z", "user": 1, "content_type": 13, "object_id": "28", "object_repr": "artical object (28)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 241, "fields": {"action_time": "2021-11-10T10:29:21.586Z", "user": 1, "content_type": 13, "object_id": "27", "object_repr": "artical object (27)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 242, "fields": {"action_time": "2021-11-10T10:29:21.752Z", "user": 1, "content_type": 13, "object_id": "26", "object_repr": "artical object (26)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 243, "fields": {"action_time": "2021-11-10T10:29:21.886Z", "user": 1, "content_type": 13, "object_id": "25", "object_repr": "artical object (25)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 244, "fields": {"action_time": "2021-11-10T10:29:22.030Z", "user": 1, "content_type": 13, "object_id": "24", "object_repr": "artical object (24)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 245, "fields": {"action_time": "2021-11-10T10:29:22.163Z", "user": 1, "content_type": 13, "object_id": "23", "object_repr": "artical object (23)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 246, "fields": {"action_time": "2021-11-10T10:29:22.329Z", "user": 1, "content_type": 13, "object_id": "22", "object_repr": "artical object (22)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 247, "fields": {"action_time": "2021-11-10T10:29:22.485Z", "user": 1, "content_type": 13, "object_id": "21", "object_repr": "artical object (21)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 248, "fields": {"action_time": "2021-11-10T10:29:21.063Z", "user": 1, "content_type": 13, "object_id": "57", "object_repr": "artical object (57)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 249, "fields": {"action_time": "2021-11-10T10:29:23.087Z", "user": 1, "content_type": 13, "object_id": "56", "object_repr": "artical object (56)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 250, "fields": {"action_time": "2021-11-10T10:29:23.255Z", "user": 1, "content_type": 13, "object_id": "55", "object_repr": "artical object (55)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 251, "fields": {"action_time": "2021-11-10T10:29:23.386Z", "user": 1, "content_type": 13, "object_id": "54", "object_repr": "artical object (54)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 252, "fields": {"action_time": "2021-11-10T10:29:23.554Z", "user": 1, "content_type": 13, "object_id": "53", "object_repr": "artical object (53)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 253, "fields": {"action_time": "2021-11-10T10:29:23.685Z", "user": 1, "content_type": 13, "object_id": "52", "object_repr": "artical object (52)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 254, "fields": {"action_time": "2021-11-10T10:29:23.863Z", "user": 1, "content_type": 13, "object_id": "51", "object_repr": "artical object (51)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 255, "fields": {"action_time": "2021-11-10T10:29:23.995Z", "user": 1, "content_type": 13, "object_id": "50", "object_repr": "artical object (50)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 256, "fields": {"action_time": "2021-11-10T10:29:24.176Z", "user": 1, "content_type": 13, "object_id": "49", "object_repr": "artical object (49)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 257, "fields": {"action_time": "2021-11-10T10:29:24.398Z", "user": 1, "content_type": 13, "object_id": "48", "object_repr": "artical object (48)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 258, "fields": {"action_time": "2021-11-10T10:29:24.539Z", "user": 1, "content_type": 13, "object_id": "47", "object_repr": "artical object (47)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 259, "fields": {"action_time": "2021-11-10T10:29:24.698Z", "user": 1, "content_type": 13, "object_id": "46", "object_repr": "artical object (46)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 260, "fields": {"action_time": "2021-11-10T10:29:24.908Z", "user": 1, "content_type": 13, "object_id": "45", "object_repr": "artical object (45)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 261, "fields": {"action_time": "2021-11-10T10:29:25.164Z", "user": 1, "content_type": 13, "object_id": "44", "object_repr": "artical object (44)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 262, "fields": {"action_time": "2021-11-10T10:29:25.310Z", "user": 1, "content_type": 13, "object_id": "43", "object_repr": "artical object (43)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 263, "fields": {"action_time": "2021-11-10T10:29:25.555Z", "user": 1, "content_type": 13, "object_id": "42", "object_repr": "artical object (42)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 264, "fields": {"action_time": "2021-11-10T10:29:25.684Z", "user": 1, "content_type": 13, "object_id": "41", "object_repr": "artical object (41)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 265, "fields": {"action_time": "2021-11-10T10:29:25.840Z", "user": 1, "content_type": 13, "object_id": "40", "object_repr": "artical object (40)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 266, "fields": {"action_time": "2021-11-10T10:29:26.009Z", "user": 1, "content_type": 13, "object_id": "39", "object_repr": "artical object (39)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 267, "fields": {"action_time": "2021-11-10T10:29:26.164Z", "user": 1, "content_type": 13, "object_id": "38", "object_repr": "artical object (38)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 268, "fields": {"action_time": "2021-11-10T10:29:26.523Z", "user": 1, "content_type": 13, "object_id": "37", "object_repr": "artical object (37)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 269, "fields": {"action_time": "2021-11-10T10:29:26.687Z", "user": 1, "content_type": 13, "object_id": "36", "object_repr": "artical object (36)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 270, "fields": {"action_time": "2021-11-10T10:29:26.841Z", "user": 1, "content_type": 13, "object_id": "35", "object_repr": "artical object (35)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 271, "fields": {"action_time": "2021-11-10T10:29:26.973Z", "user": 1, "content_type": 13, "object_id": "34", "object_repr": "artical object (34)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 272, "fields": {"action_time": "2021-11-10T10:29:27.696Z", "user": 1, "content_type": 13, "object_id": "33", "object_repr": "artical object (33)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 273, "fields": {"action_time": "2021-11-10T10:29:27.842Z", "user": 1, "content_type": 13, "object_id": "32", "object_repr": "artical object (32)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 274, "fields": {"action_time": "2021-11-10T10:29:27.998Z", "user": 1, "content_type": 13, "object_id": "31", "object_repr": "artical object (31)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 275, "fields": {"action_time": "2021-11-10T10:29:28.175Z", "user": 1, "content_type": 13, "object_id": "30", "object_repr": "artical object (30)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 276, "fields": {"action_time": "2021-11-10T10:29:28.311Z", "user": 1, "content_type": 13, "object_id": "29", "object_repr": "artical object (29)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 277, "fields": {"action_time": "2021-11-10T10:29:28.499Z", "user": 1, "content_type": 13, "object_id": "28", "object_repr": "artical object (28)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 278, "fields": {"action_time": "2021-11-10T10:29:28.675Z", "user": 1, "content_type": 13, "object_id": "27", "object_repr": "artical object (27)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 279, "fields": {"action_time": "2021-11-10T10:29:28.810Z", "user": 1, "content_type": 13, "object_id": "26", "object_repr": "artical object (26)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 280, "fields": {"action_time": "2021-11-10T10:29:28.941Z", "user": 1, "content_type": 13, "object_id": "25", "object_repr": "artical object (25)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 281, "fields": {"action_time": "2021-11-10T10:29:29.075Z", "user": 1, "content_type": 13, "object_id": "24", "object_repr": "artical object (24)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 282, "fields": {"action_time": "2021-11-10T10:29:29.220Z", "user": 1, "content_type": 13, "object_id": "23", "object_repr": "artical object (23)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 283, "fields": {"action_time": "2021-11-10T10:29:29.386Z", "user": 1, "content_type": 13, "object_id": "22", "object_repr": "artical object (22)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 284, "fields": {"action_time": "2021-11-10T10:29:29.521Z", "user": 1, "content_type": 13, "object_id": "21", "object_repr": "artical object (21)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 285, "fields": {"action_time": "2021-11-10T10:30:34.603Z", "user": 1, "content_type": 11, "object_id": "6", "object_repr": "2021", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 286, "fields": {"action_time": "2021-11-10T10:30:34.758Z", "user": 1, "content_type": 11, "object_id": "5", "object_repr": "2020", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 287, "fields": {"action_time": "2021-11-10T10:30:34.892Z", "user": 1, "content_type": 11, "object_id": "4", "object_repr": "2019", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 288, "fields": {"action_time": "2021-11-10T10:30:35.025Z", "user": 1, "content_type": 11, "object_id": "3", "object_repr": "2018", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 289, "fields": {"action_time": "2021-11-10T10:30:35.157Z", "user": 1, "content_type": 11, "object_id": "2", "object_repr": "2017", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 290, "fields": {"action_time": "2021-11-10T10:30:35.347Z", "user": 1, "content_type": 11, "object_id": "1", "object_repr": "2016", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 291, "fields": {"action_time": "2021-11-10T10:30:43.727Z", "user": 1, "content_type": 10, "object_id": "5", "object_repr": "Vol 5", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 292, "fields": {"action_time": "2021-11-10T10:30:43.872Z", "user": 1, "content_type": 10, "object_id": "4", "object_repr": "Vol 4", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 293, "fields": {"action_time": "2021-11-10T10:30:44.004Z", "user": 1, "content_type": 10, "object_id": "3", "object_repr": "Vol 3", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 294, "fields": {"action_time": "2021-11-10T10:30:44.137Z", "user": 1, "content_type": 10, "object_id": "2", "object_repr": "Vol 2", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 295, "fields": {"action_time": "2021-11-10T10:30:44.259Z", "user": 1, "content_type": 10, "object_id": "1", "object_repr": "Vol 1", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 296, "fields": {"action_time": "2021-11-10T10:34:11.049Z", "user": 1, "content_type": 10, "object_id": "5", "object_repr": "Vol 5", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 297, "fields": {"action_time": "2021-11-10T10:34:11.233Z", "user": 1, "content_type": 10, "object_id": "4", "object_repr": "Vol 4", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 298, "fields": {"action_time": "2021-11-10T10:34:11.380Z", "user": 1, "content_type": 10, "object_id": "2", "object_repr": "Vol 2", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 299, "fields": {"action_time": "2021-11-10T10:34:11.531Z", "user": 1, "content_type": 10, "object_id": "1", "object_repr": "Vol 1", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 300, "fields": {"action_time": "2021-11-10T10:35:05.742Z", "user": 1, "content_type": 13, "object_id": "133", "object_repr": "artical object (133)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 301, "fields": {"action_time": "2021-11-10T10:35:05.870Z", "user": 1, "content_type": 13, "object_id": "132", "object_repr": "artical object (132)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 302, "fields": {"action_time": "2021-11-10T10:35:06.025Z", "user": 1, "content_type": 13, "object_id": "131", "object_repr": "artical object (131)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 303, "fields": {"action_time": "2021-11-10T10:35:06.148Z", "user": 1, "content_type": 13, "object_id": "130", "object_repr": "artical object (130)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 304, "fields": {"action_time": "2021-11-10T10:35:06.281Z", "user": 1, "content_type": 13, "object_id": "129", "object_repr": "artical object (129)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 305, "fields": {"action_time": "2021-11-10T10:35:06.393Z", "user": 1, "content_type": 13, "object_id": "128", "object_repr": "artical object (128)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 306, "fields": {"action_time": "2021-11-10T10:35:06.526Z", "user": 1, "content_type": 13, "object_id": "127", "object_repr": "artical object (127)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 307, "fields": {"action_time": "2021-11-10T10:35:06.659Z", "user": 1, "content_type": 13, "object_id": "126", "object_repr": "artical object (126)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 308, "fields": {"action_time": "2021-11-10T10:35:06.792Z", "user": 1, "content_type": 13, "object_id": "125", "object_repr": "artical object (125)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 309, "fields": {"action_time": "2021-11-10T10:35:06.952Z", "user": 1, "content_type": 13, "object_id": "124", "object_repr": "artical object (124)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 310, "fields": {"action_time": "2021-11-10T10:35:07.185Z", "user": 1, "content_type": 13, "object_id": "123", "object_repr": "artical object (123)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 311, "fields": {"action_time": "2021-11-10T10:35:07.336Z", "user": 1, "content_type": 13, "object_id": "122", "object_repr": "artical object (122)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 312, "fields": {"action_time": "2021-11-10T10:35:07.471Z", "user": 1, "content_type": 13, "object_id": "121", "object_repr": "artical object (121)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 313, "fields": {"action_time": "2021-11-10T10:35:07.737Z", "user": 1, "content_type": 13, "object_id": "120", "object_repr": "artical object (120)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 314, "fields": {"action_time": "2021-11-10T10:35:07.981Z", "user": 1, "content_type": 13, "object_id": "119", "object_repr": "artical object (119)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 315, "fields": {"action_time": "2021-11-10T10:35:08.193Z", "user": 1, "content_type": 13, "object_id": "118", "object_repr": "artical object (118)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 316, "fields": {"action_time": "2021-11-10T10:35:08.405Z", "user": 1, "content_type": 13, "object_id": "117", "object_repr": "artical object (117)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 317, "fields": {"action_time": "2021-11-10T10:35:08.536Z", "user": 1, "content_type": 13, "object_id": "116", "object_repr": "artical object (116)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 318, "fields": {"action_time": "2021-11-10T10:35:08.670Z", "user": 1, "content_type": 13, "object_id": "115", "object_repr": "artical object (115)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 319, "fields": {"action_time": "2021-11-10T10:35:08.814Z", "user": 1, "content_type": 13, "object_id": "114", "object_repr": "artical object (114)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 320, "fields": {"action_time": "2021-11-10T10:35:08.937Z", "user": 1, "content_type": 13, "object_id": "113", "object_repr": "artical object (113)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 321, "fields": {"action_time": "2021-11-10T10:35:09.070Z", "user": 1, "content_type": 13, "object_id": "112", "object_repr": "artical object (112)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 322, "fields": {"action_time": "2021-11-10T10:35:09.206Z", "user": 1, "content_type": 13, "object_id": "111", "object_repr": "artical object (111)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 323, "fields": {"action_time": "2021-11-10T10:35:09.379Z", "user": 1, "content_type": 13, "object_id": "110", "object_repr": "artical object (110)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 324, "fields": {"action_time": "2021-11-10T10:35:09.523Z", "user": 1, "content_type": 13, "object_id": "109", "object_repr": "artical object (109)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 325, "fields": {"action_time": "2021-11-10T10:35:09.647Z", "user": 1, "content_type": 13, "object_id": "108", "object_repr": "artical object (108)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 326, "fields": {"action_time": "2021-11-10T10:35:09.770Z", "user": 1, "content_type": 13, "object_id": "107", "object_repr": "artical object (107)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 327, "fields": {"action_time": "2021-11-10T10:35:09.914Z", "user": 1, "content_type": 13, "object_id": "106", "object_repr": "artical object (106)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 328, "fields": {"action_time": "2021-11-10T10:35:10.024Z", "user": 1, "content_type": 13, "object_id": "105", "object_repr": "artical object (105)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 329, "fields": {"action_time": "2021-11-10T10:35:10.192Z", "user": 1, "content_type": 13, "object_id": "104", "object_repr": "artical object (104)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 330, "fields": {"action_time": "2021-11-10T10:35:10.314Z", "user": 1, "content_type": 13, "object_id": "103", "object_repr": "artical object (103)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 331, "fields": {"action_time": "2021-11-10T10:35:10.437Z", "user": 1, "content_type": 13, "object_id": "102", "object_repr": "artical object (102)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 332, "fields": {"action_time": "2021-11-10T10:35:10.606Z", "user": 1, "content_type": 13, "object_id": "101", "object_repr": "artical object (101)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 333, "fields": {"action_time": "2021-11-10T10:35:10.759Z", "user": 1, "content_type": 13, "object_id": "100", "object_repr": "artical object (100)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 334, "fields": {"action_time": "2021-11-10T10:35:10.892Z", "user": 1, "content_type": 13, "object_id": "99", "object_repr": "artical object (99)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 335, "fields": {"action_time": "2021-11-10T10:35:11.013Z", "user": 1, "content_type": 13, "object_id": "98", "object_repr": "artical object (98)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 336, "fields": {"action_time": "2021-11-10T10:35:11.158Z", "user": 1, "content_type": 13, "object_id": "97", "object_repr": "artical object (97)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 337, "fields": {"action_time": "2021-11-10T10:35:11.292Z", "user": 1, "content_type": 13, "object_id": "96", "object_repr": "artical object (96)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 338, "fields": {"action_time": "2021-11-10T10:35:11.436Z", "user": 1, "content_type": 13, "object_id": "95", "object_repr": "artical object (95)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 339, "fields": {"action_time": "2021-11-10T10:35:11.581Z", "user": 1, "content_type": 13, "object_id": "94", "object_repr": "artical object (94)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 340, "fields": {"action_time": "2021-11-10T10:35:11.714Z", "user": 1, "content_type": 13, "object_id": "93", "object_repr": "artical object (93)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 341, "fields": {"action_time": "2021-11-10T10:35:12.120Z", "user": 1, "content_type": 13, "object_id": "92", "object_repr": "artical object (92)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 342, "fields": {"action_time": "2021-11-10T10:35:12.596Z", "user": 1, "content_type": 13, "object_id": "91", "object_repr": "artical object (91)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 343, "fields": {"action_time": "2021-11-10T10:35:12.886Z", "user": 1, "content_type": 13, "object_id": "90", "object_repr": "artical object (90)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 344, "fields": {"action_time": "2021-11-10T10:35:13.015Z", "user": 1, "content_type": 13, "object_id": "89", "object_repr": "artical object (89)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 345, "fields": {"action_time": "2021-11-10T10:35:13.354Z", "user": 1, "content_type": 13, "object_id": "88", "object_repr": "artical object (88)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 346, "fields": {"action_time": "2021-11-10T10:35:13.519Z", "user": 1, "content_type": 13, "object_id": "87", "object_repr": "artical object (87)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 347, "fields": {"action_time": "2021-11-10T10:35:13.648Z", "user": 1, "content_type": 13, "object_id": "86", "object_repr": "artical object (86)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 348, "fields": {"action_time": "2021-11-10T10:35:13.854Z", "user": 1, "content_type": 13, "object_id": "85", "object_repr": "artical object (85)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 349, "fields": {"action_time": "2021-11-10T10:35:14.062Z", "user": 1, "content_type": 13, "object_id": "84", "object_repr": "artical object (84)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 350, "fields": {"action_time": "2021-11-10T10:35:14.231Z", "user": 1, "content_type": 13, "object_id": "83", "object_repr": "artical object (83)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 351, "fields": {"action_time": "2021-11-10T10:35:14.406Z", "user": 1, "content_type": 13, "object_id": "82", "object_repr": "artical object (82)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 352, "fields": {"action_time": "2021-11-10T10:35:14.569Z", "user": 1, "content_type": 13, "object_id": "81", "object_repr": "artical object (81)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 353, "fields": {"action_time": "2021-11-10T10:35:14.727Z", "user": 1, "content_type": 13, "object_id": "80", "object_repr": "artical object (80)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 354, "fields": {"action_time": "2021-11-10T10:35:14.861Z", "user": 1, "content_type": 13, "object_id": "79", "object_repr": "artical object (79)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 355, "fields": {"action_time": "2021-11-10T10:37:38.338Z", "user": 1, "content_type": 11, "object_id": "10", "object_repr": "2021", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 356, "fields": {"action_time": "2021-11-10T10:37:38.514Z", "user": 1, "content_type": 11, "object_id": "9", "object_repr": "2020", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 357, "fields": {"action_time": "2021-11-10T10:37:38.649Z", "user": 1, "content_type": 11, "object_id": "8", "object_repr": "2018", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 358, "fields": {"action_time": "2021-11-10T10:37:38.794Z", "user": 1, "content_type": 11, "object_id": "7", "object_repr": "2017", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 359, "fields": {"action_time": "2021-11-10T10:39:19.052Z", "user": 1, "content_type": 13, "object_id": "188", "object_repr": "artical object (188)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 360, "fields": {"action_time": "2021-11-10T10:39:19.206Z", "user": 1, "content_type": 13, "object_id": "187", "object_repr": "artical object (187)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 361, "fields": {"action_time": "2021-11-10T10:39:19.357Z", "user": 1, "content_type": 13, "object_id": "186", "object_repr": "artical object (186)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 362, "fields": {"action_time": "2021-11-10T10:39:19.503Z", "user": 1, "content_type": 13, "object_id": "185", "object_repr": "artical object (185)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 363, "fields": {"action_time": "2021-11-10T10:39:19.657Z", "user": 1, "content_type": 13, "object_id": "184", "object_repr": "artical object (184)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 364, "fields": {"action_time": "2021-11-10T10:39:19.792Z", "user": 1, "content_type": 13, "object_id": "183", "object_repr": "artical object (183)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 365, "fields": {"action_time": "2021-11-10T10:39:19.925Z", "user": 1, "content_type": 13, "object_id": "182", "object_repr": "artical object (182)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 366, "fields": {"action_time": "2021-11-10T10:39:20.081Z", "user": 1, "content_type": 13, "object_id": "181", "object_repr": "artical object (181)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 367, "fields": {"action_time": "2021-11-10T10:39:20.233Z", "user": 1, "content_type": 13, "object_id": "180", "object_repr": "artical object (180)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 368, "fields": {"action_time": "2021-11-10T10:39:20.391Z", "user": 1, "content_type": 13, "object_id": "179", "object_repr": "artical object (179)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 369, "fields": {"action_time": "2021-11-10T10:39:20.536Z", "user": 1, "content_type": 13, "object_id": "178", "object_repr": "artical object (178)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 370, "fields": {"action_time": "2021-11-10T10:39:20.791Z", "user": 1, "content_type": 13, "object_id": "177", "object_repr": "artical object (177)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 371, "fields": {"action_time": "2021-11-10T10:39:20.913Z", "user": 1, "content_type": 13, "object_id": "176", "object_repr": "artical object (176)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 372, "fields": {"action_time": "2021-11-10T10:39:21.082Z", "user": 1, "content_type": 13, "object_id": "175", "object_repr": "artical object (175)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 373, "fields": {"action_time": "2021-11-10T10:39:21.250Z", "user": 1, "content_type": 13, "object_id": "174", "object_repr": "artical object (174)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 374, "fields": {"action_time": "2021-11-10T10:39:21.393Z", "user": 1, "content_type": 13, "object_id": "173", "object_repr": "artical object (173)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 375, "fields": {"action_time": "2021-11-10T10:39:21.581Z", "user": 1, "content_type": 13, "object_id": "172", "object_repr": "artical object (172)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 376, "fields": {"action_time": "2021-11-10T10:39:21.758Z", "user": 1, "content_type": 13, "object_id": "171", "object_repr": "artical object (171)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 377, "fields": {"action_time": "2021-11-10T10:39:21.892Z", "user": 1, "content_type": 13, "object_id": "170", "object_repr": "artical object (170)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 378, "fields": {"action_time": "2021-11-10T10:39:22.026Z", "user": 1, "content_type": 13, "object_id": "169", "object_repr": "artical object (169)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 379, "fields": {"action_time": "2021-11-10T10:39:22.159Z", "user": 1, "content_type": 13, "object_id": "168", "object_repr": "artical object (168)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 380, "fields": {"action_time": "2021-11-10T10:39:22.313Z", "user": 1, "content_type": 13, "object_id": "167", "object_repr": "artical object (167)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 381, "fields": {"action_time": "2021-11-10T10:39:22.446Z", "user": 1, "content_type": 13, "object_id": "166", "object_repr": "artical object (166)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 382, "fields": {"action_time": "2021-11-10T10:39:22.569Z", "user": 1, "content_type": 13, "object_id": "165", "object_repr": "artical object (165)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 383, "fields": {"action_time": "2021-11-10T10:39:22.702Z", "user": 1, "content_type": 13, "object_id": "164", "object_repr": "artical object (164)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 384, "fields": {"action_time": "2021-11-10T10:39:22.847Z", "user": 1, "content_type": 13, "object_id": "163", "object_repr": "artical object (163)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 385, "fields": {"action_time": "2021-11-10T10:39:22.991Z", "user": 1, "content_type": 13, "object_id": "162", "object_repr": "artical object (162)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 386, "fields": {"action_time": "2021-11-10T10:39:23.124Z", "user": 1, "content_type": 13, "object_id": "161", "object_repr": "artical object (161)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 387, "fields": {"action_time": "2021-11-10T10:39:23.269Z", "user": 1, "content_type": 13, "object_id": "160", "object_repr": "artical object (160)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 388, "fields": {"action_time": "2021-11-10T10:39:23.567Z", "user": 1, "content_type": 13, "object_id": "159", "object_repr": "artical object (159)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 389, "fields": {"action_time": "2021-11-10T10:39:23.739Z", "user": 1, "content_type": 13, "object_id": "158", "object_repr": "artical object (158)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 390, "fields": {"action_time": "2021-11-10T10:39:23.928Z", "user": 1, "content_type": 13, "object_id": "157", "object_repr": "artical object (157)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 391, "fields": {"action_time": "2021-11-10T10:39:24.057Z", "user": 1, "content_type": 13, "object_id": "156", "object_repr": "artical object (156)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 392, "fields": {"action_time": "2021-11-10T10:39:24.225Z", "user": 1, "content_type": 13, "object_id": "155", "object_repr": "artical object (155)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 393, "fields": {"action_time": "2021-11-10T10:39:24.389Z", "user": 1, "content_type": 13, "object_id": "154", "object_repr": "artical object (154)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 394, "fields": {"action_time": "2021-11-10T10:39:24.537Z", "user": 1, "content_type": 13, "object_id": "153", "object_repr": "artical object (153)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 395, "fields": {"action_time": "2021-11-10T10:39:24.683Z", "user": 1, "content_type": 13, "object_id": "152", "object_repr": "artical object (152)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 396, "fields": {"action_time": "2021-11-10T10:39:24.849Z", "user": 1, "content_type": 13, "object_id": "151", "object_repr": "artical object (151)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 397, "fields": {"action_time": "2021-11-10T10:39:25.003Z", "user": 1, "content_type": 13, "object_id": "150", "object_repr": "artical object (150)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 398, "fields": {"action_time": "2021-11-10T10:39:25.147Z", "user": 1, "content_type": 13, "object_id": "149", "object_repr": "artical object (149)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 399, "fields": {"action_time": "2021-11-10T10:39:25.283Z", "user": 1, "content_type": 13, "object_id": "148", "object_repr": "artical object (148)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 400, "fields": {"action_time": "2021-11-10T10:39:25.728Z", "user": 1, "content_type": 13, "object_id": "147", "object_repr": "artical object (147)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 401, "fields": {"action_time": "2021-11-10T10:39:25.903Z", "user": 1, "content_type": 13, "object_id": "146", "object_repr": "artical object (146)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 402, "fields": {"action_time": "2021-11-10T10:39:26.289Z", "user": 1, "content_type": 13, "object_id": "145", "object_repr": "artical object (145)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 403, "fields": {"action_time": "2021-11-10T10:39:26.521Z", "user": 1, "content_type": 13, "object_id": "144", "object_repr": "artical object (144)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 404, "fields": {"action_time": "2021-11-10T10:39:26.711Z", "user": 1, "content_type": 13, "object_id": "143", "object_repr": "artical object (143)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 405, "fields": {"action_time": "2021-11-10T10:39:26.908Z", "user": 1, "content_type": 13, "object_id": "142", "object_repr": "artical object (142)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 406, "fields": {"action_time": "2021-11-10T10:39:27.062Z", "user": 1, "content_type": 13, "object_id": "141", "object_repr": "artical object (141)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 407, "fields": {"action_time": "2021-11-10T10:39:27.207Z", "user": 1, "content_type": 13, "object_id": "140", "object_repr": "artical object (140)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 408, "fields": {"action_time": "2021-11-10T10:39:27.355Z", "user": 1, "content_type": 13, "object_id": "139", "object_repr": "artical object (139)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 409, "fields": {"action_time": "2021-11-10T10:39:27.536Z", "user": 1, "content_type": 13, "object_id": "138", "object_repr": "artical object (138)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 410, "fields": {"action_time": "2021-11-10T10:39:27.693Z", "user": 1, "content_type": 13, "object_id": "137", "object_repr": "artical object (137)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 411, "fields": {"action_time": "2021-11-10T10:39:27.864Z", "user": 1, "content_type": 13, "object_id": "136", "object_repr": "artical object (136)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 412, "fields": {"action_time": "2021-11-10T10:39:28.018Z", "user": 1, "content_type": 13, "object_id": "135", "object_repr": "artical object (135)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 413, "fields": {"action_time": "2021-11-10T10:39:28.172Z", "user": 1, "content_type": 13, "object_id": "134", "object_repr": "artical object (134)", "action_flag": 3, "change_message": ""}}, {"model": "admin.logentry", "pk": 414, "fields": {"action_time": "2021-11-10T11:00:48.270Z", "user": 1, "content_type": 13, "object_id": "25", "object_repr": "artical object (25)", "action_flag": 2, "change_message": "[{\"changed\": {\"fields\": [\"Authors\", \"Otherauthors\", \"Abstract\", \"Keywords\", \"Do\", \"References\"]}}]"}}, {"model": "admin.logentry", "pk": 415, "fields": {"action_time": "2021-11-10T11:07:43.273Z", "user": 1, "content_type": 17, "object_id": "3", "object_repr": "Faizan Ali (Head of Training, Senior Scientis )", "action_flag": 2, "change_message": "[]"}}, {"model": "auth.permission", "pk": 1, "fields": {"name": "Can add log entry", "content_type": 1, "codename": "add_logentry"}}, {"model": "auth.permission", "pk": 2, "fields": {"name": "Can change log entry", "content_type": 1, "codename": "change_logentry"}}, {"model": "auth.permission", "pk": 3, "fields": {"name": "Can delete log entry", "content_type": 1, "codename": "delete_logentry"}}, {"model": "auth.permission", "pk": 4, "fields": {"name": "Can view log entry", "content_type": 1, "codename": "view_logentry"}}, {"model": "auth.permission", "pk": 5, "fields": {"name": "Can add permission", "content_type": 2, "codename": "add_permission"}}, {"model": "auth.permission", "pk": 6, "fields": {"name": "Can change permission", "content_type": 2, "codename": "change_permission"}}, {"model": "auth.permission", "pk": 7, "fields": {"name": "Can delete permission", "content_type": 2, "codename": "delete_permission"}}, {"model": "auth.permission", "pk": 8, "fields": {"name": "Can view permission", "content_type": 2, "codename": "view_permission"}}, {"model": "auth.permission", "pk": 9, "fields": {"name": "Can add group", "content_type": 3, "codename": "add_group"}}, {"model": "auth.permission", "pk": 10, "fields": {"name": "Can change group", "content_type": 3, "codename": "change_group"}}, {"model": "auth.permission", "pk": 11, "fields": {"name": "Can delete group", "content_type": 3, "codename": "delete_group"}}, {"model": "auth.permission", "pk": 12, "fields": {"name": "Can view group", "content_type": 3, "codename": "view_group"}}, {"model": "auth.permission", "pk": 13, "fields": {"name": "Can add user", "content_type": 4, "codename": "add_user"}}, {"model": "auth.permission", "pk": 14, "fields": {"name": "Can change user", "content_type": 4, "codename": "change_user"}}, {"model": "auth.permission", "pk": 15, "fields": {"name": "Can delete user", "content_type": 4, "codename": "delete_user"}}, {"model": "auth.permission", "pk": 16, "fields": {"name": "Can view user", "content_type": 4, "codename": "view_user"}}, {"model": "auth.permission", "pk": 17, "fields": {"name": "Can add content type", "content_type": 5, "codename": "add_contenttype"}}, {"model": "auth.permission", "pk": 18, "fields": {"name": "Can change content type", "content_type": 5, "codename": "change_contenttype"}}, {"model": "auth.permission", "pk": 19, "fields": {"name": "Can delete content type", "content_type": 5, "codename": "delete_contenttype"}}, {"model": "auth.permission", "pk": 20, "fields": {"name": "Can view content type", "content_type": 5, "codename": "view_contenttype"}}, {"model": "auth.permission", "pk": 21, "fields": {"name": "Can add session", "content_type": 6, "codename": "add_session"}}, {"model": "auth.permission", "pk": 22, "fields": {"name": "Can change session", "content_type": 6, "codename": "change_session"}}, {"model": "auth.permission", "pk": 23, "fields": {"name": "Can delete session", "content_type": 6, "codename": "delete_session"}}, {"model": "auth.permission", "pk": 24, "fields": {"name": "Can view session", "content_type": 6, "codename": "view_session"}}, {"model": "auth.permission", "pk": 25, "fields": {"name": "Can add blogs", "content_type": 7, "codename": "add_blogs"}}, {"model": "auth.permission", "pk": 26, "fields": {"name": "Can change blogs", "content_type": 7, "codename": "change_blogs"}}, {"model": "auth.permission", "pk": 27, "fields": {"name": "Can delete blogs", "content_type": 7, "codename": "delete_blogs"}}, {"model": "auth.permission", "pk": 28, "fields": {"name": "Can view blogs", "content_type": 7, "codename": "view_blogs"}}, {"model": "auth.permission", "pk": 29, "fields": {"name": "Can add submenuscripts", "content_type": 8, "codename": "add_submenuscripts"}}, {"model": "auth.permission", "pk": 30, "fields": {"name": "Can change submenuscripts", "content_type": 8, "codename": "change_submenuscripts"}}, {"model": "auth.permission", "pk": 31, "fields": {"name": "Can delete submenuscripts", "content_type": 8, "codename": "delete_submenuscripts"}}, {"model": "auth.permission", "pk": 32, "fields": {"name": "Can view submenuscripts", "content_type": 8, "codename": "view_submenuscripts"}}, {"model": "auth.permission", "pk": 33, "fields": {"name": "Can add issue", "content_type": 9, "codename": "add_issue"}}, {"model": "auth.permission", "pk": 34, "fields": {"name": "Can change issue", "content_type": 9, "codename": "change_issue"}}, {"model": "auth.permission", "pk": 35, "fields": {"name": "Can delete issue", "content_type": 9, "codename": "delete_issue"}}, {"model": "auth.permission", "pk": 36, "fields": {"name": "Can view issue", "content_type": 9, "codename": "view_issue"}}, {"model": "auth.permission", "pk": 37, "fields": {"name": "Can add vol", "content_type": 10, "codename": "add_vol"}}, {"model": "auth.permission", "pk": 38, "fields": {"name": "Can change vol", "content_type": 10, "codename": "change_vol"}}, {"model": "auth.permission", "pk": 39, "fields": {"name": "Can delete vol", "content_type": 10, "codename": "delete_vol"}}, {"model": "auth.permission", "pk": 40, "fields": {"name": "Can view vol", "content_type": 10, "codename": "view_vol"}}, {"model": "auth.permission", "pk": 41, "fields": {"name": "Can add year", "content_type": 11, "codename": "add_year"}}, {"model": "auth.permission", "pk": 42, "fields": {"name": "Can change year", "content_type": 11, "codename": "change_year"}}, {"model": "auth.permission", "pk": 43, "fields": {"name": "Can delete year", "content_type": 11, "codename": "delete_year"}}, {"model": "auth.permission", "pk": 44, "fields": {"name": "Can view year", "content_type": 11, "codename": "view_year"}}, {"model": "auth.permission", "pk": 45, "fields": {"name": "Can add authors", "content_type": 12, "codename": "add_authors"}}, {"model": "auth.permission", "pk": 46, "fields": {"name": "Can change authors", "content_type": 12, "codename": "change_authors"}}, {"model": "auth.permission", "pk": 47, "fields": {"name": "Can delete authors", "content_type": 12, "codename": "delete_authors"}}, {"model": "auth.permission", "pk": 48, "fields": {"name": "Can view authors", "content_type": 12, "codename": "view_authors"}}, {"model": "auth.permission", "pk": 49, "fields": {"name": "Can add artical", "content_type": 13, "codename": "add_artical"}}, {"model": "auth.permission", "pk": 50, "fields": {"name": "Can change artical", "content_type": 13, "codename": "change_artical"}}, {"model": "auth.permission", "pk": 51, "fields": {"name": "Can delete artical", "content_type": 13, "codename": "delete_artical"}}, {"model": "auth.permission", "pk": 52, "fields": {"name": "Can view artical", "content_type": 13, "codename": "view_artical"}}, {"model": "auth.permission", "pk": 53, "fields": {"name": "Can add wp_posts", "content_type": 14, "codename": "add_wp_posts"}}, {"model": "auth.permission", "pk": 54, "fields": {"name": "Can change wp_posts", "content_type": 14, "codename": "change_wp_posts"}}, {"model": "auth.permission", "pk": 55, "fields": {"name": "Can delete wp_posts", "content_type": 14, "codename": "delete_wp_posts"}}, {"model": "auth.permission", "pk": 56, "fields": {"name": "Can view wp_posts", "content_type": 14, "codename": "view_wp_posts"}}, {"model": "auth.permission", "pk": 57, "fields": {"name": "Can add contact us", "content_type": 15, "codename": "add_contactus"}}, {"model": "auth.permission", "pk": 58, "fields": {"name": "Can change contact us", "content_type": 15, "codename": "change_contactus"}}, {"model": "auth.permission", "pk": 59, "fields": {"name": "Can delete contact us", "content_type": 15, "codename": "delete_contactus"}}, {"model": "auth.permission", "pk": 60, "fields": {"name": "Can view contact us", "content_type": 15, "codename": "view_contactus"}}, {"model": "auth.permission", "pk": 61, "fields": {"name": "Can add comment", "content_type": 16, "codename": "add_comment"}}, {"model": "auth.permission", "pk": 62, "fields": {"name": "Can change comment", "content_type": 16, "codename": "change_comment"}}, {"model": "auth.permission", "pk": 63, "fields": {"name": "Can delete comment", "content_type": 16, "codename": "delete_comment"}}, {"model": "auth.permission", "pk": 64, "fields": {"name": "Can view comment", "content_type": 16, "codename": "view_comment"}}, {"model": "auth.permission", "pk": 65, "fields": {"name": "Can add team model", "content_type": 17, "codename": "add_teammodel"}}, {"model": "auth.permission", "pk": 66, "fields": {"name": "Can change team model", "content_type": 17, "codename": "change_teammodel"}}, {"model": "auth.permission", "pk": 67, "fields": {"name": "Can delete team model", "content_type": 17, "codename": "delete_teammodel"}}, {"model": "auth.permission", "pk": 68, "fields": {"name": "Can view team model", "content_type": 17, "codename": "view_teammodel"}}, {"model": "auth.permission", "pk": 69, "fields": {"name": "Can add category", "content_type": 18, "codename": "add_category"}}, {"model": "auth.permission", "pk": 70, "fields": {"name": "Can change category", "content_type": 18, "codename": "change_category"}}, {"model": "auth.permission", "pk": 71, "fields": {"name": "Can delete category", "content_type": 18, "codename": "delete_category"}}, {"model": "auth.permission", "pk": 72, "fields": {"name": "Can view category", "content_type": 18, "codename": "view_category"}}, {"model": "auth.permission", "pk": 73, "fields": {"name": "Can add research model", "content_type": 19, "codename": "add_researchmodel"}}, {"model": "auth.permission", "pk": 74, "fields": {"name": "Can change research model", "content_type": 19, "codename": "change_researchmodel"}}, {"model": "auth.permission", "pk": 75, "fields": {"name": "Can delete research model", "content_type": 19, "codename": "delete_researchmodel"}}, {"model": "auth.permission", "pk": 76, "fields": {"name": "Can view research model", "content_type": 19, "codename": "view_researchmodel"}}, {"model": "auth.permission", "pk": 77, "fields": {"name": "Can add services", "content_type": 20, "codename": "add_services"}}, {"model": "auth.permission", "pk": 78, "fields": {"name": "Can change services", "content_type": 20, "codename": "change_services"}}, {"model": "auth.permission", "pk": 79, "fields": {"name": "Can delete services", "content_type": 20, "codename": "delete_services"}}, {"model": "auth.permission", "pk": 80, "fields": {"name": "Can view services", "content_type": 20, "codename": "view_services"}}, {"model": "auth.permission", "pk": 81, "fields": {"name": "Can add faq", "content_type": 21, "codename": "add_faq"}}, {"model": "auth.permission", "pk": 82, "fields": {"name": "Can change faq", "content_type": 21, "codename": "change_faq"}}, {"model": "auth.permission", "pk": 83, "fields": {"name": "Can delete faq", "content_type": 21, "codename": "delete_faq"}}, {"model": "auth.permission", "pk": 84, "fields": {"name": "Can view faq", "content_type": 21, "codename": "view_faq"}}, {"model": "auth.permission", "pk": 85, "fields": {"name": "Can add process", "content_type": 22, "codename": "add_process"}}, {"model": "auth.permission", "pk": 86, "fields": {"name": "Can change process", "content_type": 22, "codename": "change_process"}}, {"model": "auth.permission", "pk": 87, "fields": {"name": "Can delete process", "content_type": 22, "codename": "delete_process"}}, {"model": "auth.permission", "pk": 88, "fields": {"name": "Can view process", "content_type": 22, "codename": "view_process"}}, {"model": "auth.permission", "pk": 89, "fields": {"name": "Can add category", "content_type": 23, "codename": "add_category"}}, {"model": "auth.permission", "pk": 90, "fields": {"name": "Can change category", "content_type": 23, "codename": "change_category"}}, {"model": "auth.permission", "pk": 91, "fields": {"name": "Can delete category", "content_type": 23, "codename": "delete_category"}}, {"model": "auth.permission", "pk": 92, "fields": {"name": "Can view category", "content_type": 23, "codename": "view_category"}}, {"model": "auth.permission", "pk": 93, "fields": {"name": "Can add services contact", "content_type": 24, "codename": "add_servicescontact"}}, {"model": "auth.permission", "pk": 94, "fields": {"name": "Can change services contact", "content_type": 24, "codename": "change_servicescontact"}}, {"model": "auth.permission", "pk": 95, "fields": {"name": "Can delete services contact", "content_type": 24, "codename": "delete_servicescontact"}}, {"model": "auth.permission", "pk": 96, "fields": {"name": "Can view services contact", "content_type": 24, "codename": "view_servicescontact"}}, {"model": "auth.permission", "pk": 97, "fields": {"name": "Can add subscriber", "content_type": 25, "codename": "add_subscriber"}}, {"model": "auth.permission", "pk": 98, "fields": {"name": "Can change subscriber", "content_type": 25, "codename": "change_subscriber"}}, {"model": "auth.permission", "pk": 99, "fields": {"name": "Can delete subscriber", "content_type": 25, "codename": "delete_subscriber"}}, {"model": "auth.permission", "pk": 100, "fields": {"name": "Can view subscriber", "content_type": 25, "codename": "view_subscriber"}}, {"model": "auth.permission", "pk": 101, "fields": {"name": "Can add about", "content_type": 26, "codename": "add_about"}}, {"model": "auth.permission", "pk": 102, "fields": {"name": "Can change about", "content_type": 26, "codename": "change_about"}}, {"model": "auth.permission", "pk": 103, "fields": {"name": "Can delete about", "content_type": 26, "codename": "delete_about"}}, {"model": "auth.permission", "pk": 104, "fields": {"name": "Can view about", "content_type": 26, "codename": "view_about"}}, {"model": "auth.permission", "pk": 105, "fields": {"name": "Can add instuctions to authors", "content_type": 27, "codename": "add_instuctionstoauthors"}}, {"model": "auth.permission", "pk": 106, "fields": {"name": "Can change instuctions to authors", "content_type": 27, "codename": "change_instuctionstoauthors"}}, {"model": "auth.permission", "pk": 107, "fields": {"name": "Can delete instuctions to authors", "content_type": 27, "codename": "delete_instuctionstoauthors"}}, {"model": "auth.permission", "pk": 108, "fields": {"name": "Can view instuctions to authors", "content_type": 27, "codename": "view_instuctionstoauthors"}}, {"model": "auth.permission", "pk": 109, "fields": {"name": "Can add auditorialboard model", "content_type": 28, "codename": "add_auditorialboardmodel"}}, {"model": "auth.permission", "pk": 110, "fields": {"name": "Can change auditorialboard model", "content_type": 28, "codename": "change_auditorialboardmodel"}}, {"model": "auth.permission", "pk": 111, "fields": {"name": "Can delete auditorialboard model", "content_type": 28, "codename": "delete_auditorialboardmodel"}}, {"model": "auth.permission", "pk": 112, "fields": {"name": "Can view auditorialboard model", "content_type": 28, "codename": "view_auditorialboardmodel"}}, {"model": "auth.permission", "pk": 113, "fields": {"name": "Can add auditorial board", "content_type": 28, "codename": "add_auditorialboard"}}, {"model": "auth.permission", "pk": 114, "fields": {"name": "Can change auditorial board", "content_type": 28, "codename": "change_auditorialboard"}}, {"model": "auth.permission", "pk": 115, "fields": {"name": "Can delete auditorial board", "content_type": 28, "codename": "delete_auditorialboard"}}, {"model": "auth.permission", "pk": 116, "fields": {"name": "Can view auditorial board", "content_type": 28, "codename": "view_auditorialboard"}}, {"model": "auth.permission", "pk": 117, "fields": {"name": "Can add submenuscripts", "content_type": 29, "codename": "add_submenuscripts"}}, {"model": "auth.permission", "pk": 118, "fields": {"name": "Can change submenuscripts", "content_type": 29, "codename": "change_submenuscripts"}}, {"model": "auth.permission", "pk": 119, "fields": {"name": "Can delete submenuscripts", "content_type": 29, "codename": "delete_submenuscripts"}}, {"model": "auth.permission", "pk": 120, "fields": {"name": "Can view submenuscripts", "content_type": 29, "codename": "view_submenuscripts"}}, {"model": "auth.permission", "pk": 121, "fields": {"name": "Can add authors", "content_type": 30, "codename": "add_authors"}}, {"model": "auth.permission", "pk": 122, "fields": {"name": "Can change authors", "content_type": 30, "codename": "change_authors"}}, {"model": "auth.permission", "pk": 123, "fields": {"name": "Can delete authors", "content_type": 30, "codename": "delete_authors"}}, {"model": "auth.permission", "pk": 124, "fields": {"name": "Can view authors", "content_type": 30, "codename": "view_authors"}}, {"model": "auth.permission", "pk": 125, "fields": {"name": "Can add year", "content_type": 31, "codename": "add_year"}}, {"model": "auth.permission", "pk": 126, "fields": {"name": "Can change year", "content_type": 31, "codename": "change_year"}}, {"model": "auth.permission", "pk": 127, "fields": {"name": "Can delete year", "content_type": 31, "codename": "delete_year"}}, {"model": "auth.permission", "pk": 128, "fields": {"name": "Can view year", "content_type": 31, "codename": "view_year"}}, {"model": "auth.permission", "pk": 129, "fields": {"name": "Can add vol", "content_type": 32, "codename": "add_vol"}}, {"model": "auth.permission", "pk": 130, "fields": {"name": "Can change vol", "content_type": 32, "codename": "change_vol"}}, {"model": "auth.permission", "pk": 131, "fields": {"name": "Can delete vol", "content_type": 32, "codename": "delete_vol"}}, {"model": "auth.permission", "pk": 132, "fields": {"name": "Can view vol", "content_type": 32, "codename": "view_vol"}}, {"model": "auth.permission", "pk": 133, "fields": {"name": "Can add issue", "content_type": 33, "codename": "add_issue"}}, {"model": "auth.permission", "pk": 134, "fields": {"name": "Can change issue", "content_type": 33, "codename": "change_issue"}}, {"model": "auth.permission", "pk": 135, "fields": {"name": "Can delete issue", "content_type": 33, "codename": "delete_issue"}}, {"model": "auth.permission", "pk": 136, "fields": {"name": "Can view issue", "content_type": 33, "codename": "view_issue"}}, {"model": "auth.permission", "pk": 137, "fields": {"name": "Can add artical", "content_type": 34, "codename": "add_artical"}}, {"model": "auth.permission", "pk": 138, "fields": {"name": "Can change artical", "content_type": 34, "codename": "change_artical"}}, {"model": "auth.permission", "pk": 139, "fields": {"name": "Can delete artical", "content_type": 34, "codename": "delete_artical"}}, {"model": "auth.permission", "pk": 140, "fields": {"name": "Can view artical", "content_type": 34, "codename": "view_artical"}}, {"model": "auth.permission", "pk": 141, "fields": {"name": "Can add home slider", "content_type": 35, "codename": "add_homeslider"}}, {"model": "auth.permission", "pk": 142, "fields": {"name": "Can change home slider", "content_type": 35, "codename": "change_homeslider"}}, {"model": "auth.permission", "pk": 143, "fields": {"name": "Can delete home slider", "content_type": 35, "codename": "delete_homeslider"}}, {"model": "auth.permission", "pk": 144, "fields": {"name": "Can view home slider", "content_type": 35, "codename": "view_homeslider"}}, {"model": "auth.permission", "pk": 145, "fields": {"name": "Can add certificates", "content_type": 36, "codename": "add_certificates"}}, {"model": "auth.permission", "pk": 146, "fields": {"name": "Can change certificates", "content_type": 36, "codename": "change_certificates"}}, {"model": "auth.permission", "pk": 147, "fields": {"name": "Can delete certificates", "content_type": 36, "codename": "delete_certificates"}}, {"model": "auth.permission", "pk": 148, "fields": {"name": "Can view certificates", "content_type": 36, "codename": "view_certificates"}}, {"model": "auth.permission", "pk": 149, "fields": {"name": "Can add blogviews", "content_type": 37, "codename": "add_blogviews"}}, {"model": "auth.permission", "pk": 150, "fields": {"name": "Can change blogviews", "content_type": 37, "codename": "change_blogviews"}}, {"model": "auth.permission", "pk": 151, "fields": {"name": "Can delete blogviews", "content_type": 37, "codename": "delete_blogviews"}}, {"model": "auth.permission", "pk": 152, "fields": {"name": "Can view blogviews", "content_type": 37, "codename": "view_blogviews"}}, {"model": "auth.permission", "pk": 153, "fields": {"name": "Can add downloadcount", "content_type": 38, "codename": "add_downloadcount"}}, {"model": "auth.permission", "pk": 154, "fields": {"name": "Can change downloadcount", "content_type": 38, "codename": "change_downloadcount"}}, {"model": "auth.permission", "pk": 155, "fields": {"name": "Can delete downloadcount", "content_type": 38, "codename": "delete_downloadcount"}}, {"model": "auth.permission", "pk": 156, "fields": {"name": "Can view downloadcount", "content_type": 38, "codename": "view_downloadcount"}}, {"model": "auth.permission", "pk": 157, "fields": {"name": "Can add abstrating and indexing", "content_type": 39, "codename": "add_abstratingandindexing"}}, {"model": "auth.permission", "pk": 158, "fields": {"name": "Can change abstrating and indexing", "content_type": 39, "codename": "change_abstratingandindexing"}}, {"model": "auth.permission", "pk": 159, "fields": {"name": "Can delete abstrating and indexing", "content_type": 39, "codename": "delete_abstratingandindexing"}}, {"model": "auth.permission", "pk": 160, "fields": {"name": "Can view abstrating and indexing", "content_type": 39, "codename": "view_abstratingandindexing"}}, {"model": "auth.permission", "pk": 161, "fields": {"name": "Can add email setup", "content_type": 40, "codename": "add_emailsetup"}}, {"model": "auth.permission", "pk": 162, "fields": {"name": "Can change email setup", "content_type": 40, "codename": "change_emailsetup"}}, {"model": "auth.permission", "pk": 163, "fields": {"name": "Can delete email setup", "content_type": 40, "codename": "delete_emailsetup"}}, {"model": "auth.permission", "pk": 164, "fields": {"name": "Can view email setup", "content_type": 40, "codename": "view_emailsetup"}}, {"model": "auth.permission", "pk": 165, "fields": {"name": "Can add nortification mail", "content_type": 41, "codename": "add_nortificationmail"}}, {"model": "auth.permission", "pk": 166, "fields": {"name": "Can change nortification mail", "content_type": 41, "codename": "change_nortificationmail"}}, {"model": "auth.permission", "pk": 167, "fields": {"name": "Can delete nortification mail", "content_type": 41, "codename": "delete_nortificationmail"}}, {"model": "auth.permission", "pk": 168, "fields": {"name": "Can view nortification mail", "content_type": 41, "codename": "view_nortificationmail"}}, {"model": "auth.permission", "pk": 169, "fields": {"name": "Can add about contace", "content_type": 42, "codename": "add_aboutcontace"}}, {"model": "auth.permission", "pk": 170, "fields": {"name": "Can change about contace", "content_type": 42, "codename": "change_aboutcontace"}}, {"model": "auth.permission", "pk": 171, "fields": {"name": "Can delete about contace", "content_type": 42, "codename": "delete_aboutcontace"}}, {"model": "auth.permission", "pk": 172, "fields": {"name": "Can view about contace", "content_type": 42, "codename": "view_aboutcontace"}}, {"model": "auth.permission", "pk": 173, "fields": {"name": "Can add about contact", "content_type": 42, "codename": "add_aboutcontact"}}, {"model": "auth.permission", "pk": 174, "fields": {"name": "Can change about contact", "content_type": 42, "codename": "change_aboutcontact"}}, {"model": "auth.permission", "pk": 175, "fields": {"name": "Can delete about contact", "content_type": 42, "codename": "delete_aboutcontact"}}, {"model": "auth.permission", "pk": 176, "fields": {"name": "Can view about contact", "content_type": 42, "codename": "view_aboutcontact"}}, {"model": "auth.permission", "pk": 177, "fields": {"name": "Can add about contact", "content_type": 43, "codename": "add_aboutcontact"}}, {"model": "auth.permission", "pk": 178, "fields": {"name": "Can change about contact", "content_type": 43, "codename": "change_aboutcontact"}}, {"model": "auth.permission", "pk": 179, "fields": {"name": "Can delete about contact", "content_type": 43, "codename": "delete_aboutcontact"}}, {"model": "auth.permission", "pk": 180, "fields": {"name": "Can view about contact", "content_type": 43, "codename": "view_aboutcontact"}}, {"model": "auth.user", "pk": 1, "fields": {"password": "pbkdf2_sha256$260000$iYxzdxwz8XM8H4JUCDE2XD$UiBYQbZbTyWavheUWIJ2cXaSNDZo5C7arrvVNns0aN8=", "last_login": "2021-12-10T11:11:22.995Z", "is_superuser": true, "username": "root", "first_name": "", "last_name": "", "email": "", "is_staff": true, "is_active": true, "date_joined": "2021-10-22T05:38:12.963Z", "groups": [], "user_permissions": []}}, {"model": "contenttypes.contenttype", "pk": 0, "fields": {"app_label": "about", "model": "openaccesspolicy"}}, {"model": "contenttypes.contenttype", "pk": 1, "fields": {"app_label": "admin", "model": "logentry"}}, {"model": "contenttypes.contenttype", "pk": 2, "fields": {"app_label": "auth", "model": "permission"}}, {"model": "contenttypes.contenttype", "pk": 3, "fields": {"app_label": "auth", "model": "group"}}, {"model": "contenttypes.contenttype", "pk": 4, "fields": {"app_label": "auth", "model": "user"}}, {"model": "contenttypes.contenttype", "pk": 5, "fields": {"app_label": "contenttypes", "model": "contenttype"}}, {"model": "contenttypes.contenttype", "pk": 6, "fields": {"app_label": "sessions", "model": "session"}}, {"model": "contenttypes.contenttype", "pk": 7, "fields": {"app_label": "blogs", "model": "blogs"}}, {"model": "contenttypes.contenttype", "pk": 8, "fields": {"app_label": "article", "model": "submenuscripts"}}, {"model": "contenttypes.contenttype", "pk": 9, "fields": {"app_label": "article", "model": "issue"}}, {"model": "contenttypes.contenttype", "pk": 10, "fields": {"app_label": "article", "model": "vol"}}, {"model": "contenttypes.contenttype", "pk": 11, "fields": {"app_label": "article", "model": "year"}}, {"model": "contenttypes.contenttype", "pk": 12, "fields": {"app_label": "article", "model": "authors"}}, {"model": "contenttypes.contenttype", "pk": 13, "fields": {"app_label": "article", "model": "artical"}}, {"model": "contenttypes.contenttype", "pk": 14, "fields": {"app_label": "article", "model": "wp_posts"}}, {"model": "contenttypes.contenttype", "pk": 15, "fields": {"app_label": "about", "model": "contactus"}}, {"model": "contenttypes.contenttype", "pk": 16, "fields": {"app_label": "blogs", "model": "comment"}}, {"model": "contenttypes.contenttype", "pk": 17, "fields": {"app_label": "team", "model": "teammodel"}}, {"model": "contenttypes.contenttype", "pk": 18, "fields": {"app_label": "research", "model": "category"}}, {"model": "contenttypes.contenttype", "pk": 19, "fields": {"app_label": "research", "model": "researchmodel"}}, {"model": "contenttypes.contenttype", "pk": 20, "fields": {"app_label": "services", "model": "services"}}, {"model": "contenttypes.contenttype", "pk": 21, "fields": {"app_label": "services", "model": "faq"}}, {"model": "contenttypes.contenttype", "pk": 22, "fields": {"app_label": "research", "model": "process"}}, {"model": "contenttypes.contenttype", "pk": 23, "fields": {"app_label": "blogs", "model": "category"}}, {"model": "contenttypes.contenttype", "pk": 24, "fields": {"app_label": "about", "model": "servicescontact"}}, {"model": "contenttypes.contenttype", "pk": 25, "fields": {"app_label": "about", "model": "subscriber"}}, {"model": "contenttypes.contenttype", "pk": 26, "fields": {"app_label": "superuser", "model": "about"}}, {"model": "contenttypes.contenttype", "pk": 27, "fields": {"app_label": "about", "model": "instuctionstoauthors"}}, {"model": "contenttypes.contenttype", "pk": 28, "fields": {"app_label": "about", "model": "auditorialboard"}}, {"model": "contenttypes.contenttype", "pk": 29, "fields": {"app_label": "artical", "model": "submenuscripts"}}, {"model": "contenttypes.contenttype", "pk": 30, "fields": {"app_label": "artical", "model": "authors"}}, {"model": "contenttypes.contenttype", "pk": 31, "fields": {"app_label": "artical", "model": "year"}}, {"model": "contenttypes.contenttype", "pk": 32, "fields": {"app_label": "artical", "model": "vol"}}, {"model": "contenttypes.contenttype", "pk": 33, "fields": {"app_label": "artical", "model": "issue"}}, {"model": "contenttypes.contenttype", "pk": 34, "fields": {"app_label": "artical", "model": "artical"}}, {"model": "contenttypes.contenttype", "pk": 35, "fields": {"app_label": "home", "model": "homeslider"}}, {"model": "contenttypes.contenttype", "pk": 36, "fields": {"app_label": "about", "model": "certificates"}}, {"model": "contenttypes.contenttype", "pk": 37, "fields": {"app_label": "artical", "model": "blogviews"}}, {"model": "contenttypes.contenttype", "pk": 38, "fields": {"app_label": "artical", "model": "downloadcount"}}, {"model": "contenttypes.contenttype", "pk": 39, "fields": {"app_label": "home", "model": "abstratingandindexing"}}, {"model": "contenttypes.contenttype", "pk": 40, "fields": {"app_label": "about", "model": "emailsetup"}}, {"model": "contenttypes.contenttype", "pk": 41, "fields": {"app_label": "about", "model": "nortificationmail"}}, {"model": "contenttypes.contenttype", "pk": 42, "fields": {"app_label": "about", "model": "aboutcontact"}}, {"model": "contenttypes.contenttype", "pk": 43, "fields": {"app_label": "superuser", "model": "aboutcontact"}}, {"model": "sessions.session", "pk": "0ns64xf6mczmvcmgwf5jagffuoogcg9d", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mvdoA:9i7ANCqPq86wC57VPMq_hmKm7GqyghaUtSH9qjQ0pi4", "expire_date": "2021-12-24T11:11:22.996Z"}}, {"model": "sessions.session", "pk": "18ddjxkxcixx7gcf154akovaaghh6yhe", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mxx0C:MMOHJm2OAQxw3nbhr5qhs8Ea9sml4iuYOZaniDkQFsI", "expire_date": "2021-12-30T20:05:20.746Z"}}, {"model": "sessions.session", "pk": "1ir3jh9tray04169ljnqx2o7clae46ge", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mxc5p:dMvgNr8cGIjdLsYaAO_i4DVfSP4o6ZJaQPq3KD7WGH8", "expire_date": "2021-12-29T21:45:45.363Z"}}, {"model": "sessions.session", "pk": "1ox5vrn23z8f35qbtwxf20r2nldlzrbi", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n0Jd9:v76VI5FxT267x1vid2FJqqpivmZ5elXNuBAGPr5NW9I", "expire_date": "2022-01-06T08:39:19.816Z"}}, {"model": "sessions.session", "pk": "1xsoqejbsp75cy275dtrw1giojvqppae", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n0DGp:USRJqIOam88cuC1Q5hBrG_zbUV7zsGKIhSTa-12s3_I", "expire_date": "2022-01-06T01:51:51.409Z"}}, {"model": "sessions.session", "pk": "20aamorml3xeq8nuohbsr0vb4p2ipsqc", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n0FpC:CW0j9Z_DaQxc_i0UOmY9gRRMySKvjFjjm3uTq95pZ28", "expire_date": "2022-01-06T04:35:30.227Z"}}, {"model": "sessions.session", "pk": "2cgh8o1kq3anlue1hg4sulnm8pg6k5c3", "fields": {"session_data": ".eJxVjEEOgyAQRe_CuiEiiKPL7nsGMjBD1RpIRFZN715NXLTb_95_b-Gw7pOrhTc3kxiFErffzWN4cToBLZieWYac9m328lTkRYt8ZOL1frl_gQnLdLwBMBjldQd2CL1uGvCdbdl4VBxpUA0zdDFabXVPLZLpkQJqCHZoWUV_RJdc04arGCOuhT9fi_096Q:1mqAVO:uBiSxmy42LfGFCdns_MA0ECPapTfbI570Isg7QgjYMc", "expire_date": "2021-12-09T08:53:22.490Z"}}, {"model": "sessions.session", "pk": "2jd9c0hjdlytmh1e5kpu65zn0fqe46wk", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mg65c:8Vl4m_GkLnnzVwPXs8Yg-gGgrNfXAoVgFm-OVIZcSS8", "expire_date": "2021-11-11T14:09:08.968Z"}}, {"model": "sessions.session", "pk": "39h6es4qwrokm6hbszkxe86rpallb354", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mfwvn:C6L16nPjO5IulBA2tarTPi2Au4x-P3PCLahFuNhe-fA", "expire_date": "2021-11-11T04:22:23.364Z"}}, {"model": "sessions.session", "pk": "3whlp72f6zur3bm2zm4ct4s2qc5c71rx", "fields": {"session_data": ".eJxVjEEOgyAQRe_CuiEiiKPL7nsGMjBD1RpIRFZN715NXLTb_95_b-Gw7pOrhTc3kxiFErffzWN4cToBLZieWYac9m328lTkRYt8ZOL1frl_gQnLdLwBMBjldQd2CL1uGvCdbdl4VBxpUA0zdDFabXVPLZLpkQJqCHZoWUV_RJdc04arGCOuhT9fi_096Q:1mmY54:wlf9cGi11BZzo7wTK6Zu5z-N-fM25XKAy2N1Dcwh4pQ", "expire_date": "2021-11-29T09:15:14.637Z"}}, {"model": "sessions.session", "pk": "439vigtpy33cxkyzl39u7ymcasq3ulpy", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1myE9g:z4dK-MT2xhGGhkrB-KA4HdsGPdFcLOkwKiVICaleClQ", "expire_date": "2021-12-31T14:24:16.327Z"}}, {"model": "sessions.session", "pk": "486v1x5ij8kbxsz2hhekxs8zeitpg55d", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1muR3W:ui4pSWvEgcZhZnFFzRg1esGkckbieQkRZtaLXYKN-ks", "expire_date": "2021-12-21T03:22:14.606Z"}}, {"model": "sessions.session", "pk": "4nwt7wrk5t4f4ygul0fma89iil2nfxko", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1n0YTY:1DvzS_jr3gzGCOqATVanJ-RbJOgFY2GW2XgAP53iAPM", "expire_date": "2022-01-07T00:30:24.368Z"}}, {"model": "sessions.session", "pk": "5rj3a7y6pyyinc0l683hzdp7rgmpaw3s", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mzrjg:bYYxsQe0NMRsxI1ImCBemJ8bV5HRNOxb0smiff464ns", "expire_date": "2022-01-05T02:52:12.847Z"}}, {"model": "sessions.session", "pk": "6g8w9d6mvsus7hdi4u66rgd6rl8xkhkd", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1my5KW:nkd6EJQ4ceYQ12FVUqocuGUAfyuMgnmpPJVeWGPweQE", "expire_date": "2021-12-31T04:58:52.275Z"}}, {"model": "sessions.session", "pk": "726pgak7extfdr87d86a2u8w1kcc0ian", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1n01SO:1GgffpZUNZX9W5enkOy6xOAeQE0TVr674L5Ky3AW-Bo", "expire_date": "2022-01-05T13:15:00.137Z"}}, {"model": "sessions.session", "pk": "735oq46ycd2gy5wnrpl59x71egsmte9g", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1meWJL:Fw_wHK9mOJD91o65kO6eeXTLoWbJlW16PhCIdyufTWs", "expire_date": "2021-11-07T05:44:47.465Z"}}, {"model": "sessions.session", "pk": "79a12p5njk4epc7tk0i83xcwu0aju2wd", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1muBQz:WFtvjXfPjWK4ntdcQ7rfQRXq15NLrnfpbcqpxnzUorM", "expire_date": "2021-12-20T10:41:25.522Z"}}, {"model": "sessions.session", "pk": "7ihqunajx2lg09uvk9s75hqebk3ah51m", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1meuBa:LvZ_yTYAw8A1Ei7BrkMPASBa7JqQ4WHvq8wUSu6dohA", "expire_date": "2021-11-08T07:14:22.506Z"}}, {"model": "sessions.session", "pk": "7v1cxlcacuvznushai6kpqp2f6iy60ll", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n0K4K:-rYXzQSwh3NIljywGV9P_7cGCqmpAeIErtITfjFPAyw", "expire_date": "2022-01-06T09:07:24.313Z"}}, {"model": "sessions.session", "pk": "83gmhe7oteh14te3al5yhzwead6g0gwq", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mwQdq:lr6_yHIxVOy4DRv5tXBi_mZQLno9slx-zlpfoFkhAE4", "expire_date": "2021-12-26T15:19:58.712Z"}}, {"model": "sessions.session", "pk": "8oy7shn4e7bvia2zbtzdk5d3tbeatz52", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mzx2Y:AbLCh-6Lh5LivgqPerf0eJeHkXuzeuEC9bqxJAKYjns", "expire_date": "2022-01-05T08:32:02.405Z"}}, {"model": "sessions.session", "pk": "904cmjnuek5u290idbcfe884ked81zwe", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mxtdd:rly31FALuZrtNQvoBabfRF3a_k91OaJ1e464U4iuI7o", "expire_date": "2021-12-30T16:29:49.404Z"}}, {"model": "sessions.session", "pk": "9asi1f8stp0bpyjyyz0yrbtrvri56njq", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mreOv:cSnYcWPmkrRlsCu5cJnet08iEZ-_aUBoRQzWwSdHIh0", "expire_date": "2021-12-13T11:00:49.315Z"}}, {"model": "sessions.session", "pk": "9og17oaow5neh0om7zssqc7ceitmlzla", "fields": {"session_data": ".eJxVjEEOgyAQRe_CuiEiiKPL7nsGMjBD1RpIRFZN715NXLTb_95_b-Gw7pOrhTc3kxiFErffzWN4cToBLZieWYac9m328lTkRYt8ZOL1frl_gQnLdLwBMBjldQd2CL1uGvCdbdl4VBxpUA0zdDFabXVPLZLpkQJqCHZoWUV_RJdc04arGCOuhT9fi_096Q:1mprGz:4X26q4f5cXJaiwwfl-sfUcMi0j4QA_Eyq-l15WtrjYY", "expire_date": "2021-12-08T12:21:13.102Z"}}, {"model": "sessions.session", "pk": "aco0onxgrto2f5tzycr52kaxi87d3zbq", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mu5jY:qnAN6ji-VH2LxKi6MPgewggPauV5qx-SV8S8perXWks", "expire_date": "2021-12-20T04:36:12.058Z"}}, {"model": "sessions.session", "pk": "ahsmssrxa77bwxa06rs507jux790vie9", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mymkU:ilYUjKLOtSFaGuW7FvSSdW25n8TN6rYveI-U02A5eQE", "expire_date": "2022-01-02T03:20:34.484Z"}}, {"model": "sessions.session", "pk": "b836c26sm5bcllr1iki4wcfp1d1azn3r", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mzxP3:IkK0IbG3CsDLVTmlezDWOHa8DhfhAHZ054Hq1mHIDdc", "expire_date": "2022-01-05T08:55:17.243Z"}}, {"model": "sessions.session", "pk": "beixwlwta2yv0sfm1n46hh927vpbl8g0", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mu5kB:2-6rMQiAu0xVzgQj1WTDfVz9_tjYQaxUkrz53vLyIYA", "expire_date": "2021-12-20T04:36:51.059Z"}}, {"model": "sessions.session", "pk": "dalzfqjdhg7t536dsmneppl7kmbjuj8x", "fields": {"session_data": ".eJxVjEEOgyAQRe_CuiEiiKPL7nsGMjBD1RpIRFZN715NXLTb_95_b-Gw7pOrhTc3kxiFErffzWN4cToBLZieWYac9m328lTkRYt8ZOL1frl_gQnLdLwBMBjldQd2CL1uGvCdbdl4VBxpUA0zdDFabXVPLZLpkQJqCHZoWUV_RJdc04arGCOuhT9fi_096Q:1mxXZZ:VbwKBGTxB7aNAG1n_Tp0GrySiGvJu_Sk18yWeJlp5N8", "expire_date": "2021-12-29T16:56:09.111Z"}}, {"model": "sessions.session", "pk": "dho46q36vsry2wyfckde37qwh2v5tub5", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n0ss9:tSHbU7vvE21v6en6hRU4foBwQlPnPqdZOhR-_aCrU4g", "expire_date": "2022-01-07T22:17:09.315Z"}}, {"model": "sessions.session", "pk": "dja07vps5apo8874z35r0eyxeovkzrxf", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mwNjJ:yYRXJPwnbXtOpeNE065Mam4uJGmr9LThEBUbI44Q7EQ", "expire_date": "2021-12-26T12:13:25.931Z"}}, {"model": "sessions.session", "pk": "djcy8v2fkdw6rxjcoaknt3c7mwbquk7h", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mquiy:1Q5IDKUZQebjYKVjhLmqgVM5iGX46UcUiN8jzP9mvd8", "expire_date": "2021-12-11T10:14:28.471Z"}}, {"model": "sessions.session", "pk": "duwuqoqbhlm5xwbtyiskghmmh4m824ly", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1munmD:Kr2GzLmHDdlvXs1arOuZb4xrj0u1v9WbvGI3ZbuvHWo", "expire_date": "2021-12-22T03:37:53.029Z"}}, {"model": "sessions.session", "pk": "eadnw64ekd5nanr65f94ww65elszbzgx", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mvbxb:sbJQH5jr4oJjj8qQ7LSB-NzIclYR4nfObYYUQ6fOQSo", "expire_date": "2021-12-24T09:12:59.989Z"}}, {"model": "sessions.session", "pk": "eokfmmjwl91694hnrei0mqxfnc6ey66b", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mefLc:cyuqDf7lTAsiFAglqw6rfGCE03TCFDGQFQARiJ5QxJU", "expire_date": "2021-11-07T15:23:44.253Z"}}, {"model": "sessions.session", "pk": "fr8fx7wv646ooy0om0vp72rghufhhtru", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1meUOj:NN3nrgWop8GdlBCcaVr5gQmMoVSMTFYlxt-_-8iV4ME", "expire_date": "2021-11-07T03:42:13.742Z"}}, {"model": "sessions.session", "pk": "fw2xdacos3cykh973okol0ay0xxr0wop", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1myD5o:y_X-C5e5ns8b1AJiWqLqpdlQEC2fvwrQTz_LHgqLOkg", "expire_date": "2021-12-31T13:16:12.797Z"}}, {"model": "sessions.session", "pk": "gksmtkmy7g41q4a4s7524nzm5mfv0abm", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1myVlS:XDd4I6a9eT3nlscMXwzSi4DiZGJ8_GfHEsIwkXp1pW8", "expire_date": "2022-01-01T09:12:26.707Z"}}, {"model": "sessions.session", "pk": "gu23utcqk757ixuilrf47urp6fvrrnc2", "fields": {"session_data": ".eJxVjMEOgyAQBf-Fc0NAFNFj7_0GsrBL0RpIQE5N_72aeGivb-bNm1loe7StUrELsplJdvvdHPgXpRPgCumZuc9pL4vjp8IvWvkjI233y_0LRKjxeBsDvpdODUZPflRCGDfojnoHkgJOUhCZIQSttBqxA-xHQA_KeD11JIM7omtuqcDG5r00-nwBTrU9ng:1mrfb3:Z5_y1WNtHDH5cbhiFd3e7AJFs_nsSmoock14u37hJFo", "expire_date": "2021-12-13T12:17:25.293Z"}}, {"model": "sessions.session", "pk": "hkvwkupnljbv66slxlmyl1vtr7zpwd0z", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mvEaO:EVVhdpV9r32IBxRuK6PMdGzv0-kjOrTkyyudHlUGsGI", "expire_date": "2021-12-23T08:15:28.490Z"}}, {"model": "sessions.session", "pk": "hoifn9f904zuc487qj6zxfr00hi4aniy", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mqWLc:ephtxtg_6YbIAXKFpIRqdv4vAuSs8ffraF-MejHZ7EI", "expire_date": "2021-12-10T08:12:44.623Z"}}, {"model": "sessions.session", "pk": "j1gg3kw2rffzqmordw5bsydr7te1xvak", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n05GA:uvqC6tfSOmUYb7nkAwYO74Cbkx4EvpOE_ghOcT7h9ck", "expire_date": "2022-01-05T17:18:38.033Z"}}, {"model": "sessions.session", "pk": "j5x0tim60ikbgi80tsibtfdzu61p165y", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1n0hNk:JMgPZB7FZvKq3qkqpPEH7HIW9qL8gWvyPJ_G3YMREZM", "expire_date": "2022-01-07T10:01:00.884Z"}}, {"model": "sessions.session", "pk": "ji18vsbtlzpnv0kmzvly03z23nd76acx", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mzxYm:h4gx6tLvn_fGRHJCIyMIT6nMbu4s5BRRe37aAyYyNZA", "expire_date": "2022-01-05T09:05:20.264Z"}}, {"model": "sessions.session", "pk": "kbkgyu5om1ttrut5rro3orkcl6yr47tb", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1n0GhN:Dvo8-nyev4UtDHV6bE4zaaxu6nmF_wJd0IOP-VJzoXE", "expire_date": "2022-01-06T05:31:29.971Z"}}, {"model": "sessions.session", "pk": "ksqu0wwg3jnfmczw8040mampmp905rdn", "fields": {"session_data": ".eJxVjMEOgyAQBf-Fc0NAFNFj7_0GsrBL0RpIQE5N_72aeGivb-bNm1loe7StUrELsplJdvvdHPgXpRPgCumZuc9pL4vjp8IvWvkjI233y_0LRKjxeBsDvpdODUZPflRCGDfojnoHkgJOUhCZIQSttBqxA-xHQA_KeD11JIM7omtuqcDG5r00-nwBTrU9ng:1mxj5k:LBuu_VoGuUqA0rekS_ZKQvy5tFmQTMYMBmw7aZG2cHk", "expire_date": "2021-12-30T05:14:08.844Z"}}, {"model": "sessions.session", "pk": "mdznzysn3op9c6wiywx9vtf5u8qkfd9h", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n03at:SjDL-dNMnEe_u_Lmlfrt12jY7uZbcQupn451QHnussA", "expire_date": "2022-01-05T15:31:55.307Z"}}, {"model": "sessions.session", "pk": "mf5nwigjwi01fj9wuu1qn105t10pq5yg", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mdsNg:m33UtFeoqQ_j5wz0XSefSrkMm4Q-DmfLyeO8cizYKhE", "expire_date": "2021-11-05T11:06:36.434Z"}}, {"model": "sessions.session", "pk": "nkh4kopjdykbegt7zs5pvj4gy50ggrue", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1my5Jl:BpaIBnoZVSUTngMd15RbrMRu65wChvxvhumz73IUtac", "expire_date": "2021-12-31T04:58:05.119Z"}}, {"model": "sessions.session", "pk": "o1qu52tz7biyjynmigap60l8gpazs86z", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mxToY:CRnu7quQqBxcTLFjBMjfIaNPXsWD8xrpTaxYxtmK2Zc", "expire_date": "2021-12-29T12:55:22.589Z"}}, {"model": "sessions.session", "pk": "o79d88ck3matid5ugb2zn3lpipzx88ev", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mdnG3:_sZ3prUWGW_Y7e6OAvN5ruPoCtB3MwAjgdTKJ5jTnsc", "expire_date": "2021-11-05T05:38:23.008Z"}}, {"model": "sessions.session", "pk": "optg3wrjs75aj66xmd5wze8nlvk1hok6", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mgXbz:grdyTEpCsMgNtm8XGy9O-TQTueMe9vv1diAwpX_6ixE", "expire_date": "2021-11-12T19:32:23.265Z"}}, {"model": "sessions.session", "pk": "oq7y4w7sq2d3drhx60mix0bklu6agml4", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1n0ssT:E9Z4dDUFsc4gbhOmsiwnIRgwvxkSKcz1s5FGyL0Mu3Q", "expire_date": "2022-01-07T22:17:29.272Z"}}, {"model": "sessions.session", "pk": "ov83008x92zncvtb8c6teb7eagalrxjl", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1muR01:zPVj3sJoDoFzEEhwFvtOCyJhcQkp6bA6k6yXpTkkZx0", "expire_date": "2021-12-21T03:18:37.442Z"}}, {"model": "sessions.session", "pk": "p9wtycg2k3tc112t9n2wegf669uf9qwe", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1muE2I:wIfoKazoMOg6yLpEtJnr2Mz7ww80YXSN4XPq-LqdnUI", "expire_date": "2021-12-20T13:28:06.490Z"}}, {"model": "sessions.session", "pk": "p9yi4uce92jicqyem1nf7avrxkvuahw7", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mso1t:39I1oXQXtId9C_kASmmlsdr7hjhGyTkOk_2T0DtSnqM", "expire_date": "2021-12-16T15:29:49.086Z"}}, {"model": "sessions.session", "pk": "phw386en6g3zcn1lwka93s8kukpewdyt", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1myD5Y:bFLCDCjIi5UrePX5QPmZj1NqY8aHQgrEKQXOlJ-OjIo", "expire_date": "2021-12-31T13:15:56.371Z"}}, {"model": "sessions.session", "pk": "q1z4ay6oixnbfqyi1d3etpgn1dz1v4r4", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n0unF:mr235FBXXbB3pSokWEe8oeh2TrTSC7_PCUym-tFgizU", "expire_date": "2022-01-08T00:20:13.935Z"}}, {"model": "sessions.session", "pk": "q2ztd2uxrx71bhw2yoybjeifh7l1j3ql", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mwDKS:ohFdBbS1M7FtUIwGUUymCm7L30-YVkuIsRjhCvi3VmY", "expire_date": "2021-12-26T01:07:04.043Z"}}, {"model": "sessions.session", "pk": "q904pvnqu3jjsne8ofbhl30oob2hhx6k", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mydFl:68Kovc8ySHT5DKrLlXoZUeMWVSRLU2fii4QhPX4pVpc", "expire_date": "2022-01-01T17:12:13.138Z"}}, {"model": "sessions.session", "pk": "qnp1dk3dgm3op23nly6tbrfwbxxq3iyz", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1n0DGN:EV3wPn5IallfY9x8jPm13HsfRZHrVSJGBV4t9p555tA", "expire_date": "2022-01-06T01:51:23.756Z"}}, {"model": "sessions.session", "pk": "qsu1e9fc86aliqr3ltjkkgg2soj30b1r", "fields": {"session_data": ".eJxVjEEOgyAQRe_CuiEiiKPL7nsGMjBD1RpIRFZN715NXLTb_95_b-Gw7pOrhTc3kxiFErffzWN4cToBLZieWYac9m328lTkRYt8ZOL1frl_gQnLdLwBMBjldQd2CL1uGvCdbdl4VBxpUA0zdDFabXVPLZLpkQJqCHZoWUV_RJdc04arGCOuhT9fi_096Q:1n01Mc:nU38UBBeVM8spRzbzGnTbnQ2Py-Umt5yG9XCKd1LMqk", "expire_date": "2022-01-05T13:09:02.214Z"}}, {"model": "sessions.session", "pk": "qt5vf4i6i4w4uj0gi5sgy1ceviszihuw", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mxgaw:vWeIdUeof7rrbayiQxpYnfY1Uu_GZIH4mdCkOz28iP0", "expire_date": "2021-12-30T02:34:10.871Z"}}, {"model": "sessions.session", "pk": "rcuepenr0ozimmgx11cwb6kuw69987a4", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mekyG:hVsSNXA3zewoHVvXtrL5zM2tBzcXqzkkrK8f_e4o6BY", "expire_date": "2021-11-07T21:24:00.348Z"}}, {"model": "sessions.session", "pk": "rviigfcz9wla9r4nvz57jkw5g2vvih4w", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mfJa8:bbKlWXYM68JTddrjLETiqU3gtNt3PYRXEKV4qBAWd7Y", "expire_date": "2021-11-09T10:21:24.268Z"}}, {"model": "sessions.session", "pk": "tbnqyxqd8zyx50umlawz3bkhzt7ru2x7", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mvbRv:t0Of2MqmAwOm1af9QoFadJ9mVNW8lOqckwzovZhGXwY", "expire_date": "2021-12-24T08:40:15.590Z"}}, {"model": "sessions.session", "pk": "tf161j9ceqyjk6vr7enai6l8tpted221", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1myn70:8pmTTWK8_OE7s0jrZaZBrH0xsR-BSLcrUIjX7PblZC0", "expire_date": "2022-01-02T03:43:50.914Z"}}, {"model": "sessions.session", "pk": "tlo6jwzkfxfbavwhwuk80lvxcp3kuwap", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n0mjq:bPXbsLMZ7XxIZUma-MlKnN1cqak6XY4xEvDYf4egB2k", "expire_date": "2022-01-07T15:44:10.888Z"}}, {"model": "sessions.session", "pk": "uu12rcrso7e729gi3w4xyjxo9dvpwr48", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1msrbf:pbhn74ru42eU98uTbKDjod1ONteitN_gOwZRXb0vlWM", "expire_date": "2021-12-16T19:18:59.211Z"}}, {"model": "sessions.session", "pk": "uue1lvu17q0viyg9gbv0qjsx212g7tum", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mfgV1:PQQaOujmnT0IZAhuTmJgZbaN8117G-7URX5YfSRUCkE", "expire_date": "2021-11-10T10:49:39.664Z"}}, {"model": "sessions.session", "pk": "v130m2y9q9tr3e1llaavispvfpv7dspu", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mxgug:FcMeqc6gqygLlsjeq2G1HZP-AYOFLEBRHtl_LtpF_Sk", "expire_date": "2021-12-30T02:54:34.910Z"}}, {"model": "sessions.session", "pk": "v4ad1tvb7pc4z5we3gnfskmg61ej6rbk", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mwPII:EoAFQR34MRNKfnebpCJxQSoE3vEywdjCXLpLso5bKN4", "expire_date": "2021-12-26T13:53:38.565Z"}}, {"model": "sessions.session", "pk": "valmtrgfnwzqhh5gqy4as4luozkp76rk", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mshjq:IRa0ea_BqZqCnkSmOUENycOKqU6lTopF_KQfKG7dscU", "expire_date": "2021-12-16T08:46:46.523Z"}}, {"model": "sessions.session", "pk": "vkw6mdtnm0k0ahjygbtnjeavm0kgv4xp", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1msqYt:XNBKke0OvuTzsuSlsRvgtTOoJNhhAGTG3JN7Ns78XKc", "expire_date": "2021-12-16T18:12:03.827Z"}}, {"model": "sessions.session", "pk": "vw5gt4mpe0qdw4yw3j5bpfqfouum081y", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1myOQd:u1TxYgfh3e0aconNXZj10HRb06zV4TxHbjxG__XgLus", "expire_date": "2022-01-01T01:22:27.026Z"}}, {"model": "sessions.session", "pk": "w8u722snm4358i0w5r6b43tvlrphibry", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1mvpXy:V3Bg7vLnXzT0FzY04gc7aEEbXTIgePCVeNsS2DvtP4s", "expire_date": "2021-12-24T23:43:26.120Z"}}, {"model": "sessions.session", "pk": "wdpmnknvm44oi98az7g8q21nscnbckdi", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mz74h:uoP4LWUspasBFz7Ct7hEjMKCvnZ2wtg5yAJJyVVQcI0", "expire_date": "2022-01-03T01:02:47.756Z"}}, {"model": "sessions.session", "pk": "xrblhm84e183r68ebdo7mj3ilrkjrz1a", "fields": {"session_data": ".eJxVjMsOgyAURP-FtSEiiuiy-36DuXAvRWsg4bFq-u_V1EW7nJkz58UWqMUvNVNaVmQzE6z57QzYJ4VzwA3CI3IbQ0mr4SfCrzXze0Tabxf7J_CQ_fHWGmwvjBy0muwo21abQXXUGxDkcBItkR6cU1LJETvAfgS0ILVVU0fCmUNa_JrZXFKlhm2xhgT7N74_RlhBwA:1ml9zR:EeaEoPyzgqhFUzAvYllxU16n6yHM3-X6zGfwHkeeIqs", "expire_date": "2021-11-25T13:19:41.129Z"}}, {"model": "sessions.session", "pk": "ysudpob2k0dnkbkqlnqdgnb4vc8wiimk", "fields": {"session_data": ".eJxVjDsOwjAQBe_iGln-fyjpOYO19q5xADlSnFSIu0OkFNC-mXkvlmBbW9oGLWlCdmaSnX63DOVBfQd4h36beZn7ukyZ7wo_6ODXGel5Ody_gwajfesQoBiZtQ0uFq-FCNk6RSaDpIpRCqJga3XaaY8K0HjAAjoUFxXJmtn7A9xWODk:1mlRv2:sBccSLwpDhzvSxjxz-_ZTNK-BgI1FAQqL8Ot3uwbEHU", "expire_date": "2021-11-26T08:28:20.685Z"}}, {"model": "sessions.session", "pk": "ytq6eb7lk6ryc7hoiedzj8mlpkfn2b5z", "fields": {"session_data": "eyJqb3VucmFsIjp0cnVlfQ:1n0qjy:hDkH4ZWl92-T9OL7l2MsGuBwNSnLmkbtNfau2UlZzwc", "expire_date": "2022-01-07T20:00:34.863Z"}}, {"model": "sessions.session", "pk": "z59uy53g1a1yw9j9axb5lwe48miy6kiy", "fields": {"session_data": "eyJqb3VucmFsIjpmYWxzZX0:1mvbRr:ts384vncwIVLptJqhAuYTcBqdkYCcVMKl-SYx7egDbo", "expire_date": "2021-12-24T08:40:11.533Z"}}, {"model": "home.homeslider", "pk": 1, "fields": {"type": "2", "slider_image": "sliders/slider2.jpg", "title": "Keeping The Word Surface Safe", "keys": "Knowledge, Wishdom , Exellent Service", "learnMoreurl": "/Services/vision-mission-scientific-aims-research-areas-orga"}}, {"model": "home.homeslider", "pk": 2, "fields": {"type": "2", "slider_image": "sliders/slider1.jpg", "title": "Journal of Pharmacology and Biomedicine", "keys": "Services, Training , More", "learnMoreurl": "/jounrals/"}}, {"model": "home.homeslider", "pk": 3, "fields": {"type": "1", "slider_image": "sliders/IMG-20190709-WA0036-rotated.jpg", "title": "JOURNAL OF PHARMACOLOGY AND BIOMEDICINE", "keys": "Article,Submit,Archives", "learnMoreurl": "/jounrals/"}}, {"model": "home.abstratingandindexing", "pk": 1, "fields": {"title": "road", "logo": "abstractIndexing/download.png"}}, {"model": "home.abstratingandindexing", "pk": 2, "fields": {"title": "international", "logo": "abstractIndexing/download_JT5vDS3.png"}}, {"model": "home.abstratingandindexing", "pk": 3, "fields": {"title": "Acadmic", "logo": "abstractIndexing/download_gbUgAui.png"}}, {"model": "home.abstratingandindexing", "pk": 4, "fields": {"title": "corpernicus", "logo": "abstractIndexing/download_ky6f2NM.png"}}, {"model": "about.emailsetup", "pk": 1, "fields": {"host": "mail.rbscience.co.in", "port": 587, "tsl": true, "ssl": false, "email": "info@rbscience.co.in", "password": "rbscience@123", "activate": true}}, {"model": "about.emailsetup", "pk": 3, "fields": {"host": "mail.rbscience.co.in", "port": 587, "tsl": true, "ssl": false, "email": "info@rbscience.co.in", "password": "rbscience@123", "activate": false}}, {"model": "about.nortificationmail", "pk": 1, "fields": {"email": "ritik.s10120@gmail.com"}}, {"model": "about.contactus", "pk": 1, "fields": {"name": "Ritik Sisodiya", "email": "leporol173@play588.com", "phone": 2147483647, "subject": "Computer", "message": "whatapp"}}, {"model": "about.contactus", "pk": 2, "fields": {"name": "Ritik Sisodiya", "email": "leporol173@play588.com", "phone": 2147483647, "subject": "new subjects", "message": "whatapp"}}, {"model": "about.contactus", "pk": 3, "fields": {"name": "ritik ", "email": "ritik@gmail.com", "phone": 2147483647, "subject": "this is subject", "message": "this is message"}}, {"model": "about.contactus", "pk": 4, "fields": {"name": "sdds", "email": "dhdh@gmail.com", "phone": 123456789, "subject": "ddd", "message": "ddd"}}, {"model": "about.contactus", "pk": 5, "fields": {"name": "ritik", "email": "test@gmail.com", "phone": 2147483647, "subject": "subject", "message": "this is message"}}, {"model": "about.contactus", "pk": 6, "fields": {"name": "ritik", "email": "test@gmail.com", "phone": 2147483647, "subject": "sdfsubject", "message": "this is messagdfse"}}, {"model": "about.contactus", "pk": 7, "fields": {"name": "ritik", "email": "test@gmail.com", "phone": 2147483647, "subject": "sdfsubject", "message": "this is messagdfse"}}, {"model": "about.contactus", "pk": 8, "fields": {"name": "ritik", "email": "test@gmail.com", "phone": 2147483647, "subject": "sdfsubject", "message": "this is messagdfse"}}, {"model": "about.contactus", "pk": 9, "fields": {"name": "ritik sisodiya", "email": "ritik.s10120@gmail.com", "phone": 2147483647, "subject": "ENGLISH", "message": "yes it is working"}}, {"model": "about.servicescontact", "pk": 1, "fields": {"fname": "ritik", "lname": "sisodiya", "phone": "8602276724", "service": null, "message": "this is my message", "time": "2021-11-11T09:56:47.991Z"}}, {"model": "about.subscriber", "pk": 1, "fields": {"email": "ritik@gmail.com"}}, {"model": "about.subscriber", "pk": 2, "fields": {"email": "ritik.s10120@gmail.com"}}, {"model": "about.subscriber", "pk": 3, "fields": {"email": "ritik.cyberflax@gmail.com"}}, {"model": "about.subscriber", "pk": 4, "fields": {"email": "rrrr.10120@gmail.com"}}, {"model": "about.subscriber", "pk": 5, "fields": {"email": "pravesh1352000@gmail.com"}}, {"model": "about.subscriber", "pk": 6, "fields": {"email": "bawoy43444@ateampc.com"}}, {"model": "about.subscriber", "pk": 7, "fields": {"email": "xeheg87937@fretice.com"}}, {"model": "about.instuctionstoauthors", "pk": 1, "fields": {"title": "Instructions To Authors", "content": "<p><strong>SCOPE OF SUBMITTED MANUSCRIPTS</strong></p>\r\n\r\n<p>Journal of Pharmacology and Biomedicine (J Pharmacol Biomed)&nbsp;is a quaterly peer reviewed journal aiming to publish quality research articles, reviews and general articles in the field of pharmacology, pharmacotherapeutics, biomedicine and drug delivery &amp; analysis. J Pharmacol Biomed is an open access, peer-reviewed online journal that encompasses all aspects of basic research/clinical studies related to the field of pharmacology, pharmacotherapeutics and biomedicine. J Pharmacol Biomed provides an inducive platform for exchange of latest scientific information in precise way to achieve timely publication of information and novel ideas.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>SUBMISSION OF MANUSCRIPTS</strong></p>\r\n\r\n<p>ALL manuscripts submissions must be made through the journal&#39;s website either online or by email to the editorial office at edt.jpb@gmail.com. Manuscripts must be in English, typewritten using&nbsp;Arial&nbsp;or&nbsp;Times New Roman&nbsp;fonts only, and double-spaced throughout, including references, tables, and figure legends, with at least 1 inch (25 mm) margins. Authors for whom English is not their native language are encouraged to have their manuscripts reviewed for grammar, vocabulary, syntax, and punctuation. Once manuscript preparation is complete, convert the text and figure files (but not supplemental data) into a single word file (.doc, .docx).</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>ORGANIZATION OF THE MANUSCRIPT</strong></p>\r\n\r\n<p>Manuscripts should contain the following sections in the order listed. Each section should be titled and begin on a new page. All pages should be numbered consecutively.</p>\r\n\r\n<p><strong>1.&nbsp;Title page.</strong>&nbsp;This should contain the complete title of the article, the names of all authors and affiliation of all the authors The name, address, telephone and fax numbers, and e-mail address of the corresponding author.</p>\r\n\r\n<p><strong>2. Abstract.</strong>&nbsp;The abstract should be structured and concisely present the hypothesis being tested, general methods, results, and conclusions. Abstracts of more than 250 words will not be accepted. Key words: Provide 3-5 keywords which will help readers or indexing agencies in cross-indexing the study. The words found in title need not be given as key words.</p>\r\n\r\n<p><strong>3. Visual/Graphical Abstract (Optional).</strong>&nbsp;In addition to a text abstract, authors may submit a visual or graphic abstract that is intended to catch a reader&rsquo;s attention and provides a quick visual impression of the gist of the article.&nbsp;&nbsp;The graphic must be 440 pixels wide by 350-365 pixels tall, saved as RGB. &nbsp;TIFF or PDF file formats are preferred.</p>\r\n\r\n<p><strong>4. Introduction.</strong>&nbsp;This section must contain a clear statement of the aims of the work or of the hypotheses being tested. A brief account of the relevant background that supports the rationale of the study should also be given.</p>\r\n\r\n<p><strong>5. Materials and Methods.</strong>&nbsp;Authors must affirm that original studies in animals have been carried out in accordance with the Guidelines for Animal Handling and Experimentation and were approved by the Institution&rsquo;s Animal Care and use Committee or local equivalent.&nbsp; For investigations involving human subjects, authors must affirm that they have been carried out in accordance with the Declaration of Helsinki and approved by the Institutional Review Board(s) or equivalent ethics committee.&nbsp; For multisite studies, all IRBs must be in agreement.<br />\r\nThis section should contain explicit, detailed, and concise descriptions of all new methods or procedures employed. Descriptions of methods must not only be sufficient to enable the reader to judge the accuracy, reproducibility, and reliability of the experiment(s) but also to be able to reproduce the results. The name and location (city and state or country) of commercial suppliers of chemicals, reagents, and equipment must be given. Sources of compounds, reagents, and equipment not available commercially should be identified by name and affiliation here or in the Acknowledgments section. The chemical identity or structure of novel drugs or research compounds must be provided. The structures of novel biologic agents must also be provided, at the level of current knowledge. &nbsp; Report the source of cell lines.<br />\r\nFor animal experiments, authors should report the source, species, strain, sex, age, randomization, blinding, and husbandry of the animals. Report the strain characteristics of genetically engineered animals including generations of back-crossing, or percentage of contributing strains if genetic analysis was performed. In vivo studies and studies using primary cultures of cells or tissues from animals or humans must state the sex of the experimental subjects or tissue donors in the Materials and Methods section. The designations &quot;mixed&quot; or &quot;unknown&quot; should be used as appropriate when the sex cannot be determined (e.g., embryonic or early postnatal cultures, cell lines immortalized from a mixed culture, previously completed experiments for which sex was not documented).</p>\r\n\r\n<p><strong>6. Results.</strong>&nbsp;Contained in this section are the experimental data, with no discussion of their significance. Results are typically presented in figures or tables, with no duplication of information in the text. If a table or figure includes less than four values, the data should be presented in the text rather than as a separate table or figure. Magnitudes of variables reported should be expressed in numerals. Generally, units are abbreviated without punctuation and with no distinction between singular and plural forms (e.g., 1 mg, 25 mg).&nbsp;Data should be presented in a quantitative manner where possible, with descriptive statistical measures. &nbsp;Report not only the statistical tests used but also the exact value of N for each group. Statistical probability (p) in tables, figures, and figure legends should be expressed as *p&nbsp;&lt; 0.05, **p&nbsp;&lt; 0.01, and ***p&nbsp;&lt; 0.001. For second comparisons, one, two, or three daggers may be used. For multiple comparisons within a table, footnotes italicized in lower case, superscript letters are used and defined in the table legend.<br />\r\nAll data upon which the conclusion of the paper rely must be made available upon request (where ethically appropriate) during consideration of the manuscript and to members of the scientific community thereafter.</p>\r\n\r\n<p><strong>7. Discussion.</strong>&nbsp;Conclusions drawn from the results presented are included in this section. Whereas speculative discussion is allowed, it must be identified as such and be based on the data presented.</p>\r\n\r\n<p><strong>8. Acknowledgments.</strong>&nbsp;The&nbsp;Acknowledgments&nbsp;section is placed at the end of the text. Personal assistance is noted here. Financial support is acknowledged.</p>\r\n\r\n<p><strong>9. References.</strong>&nbsp;References are cited in the text by giving the first author&#39;s name (or the first and second if they are the only authors) and the year of publication (e.g., Ruth and Gehrig, 1929; McCarthy, 1952; or Kennedy et al., 1960). In the reference list, the references should be arranged alphabetically by author and not numbered. The names of all authors should be given in the reference list. If reference is made to more than one publication by the same author(s) in the same year, suffixes (a, b, c, etc.) should be added to the year in the text citation and in the references list. Journal titles should be abbreviated as given in the&nbsp;<a href=\"http://rbscience.co.in/instructions_to_authors/#\">National Center for Biotechnology Information U.S. National Library of Medicine catalog.</a>&nbsp; References to personal communications, unpublished observations, and papers submitted for publication are given in parentheses at the appropriate location in the text, not in the list of references. Only papers that have been officially accepted for publication may be cited as &quot;in press&quot; in the reference list. The authors are responsible for the accuracy of the references. The format for journal article, chapter, book, and publish-ahead-of-print journal article references is as follows:</p>\r\n\r\n<p><em><strong>Journal Reference:</strong></em>&nbsp;Fricks IP, Maddileti S, Carter SRL, Lazarowski ER, Nicholas RA, Jacobson KA, and Harden TK (2008) UDP is a competitive antagonist at the human P2Y14 receptor.&nbsp;J Pharmacol Exp Ther&nbsp;325:&nbsp;588-594.</p>\r\n\r\n<p><em><strong>Book Reference:</strong></em>&nbsp;Wilson JH and Hunt T (2008)&nbsp;Molecular Biology of the Cell: A Problems Approach, 5th ed. Garland Science, New York.</p>\r\n\r\n<p><em><strong>Chapter in Book Reference:</strong></em>&nbsp;Kappas A (2002) Development of heme oxygenase inhibitors for the prevention of sever jaundice in infants: studies from laboratory bench to newborn nursery, in&nbsp;Heme Oxygenase in Biology and Medicine&nbsp;(Abraham NG, Alam J, and Nath KA eds) pp 3-17, Kluwer Academic/Plenum Publishers, New York.</p>"}}, {"model": "about.auditorialboard", "pk": 1, "fields": {"type": "1", "name": "Dr.Richa Mishra", "position": "Director, RB Science,", "address": "Bhopal"}}, {"model": "about.auditorialboard", "pk": 2, "fields": {"type": "2", "name": "Dr. Yeun Kan Hay", "position": "Professor, School of Pharmaceutical Sciences,", "address": "University Sains Malaysia"}}, {"model": "about.auditorialboard", "pk": 3, "fields": {"type": "2", "name": "Dr. R.K.Gupta,", "position": "Senior Consultant,", "address": "Greater Noida, Uttar Pradesh, India"}}, {"model": "about.auditorialboard", "pk": 4, "fields": {"type": "2", "name": "Dr.Amit Joshi", "position": "Principal, Jagat Guru Dattatraya College of Pharmacy (LNCT Group),", "address": "Indore, Madhya Pradesh, India"}}, {"model": "about.auditorialboard", "pk": 5, "fields": {"type": "2", "name": "Dr.BiswajitBatabyal,", "position": "Microbiologist, Serum Analysis Centre,", "address": "Howrah, West Bengal, India"}}, {"model": "about.auditorialboard", "pk": 6, "fields": {"type": "2", "name": "Dr. Mahesh Verma", "position": "CEO & Scientist, Aadya Herbals Pvt Ltd.,", "address": "Lucknow, Uttar Pradesh, India"}}, {"model": "about.auditorialboard", "pk": 7, "fields": {"type": "2", "name": "Dr.Virendra Sharma,", "position": "Professor, LN Univeristy,", "address": "Bhopal, Madhya Pradesh, India"}}, {"model": "about.auditorialboard", "pk": 8, "fields": {"type": "2", "name": "Ms. Meenakshi Jaiswal,", "position": "Assistant Professor, Guru Ghasidas University,", "address": "Bilaspur, Chhatisgarh, `India"}}, {"model": "about.certificates", "pk": 1, "fields": {"name": "MSME  certification", "shortdes": "Among business enterprises, the Micro, Small and Medium Enterprises (MSME) deserve special attention. Though MSMEs are small investment enterprises, their contribution to the Indian economy is very significant.", "logo": "certificatelogo/msme-logo-png-7.png", "Certificate": ""}}, {"model": "about.certificates", "pk": 2, "fields": {"name": "ISO certified", "shortdes": "ISO certification is a seal of approval from a third party body that a company runs to one of the international standards developed and published by the International Organization for Standardization (ISO).", "logo": "certificatelogo/iso-9001-certified-logo-png-transparent.png", "Certificate": ""}}, {"model": "artical.year", "pk": 1, "fields": {"year": "2017"}}, {"model": "artical.year", "pk": 2, "fields": {"year": "2018"}}, {"model": "artical.year", "pk": 3, "fields": {"year": "2020"}}, {"model": "artical.year", "pk": 4, "fields": {"year": "2021"}}, {"model": "artical.vol", "pk": 1, "fields": {}}, {"model": "artical.vol", "pk": 2, "fields": {}}, {"model": "artical.vol", "pk": 4, "fields": {}}, {"model": "artical.vol", "pk": 5, "fields": {}}, {"model": "artical.issue", "pk": 1, "fields": {"issue": 1, "year": 1, "vol": 1}}, {"model": "artical.issue", "pk": 2, "fields": {"issue": 2, "year": 1, "vol": 1}}, {"model": "artical.issue", "pk": 3, "fields": {"issue": 3, "year": 1, "vol": 1}}, {"model": "artical.issue", "pk": 4, "fields": {"issue": 4, "year": 1, "vol": 1}}, {"model": "artical.issue", "pk": 5, "fields": {"issue": 5, "year": 1, "vol": 1}}, {"model": "artical.issue", "pk": 6, "fields": {"issue": 6, "year": 1, "vol": 1}}, {"model": "artical.issue", "pk": 7, "fields": {"issue": 1, "year": 2, "vol": 2}}, {"model": "artical.issue", "pk": 8, "fields": {"issue": 2, "year": 2, "vol": 2}}, {"model": "artical.issue", "pk": 9, "fields": {"issue": 3, "year": 2, "vol": 2}}, {"model": "artical.issue", "pk": 10, "fields": {"issue": 4, "year": 2, "vol": 2}}, {"model": "artical.issue", "pk": 11, "fields": {"issue": 1, "year": 3, "vol": 4}}, {"model": "artical.issue", "pk": 12, "fields": {"issue": 2, "year": 3, "vol": 4}}, {"model": "artical.issue", "pk": 13, "fields": {"issue": 1, "year": 4, "vol": 5}}, {"model": "artical.issue", "pk": 14, "fields": {"issue": 2, "year": 4, "vol": 5}}, {"model": "artical.issue", "pk": 15, "fields": {"issue": 3, "year": 4, "vol": 5}}, {"model": "artical.issue", "pk": 16, "fields": {"issue": 4, "year": 4, "vol": 5}}, {"model": "artical.artical", "pk": 1, "fields": {"issue": 1, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAmit Kaushik, Ajay Kumar and Dewasya Pratap Singh*\t\t\t\t\t", "pdf": "achivesPdf/61-70-1_ipCagYI.pdf", "heading": "Pharmacological Appraisal of Herbal Medicines in treating Hepatic Diseases with Recent Advances: A review", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tLiver is the most vital organ of the. body, which perform fundamental role in the regulation of diverse processes, such as metabolism, secretion, storage, and detoxification of endogenous and exogenous substances. Due to these functions, hepatic diseases continue to arise as main problem for mankind worldwide. Despite advances in modern medicine, there are no completely effective drugs that stimulate hepatic function, that offer complete protection of the organ, or that help to regenerate hepatic cells. The use of natural remedies for the treatement of liver disease has a long history, starting with the Ayurvedic treatement. Among several novel approaches, probiotics, development of a human recombinant single chain antibody and bone marrow transplant based therapy could also be a hope for the treatement of liver diseases in future.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tLiver, Hepatic cells, Ayurvedic, Liver diseases\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Rao B Ganga, Rao Y Venkateswara and Rao T Mallikarjuna; 2013. Hepatoprotective and antioxidant capacity of Melochia corchorifolia extracts. Asian Pacific Journal of Tropical Medicine. pp. 537-543.&#13;\n2. Nilanjan Ghosh, Rituparna Ghosh, Vivekananda Mandal, and Subhash Mandal; 2011. Recent advances in herbal medicine for treatment of liver diseases. Pharmaceutical Biology. Vol. 49 (9), pp. 970–988.&#13;\n3. Rakesh Sagar, Amrita Bhaiji, Fedelic Ashish Toppo, Bandana Rath and Himanshu Bhusan Sahoo; 2014. A comprehensive review on herbal drugs for hepatoprotection of 21st Century. International Journal of Nutrition, Pharmacology, Neurological Diseases. Vol. 4 (4), pp. 191-197.&#13;\n4. Howida S. and Abou Seif; 2016. Physiological changes due to hepatotoxicity and the protective role of some medicinal plants. Beni-suef university journal of basic and applied sciences. Vol. 5, pp. 134–146.&#13;\n5. Aashish Pandit, Tarun Sachdeva and Pallavi Bafna; 2012. Drug-Induced Hepatotoxicity: A Review. Journal of Applied Pharmaceutical Science. Vol. 02 (05), pp. 233-243.&#13;\n6. Bent S and KO R; 2004. Commonly used herbal medicines in United St Review. American Journal of Medicines, Vol. 116, pp. 478-485.&#13;\n7. Bent S; 2008. Herbal medicine in the United States: Review of efficacy, safety and regulation: grand rounds at University of California, San Francisco Medical Center. Journal of General Internal Medicine. Vol. 23, pp. 854-859.&#13;\n8. Jamal AK, Yaacob WA, Laily BD; 2009. A chemical study on Phyllanthus Columnaris. European journal of Scientific Research. Vol. 28, pp. 76-81.&#13;\n9. Karthikeyan and Deepa K; 2010. Hepatoprotective effect of Premna corymbosa (Burn. F.) Rottl. &amp; Wild. Leaves extract on CCl4 induced hepatic damage in Wistar albino rats. Asian Pac J Tro med. Vol. 3(1), pp. 17-20.&#13;\n10. Gosh A; 2003. Herbal folk remedies of Bantura &amp; Medinipur districts,West Bengal (India): Indian Journal of Traditional Knowledge. Vol. 2, pp. 393-396.&#13;\n11. WHO; 2002. World Health Organization, Traditional medicine Strategy Report, Document.&#13;\n12. Handa SS, Sharma A, Chakarborty KK; 1986. Natural products a silver protecting drugs. Fitoterapia. Vol. 57, pp. 307-351.&#13;\n13. Primchanien Moongkarndi, Nuttavut Kosema, Sineenart Kaslungka, Omboon Luanratana, Narongchai Pongpan and Neelobol Neungton; 2004. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. Journal of Ethnopharmacology. Vol. 90, pp. 161-166.&#13;\n14. Jose Pedraza Chaverri, Noemi Cardenas- Rodriguez, Marisol Orozco- Ibarra, Jazmin M and Perez Rojas; 2008. Medicinal properties of mangosteen (Garcinia mangostana). Journal of food and toxicology. Vol. 3 (30) pp. 24-27.&#13;\n15. The Wealth of India Publication and Information Directorate CSIR, New Delhi, 1985. Vol. 2, pp. 116-117.&#13;\n16. Gilani AH, Janbaz KH, Aziz N, Herzig MJU, Kazmi MM, Choudhay MI and Herzig JW; 1999. Possible mechanism of selective inotropic activity of n-Butanolic fraction from Berberis aristata fruits- distinguishing hype from hope. General Pharmacology. Vol. 33(5), pp. 407-414.&#13;\n17. Upadhyay k Avanish, Kumar Kaushal, Kumar Arvind and Mishra S Hari; 2010. Tinospora cordifolia (Wild.) Hook. F. and Thoms. (Guduchi); Validation of the Ayurvedic Pharmacology through experimental and clinical studies. Int J Ayurveda Res. Vol. 1, pp. 112-21.&#13;\n18. A Arun Sam Lal, P Balakrishna Murthy and K Sadasivan Pillai; 2007. Screening of hepatoprorective effect of an herbal mixture against CCl4 induced hepatotoxicity in Swiss albino mice. Journal of Environmental Biology. Vol. 28, pp. 201-207.&#13;\n19. Chandan BK, Sharma AK and Anand KK; 1991. Boerhavia diffusa- A Study of its Hepatoprotective activity, Journal of Ethnopharmacology. Vol. 31, pp. 299-307.&#13;\n20. Shivananda Nayak B, Julien R Marshall, Godwin Isitor and Andrew Adogwa; 2011. Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (Noni) in diabetic rats, Evidence-based Complementary and alternative Medicine. pp. 1-5.&#13;\n21. Chopra RN, Nayar SL and Chopra IC; 1996. In: Glossary of medicinal plants, CSIR Publication, New Delhi. pp. 104.&#13;\n22. Khin MaMa, Nyunt Nyunt and Maung Tin; 1978. The protective effects of Eclipta alba in carbon tetrachloride Induced Acute Liver Damage. Toxicol. And Applied Pharmacol. Vol. 45, pp. 723-728.&#13;\n23. Meena B, Ezhilan RA, Rajesh R, Hussain KS, Ganesan B and Anandan R; 2008. Antihepatotoxic potential of Sargassum polycystum (Phaeophyceae) on antioxidant defense status in D-galactosamine induced hepatitis in rats. African J Biochem Res. Vol. 2 (2), pp. 51-55.&#13;\n24. Vetrivel R, Shanmugavalli N, Greety S and Umashankar V; 2009. Hepatoprotective effects of Cassia tora on CCl4 induced liver damage in albino rats. Ind J Sci Tech. Vol. 2 (3), pp. 41-44.&#13;\n25. Dhanabal SP, Syamala G, Satish Kumar MN and Suresh B, 2006. Hepatoprotective activity of the Indian medicinal plant Polygala arvensis on D-galactosamine induced hepatic injury in rats. Fitoterapia. Vol. 77 (6), pp. 472-4.&#13;\n26. Kharpate S, Vadnerkar G and Jain S; 2007. Hepatoprotective activity of ethanol extract of the leaf of Ptrospermum acerifolium. Indian Journal of Pharmaceutical Sciences. Vol. 69 (6), pp. 850-52.&#13;\n27. Kirtikar KR and Basu BD; 1975. Indian Medicinal Plants, vol. 1; reprint ed.&#13;\n28. CD Sreedevi, PG Larhab, P Ancya, SR Sujab, S Shyamalb, VJ Shineb, S Sini b, GI Anujab and S Rajasekhaeanb; 2009. Hepatoprotective studies on Sida acuta Burn. F. Journal of Ethnopharmacology. Vol. 124, pp. 171-175.&#13;\n29. Adwankar MK, Chitnis MP, Khandalekar DD, Bhadsavale CG; 1980. Anticancer activity of the extracts of Rubia cordifolia Linn. Indian Journal of Experimental Biolog., Vol. 18, pp. 102-106.&#13;\n30. Guntupalli M Mohana Rao, Chandana V Rao, Palpu Pushpangadan and Annie Shirwaikar; 2006. Hepatoprotective effects of rubiadin, a major constituent of Rubia cordifolia Linn. Journal of Ethnopharmacology. Vol. 103, pp. 484-490.&#13;\n31. AK Meena, MM Raol, RP Meena, P Pandal and Renu; 2011. Pharmacological and phytochemical evidences for the plants of Wedelia Genus: A review. Asian J. Pharm. Res. Vol. 1, no. 1, pp. 07-12.&#13;\n32. Martin KP, MR Benna and D Joseph; 2003. High frequency auxillary bud multiplication and ex-vitro rooting of Wedelia chinensis (osbeck) Merr.- A medicinal plant. Indian Journal of Experimental Biology. Vol. 41, no. 3, pp. 262-266.&#13;\n33. Arshed Iqbql Dar, Ramesh Chandra Saxena and Suresh Ku; 2012. Hepatoprotection: A hallmark of Citrus colocynthis L. against paracetamol induced hepatotoxicity in Swiss albino rats. American Journal of Plant Sciences. Vol. 3, pp. 1022-1027.&#13;\n34. F Ghaithi, MR Ridi, E Adeghate and MH Amiri; 2004. Biochemical effects of Citrullus colocynthis in normal and Diabetic rats. Molecular and Cellular Bio-chemistry. Vol. 261, no. 1, pp. 143-149.&#13;\n35. Hong-Jhang Chen, Tzu-Ming Liang, I Jung Lee, Yi-Tasu Huang and Yun-Lian Lin; 2013. Scutellariae Radix suppresses LPS-induced liver endothelial cell activation and inhibits hepatic stellate cell migration. Journal of Ethnopharmacology. Vol. 150, pp. 835-842.&#13;\n36. Silvia Wilson Gratz, Hannu Mykkanen and Hani S El-Nezami; 2010. Probiotics and gut health: A special focus on liver diseases World J Gastroenterol. Vol. 28; 16 (4) pp. 403-410.&#13;\n37. Angela Douglass, Karen Wallace, Matthew Koruth, Caroline Barelle, Andrew J. Porter, and Matthew C; 2010. Wright. Using a recombinant single chain antibody for targeting liver myofibroblasts with anti-fibrogenic therapeutics. Arab Journal of Gastroenterology. Vol. 10. Pp. S3–S6.&#13;\n38. Sei Kakinuma, Yujiro Tanaka, Ryoko Chinzei, Mamoru Watanabe, Keiko Shimizu-Saito, Yuzuru Hara, Kenichi Teramoto, Shigeki Arii, Chifumi Sato, Kozo Takase, Takehiko Yasumizu, and Hirobumi Teraoka; 2003. Human Umbilical Cord Blood as a Source of Transplantable Hepatic Progenitor Cells. Stem Cells. Vol. 21, pp. 217-227.&#13;\n39. Y N Kallis, M R Alison and S J Forbes; 2007. Bone Marrow Stem Cells and Liver Disease Gut. Vol. 56, pp. 716–724.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:47.991Z", "slug": "pharmacological-appraisal-of-herbal-medicines-in-t", "authors": []}}, {"model": "artical.artical", "pk": 2, "fields": {"issue": 1, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tSurendra Dangi*, Anup K. Chakraborty, Neeraj Upmanyu, Sanjay K. Dwivedi, Bhaskar Gupta\t\t\t\t\t", "pdf": "achivesPdf/44-60_I4szgNX.pdf", "heading": "Recent Technological Approaches on Floating Drug Delivery System", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tLatest technological processes has been committed to the improvement of managed launch (CR) dosage forms transport structures to triumph over physiological troubles along with unpredictable gastric emptying times (GRT) and less gastric house instances (GRT). Floating drug delivery device are of specific attraction for deliver pills this is regionally active and have limited absorption window within the stomach and upper part of small gut, displaying low solubility at high pH and drug that is risky in the intestinal or colonic environment. Floating drug shipping systems (FDDS) are substances that go with the flow immediately upon touch with gastric fluids gift within the belly and by using floating drug shipping systems for reinforcing the bioavailability of medicine. The concept of gastric retention comes from the need to localize tablets at a selected target a part of gastrointestinal tract (GIT) which include the belly inside the body. The promising methods, methodologies and technique used within the improvement of FDDS by formulating both effervescent and non-effervescent floating tablets based totally on buoyancy mechanism. By using above suitable promising methods it is viable to supply tablets that have slender therapeutic window at specific area.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tGastric residence time, Bioavailability, absorption window, swell able polymers\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tBabu VBM, Khar RK. In vitro and In vivo studies of sustained release floating dosage forms containing salbutamol sulphate. Pharmazie1990; 45: 268-270.&#13;\nBhowmik D, Chiranjib. B, Chandira M, Jayakar B, Sampath KK. Floating Drug Delivery System-A Review. Der Pharmacia Lettre 2009; 1(2):199-218&#13;\nChein YW. Rate-control drug delivery systems, controlled release vs sustained release. Med Prog Techn 1989; 15:21-46&#13;\nControlled Release Matrix Tablets. The Indian Pharmacist 2006; 2: 66-70.&#13;\nEl-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm. 2001; 220(1-2): 13-21&#13;\nFaraz Jamil. Review on Stomach Specific Drug Delivery Systems. Development and Evaluation 2011; 2 (4):1427-1433.&#13;\nGansbeke BV, Timmermans J, Schoutens A, Moes AJ. Intragastric positioning of two concurrently ingested pharmaceut-ical matrix dosage forms. Nucl Med Biol 1991; 18: 711-718.&#13;\nGarg R, Gupta GD. Progress in Controlled Gastro retentive Delivery Systems. Trop J Pharm Res 2008; 7 (3):1055-1066.&#13;\nGarg S, Sharma S. Gastroretentive Drug Delivery System: Business Briefing. Pharmatech 2003; 160-166.&#13;\nIannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric resi-dence. Part I. Formulation study. Int J Pharm 1998; 174: 47-54.&#13;\nIkura H, Suzuki Y. 1988; United States Patent 4777033.&#13;\nKamalakkannan V, Puratchikody A, Prasanth VV and Masilamani K: Enhancement of Drugs Bioavailability by Floating Drug Delivery System-A Review. Internat J Drug Del 2011; 1: 558-70.&#13;\nKikani HN. A Thesis on Floating Drug Delivery System. The North Gujarat University, Patan, 2001; 11-12.&#13;\nMathurn P, Saroha K, Syan N, Verma S, Nanda S. An overview on recent advancements and developments ingastroretentive buoyant drug delivery system. Der Pharmacia Sinica, 2011; 2 (1):161-169&#13;\nMayavanshi AV, Gajjar SS. Floating drug delivery system to increase gastric retention of drugs: A review. Res J Pharmaceutical Tech 2008; 1(4): 345-48.&#13;\nMojaverian P, Vlasses PH, Kellner PE, Rocci ML. Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations. Pharm Res 1988; 10: 639-644.&#13;\nMoursy NM, Ghorab DM, Saharty EY. Formulation and evaluation of sustained release floating capsules of Nicardipine hydrochloride. Pharmazie 2003; 58: 38-43.&#13;\nOth M, Franz M, Timmermans J, Moes A. The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm Res 1992; 9: 298-302.&#13;\nPaterson RS, Omahony B, Eccleston GM. Stevens HNE. Foster J. Murray JG. An assessment of floating raft formation in a man using magnetic resonance imaging. J Pharm Pharmacol 2008; 8: 32&#13;\nRahman Z, Khar RK. Design and Evaluation of Bilayer Floating Tablets of Captopril. Acta Pharma 2006; 56: 49-57.&#13;\nRathod H, Patel V, Modasia M. Floating drug delivery system: innovative approach of gastroretention. Internat J Pharm Sci Rev Res 2010; 4 (3): 183-192&#13;\nRoy HM. 1977; United States Patent no. 4055178.&#13;\nRubinstein A, Friend DR. Specific delivery to the gastrointestinal tract. Polymeric Site-Specific Pharmacotherapy, Wiley, Chichester.1994; 282-283.&#13;\nRubinstein A., Friend D.R. 1979; U.S. Patent no. 4140755.&#13;\nShiv Shankar Hardenia. Floating drug delivery systems: A review. Asian J Pharmacy Life Sci 2011; 1 (3):284-293&#13;\nShubhrajit M, Thilothama LR, Shashanka D. Formulation and in vitro evaluation of metoprolol succinate floating tablets by using two viscosity grade of HPMC. Internat J Pharm Sci Res 2012; 3 (9): 3507-13.&#13;\nShweta A, Javed A, Alka A, Roop KK, Sanjula B. Floating drug delivery systems: a review. AAPS Pharm Sci tech 2005; 6(3): 72-90.&#13;\nStops F, Fell JT, Collett JH, Martini LG. Floating dosage forms to prolong gastro retention the characterisation of calcium alginate beads. Int. J. Pharm. 2008; 350: 301-311.&#13;\nSuryawanshi A, Hiremath SP. Floating Drug Delivery System – A Review. Am J Pharmatech Res 2011; 2(1): 138-53.&#13;\nThanoo BC, Sunny MC, Jayakrishnan A. Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid. J Pharm Pharmacol 1993; 45: 21-24.&#13;\nThe American Society for Gastrointestinal Endoscopy: A history. Gastrointestinal Endoscopy 1991; 37(2):S1-S26&#13;\nTimmermans J, Moes AJ. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. J Pharm Sci, 1994; 83(1): 18-24.&#13;\nTimmermans J, Moes AJ. How well floating dosage does forms float. Int J Pharm.1990; 62: 207-216.&#13;\nVarshosaz J, Tavakoli N. Formulation and In Vitro Characterization of Captopril Floating Extended Release Tablet. Drug Delivery 2006; 13: 277-285.&#13;\nVidyadhara S, Chowdary YA, Murthy TEGK, Rao MV, Reddy KNK. Influence of Electrolyte on Controlled Release of Ambroxol Hydrochloride from Methocel Matrix Tablet. The Pharma Review 2006; 101- 104.&#13;\nVidyadhara S, Rao PR, Prasad JA. Development and In-Vitro Kinetic of Propanolol Hydrochloride controlled release matrix tablets. The Indian Pharmacist 2006; 2:66-70.&#13;\nWhitehead L, Fell J, Sharma HL. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention, J Control Rel 1998; 55: 3-12.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:50.447Z", "slug": "recent-technological-approaches-on-floating-drug-d", "authors": []}}, {"model": "artical.artical", "pk": 3, "fields": {"issue": 1, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tPurva Tiwari*, Amit Joshi, B. K. Dubey\t\t\t\t\t", "pdf": "achivesPdf/30-43_Lv2BRCK.pdf", "heading": "Total phenolic content, flavonoid concentration, antimicrobial and insecticidal screening of aqueous extracts of Annona squamosa (seeds), Azadirachta indica (leaves) and Lavandula angustifolia (flower)", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe present study describes the total phenolic content, flavonoid concentration, antimicrobial and insecticidal screening of aqueous extracts of Annona squamosa (seeds), Azadirachta indica (leaves) and Lavandula angustifolia (flower). The total phenolic content in the extracts was determined using Folin-Ciocalteu reagent and their amounts were found to be 0.045, 0.052 and 0.56 mg GA (gallic acid)/mg. The concentrations of flavonoids were found to be 0.98, 1.25 and 1.12 mg Qu (quercetin)/mg. The extract exhibited dose dependent inhibition of test bacteria. Search for natural insecticides, which are easily degradable and do not have any ill effects on the non-target population, remains one of the top priority issues for many countries. In this study, the aqueous extract have exhibited potent insecticidal activity. This finding suggests that Annona squamosa, Azadirachta indica and Lavandula angustifolia may be considered as a natural source of antioxidants and antimicrobial agents.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tAntimicrobial activity, Phenols, Flavonoids, insecticidal, Annona squamosa, Azadirachta indica, Lavandula angustifolia\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Singh TP et al. Analgesic and anti-inflammatory activities of Annona squamosa Linn bark. Jf Sci Innov Res 2014; 3(1): 60-64.&#13;\n2. Dallaqua B, Saito FH, Rodrigues T , Calderon IMP, Rudge MVC, Herrera E, Damasceno DC. Treatment with Azadirachta indica in diabetic pregnant rats: Negative effects on maternaloutcome. J Ethnopharmacol 2012; 143: 805–811.&#13;\n3. Lis-Balchin MT, Deans SG. Bioactivity of selected plant essential oil against Listeria monocytogenes. J Appl Microbiol 1997; 82: 759-762.&#13;\n4. Kokate CK. “Practical Pharmacognosy’’ Vallabh Prakashan, New Delhi, India, 54, 1994.&#13;\n5. Hossain MA et al. In vitro total phenolics, flavonoids contents and antioxidant activity of essential oil, various organic extracts from the leaves of tropical medicinal plant Tetrastigma from Sabah. Asian Pac J Trop Med., 2011; 4(9):717–721.&#13;\n6. Tepe B, Donmez E, Unlu M, Candan F, Daferera D, Vardar-Unlu G, Polissiou M, Sokmen A. Antimicrobial and antioxidative activities of the essential oils and methanol extracts of Salvia cryptantha (Montbret et Aucherex Benth.) and Salvia multicaulis (Vahl). Food Chem. 2004; 84(4):519-525.&#13;\n7. Redwane A, Lazrek HB, Bouallam S, Markouk M, Amarouch H, Jana M. Larvicidal activity of extracts from Quercus lusitania var infectoria galls (oliv). J. Ethnopharmacol. 2002; 79:261-263.&#13;\n8. Penso G. The role of WHO in the selection and characterization of medicinal plants. J. Ethnopharmacol. 1980; 2:183-188.&#13;\n9. Gupta M, Mazumder UK, Kumar RS, Sivakumar T and Vamsi MLM. Antitumor and Antioxidant status of Caesalpinia bonducella against Ehrlich ascites Carcinoma in swiss albino mice. J Pharmacol Sci 2004; 940 177-184.&#13;\n10. Ahmed I, Mehmood Z, Mohammad F. Screening of Indian medicinal for their antimicrobial properties. J. Ethnopharmacol 1998; 62: 183-193.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:51.019Z", "slug": "total-phenolic-content-flavonoid-concentration-ant", "authors": []}}, {"model": "artical.artical", "pk": 4, "fields": {"issue": 1, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tPandey GK*, Pandey D, Jain D, Joshi A, Dubey BK\t\t\t\t\t", "pdf": "achivesPdf/15-29_s0sFFW7.pdf", "heading": "Design and Optimization of Lamivudine Floating Microspheres", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe present study was focused to develop floating microspheres of Lamivudine in order to achieve an extended retention in the upper gastrointestinal tract, which may result in enhanced absorption and thereby improved bioavailability. The present study involves preparation and evaluation of floating microspheres using Lamivudine as a model drug for prolongation of the gastric retention time. As Lamivudine is mainly absorbed from stomach, thus using floating microspheres as a mode of drug delivery helps in increasing its residence time and hence increasing the bioavailability of drug. The microspheres were prepared by the Ionic gelation method. The average diameter and surface morphology of the prepared microspheres were characterized by optical microscope and scanning electron microscopic methods respectively. The prepared microspheres were evaluated for particle size, micromeritic study, drug entrapment efficiency, in vitro buoyancy, swelling index and in vitro release. The effect of various formulation variables on the size and drug release was also investigated. All the formulated microspheres were found to possess good flow properties. Scanning electron microscopy confirmed spherical structure of the prepared microspheres. The best formulation F3 drug release kinetics were evaluated using Zero order, First order, Higuchi model, Korsmeyer - Peppas model. After the interpretation of data that was based on the value of a resulting regression coefficient, it was observed that the Korsmeyer- Peppas model has a highest regression coefficient values indicating that the drug release was based on the erosion of polymeric chain matrix system\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tLamuvudine, Floating microspheres, Gum acacia, Zero order, First order, Higuchi model, Korsmeyer-Peppas model\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAulton, M. E., 2002. Pharmaceutics: The Science of Dosage Form Design. 2nd ed., Livingstone C. Elsevier science Ltd. Dubey M, Kesharwani P, Tiwari A, Chandel R, Raja K, Sivakumar T. Formulation and Evaluation of Floating Microsphere Containing Anti Diabetic Drug. Internat J Pharm Chem Sci 2012; 3: 1038-1047.&#13;\nFreiberg S. Polymer microspheres for controlled drug release. XX. Internat J Pharm 2004; 282 (1-2):1–18. Gangadharappa HV, Biswas S, Getyala A, Vishal N, Gupta PK. Development, in- vitro and in-vivo Evaluation of Novel Floating. Der Pharmacia Lettre 2011; 3 (4): 299-316. Jamadar SA, Snehal P, Mulye K, Poonam S, Pore YV, Burade KB. Development and validation of UV spectrophotometric method for the determination of Lamivudine in tablet dosage form. Scholars Research Library 2011; 3(4):338-343. Kokate, C.K., Purohit, A.P., Gokhale, S.B., 2010. Pharmacognosy. 45th ed., Nirali prakashan. pp 7.12-7.13. Pande AV, Vaidya PD, Arora A, Dhoka MV. In vitro and In vivo evaluation of ethyl cellulose based floating microspheres of cefpodoxime proxetil. Internat J Pharm Biomed Res 2010; 1(4): 122-128. Prak J, Ye M, Park K. Review Biodegradable Polymers for Microencapsulation of Drugs. Molecules 2005; 10 (1): 146-161. Prakash S, Bhandari A, Mishra R, Sharma PK. Development and optimization of floating microspheres of gliclazide. Internat J Pharm Sci Res 2015; 6(5): 807-817&#13;\nPunitha K, Kadhir S, Umadevis K, Vaijayanti VS, Padma PS, Suresh K. Intragastric Floating Drug Delivery System Of Ranitidine Hydrochloride: Formulation And Evaluation. Internat J Pharm Pharm. Council 2010; 2(4): 975-1491. Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients. 6th edition. RPS publication 2009. Swarnkar K, Tanwar P, Sharma M, Singhal A, Sharma M, Ashish K Preparation and optimization of oral floating alginate gel beads of famotidine. IJPSRS 2012; 3(2):04-08. Tang YD, Venkatraman SS, Boey FYC, Wang Li-Wei. Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form. Int J Pharm 2007; 336: 159-165. Trivedi P, Verma ML, Garud N. Preparation and characterization of aceclofenac microspheres. Asian J Pharm 2008; 2: 110-115. Wilding IR, Davis SS, O’Hagan DT. Targeting of Drugs and Vaccines to the Gut. Pharmac Ther 1994; 98–124.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:51.618Z", "slug": "design-and-optimization-of-lamivudine-floating-mic", "authors": []}}, {"model": "artical.artical", "pk": 5, "fields": {"issue": 1, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tPrakash Sahu and Shweta Singh\t\t\t\t\t", "pdf": "achivesPdf/9-14_p3pwUvG.pdf", "heading": "Validated RP-HPLC method for estimation of Etoricoxib & Paracetamol and its applications in analysis of formulations", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe current paper describes a reversed phase high performance liquid chromatographic&#13;\nmethod for the simultaneous estimation of Etoricoxib and Paracetamol in formulations. The&#13;\nseparation was achieved on the LUNA C18 column 5μ (250 x 4.6 mm id), using methanol -&#13;\nwater in the ratio 63 - 37 as the mobile phase at 1 ml/min flow rate and 237 nm as detection&#13;\nwavelength. The retention time of Etoricoxib and Paracetamol were 1.6 and 2.9 min&#13;\nrespectively. The method was validated in terms of linearity, accuracy, precision, as per ICH&#13;\nGuidelines. The calibration curve was linear in the concentration range from 10-60 μg/ml&#13;\nfor etoricoxib and 100-600 μg/ml for paracetamol. Percentage recovery obtained for&#13;\netoricoxib and paracetamol were 99.60 % and 99.04 % respectively.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tICH, HPLC, Validation, Etoricoxib, Paracetamol, Calibration\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tBrautigam L, Nefflen JU, and Geisslinger G (2003) Determination of etoricoxib in human&#13;\nplasma by liquid chromatography-tandem mass spectrometry with electrospray&#13;\nionization. J Chromatogr b 788: 309-315.&#13;\nDallob A (2003) Characterization of&#13;\nEtoricoxib, a Novel Selective Cox-2 inhibitor,&#13;\nJ Clin Pharmacol 43: 573 – 583.&#13;\nHartman R, Abrahim A, Mao B, and Crocker&#13;\nLS (2003) A HPLC method for the impurity&#13;\nand quantitative analysis of etoricoxib. J Liq&#13;\nChromatogr 26: 2551-2566.&#13;\nKalsi PS (2001) Ultraviolet &amp; Visible&#13;\nSpectroscopy, in Spectroscopy of organic&#13;\ncompounds, 4th ed., pp 7-58, New age&#13;\ninternational publishers, New Delhi.&#13;\nLiberato BJ, Danieli CC, Marcio F, Paulo RO,&#13;\nand Sergio LD (2006) LC-Tandam MS/MS&#13;\nmethod for the determination of etoricoxib in&#13;\nhuman plasma and pharmaceutical&#13;\nformulations. J Liq Chromatogr 29: 123-135.&#13;\nMaheshwar G, Subramanian GS, Karthik A,&#13;\nMusmade P, Gunjupalli K, and Uupa N (2007)&#13;\nHigh performance liquid chromatograpy&#13;\nmethod for the determination of etoricoxib in&#13;\nthe bulk drug and in pharmaceutical dosage&#13;\nform. J Planar Chromatogr-Modern TLC 20: 335-&#13;\n339.&#13;\nMandal U, Senthil RD, Bose A, Gowda KV,&#13;\nand Pal TK (2006) HPLC method for analysis of etoricoxib in human plasma. J Pharm Sci 68:&#13;\n485-489.&#13;\nPatel HM, Suhagia BN, Shah SA, and Rathod&#13;\nIS (2007) Determination of etoricoxib in&#13;\npharmaceutical formulation by HPLC method.&#13;\nJ Pharm Sci 69: 703-704.&#13;\nPatrignani P (2003) Clinical Pharmacology of&#13;\nEtoricoxib: A Novel selective Cox Inhibitors.&#13;\nExpert Opin Pharmacother 4: 265 – 284.&#13;\nPattan SR, Jamdas SG, Godgel RK, Dighe NS,&#13;\nDaithankari AV, Nirmal SA, and Pai MG&#13;\n(2006) RP-HPLC method for simultaneous&#13;\nestimation of paracetamol and etoricoxib from&#13;\nbulk tablets, J Liq Chromatogr 20: 112-120.&#13;\nSethi PD (2007) HPLC quantitative analysis of&#13;\npharmaceutical formulation, 5th ed. CBS&#13;\nPublishers &amp; Distributers, New Delhi&#13;\nVenkata VA, Menon CA, Addepalli VR, and&#13;\nMullangi R (2005) Simultaneous quantitation&#13;\nof etoricoxib, salicylic acid, valdecoxib,&#13;\nketoprofen, nimesulide and celecoxib in&#13;\nplasma by high-performance liquid&#13;\nchromatography with UV detection. J Biomed&#13;\nAnal 21: 125-132.&#13;\nWerner U, Werner D, Hinz B, Lambrecht C,&#13;\nand Brune K (2004) Liquid chromatographymass&#13;\nspectrometry method for the&#13;\nquantification of both etoricoxib and&#13;\nvaldecoxib in human plasma. J Biomed&#13;\nChromatopgr 19:113-118.&#13;\nWillard HH, Merritt LL Jr, and Settle FA Jr&#13;\n(2001) An Introduction to Instrumental&#13;\nMethods, in Instrumental methods of analysis,&#13;\n7th ed., pp 1-12, CBS Publisher &amp;&#13;\nDistributors, Delhi.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:52.170Z", "slug": "validated-rp-hplc-method-for-estimation-of-etorico", "authors": []}}, {"model": "artical.artical", "pk": 6, "fields": {"issue": 1, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tBrijeshkunvar J Mishra*\t\t\t\t\t", "pdf": "achivesPdf/1-8-1_uodHX8V.pdf", "heading": "Synthesis of 1,8-Napthyridine derivatives and their evaluation as possible antiepileptic agents", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAminopropyloxy derivatives of 1,8-naphthyridines have been synthesized using the principle of Conrad-Limpach synthesis of quinolines. The hydroxy group at 2- position of the naphthyridine ring was converted to the corresponding epoxypropane ether derivative by etherification with epichlorhydrin. The epoxy ether was then aminated in presence of KOH with the corresponding amines to obtain the aminopropyloxy derivatives. The compounds were tested for anti convulsant action at dose of 150mg/Kg relative to diazepam (5mg/Kg) by prevention of PTZ-induced seizures in mice.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tNaphthyridine, anticonvulsant, Pentylenetetrazole, tonic clonic, aminopropyloxy\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAgrawal SK, Saxena AK, Jain PC, Anand N, Sur RN, Srimal RC, and Shawan BN (1990) Synthesis and structure activity relationship in aryloxyalkylamines. Indian J Chem 29B: 80-84.&#13;\nBouzard D, Cesare PD, Essiz M, Jacquet J, Ledoussal B, Remuzon P, Kessler R, and Tomc JF (1992) Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloamino)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids. J Med Chem 35(3): 518-525.&#13;\nDrug Discovery and Evaluation: Pharmacological Assays (Ed. H. G. Vogel), Springer-Verlag, Berlin Heidelberg (2002), pp. 385-593.&#13;\nFerrarini P, Manera C, Mori C, Badawneh M, and Saccomanni G (1998) Synthesis and evaluation of antimycobacterial activity of 4-phenyl-1,8-naphthtyridine derivatives Farmaco 53(12): 741-746.&#13;\nFerrarini P, Mori C, and Tellini N (1990) Synthesis and local anesthetic activity of (E)- and (Z)-diethylaminoethyl-iminoethers of 1,8-naphthyridine. Farmaco 45(3): 385-389.&#13;\nFerrarini PL, Badawneh M, Franconi F, Manera C, Miceli M, Mori C, and Saccomani G (2001) Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives. Farmaco 56(4): 311-318.&#13;\nKuo S, Tsai S, Li H, Wu C, Ishii K, and Nakamura H (1988) Studies on heterocyclic compounds. IX. Synthesis and antiallergic activity of furo [2,3-b] [1,8] naphthyridine-3,4 (2H, 9H)-diones, and 4H-furo [2,3-d] pyrido [1,2-alpha]-pyrimidine-3,4 (20-diones). Chem Pharm Bull 36(11): 4403-4407.&#13;\nScotese SA, Bauer R, and Bell S (1987) 2-Oxo-1,8-naphthyridine-3-carboxylic acid derivatives with potent gastric antisecretory properties J Med Chem 30(12): 2270-2277.&#13;\nSettimo AD, Primofiore G, Settimo FD, Simorini F, Barili P, Senatore G, Martini C, and Luccacchini A (1994) Synthesis and benzodiazepine receptor activity of some 4,5-dihydro-1H-pyrazolo [4,3-c] [1,8] naphthyridine derivatives. Drug Des Discov 11(40): 307-328.&#13;\nSur RN, Shanker G, Rathore RSK, Chak IM, Agrawal SK, and Jain PC (1980) Pharmacological studies on 1-(p-aminophenoxy)-3-[N1-(O-methoxypheynyl)-N4-piperazinyl]propane dihydrochloride. Indian J Exp Biol 18: 1190-1191.&#13;\nTakeshi K, Fumio K, and Tadafumi T (1992) A novel synthesis and potent anti-inflammatory activity of 4-Hydroxy-2(1H)-oxo-1-phenyl-1,8-naphthyridine-3-carboxamides, J Med Chem 35(6): 1130-1135.&#13;\nThomas LJ, Gangadhar R, Kishore SG, Ramchandran S, Saravanan M, and Sridhar SK (2003) Synthesis and pharmacological activities of 1,8-naphthyridine derivatives. Indian Drugs 40(6): 320-327.&#13;\nZhang SX, Bastow KF, Tachibana Y, Kuo SC, Hamel E, Mauger A, Narayana VL, and Lee KH (1999) Antitumor Agents. 196. Substituted 2-Thienyl-1,8-naphthyridin-4-ones: Their synthesis, cytotoxicity, and inhibition of Tubulin Polymerization 1. J Med Chem 42(20): 4081-4087.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:52.949Z", "slug": "synthesis-of-18-napthyridine-derivatives-and-their", "authors": []}}, {"model": "artical.artical", "pk": 7, "fields": {"issue": 2, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tKailashpati Pandey*, Prabhat Jain, Brijeshkunvar Mishra\t\t\t\t\t", "pdf": "achivesPdf/85-93_4FzNwRG.pdf", "heading": "Estimation of Diacerein using hydrotropic agent and dye drug reaction", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThis study was designed to develop and validate hydrotropic agent and dye drug reaction&#13;\nmethods for estimation of diacerein in capsule formulation. Hydrotropic solubilization is a&#13;\ntechnique used to increase the aqueous solubility of poorly water-soluble drugs and the&#13;\npresent study was aimed at developing a hydrotropic technique to increase the solubility of&#13;\ndiacerein. The analysis of tablets indicated good correlation between the amounts estimated&#13;\nand label claim. The study results indicate good sensitivity of the proposed method. The&#13;\nresults of analysis were validated statistically and by recovery studies. The developed&#13;\nmethods were validated according to ICH guidelines and values of accuracy, precision and&#13;\nother statistical analysis were found to be in good accordance with the prescribed values.&#13;\nThus the proposed method was found to be simple, environmentally friendly, accurate and&#13;\ncost effective and can be successfully employed in routine analysis of diacerein in capsule.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tHydrotropic Solubilizing Agents, Diacerein, Dye Drug Reaction, ICH, validation\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Shete AS, Yadav AV, Dabke AP, Sakhare&#13;\nSS. Formulation and evaluation of&#13;\nhydrotropic solubilization based&#13;\nsuspensions of griseofulvin. International&#13;\nJournal of Pharma Sciences and Research&#13;\n2010; 1(1): 51–57.&#13;\n2. Vinnakota SNA, Deveswaran R, Bharath S,&#13;\nBasavaraj BV, Madhavan V. Application of&#13;\nmixed hydrotropic solubilization in spectrophotometric estimation of&#13;\naceclofenac in tablets. Journal of Current&#13;\nPharmaceutical Research 2011; 1(3): 223–&#13;\n226.&#13;\n3. Gurumurthy V, Deveswaran R, Bharath S,&#13;\nBasavaraj BV, Madhavan V. Application of&#13;\nhydrotropic solubilisation in simultaneous&#13;\nestimation of atenolol and amlodipine&#13;\nbesylate. Asian Journal of Research&#13;\nChemistry 2012; 5 (1): 57–60.&#13;\n4. Renapurkar DK, Mathur S, Rao KJ.&#13;\nEvaluation of efficacy and safety of&#13;\ndiacerein in osteoarthritis of knee joint,&#13;\nInternational Journal of Pharma and Bio&#13;\nSciences 2010; 1(3):1-12.&#13;\n5. Yao HC, Yang XF. Sensitive determination&#13;\nof nanogram levels of diacerein in a&#13;\npharmaceutical formulation by flow&#13;\ninjection chemiluminescence analysis.&#13;\nJournal of the Chinese Chemical Society,&#13;\n2007, 54, 949-956.&#13;\n6. Gupta KR, Samrit VE, Thakur V, Hemke&#13;\nAT. UV-spectrophotometric estimation of&#13;\ndiacerein in pharmaceutical formulation. J&#13;\nChem Pharm Res. 2010;2:467–72.&#13;\n7. Sivakumar R, Nallasivan PK, Saranya KC,&#13;\nSam Solomon WD, Akelesh T,&#13;\nVenkatnarayanan R. Visible&#13;\nspectrophotometric estimation of diacerein&#13;\nin bulk and pharmaceutical dosage&#13;\nforms. Pharm Anal. 2010;2:414-416.&#13;\n8. ICH, Q2A: Text on Validation of&#13;\nAnalytical Procedures, International&#13;\nConference on Harmonization. 1994.&#13;\n9. ICH, Q3B: Validation of Analytical&#13;\nProcedures: Methodology, International&#13;\nConference on Harmonization. 1996.&#13;\n10. ICH Harmonized Tripartite Guideline, Q2&#13;\n(R1): Validation of Analytical Procedures:&#13;\nText and Methodology. 2005.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:53.905Z", "slug": "estimation-of-diacerein-using-hydrotropic-agent-an", "authors": []}}, {"model": "artical.artical", "pk": 8, "fields": {"issue": 2, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tNeelam Singh, Madhulika Singh\t\t\t\t\t", "pdf": "achivesPdf/77-84_PmDvkRp.pdf", "heading": "An Evaluation of Phytochemicals in Maceration and Infusion Extracts of Cyperus rotundus Linn Leaves in Two Different Solvents", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the study to evaluate the hepatoprotective effect of ethanolic extract of&#13;\nCurcuma caesia rhizomes in Wistar rats on paracetamol induced liver. Albino wistar rats were&#13;\nseparated into five groups (n=6). Ethanolic extract of Curcuma caesia rhizomes was prepared&#13;\nand evaluated for its hepatoprotective efficacy against paracetamol (PCM) (2g/kg p.o.)&#13;\ninduced hepatotoxicity in rats. Silymarin (100mg/kg p.o.) was used as standard. Levels of&#13;\nSerum glutamic pyruvate transaminase (SGPT), Serum glutamic oxaloacetic transaminase&#13;\n(SGOT), alkaline phosphatase (ALP), and total protein was evaluated along with&#13;\nhistopathological investigation in various experimental groups of rats. Present study&#13;\nsuggested thatthe protective effect of ethanolic extract of Curcuma caesia against paracetamol&#13;\ninduced hepatic damage.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tCyperus rotundus, Phytochemicals, Infusion, Maceration\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAnonymous (2001). The Wealth of India: A&#13;\nDictionary of Indian Raw Materials Boulos L and El-Hadidi MN (1984). The&#13;\nWeed Flora of Egypt. Cairo: (1984). The&#13;\nAmerican University in Cairo Press. p.58.&#13;\nElezabeth DV and Arumugam S (2013). Study&#13;\nof the Phytochemical Analysis and Antimicrobial&#13;\nActivity of Cyperus rotundus Leaves. International J&#13;\nCurrent Biotechnol 1(8): 5-8.&#13;\nElezabeth DV and Arumugam S (2014).&#13;\nPhytochemical Screening of the Various Extracts&#13;\nof Cyperus rotundus. L. American J Pharmtech 4(3):&#13;\n545-553.&#13;\nHarborne JB (1983). Phytochemical methods; A&#13;\nguide to modern Techniques of plant analysis. 3rd&#13;\nedition Chapman and Hall; New York.&#13;\nJeong SJ, Miyamoto T, Inagaki M, Kim YC,&#13;\nand Higuchi R (2000). Rotundines A-C, Three&#13;\nNovel Sesquiterpene Alkaloids from Cyperus&#13;\nrotundus. J Nat Prod 63: 673-675.&#13;\nKhan S, Choi RJ, Lee DU and Kim YS (2011).&#13;\nSesquiterpene Derivatives isolated from Cyperus&#13;\nrotundus L. inflammatory signaling mediated by&#13;\nNFxB. Natural Product Sciences 17(3): 250-255.&#13;\nKhandelwal KR (1997). Practical&#13;\nPharmacognosy; Techniques and experiments,&#13;\nfirst Edition, Nirali Publication, Pune; p 146&#13;\nLansdown RV and JuffeBignoli D (2013).&#13;\nCyperus rodundus. The IUCN Red List of&#13;\nThreatened Species 2013: e.T158183A68258847.&#13;\nwww.iucnredlist.org/details/158183/0&#13;\nMuthu K, Hema M, Nagaraj S and&#13;\nRengasamy R (2014). In-vitro antibacterial&#13;\npotential, Phytochemical characterization of&#13;\nCyperus rotundus flower extract. Internat J Nat Prod&#13;\nRes 4(1): 6-8.&#13;\nRai PK, Kumar R, Malhotra Y, Sharma D and&#13;\nKarthiyagini T (2010). Standardization and&#13;\nPreliminary Phytochemical Investigation on&#13;\nCyperus rotundus Linn Rhizome. Internat J Res&#13;\nAyurveda and Pharmacy 1(2): 536-542.&#13;\nKilani-Jaziri S, Bhouri W, Skandrani I,&#13;\nLimem I, Chekir-Ghedira L and Ghedira K&#13;\n(2011). Phytochemical, Antimicrobial,&#13;\nAntioxidant and Antigenotoxic Potentials of&#13;\nCyperus rotundus Extracts. South African J Botany 77:&#13;\n767–776.&#13;\nSharma SK and Singh AP (2011).&#13;\nMorphological, Microscopical and PhysicoChemical Investigations on the Rhizomes of&#13;\nCyperus rotundus Linn. Res J Pharmaceutical, Biological&#13;\nChem Sci 2(3): 798-806.&#13;\nSingh N, Pandey BR, Verma P, Bhalla M and&#13;\nGilca M (2012). Phyto-Pharmacotherapeutics of&#13;\nCyperus rotundus Linn.(Motha): An Overview. Indian&#13;\nJ Natural Products Resources 3(4): 467-476.&#13;\nSivapalan SR (2013). Medicinal Uses and&#13;\nPharmacological Activities of Cyperus rotundus&#13;\nLinn. – A Review. Internat J Scientific Research&#13;\nPublication 3(5): 01-08.&#13;\nSivapalan SR and Jeyadevan P. (2012).&#13;\nPhysico-Chemical AndPhyto-Chemical Study of&#13;\nRhizome of Cyperus rotundusLinn. Internat J&#13;\nPharmacol Pharmaceutical Technol 2(1): 42-46.&#13;\nSofowora A (1993). Medicinal Plants and&#13;\nTraditional medicines in Africa. John Wily and&#13;\nSons New York; p 6&#13;\nSreenu P, Samatha T, Gandhi N and Naik AS&#13;\n(2014). Phytochemical Analysis of Root, Stem&#13;\nand Leaf Extracts in Rubia cordifolia L. an&#13;\nImportant Medicinal Plant. World J Pharm and&#13;\nPharmaceutical Sci 3 (10): 826-838.&#13;\nVershaeve L, Kestens J, Tylor E and Maes A&#13;\n(2004). Investigation of the Antimutagenic&#13;\nEffects of Selected Northeast Medicinal Plants&#13;\nExtracts. J Essential Oil Res 18: 29-35.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:55.251Z", "slug": "an-evaluation-of-phytochemicals-in-maceration-and-", "authors": []}}, {"model": "artical.artical", "pk": 9, "fields": {"issue": 2, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRizwan Arif, Sanjay Dwivedi*\t\t\t\t\t", "pdf": "achivesPdf/71-76_BroVCHf.pdf", "heading": "Hepatoprotective effect of ethanolic extract of Curcuma caesia rhizomes in rats on paracetamol induced liver cirrhosis", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the study to evaluate the hepatoprotective effect of ethanolic extract of&#13;\nCurcuma caesia rhizomes in Wistar rats on paracetamol induced liver. Albino wistar rats were&#13;\nseparated into five groups (n=6). Ethanolic extract of Curcuma caesia rhizomes was prepared&#13;\nand evaluated for its hepatoprotective efficacy against paracetamol (PCM) (2g/kg p.o.)&#13;\ninduced hepatotoxicity in rats. Silymarin (100mg/kg p.o.) was used as standard. Levels of&#13;\nSerum glutamic pyruvate transaminase (SGPT), Serum glutamic oxaloacetic transaminase&#13;\n(SGOT), alkaline phosphatase (ALP), and total protein was evaluated along with&#13;\nhistopathological investigation in various experimental groups of rats. Present study&#13;\nsuggested thatthe protective effect of ethanolic extract of Curcuma caesia against paracetamol&#13;\ninduced hepatic damage.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tCurcuma caesia, Hepatoprotective effect, paracetamol, Histopathological study,&#13;\ncirrhosis\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Wang S, Nagrath D: Liver Tissue Engineering. Biomaterials for Tissue Engineering Applications: A Review of the Past and Future Trends 2010, 14: 389.&#13;\n2. Friedman SL, McQuaid KR, Grendell JH: Current diagnosis &amp; treatment in gastroenterology. New York: Lang Medical Books/McGraw-Hill 2002.&#13;\n3. O'Connell M, Rushworth S: Curcumin: potential for hepatic fibrosis therapy? Br J Pharmacol 2008, 153 (3): 403-405.&#13;\n4. Thamizh Selvam N, Venkatakrishnan V, et al. Hepatoprotective activity of methanolic extract of Syzygium jambos (Linn.) leaf against paracetamol intoxicated Wistaralbino rats. Ayu 2013, 34: 305-307.&#13;\n5. Akindele AJ, Ezenwanebe KO, et al. Hepatoprotective and in vivo antioxidant effects of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae). J Ethnopharmacol 2010, 129: 46–52.&#13;\n6. Kallappa SG and Jambilingappa LK. Evaluation of hepatoprotective activity of aqueous extract of Azadirachta indica (neem) leaves against paracetamol induced hepatotoxicity in albino rats. Pharmacologyonline 2011, 2: 96–108.&#13;\n7. Sharma PC, Yelne MB et al. Database on Medicinal plants used in Ayurveda. CCRAS 2002, 4: 34-8.&#13;\n8. World Health Organization. WHO Monographs on selected medicinal plants. Geneva: AITPBS Publications and Distributors 2002, 2: 12-24.&#13;\n9. OECD. Guideline for Testing of Chemicals-Acute Oral Toxicity-Acute Toxic Class Method. Paris: OECD 2001.&#13;\n10. Narasimhanaidu K, Rajagopalan R, Varma PS, et al. Comparative Effects of Curcumin and an analogue of Curcumin in Carbon Tetrachloride induced Hepatotoxicity in Rats, Basic and Clinical Pharmacology and Toxicology 2005; 97: 15-21.&#13;\n11. Somchit MN, Ahmad BA, Somchit N, Sulaiman MR, Noratunlina R. Protective activity of Turmeric (curcuma longa) in Paracetamol induced Hepatotoxicity in Rats. Internat J Pharmacol 2005; 3:252-256.&#13;\n12. Galighor, AE, Kozloff EN. Essentials of practical microtechnique 2nd edn, Lea and Febiger, NewYork 1976.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:55.873Z", "slug": "hepatoprotective-effect-of-ethanolic-extract-of-cu", "authors": []}}, {"model": "artical.artical", "pk": 10, "fields": {"issue": 3, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tNeelima Mishra*, Prabhat Jain, Brijeshkunvar Mishra\t\t\t\t\t", "pdf": "achivesPdf/94-102_1OvVDRY.pdf", "heading": "Derivatization of Gallic Acid with amino acids for accentuation of its antioxidant potential", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tPhenolics like gallic acid have been known for their anti oxidant activity since long time. Many attempts for increasing antioxidant potency of phenolics have been made utilizing synthetic and drug discovery tools. In an attempt to improve the antioxidant potential of gallic acid, it was decided to introduce a few amino acids into the structure of gallic acid and evaluate their antioxidant potential in vitro. The amino acid derivatized gallic acid molecules were confirmed for their formation by spectral studies and the in vitro antioxidant potential was evaluated using DPPH free radical scavenging protocol and hydrogen peroxide free radical scavenging assay method. The results revealed that presence of cysteine residues in the amino acids were particularly beneficial for the antioxidant potential.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tGallic acid, antioxidant, amino acids, derivatization, radical scavenging\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Abe I, Seki T and Noguchi H (2000). Potent and selective inhibition of squalene epoxidase by synthetic gallic esters. Biochemical and Biophysics Research Communication, 270, 137- 140.&#13;\n2. Ahmad I, Aqil F and Owais M (2006). Modern Phytomedicine: Turning Medicinal Plants into Drugs. WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim, Germany.&#13;\n3. Hack- Seang K (2005). Do not put too much value on conventional medicine. Journal of Ethnopharmacology, 100, 37-39&#13;\n4. Inoue M, Suzuki R, Sakaguchi N, Li Z, Takeda T, Ogihara Y, Jiang B and Chen Y (1995). Selective induction of cell death in cancer cells by gallic acid. Biological and Pharmaceutical Bulletin, 18, 1526–1530.&#13;\n5. Kaur M, Velmurugan B, Rajamanickam S, Agarwal R and Agarwal C (2009). Gallic acid, an active constituent of grape seed extract, exhibits antiproliferative, pro apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharmaceutical Research, 26, 2133–2140.&#13;\n6. Kim DO, Lee KW, Lee HJ and Lee CY (2002). Vitamin C equivalent antioxidant capacity of phenolic phytochemicals. Journal of Agriculture and Food Chemistry, 50, 3713–3717.&#13;\n7. Kroes BH, Van den Berg AJJ, Quarles van Ufford HC, Van Dijk H and Labadie RP (1992). Anti-inflammatory activity of gallic acid. Planta Medica, 58, 499–504.&#13;\n8. Li N, Ning-hua T and Zhou J (2004). New chlorine-containing phenoloid from Curculigo capitulata. Journal of Asian Natural Product Research, 6, 7–10.&#13;\n9. Locatelli C, Filippin MFB and Creczynski PTB (2013). Alkyl esters of gallic acid as anticancer agents: a review. European Journal of Medicnal Chemistry, 60, 233-239.&#13;\n10. Mamdouh SM, Sawsan SH, Alaa EA and Nessma MN (2012) Synthesis and spectroscopic characterization of gallic acid and some of its azo complexes. Journal of Molecular Structure, 1014: 17-25.&#13;\n11. Maximo da Silva M, Comin M, Duarte TS, Foglio MA, de Carvalho JE, et al. (2015). Synthesis, Antiproliferative Activity and Molecular Properties Predictions of Galloyl Derivatives. Molecules, 20, 5360-5373&#13;\n12. Mishra BJ, Kaul A and Trivedi T (2015). L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo. Drug Delivery, 22 (2), 214-222&#13;\n13. Peter A and Dosa G (2002). Detection of phenoloids in some Hungarian inula and Centaurea species. Acta Botanica Hungaria, 44, 129–135.&#13;\n14. Plotkin MJ (1991). Traditional Knowledge of Medicinal Plants- the search for new jungle medicine. Cambridge University Press, Cambridge UK. 245-246.&#13;\n15. Polewski K, Kniat S and Slawinska D (2002). Gallic acid, a natural antioxidant, in aqueous and micellar environment: spectroscopic studies. Current Topics in Biophysics, 26, 217–227.&#13;\n16. Saeki K, You A, Isemura M, Abe I, Seki T, et al. (2000). Apoptosis inducing activity of lipid derivatives of gallic acid. Biological and Pharmaceutical Bulletin, 23, 1391-1394.&#13;\n17. Sakaguchi N, Inoue M and Ogihara Y (1998). Reactive oxygen species and intracellular Ca2+, common signals for apoptosis induced by gallic acid. Biochemical Pharmacology, 55, 1973-1981.&#13;\n18. Sheetal A, Honnegowda S and Mandapati R (2007). Isolation and TLC Densitometric Quantification of Gallicin, Gallic Acid, Lupeol and β-Sitosterol from Bergia suffruticosa, a Hitherto Unexplored Plant. Chromatographia, 66, 725-734.&#13;\n19. Singh J, Rai GK, Upadhyay AK, Kumar R and Singh KP (2004). Antioxidant phytochemicals in tomato (Lycopersicon esculentum). Indian Journal of Agricultural Science, 74, 3–5.&#13;\n20. Solecki R (1977). A Neanderthal flower burial in northern Iraq. Science, 190,880-881.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:56.748Z", "slug": "derivatization-of-gallic-acid-with-amino-acids-for", "authors": []}}, {"model": "artical.artical", "pk": 11, "fields": {"issue": 4, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tMeenakshi Jaiswal*\t\t\t\t\t", "pdf": "achivesPdf/115-118_P9fqwV5.pdf", "heading": "Microwave-Assisted Synthesis of Pyrimidinethione Derivatives", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tIn the present article a few pyrimidinethione derivatives are synthesized in a two step procedure using microwave radiation. The compounds are screened for antibacterial activity against four bacterial species. The results revealed that the compounds are obtained in good yields as compared to the conventional method of synthesis and the time required for the completion of the reaction was considerably less. All the compounds exhibited antibacterial potential against the gram negative and gram positive bacteria tested\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tPyrmidinethione, antimicrobial, microwave assisted synthesis, chalcone\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tKhan M S Y and S M Hasan, Indian Journal of Chemistry,Vol-42B, 2003 , pp. 197-1974.&#13;\nOrganic Reaction Vol.16, „The Aldol Condension‟ ,pp.5-45.&#13;\nSalama M A and El-Essa S A., Synthesis and reactions of some new 2, 3-dihydro-5-H-5, 7-diarylthiazolo-[3, 2-a] pyrimidine-3-one derivatives and their antibacterial and fungicidalctivity.vol-42B, January 2003, pp. 173-179.&#13;\nSilverstrein Bassler and Moril, Spectrophotometric Identification of Organic Compounds, 4 th Edn. 1980.&#13;\nVogel‟sTextbook of Practical Organic Chemistry, Edn. (4th), 1978, p.1081, 1125, 1126, 682-685.&#13;\nAult, A. Separation of substances: Purificatin of substances. In Techinques and experiments for organic chemistry; University science Books: Sausalito, 1998; pp 44-137.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:57.585Z", "slug": "microwave-assisted-synthesis-of-pyrimidinethione-d", "authors": []}}, {"model": "artical.artical", "pk": 12, "fields": {"issue": 4, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRicha Mishra, Brijeshkunvar Mishra *\t\t\t\t\t", "pdf": "achivesPdf/103-114_rYwI5pG.pdf", "heading": "Drug Discovery Tools: Computer Aided Molecular Design and Chemo-Informatics", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe article reviews the different approaches used in computer aided molecular design. It also reviews current achievements in the field of chemo-informatics and their impact on modern drug discovery processes. The main data mining approaches used in chemo-informatics such as structural similarity matrices, and classification algorithms, are also outlined. In the conclusion, future prospects of chemo-informatics are also mentioned.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tComputer aided molecular design, chemo-informatics, drug discovery, combinatorial chemistry.\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAugen, J. Drug Discov. Today, 2002, 7, 315.&#13;\nBaxter, A.D.; lockey, P.M. Drug Discov. World, 2001, 2, 9.&#13;\nBernard, P.; Golbraikh, A.; Kireev, D.; Chretien, J.R.; Rozhkova, N. Analysis, 1998, 26, 333.&#13;\nBrown, R.D.; Martin, Y.C. J. Chem. Inf. Comput. Sci., 1996, 36, 572.&#13;\nCox, T.F.; Cox, M.A.A. Multidimensional Scaling, Chapman &amp; Hall/CRC Press: Boca Raton, 2000.&#13;\nCramer, R.D., III; Patterson, D.E.; Bunce, J.D. J. Am. Chem. Soc., 1988, 110 (18), 5959.&#13;\nGalop, M.A.; Barrett, R.W.; Dower, W.J.; Fodor, S.P.A.; Gordon, E.M. J. Med. Chem., 1994, 37, 1233.&#13;\nHecht, P. Curr. Drug. Discov., 2002, 21.&#13;\nhttp://esc.syrres.com/interkow/doesmile.htm&#13;\nhttp://statsoft.com/textbook/stfacan.html&#13;\nhttp://www.asis.org/Features/Pioneers/wiswess.htm.&#13;\nhttp://www.statsoft.com/textbook/stmulsca.html#general&#13;\nISIS/Base help file “Remote QB in a molecule Database: Searching Concepts/Examples”.&#13;\nJarvis, R.A.; Patrick, E.A. IEEE T. Comput., 1973, C22, 1025.&#13;\nJoliffe, I.T. Principal Component Analysis, Springer-Verlag: New York, 1986.&#13;\nLipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeny, P.J. Adv. Drug Deliv. Rev., 1997, 23, 3.&#13;\nMalinowski, E.H.; Howery, D.G. Factor Analysis in Chemistry, John Wiley &amp; Sons: New York, 1980.&#13;\nMartin, Y.C. In Methods in Enzymology; Lilley, D.M.J.; Dahlberg, J.E., Eds.; Academic Press: San Diego, 1991; pp. 587-613.&#13;\nMatter, H.; aringhans, K.H.; Naumann, T.; Klabunde, T.; Pirard, B. Comb. Chem. High T. Sci., 2001, 4, 453.&#13;\nOrganic „Tectons‟ used to make networks with Inorganic Properties. Chem. Eng. News, 1995, 21.&#13;\nRebek, J., Jr. Acc. Of Chem. Res., 1990, 23 (12), 39.&#13;\nSadowski, J.; Kuninyi, H.A. J. Med. Chem., 1998, 41, 3325.&#13;\nWalters, W.p.; Murcko, M.A. J. Med. Chem., 1998, 41, 3314.&#13;\nWeiner, H. J. Am. Chem. Soc., 1947, 69, 17.&#13;\nWeininger, D. J. Chem. Inf. Comput. Sci., 1988, 28, 31.&#13;\nWillett, P.; Similarity and Clustering in Chemical Information Systems, Research Studies Press, Wiley: New York, 1987.&#13;\nXu, J.; Stevenson, J. J. Chem. Inf. Comput. Sci., 2000, 40, 1147.&#13;\nXue, L.; Stahura, F.L.; Godden, J.W.; Bajorath, J. J. Chem. Inf. Comput, Sci., 2001, 41, 394.&#13;\nZupan, J.; Gasteiger, J. Neural Networks for Chemists, VCH: Weinheim, 1993.&#13;\nXu, J.; Hagler, A. Molecules, 2002, 7, 566.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:58.163Z", "slug": "drug-discovery-tools-computer-aided-molecular-desi", "authors": []}}, {"model": "artical.artical", "pk": 13, "fields": {"issue": 5, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRahul Giri Goswami*, Brijeshkunvar Mishra, Richa Mishra\t\t\t\t\t", "pdf": "achivesPdf/129-133_amMKrz8.pdf", "heading": "Dissolution Enhancement of Cefprozil by Solid Dispersion Technique", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tOral route is the most preferred route of drug delivery for most of the drugs but it presents a considerable challenge for water insoluble drugs. In the present work solid dispersions of&#13;\ncefprozil were prepared in order to improve the water solubility and thereby its&#13;\nbioavailabilty. The solid dispersions were prepared using mannitol and PEG-6000 as the&#13;\nsolubility enhancing agent. The solid dispersion was formulated as tablet and the&#13;\ndisintegration and dissolution study were performed. The result revealed increased&#13;\ndissolution of cefprozil and improved bioavailability.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tCefprozil, solid dispersion, PEG-6000, solubility enhancement, mannitol\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAkiladevi D, Shanmugapandiyan P, Jebasing D&#13;\n(2011) J. Pharm. Sci. 3 (1): 188-191&#13;\nFord JL (1986) Acta Helv. 61: 69-88&#13;\nMogal SA, Gurjar PN, Yamgar DS, Kamod AC&#13;\n(2012) Der Pharmacia Lettre 4 (5): 1574-1586&#13;\nRajeshwari S, Bhanu K, Panda S, Swain RP,&#13;\nRamana Murthy KV, Kudamala S (2016) J. Chem.&#13;\nPharm. Res. 8 (4): 1218-1228&#13;\nSangeetha E, Rao VU, Sudhakar M, Manisha S&#13;\n(2015) Am. J. Advanced Drug Del. 3 (6): 308-316&#13;\nVaralakshmi TSNS, Ch. Siva Ramesh, Jyothi I,&#13;\nJyothi Y, Bharathi G, Chinni Babu P (2015) J.&#13;\nPharm. Res. 9 (2): 139-144\t\t\t\t\t</div>", "time": "2021-11-11T09:56:58.941Z", "slug": "dissolution-enhancement-of-cefprozil-by-solid-disp", "authors": []}}, {"model": "artical.artical", "pk": 14, "fields": {"issue": 5, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tBrijeshkunvar Mishra*, Richa Mishra\t\t\t\t\t", "pdf": "achivesPdf/119-128_RaifODz.pdf", "heading": "Comparative 2D QSAR Studies of 1,8-Naphthyridine against Tumor Cell Lines", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tIn a persevering effort to develop better anticancer drugs, a quantitative structure activity&#13;\nrelationship analysis using a set of 2-D descriptors was performed on a series of 1,8-&#13;\nnaphthyridine derivatives acting by the inhibition of tubulin polymerization. QSAR models&#13;\nthat were derived from the study were found to be statistically significant with a good&#13;\npredicting ability. The results obtained from the study justify the use of 2-D descriptors for&#13;\nexploring the requirements of binding of 1,8-naphthyridines to the heterodimer, tubulin.&#13;\nAttempt has been made to explore the structural and/or physicochemical requirements of&#13;\nthe compounds, responsible for the action against tumor cells. The physicochemical&#13;\ndescriptors and indicator variables were correlated with the biological activity\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tQSAR, tubulin, Chemotherapy, antitumor, cytotoxic, naphthyridine\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tBrijeshkunvar Mishra, Richa Mishra, NSHN&#13;\nMoorthy (2007) QSAR of anticancer agents: 1,8-&#13;\nnaphthyridine derivatives. Asian J Chem, 19 (1),&#13;\n481-487&#13;\nChen K, Kuo Sheng-chu, Hseih Ming-Cheih,&#13;\nMauger A, Lin C M, Hamel E &amp; Lee Kuo-Hsuing&#13;\n(1997) J. Med. Chem.40, 2266-2275.&#13;\nHeinemann V (2001) Oncology 60, 1-12.&#13;\nKowalsi R J, Giannakakou P &amp; Hamel E (1997)&#13;\nJ. Biol. Chem 272, 2534-2541.&#13;\nKubinyi H (1993) in Methods and Principles in&#13;\nMedicinal Chemistry (Mannhold R, Krogsgaard L &amp;&#13;\nTimmerman H eds), pp. 21-25, VCH Publishers,&#13;\nNew York.&#13;\nKubinyi H (1995) in Burger’s Medicinal Chemistry&#13;\nand Drug Discovery (Wolff M E, ed), Vol. 1, pp.&#13;\n497-572, John Wiley and Sons Inc., New york.&#13;\nLindel T, Jensen P R, Fenical W, Long B H,&#13;\nCasazza A M, Carboni J &amp;Fairchild C R (1997) J.&#13;\nAm. Chem. Soc.119, 8744-8745.&#13;\nLobert S, Vulevic B &amp; Correia J J (1996)&#13;\nBiochemistry 35, 6806-6814.&#13;\nSaravana Kumar R, Moorthy N S H N &amp; Trivedi&#13;\nP (2003) Indian J Pharm Sci 65(4), 346-350.\t\t\t\t\t</div>", "time": "2021-11-11T09:56:59.697Z", "slug": "comparative-2d-qsar-studies-of-18-naphthyridine-ag", "authors": []}}, {"model": "artical.artical", "pk": 15, "fields": {"issue": 6, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAnju Balkrishna Bhandole*, Viren Suryawanshi\t\t\t\t\t", "pdf": "achivesPdf/134-138_4hEfLgy.pdf", "heading": "Neuropharmacological activity of Azadirachta indica Leaves on Diabetes Rodunts", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAzadirachta indica have been known for their anti diabetic activity since long time. Many&#13;\nattempts for observe antidiabetic potency of Azadirachta indica have been made utilizing foe&#13;\nanti diabetic activity tools. In an attempt according to the obtained results in the present&#13;\nstudy, ethyl acetate extract of Azadirachta indica leaves (50, 100 &amp; 200 mg/kg/day, p.o.) can&#13;\nexert positive effects within two weeks in the treatment and decreasing the physiological&#13;\nsymptoms of diabetic neuropathy in rats. In the present study, response time to immobility&#13;\nin tail suspension and force swim test showed significant decrease in comparison to the&#13;\ndiabetic group.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tHyperglycaemia, endocrine disorder, insulin, neuropathy\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAmerican Diabetes Association. Gestational&#13;\ndiabetes mellitus. Diabetes Care 2001; 24 (suppl&#13;\n1): S77-S79.&#13;\nBabenkova IV, Teselkin IuO, Makashova NV,&#13;\nGuseva MR (1999) Antioxidative activity of&#13;\nhistochrome and some other drugs used in&#13;\nophthalmolog Vestn Oftalmol 115: 22-24.&#13;\nBiswas, K., Chattopadhyay, I., Banerjee, R.K., et&#13;\nal., (2002) Biological activities and medicinal&#13;\nproperties of Azadirachta indica (Azadirachta&#13;\nindica). Curr Sci, 82: 1336- 1345.&#13;\nBrownlee M (2001) Biochemistry and molecular&#13;\ncell biology of diabetic complications. Nature&#13;\n414: 813-820.&#13;\nNeelam Singh and Madhulika Singh (2017) An&#13;\nEvaluation of Phytochemicals in Maceration and&#13;\nInfusion Extracts of Cyperus rotundus Linn Leaves&#13;\nin Two Different Solvents. Journal of&#13;\nPharmacology and Biomedicine 1 (2): 77-84\t\t\t\t\t</div>", "time": "2021-11-11T09:57:00.621Z", "slug": "neuropharmacological-activity-of-azadirachta-indic", "authors": []}}, {"model": "artical.artical", "pk": 16, "fields": {"issue": 7, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tSunita Sharma\t\t\t\t\t", "pdf": "achivesPdf/147-151_dRXaMdS.pdf", "heading": "A Review on Ayurveda: Science of life", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tHerbs are often administered in combination with therapeutic drugs, raising the potential of herb-drug interactions. An extensive review of the literature identified reported herb-drug interactions with clinical significance, many of which are from case reports and limited clinical observations. Cases have been published reporting enhanced anticoagulation and bleeding when patients on long-term warfarin therapy also took Salvia miltiorrhiza (danshen). Allium sativum (garlic) decreased the area under the plasma concentration-time curve (AUC) and maximum plasma concentration of saquinavir, but not ritonavir and paracetamol (acetaminophen), in volunteers. A. sativum increased the clotting time and international normalised ratio of warfarin and caused hypoglycaemia when taken with chlorpropamide. Ginkgo biloba (ginkgo) caused bleeding when combined with warfarin or aspirin (acetylsalicylic acid), raised blood pressure when combined with a thiazide diuretic and even caused coma when combined with trazodone in patients. Panax ginseng (ginseng) reduced the blood concentrations of alcohol (ethanol) and warfarin, and induced mania when used concomitantly with phenelzine, but ginseng increased the efficacy of influenza vaccination. Scutellaria baicalensis (huangqin) ameliorated irinotecan-induced gastrointestinal toxicity in cancer patients.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tIntroduction, Ayurveda, System of Medicines, Scope, Conclusion\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tHarro H. GMBH Technology for New Drug Delivery Systems Business brieping; Pharmacogenerics 2003 Hikino H, Kiso Y, Wagner H, Fiebig M. Antihepatotoxic actions of flavonolignans from Silybum marianum fruits. Planta Med 1984;50:248-50. Sowjanya JN, Kumar YK, Das S. Phytosome: A novel entity in herbal delivery system. Int J Pharm Res Dev 2010;2:153-64. Patel J, Patel N. An overview of phytosome as an advanced drug delivery system. Asian J Pharma Sci 2009;4:363-71.&#13;\nKuntal M, Mukherjee K, Ahamed H. Enhanced therapeutic benefit of Quercitin-phospholipid complex in carbon tetrachloride induced acute liver injury in rats: A comparative study. Iran J Pharmacol Ther 2005;4:84-90. Yue PF, Yuan HL, Li XY, Yang M, Zhu WF. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm 2010;387:139-46. Naik SR, Panda VS. Hepatoprotective effect of Ginkgoselect Phytosome in rifampicin induced liver injury in rats: evidence of antioxidant activity. Fitoterapia 2008;79:439-45. Ajazuddin, Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia 2010;81:680-9.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:01.761Z", "slug": "a-review-on-ayurveda-science-of-life", "authors": []}}, {"model": "artical.artical", "pk": 17, "fields": {"issue": 7, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tDeepak Basedia*, Balkrishna Dubey, Lavakesh Omray, Suresh Dhakar\t\t\t\t\t", "pdf": "achivesPdf/139-146_cDhTeTR.pdf", "heading": "Green Chemistry, the emerging field in pharmaceutical R&D: Boosting the economy", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tGreen chemistry is the sustainable practice of chemical science and manufacturing within a&#13;\nframework of industrial ecology in a manner that is sustainable, safe and non-polluting,&#13;\nconsuming chemistry of the environment sustainable, consuming minimum amounts of&#13;\nenergy and material resources while producing virtually no wastes. The invention, design and&#13;\napplication of chemical products and processes to reduce or to eliminate the use and&#13;\ngeneration of substances hazardous to human health and the environment Fundamental and&#13;\ninnovative chemical methods that accomplish pollution prevention through source reduction&#13;\nchemistry of the environment accomplish pollution prevention through source reduction.&#13;\nGreen chemistry also called environmental chemistry focused on the designing of products&#13;\nand processes that minimize the use of materials and generation of non toxic substances. It&#13;\nis better to prevent waste than to treat or clean up waste after it is formed.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tGreen chemistry, Renewable energy, Eco-friendly technology\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. P.T. Anastas, I.T. Hovarsth, Innovations and Green Chemistry, Chem. Rev, vol. 107, pp. 2169, 2007.&#13;\n2. V.K. Ahluwalia and M. Kidwai, New Trends in Green Chemistry, Anamaya Publisher, New Delhi, pp. 435, 2004.&#13;\n3. P.T. Anastas and J.C. Warner, Green Chemistry: Theory and Practice, Oxford University Press: New York, pp.30, 1998.&#13;\n4. P.T Anastas and T.C. Williamson, Green Chemistry: Frontiers in Benign chemical Synthesis and Processes. Oxford University Press, Oxford., 1998.&#13;\n5. P. Tundo and P.T. Anastas, Green Chemistry: Challenging Perspectives, Oxford University Press, Oxford. 1998. 6. Green Chemistry, United States Environmental Protection Agency. 06,28, 2006. 7. M. Poliakoff, P. Licence, Sustainable technology: Green chemistry, Nature. 450, 810–812. 2007 8. E. J Woodhouse, S. Breyman, Green chemistry as social movement. Science, Technology, &amp; Human Values. 30 (2), 199–222. 2005&#13;\n9. D. Acemoglu, P. Aghion, and D. Hemous, The environment and directed technical change , American Economic Review 102, 131-166, 2012.&#13;\n10. G. D. Soni, Social Issues and Environmental Problems, Vol.3,9, 2015\t\t\t\t\t</div>", "time": "2021-11-11T09:57:02.443Z", "slug": "green-chemistry-the-emerging-field-in-pharmaceutic", "authors": []}}, {"model": "artical.artical", "pk": 18, "fields": {"issue": 8, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tPhoolwati Ahirwar*, Suresh Dhakar, B. K. Dubey\t\t\t\t\t", "pdf": "achivesPdf/164-170_SMGC8fy.pdf", "heading": "Formulation Development and Evaluation of Fast Dissolving Oral Films of Nebivolol", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tOral films dissolve rapidly along with drug in mouth and majority of the drug is absorbed through&#13;\nbuccal/oral mucosa in to systemic circulation avoiding first pass metabolism. Hypertension is a major&#13;\ncause of concern not just in the elderly but also in the youngsters. An effort was made to formulate a&#13;\nfast dissolving film containing Nebivolol which is used in the treatment of hypertension with an&#13;\nobjective to rapid dissolution of drug and absorption which may produce the rapid onset of action&#13;\nand provides the convenient means of administration to those patient suffering from difficulty in&#13;\nswallowing such as paediatrics, geriatric and uncooperative mentally ill patients and also improve the&#13;\nbioavailability of the drug. The fast dissolving oral film were prepared using different polymers like&#13;\nSodium starch glycolate, Hydroxy propyl methyl cellulose, Croscarmellose sodium and Tween 80 by&#13;\nsolvent casting method. The fast dissolving oral film evaluated for folding endurance, swelling index,&#13;\nsurface pH, in vitro disintegration time, drug content, drug polymer compatibility (IR Study), and in&#13;\nvitro drug release. The physical appearance and folding endurance properties were found to be good&#13;\nand electron microscopy shows that films are clear, colourless with smooth surface without any&#13;\nscratches. The drug content showed uniform mixing of drug in all prepared fast dissolving films. The&#13;\nin vitro drug release in optimized formulation F9 was found to be 69.56 % in 5 min. Drug release&#13;\nobeys the first order kinetics. The prepared films were stable. Hence it can be inferred that the fast&#13;\ndissolving oral film of nebivolol may produce the rapid action thereby improving bioavailability and&#13;\nenhance the absorption by avoiding the first pass effect.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tFast dissolving oral films, Nebivolol, Sodium starch glycolate, Hydroxy propyl&#13;\nmethyl cellulose, Croscarmellose sodium and Tween 80\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Liang AC, Chen LH. Fast-dissolving&#13;\nintraoral drug delivery systems. Exp Opin&#13;\nTher Patents 2001; 11: 981–6.&#13;\n2. Borsadia S, O’Halloran D, Osborne JL.&#13;\nQuick dissolving films-A novel approach&#13;\nto drug delivery. Drug Deliv Technol&#13;\n2003; 3: 63–6.&#13;\n3. Klancke J. Dissolution testing of orally&#13;\ndisintegrating tablets. Dissolut Technol&#13;\n2003; 10: 6–8.&#13;\n4. Parakh SR, Gothoskar AV. Review of&#13;\nmouth dissolving tablet technologies.&#13;\nPharm Tech 2003; 27: 92–100.&#13;\n5. Sweetman SC. Martindale: The Complete&#13;\nDrug Reference. 35th ed. London:&#13;\nPharmaceutical Press 2007; p.1211.&#13;\n6. Available from:&#13;\nhttp://www.drug.com/nebivolol: medline&#13;\nplus drug information.html.&#13;\n7. Koland M, Sandeep VP, Charyulu NR,&#13;\nFast Dissolving Sublingual Film of&#13;\nOndansetron Hydrochloride: Effect of&#13;\nadditives on in vitro drug release and&#13;\nmucosal permeation, J Young Pharmacist&#13;\n2010; 2(3): 216- 222.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:03.519Z", "slug": "formulation-development-and-evaluation-of-fast-dis", "authors": []}}, {"model": "artical.artical", "pk": 19, "fields": {"issue": 8, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tJeevan KR, Suresh V Kulkarni, ST Bhagwati\t\t\t\t\t", "pdf": "achivesPdf/152-163_Nx6NQas.pdf", "heading": "Formulation and Evaluation of Sustained release Ondansetron hydrochloride pellets by extrusion spheronization technique", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe aim of the present study was designed and develops model sustained release pellets formulations for Ondansetron HCL. Ondansetron HCL is widely used in the management of vomiting sensation at the time of cancer chemotherapy. The bioavailability of Ondansetron HCL is high and protein binding was found to be 91-93 %. The half-life of Ondansetron hydrochloride is about 7 hours. But the short half-life of Ondansetron hydrochloride leads to poor compliance and adverse reactions; that is why Ondansetron hydrochloride in sustained release dosage form is needed to achieve better therapeutic effects and to improve patient compliance. Ondansetron hydrochloride at different drug to polymer ratios was prepared by extrusion and spheronization technique. The influence of the proportion of the polymer on the release rate of the drug from the pellets was studied. The in-vitro&#13;\nrelease studies of pellets were carried out in 0.1N HCL for 12 hours. The release data was fitted to various mathematical models such as, Higuchi, Korsmeyer-Peppas, First-order, and Zero-order to evaluate the kinetics and mechanism of the drug release. Kinetic modeling of in-vitro dissolution profiles revealed the release mechanism ranges from Quasi-Fickian transport to Anomalous (non-Fickian transport), which was only dependent on the type and amount of polymer used. The drug release of the optimized formulation (F5) follows Zero order kinetics and the mechanism was found to be diffusion controlled. The compatability studies were performed by using FTIR and DSC which reveals that there is no interaction between the drug and the polymer/excipients mixture.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tSustained-release, Ethylcellulose, HPMC, Pellets, Ondansetron hydrochloride\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Lee TWY, Robinson JR, Remington. The&#13;\nScience and Practice of Pharmacy 2000;&#13;\n20(1):1069-70.&#13;\n2. M. Ninan, X. Lu, Internat. J. Pharmaceut.&#13;\n2008; 358: 82-90.&#13;\n3. Antinsmith A, KottaiMuthu A, Rao WBP,&#13;\nManavalan R. Formulation development&#13;\nand evaluation of ondansetron&#13;\nhydrochloride sustained release matrix&#13;\ntablet. J. Pharma. Sci. Res. 2009; 1(4): 48-54&#13;\n4. Dybdahl HP. Advanced granulation theory at&#13;\nparticle level - free learning summary; 2005.&#13;\n5. Rajan S, Coalco S, Ramesh N, Nainar&#13;\nKSM, Bhojraj S . Preparation of&#13;\nsustained&#13;\nrelease tablet of ondansetron a novalantiemetic.&#13;\nAm. J. Pharm. Tech. Res. 2013; 3(2): 691-702&#13;\n6. www.acg.gi.org&#13;\n7. www.aafp.org&#13;\n8. Gamal MM. Ketorolac enteric matrix pellets&#13;\nproduced by extrusion / spheronization. Bull.&#13;\nPharm. Sci. 2010; 33(1): 51-8.&#13;\n9. Jagadeesh T and Bala RCR. Development of&#13;\noral multi particulate drug delivery system of&#13;\nGalantamine hydrochloride by using extrusion&#13;\nspheronization technique. Internat. J. Pharm.&#13;\nTech. 2011; 3(2): 2633-43.&#13;\n10. Yashwant N, Dhanorkar, Rajkapoor B,&#13;\nPrashant DG. Development and evaluation of&#13;\noral Multiparticulate drug delivery system of&#13;\nmetformin and glimepiride by using extrusion&#13;\nand spheronization technique. Int. J. Drug&#13;\nForm. Res. 2012; 3(1): 53-68.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:03.962Z", "slug": "formulation-and-evaluation-of-sustained-release-on", "authors": []}}, {"model": "artical.artical", "pk": 20, "fields": {"issue": 9, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRavi Jalonya*, Pushpendra Soni, Kapil Malviya, Lavakesh Kumar Omray\t\t\t\t\t", "pdf": "achivesPdf/189-198_QhQ81Js.pdf", "heading": "Formulation and evaluation of bilayer tablets of diltiazem HCl", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe present investigation concerns development of bilayer floating tablets of Diltiazem HCl&#13;\nis class I drug, though its reported bioavailability is only 40 %. It is having very short half life&#13;\nof 3 to 4 hr. Hence many sustained release formulations were developed for diltiazem HCl.&#13;\nBut they take lag time to start the action. Hence a new approach is tried that gives one&#13;\nimmediate release dose and a sustained release dose in single dosage form call bilayer tablets.&#13;\nImmediate release layer delivers the initial dose, it contains superdisintegrant which increase&#13;\ndrug release rate whereas sustained release layer float due to gas generating agent and releases&#13;\ndrug at sustained manner for prolonged period. A direct compression method was used to&#13;\nformulate 9 batches. Superdisintegrants like sodium croscarmellose, crospovidone was used&#13;\nfor immediate release layer and HPMC K4 M, HPMC K 15 M, PVP K30 like polymers were&#13;\nused in floating layer. A simple visible spectrophotometric method was employed for the&#13;\nestimation of diltiazem at 236 nm and Beer’s law is obeyed in the concentration range of 5-25&#13;\nμg/ml. Preformulation studies were carried out to optimize the ratios required for various&#13;\ngrades of polymers. The prepared floating tablets were evaluated for hardness, weight&#13;\nvariation, thickness, friability, drug content uniformity, buoyancy lag time, total floating time,&#13;\nwater uptake (swelling index), and in vitro dissolution studies. Successful formulation was&#13;\ndeveloped having floating lag time as low as 30 sec and drug release was sustained up to 12&#13;\nhrs. A biphasic drug release can be obtained by using bilayer tabletting technology which&#13;\ninvolved compression of immediate and sustained release layer together. Bilayered floating&#13;\ntablets with release characteristics offer critical advantages such as, site specificity with&#13;\nimproved absorption and efficacy. This technology can be inculcated to various medicaments&#13;\nwhich have stomach as the major site of absorption.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tBilayer floating tablets, Diltiazem HCl, Biphasic drug release, HPMC K 15 M\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Santhanalaxmi G; Elango K; Ramesh&#13;\nKumar K; Farheen F; Indian Journal&#13;\nof Pharmaceutical Education and&#13;\nResearch, 2012, 46 (3), 259-264.&#13;\n2. Harshal P; Gahiwade; Manohar V&#13;\nPatil; Bharat W Tekade; Vinod M&#13;\nThakare; Patil V R; IJPBS, 2012, 2 (1),&#13;\n166-172.&#13;\n3. Tadros MI. Controlled-release&#13;\neffervescent floating matrix tablets of&#13;\nciprofloxacin hydrochloride:&#13;\nDevelopment, optimization and in&#13;\nvitro–in vivo evaluation in healthy&#13;\nhuman volunteers, Eur J Pharm and&#13;\nBiopharm, 2010, 74, 332–33.&#13;\n4. Md. Sarfaraz; Keerthi Chandra Reddy&#13;\nP; Udupi R H; Doddayya H;&#13;\nInternational journal of drug&#13;\ndevelopment and research, 2012, 4&#13;\n(3), 335-347.&#13;\n5. Mohan Guguloth; Ramesh Bomma;&#13;\nKishan Veerabrahma; PDA Journal of&#13;\nPharmaceutical science and&#13;\ntechnology, 2011, 65, 198-206&#13;\n6. Streubel, A; Siepmann, J; Bodmeier,&#13;\nR; Eur. J. Pharm. Sci, 2003, 18 (1),&#13;\n37– 45.&#13;\n7. Seth P Tossounian J, “The&#13;\nhydrodynamically balanced system&#13;\nHBSTM, A novel drug delivery&#13;\nsystem for oral use.”Drug&#13;\nDev.Ind.Pharm.1984,10,313-339&#13;\n8. Narayana Charulu; Denish Bera;&#13;\nDarshan Sakhia; Keyur Manavadaria;&#13;\nNisha G Shetty; J of Res Pharm Sci,&#13;\n2012, 3(2), 301-306.&#13;\n9. Bravo SA; Lamas MC; Salomon CJ;&#13;\nPharm Dev Technol, 2004, 9, 75–83.&#13;\n10. Hermann P; Rodger SD; Remones G;&#13;\nThenot JP; London DR; Morselli P;&#13;\nEur J Clin Pharmacol, 1983, 24, 349-&#13;\n352.&#13;\n11. Liberman HA, Lachman L, Schwartz&#13;\nJB. Pharmaceutical dosage forms:&#13;\nTablets, 3rd edition, Marcel Dekker,&#13;\nNew York, 1990.&#13;\n12. Lordi GN. Sustained release dosage&#13;\nforms. In: Lachman L, Liberman HA,&#13;\nKanig JL, 3rd edition. The Theory&#13;\nand Practice of Industrial Pharmacy.&#13;\nMumbai, India: Varghese Publishing&#13;\nHouse; 1987:430-456;&#13;\n13. Aulton ME; Wells TI; Pharmaceutics:&#13;\nThe Science of Dosage Form Design,&#13;\nChurchill Livingstone, London,&#13;\nEngland, 1988.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:04.540Z", "slug": "formulation-and-evaluation-of-bilayer-tablets-of-d", "authors": []}}, {"model": "artical.artical", "pk": 21, "fields": {"issue": 9, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAjeet Patel*, Pushpendra Soni, Neha Yadav, Lavakesh Kumar Omray\t\t\t\t\t", "pdf": "achivesPdf/181-188_oNcBbEt.pdf", "heading": "New cost effective RP-HPLC method development and evaluation for quantitative estimation of Pitavastatin in pharmaceutical formulation", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tA simple, sensitive, reliable and rapid reversed-phase high-performance liquid&#13;\nchromatographic (RP-HPLC) method has been developed and validated for the&#13;\ndetermination of pitavastatin in bulk and pharmaceutical dosage form. The chromatographic&#13;\nsystem consisted of waters (784), 515 binary Pump, data Ace with UV-Visible detector.&#13;\nSeparation was achieved on the thermo C18 (250 x 4.60), 5 μ particle size column in isocratic&#13;\nmode at room temperature. The sample was introduced through an injector valve with a 20&#13;\nμl, sample loop. 20mM KH2PO4 (pH-3.0 with OPA): Acetonitrile 20:80 (%, v/v), was used as&#13;\nmobile phase with flow rate of 1 ml/min. UV detection was performed at 250 nm. A&#13;\ncalibration graph was plotted which showed a linearity range between5-25 μg/ml with the&#13;\ncorrelation coefficient of 0.997. The LOD was 0.095μg/ ml, while the LOQ was 0.271&#13;\nμg/ml. Validation studies revealed the method is specific, rapid, reliable and reproducible. To&#13;\nstudy the validity of the method, recovery studies and repeatability studies were carried out&#13;\nusing the same optimum conditions. The system suitability studies were also calculated which&#13;\nincludes column efficiency, resolution, capacity factor and peak asymmetrical factor.&#13;\nTherefore the proposed method is reliable, rapid, precise and selective so may be used for the&#13;\nquantitative analysis of pitavastatin.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tHPLC, Pitavastatin, Pharmaceutical dosage form, Method Validation\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. M. Soyka, C. Schuetz, and U. Preuss,&#13;\nDrugs in R &amp; D, 3, 58–60 (2002)&#13;\n2. Martindale: The Complete Drug&#13;\nReference, 35th edn, Pharmaceutical&#13;\nPress, London, 2007, pp. 1234&#13;\n3. Remington: The Science and Practice&#13;\nof Pharmacy, 21st edn, Lippincott&#13;\nWilliams &amp; Wilkins, New York, 2006,&#13;\npp. 1368&#13;\n4. L. Rosa and C. John, Amer. J.&#13;\nCardiovasc. Drugs, 3, 271–281 (2003)&#13;\n5. K. Kalinami, N. Takekoshi, and Y.&#13;\nSaito, Cardiovasc. Drug Rev., 21, 199–&#13;\n215 (2003)&#13;\n6. The Merck Index, 14th edn, Merck&#13;\nResearch Laboratories, Division of&#13;\nMerck and Co. Inc., Whitehouse&#13;\nStation, NJ, 2006, pp. 1294–1295.&#13;\n7. Krishna M.V. and Sankar D.G.&#13;\nAdaptation of colour reactions for&#13;\nspectrophotometric determination of&#13;\npitavastatin calcium in bulk drugs and&#13;\nin pharmaceutical formulations. E-J.&#13;\nChem., 2007, 4, 272-278.&#13;\n8. Vadia N.H., Vandana P. and Bhalara&#13;\nH.N. Spectrophotometric&#13;\nDetermination of Cefetamet pivoxil&#13;\nhydrochloride and Pitavastatin&#13;\nCalcium in Tablet Dosage Form.&#13;\nIndian J. Pharm. Sci., 2008, 70, 649-&#13;\n651.&#13;\n9. Satheesh N.K. and Baghyalakshmi J.&#13;\nDetermination and Quantification of&#13;\nPitavastatinCalcium in Tablet Dosage&#13;\nFormulation by HPTLC Method.&#13;\nAnal. Lett., 2007, 40, 2625- 2632.&#13;\n10. Hiral J.P., Bhanubhai N.S., Natvarlal&#13;\nJ.P. and Bhavesh H.P. A Simple and&#13;\nSensitive HPTLC method for&#13;\nEstimation of Pitavastatin Calcium in&#13;\nTablet Dosage Form. J. Planar&#13;\nChrom., 2008, 21, 267-270.&#13;\n11. Kojima J., Fujino H., Yosimura M.,&#13;\nMorikawa H. and Kimata H.&#13;\nSimultaneous Determination of NK-&#13;\n104 and its lactone in Biological&#13;\nsamples by Column-switching highperformance&#13;\nliquid chromatography&#13;\nwith Ultraviolet detection. J.&#13;\nChromatogr. B, 1999, 724, 173-180.&#13;\n12. Ramakrishna N., Koteshwara M. and&#13;\nVishwottam K. Chromatography–&#13;\nMass Spectrometry Methods for the&#13;\nQuantitation of Statins in Biological&#13;\nsamples. J. Pharm. Biomed. Anal.,&#13;\n2007, 44, 379- 387.&#13;\n13. Nanjappan S.K., Narayanan N.,&#13;\nJayabalan N., Narayanan S. and&#13;\nBagyalakshmi J. HPLC Determination&#13;\nof Pitavastatin Calcium in&#13;\nPharmaceutical Dosage Form.&#13;\nPharma. Ana. Acta, 2011, 2, 119.&#13;\n14. Hiral J.P. and Bhanubhai N.S. HPLC&#13;\nDetermination of Pitavastatin Calcium in Pharmaceutical Dosage. J. AOAC&#13;\nInt., 2009, 92, 158-64.&#13;\n15. Ojha A., Guttikar S., Vayeda C. and&#13;\nPadh H. Determination of Pitavastatin&#13;\nfrom Human Plasma. Se Pu, 2007, 25,&#13;\n715-718.&#13;\n16. Pawel G., Giampietro V., Daniela V.,&#13;\nFrancesco D., Anna G. and Jadwiga&#13;\nM. Photo Stability of Pitavastatin-A&#13;\nNovel HMG-CoA reductase inhibitor.&#13;\nJ. Pharm. Biomed. Anal., 2009, 50,&#13;\n597- 601.&#13;\n17. Hiral J.P. and Bhanubhai N.S. Stability&#13;\nIndicating High Performance Liquid&#13;\nChromatographic Method for&#13;\nDetermination of Pitavastatin Calcium&#13;\nIn Tablet Dosage Form. Acta Chrom.,&#13;\n2011, 3, 81-94.&#13;\n18. Antony R.G., Pannala R.R.,&#13;\nNimmakayala S. and Jadi S.&#13;\nDegradation Pathway for Pitavastatin&#13;\nCalcium by Validated Stability&#13;\nIndicating UPLC Method. American J.&#13;\nAna. Chem., 2010, 2, 83-90.&#13;\n19. Jian W.D., Kwon B.K., Hong H.Z.,&#13;\nKwang H.L. and Jae G.S.&#13;\nDetermination of two HMG-CoA&#13;\nreductase inhibitors, Pravastatin and&#13;\nPitavastatin, in Plasma samples using&#13;\nLiquid chromatography-Tandem Mass&#13;\nSpectrometry for Pharmaceutical&#13;\nstudy. Biomed. Chrom., 2008, 22, 131-&#13;\n135.&#13;\n20. Lei T., Yiling H., Youhong J., Lu H.&#13;\nand Yishi L. Development and&#13;\nValidation of a Liquid&#13;\nchromatography-Tandem Mass&#13;\nSpectrometric assay for Pitavastatin&#13;\nand its lactone in human plasma and&#13;\nUrine. J. Chrom. B, 2008, 865, 127-&#13;\n132.&#13;\n21. Hua L.V., Jian G.S., Guang J.W., Xiao&#13;\nY.Z., Ying Z., Sheng H.G., Yan L. and Jie S. Determination of Pitavastatin in&#13;\nHuman plasma via HPLC-ESIMS/&#13;\nMS. Clin. Chimica Acta, 2007, 386, 25-&#13;\n30.&#13;\n22. Code Q2 (R1) -Text on Validation of&#13;\nAnalytical Procedures: Text and&#13;\nMethodology Current Step 4 version,&#13;\n2005, ICH Harmonised Tripartite&#13;\nGuideline.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:05.266Z", "slug": "new-cost-effective-rp-hplc-method-development-and-", "authors": []}}, {"model": "artical.artical", "pk": 22, "fields": {"issue": 9, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tPranita Biswas, Prabhat Jain, Geeta Parkhe, Brijeshkunvar Mishra*\t\t\t\t\t", "pdf": "achivesPdf/171-180_J922XGI.pdf", "heading": "Validated HPLC method for the estimation of Aspirin and Omeprazole in dosage form", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tA new simple, rapid, selective, precise and accurate high-performance liquid chromatographic method&#13;\nhas been developed for the estimation of aspirin and omeprazole in marketed formulation. The RPHPLC&#13;\nmethod was developed for estimation of aspirin and omeprazole in bulk and tablet dosage&#13;\nform by isocratically using 20 mM KH2PO4: acetonitrile (pH 3.5) in the ratio of 20:80 v/v as mobile&#13;\nphase, Thermo C-18 column (4.6 x 250 mm, 5μ particle size) column as stationary phase and&#13;\nchromatogram was recorded at 275 nm. Then developed method was validated by using various&#13;\nparameters. The parameters linearity, precision, accuracy, robustness, limit of detection and limit of&#13;\nquantitation were studied according to International Conference on Harmonization guidelines. The&#13;\nproposed method was found to be accurate, repeatability and consistent. It was successfully applied&#13;\nfor the analysis of the drug in marketed formulation and could be effectively used for the routine&#13;\nanalysis of formulation containing the drug without any alteration in the chromatography conditions.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tAspirin, Omeprazole, HPLC, Chromatography, Spectrophotometry\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Swethanagini V, Vasanth Kumar. M.&#13;\nValidated RP HPLC Method for&#13;\nSimultaneous Estimation of&#13;\nOmeprazole and Cinitapride in&#13;\nCombined Dosage Forms. I J R P C.&#13;\n2012; 2(4): 1078-1085.&#13;\n2. Chodvadiya J, Chaitanyakumar K,&#13;\nMaheshwari D.et al Simultaneous&#13;\nEstimation Of Aspirin And&#13;\nLansoprazole By RP –HPLC Method Int J R Sci Res. 2015; 6(4): 3385 -&#13;\n3390.&#13;\n3. Kayesh PR, Rahman A, Sultan M, et&#13;\nal. Development and Validation of a&#13;\nRP -HPLC Method for the&#13;\nQuantification of Omeprazole in Pharmaceutical Dosage Form. J. Sci.&#13;\nRes. 2013; 5(2): 335 -3425.&#13;\n4. International Conference on&#13;\nHarmonization (ICH). Harmonized&#13;\ntripartite guideline on, Topic Q2(R1),&#13;\nValidation of analytical procedures:&#13;\nText and methodology 2005.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:05.756Z", "slug": "validated-hplc-method-for-the-estimation-of-aspiri", "authors": []}}, {"model": "artical.artical", "pk": 23, "fields": {"issue": 10, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tKushwaha Ritu*, Kapil Malviya, Lavakesh Kumar Omray\t\t\t\t\t", "pdf": "achivesPdf/199-210-1_xhJDeh6.pdf", "heading": "Formulation development of herbal anti acne gel", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tAntibiotics have been used to treat acne vulgaris. However, antibiotic resistance has been increasing&#13;\nin prevalence within the dermatologic setting. The development of antibiotic resistance includes the&#13;\nspecific nature of the relationship of bacteria to antibiotics, how the antibacterial is used, host&#13;\ncharacteristics, and environmental factors. Natural remedies are more acceptable in the belief that&#13;\nthey are safer with fewer side effects than the synthetic ones. Herbal formulations have growing&#13;\ndemand in the world market. It is a very good attempt to establish the herbal gel containing hydroalcoholic&#13;\nextract of Rhizome of Curcuma longa, Curcuma Caesia and Curcuma Amada. This study revealed&#13;\nthat the developed single herbal formulation F3 was comparatively better than other formulation.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tHerbal, Anti-Acne, Curcuma longa, Curcuma Caesia, Curcuma Amada\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Balammal G, Sekar BM, Reddy JP.&#13;\nAnalysis of Herbal Medicines by&#13;\nModern Chromatographic Techniques. International Journal of Preclinical and&#13;\nPharmaceutical Research 2012;&#13;\n3(1):50-63.&#13;\n2. Pal KS, Shukla Y. Herbal Medicine:&#13;\nCurrent Status and the Future. Asian&#13;\nPacific J Cancer Prev 2003; 4:281-288.&#13;\n3. Kashaw V, Nema AK, Agarwal A.&#13;\nHepatoprotective Prospective of&#13;\nHerbal Drugs and Their Vesicular&#13;\nCarriers– A Review. International&#13;\nJournal of Research in Pharmaceutical&#13;\nand Biomedical Sciences 2011; 2(2).&#13;\n4. Prabhu TP, Panneerselvam P, kumar&#13;\nRV, Atlee WC, Subramanian SB. Antiinflammatory,&#13;\nanti arthritis and&#13;\nanalgesic effect of ethanolic extract of&#13;\nwhole plant of Merremia emarginata&#13;\nBurm.F. Central European Journal of&#13;\nExperimental Biology. 2012; 1(3):94-&#13;\n99.&#13;\n5. Patel P, Patel D, Patel N.&#13;\nExperimental investigation of antirheumatoid&#13;\nactivity of Pleurotus&#13;\nsajorcaju in adjuvant -induced arthritic&#13;\nrats. Chinese Journal of Natural&#13;\nMedicines. 2012; 10(4):269-274.&#13;\n6. Agarwal P, Fatima A Singh PP. Herbal&#13;\nMedicine Scenario in India and&#13;\nEuropean Countries, Journal of&#13;\nPharmacognosy and Phytochemistry.&#13;\n2012; 1(4).&#13;\n7. Gautam RK, Singh D, Nainwani R.&#13;\nMedicinal Plants having Anti-arthritic Potential: A Review, Int. J. Pharm. Sci.&#13;\nRev. Res. 2013; 19(1):96-102.&#13;\n8. Patil RB, Vora SR, Pillai MM.&#13;\nProtective effect of Spermatogenic&#13;\nactivity of Withania somnifera&#13;\n(Ashwagandha) in galactose stressed&#13;\nmice, Annals of Biological Research.&#13;\n2012; 3(8):4159-4165.&#13;\n(http://scholarsresearchlibrary.com/ar&#13;\nchive.html).&#13;\n9. Brown HM, Christie AB, Colin EJ.&#13;\nGlycyrrhetinc acid hydrogensuccinate&#13;\n(disodium) salt, a new&#13;\nantiinflammatory compound, Lancet.&#13;\n1959;2:492.&#13;\n10. Adami E, Marzzi EU, Turba C. Arch&#13;\nInt Pharmaco dyn Tuer 1964: 147:113.&#13;\n11. Kamboj VP. Herbal medicine, Current&#13;\nscience. 2000; 78(1).&#13;\n12. Partap S, Kumar A, Sharma NK, Jha&#13;\nKK. Luffa Cylindrica: An important&#13;\nmedicinal plant, J. Nat. Prod. Plant&#13;\nResour 2012; 2 (1):127-134.&#13;\n13. Verma S, Singh SP. Current and future&#13;\nstatus of herbal medicines, Veterinary&#13;\nWorld. 2008; 1(11):347-350.&#13;\n14. Padmawar A, Bhadoria U.&#13;\nPhytochemical investigation and&#13;\ncomparative evaluation of in vitro free&#13;\nradical scavenging activity of Triphala&#13;\n&amp; Curcumin. Asian Journal of&#13;\nPharmacy and Medical Science. 2011;&#13;\n1(1): 9-12.&#13;\n15. Ampofo AJ, Andoh A, Tetteh W,&#13;\nBello M. Microbiological Profile of&#13;\nSome Ghanaian Herbal Preparations-&#13;\nSafety Issues and Implications for the&#13;\nHealth Professions, Open Journal of&#13;\nMedical Microbiology. 2012; 2:121-&#13;\n130.&#13;\n16. Mosihuzzaman M, Choudhary MI.&#13;\nProtocols on Safety, Efficacy,&#13;\nStandardization, and Documentation&#13;\nof Herbal Medicine, Pure Appl. Chem.&#13;\n2008; 80(10):2195–2230.&#13;\n17. Rukangira E. The African Herbal&#13;\nIndustry: Constraints and Challenges,&#13;\nproc: “The natural Products and&#13;\nCosmeceutcals&#13;\n2001conference”.Africa. 2000: 1-20.&#13;\n18. Kamboj A. Analytical Evaluation of&#13;\nHerbal Drugs, Drug Discovery&#13;\nResearch in Pharmacognosy, 2012;&#13;\n3:23- 55.&#13;\n19. Zatz JL, Kushla GP: Gels. In:&#13;\nLieberman HA., Rieger MM and&#13;\nBanker GS. Pharmaceutical dosage&#13;\nform: Disperse system, 2nd ed. New&#13;\nYork: Marcel Dekker; 2005:399-421.&#13;\n20. Niyaz BB, Kalyani P, Divakar G:&#13;\nFormulation and evaluation of gel&#13;\ncontaining fluconazole antifungal&#13;\nagent. International Journal of Drug&#13;\nDevelopment and Research. 2011;&#13;\n3(4): 109-128.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:06.841Z", "slug": "formulation-development-of-herbal-anti-acne-gel", "authors": []}}, {"model": "artical.artical", "pk": 24, "fields": {"issue": 11, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAmresh Pratap Singh and Brijeshkunvar Mishra*\t\t\t\t\t", "pdf": "achivesPdf/211-217_3OmBeUD.pdf", "heading": "Evaluation of anti-inflammatory potential of Rutin using in vitro models", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tRutin is a secondary plant metabolite known to possess excellent antioxidant potential. The present&#13;\nwork was undertaken with an objective to evaluate the anti-inflammatory potential of rutin using in&#13;\nvitro models. Inhibition of albumin denaturation and antiprotease action were used as the models&#13;\nfor studying the anti-inflammatory action. The capacity of different concentrations of rutin to inhibit&#13;\nprotein denaturation of albumin was ranging from 27.33 ± 0.001% to 67.82 ± 0.002 comparable to&#13;\nibuprofen (standard). On the other hand the capacity of different concentrations of rutin to inhibit&#13;\nserine protease was found to be ranging from 20.36 ± 0.214% to 77.53 ± 0.138 in the assay and&#13;\ntherefore reinforces for its tremendous anti inflammatory property.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tRutin, albumin denaturation, antiprotease, anti-inflammatory, in vitro, chemical mediators\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tGhasemian M, Owlia S, Owlia MB. Review&#13;\nof anti-inflammatory herbal medicines.&#13;\nAdvances Pharmacol Sci. 2016;&#13;\nhttp://dx.doi.org/10.1155/2016/9130979&#13;\n2. Uttara, B., Singh, A.V., Zamboni, P. and&#13;\nMahajan, R.T. Oxidative stress and&#13;\nneurodegenerative diseases: A review of&#13;\nupstream and downstream antioxidant&#13;\ntherapeutic options. Curr Neuropharmacol.&#13;\n2009; 7: 65-74.&#13;\n3. Marienfeld R, Neumann M, Chuvpilo S,&#13;\nEscher C, Kneitz B, Avots A, et al.&#13;\nCyclosporin A interferes with the inducible&#13;\ndegradation of NF-k B inhibitors, but not&#13;\nwith the processing of p105/NF-k B1 in T&#13;\ncells. Eur J Immunol. 1997; 27:1601–9.&#13;\n4. Borrelli F, Romano B, Petrosino S, Pagano E,&#13;\nCapasso R, Coppola D, Battista G, Orlando&#13;\nP, Di Marzo V, Izzo AA (2015).&#13;\nPalmitoylethanolamide naturally occurring&#13;\nlipid an orally effective intestinal anti-&#13;\ninﬂammatory agent. British J Pharmacol, 172:&#13;\n142-158&#13;\n5. Leelaprakash G, Mohan Dass S (2011). In&#13;\nvitro anti inflammatory activity of methanol&#13;\nextract of Enicostemma axillare. International&#13;\nJournal of Drug Development &amp; Research, 3:&#13;\n189-196&#13;\n6. Kohli K, Ali J, Ansari MJ, Raheman Z (2005).&#13;\nCurcumin: A natural anti inflammatory agent.&#13;\nIndian J Pharmacol, 37: 141-147&#13;\n7. Achoui M, Appleton D, Abdulla MA, Awang&#13;\nK, Mohd MA, et al. (2010) In Vitro and In&#13;\nVivo Anti-Inflammatory Activity of 17-O-&#13;\nAcetylacuminolide through the Inhibition of&#13;\nCytokines, NF-kB Translocation and IKKb&#13;\nActivity. PLoS ONE 5(12): e15105.&#13;\ndoi:10.1371/journal.pone.0015105&#13;\n8. Halliwell, B. and Gutteridge, J.M. (2015) Free&#13;\nRadicals in Biology and Medicine. Oxford&#13;\nUniversity Press, USA.&#13;\n9. Jayameena P, Sivakumari K, Ashok K, Rajesh&#13;\nS (2018). In vitro anti-inflammatory&#13;\n(membrane stabilization) and antioxidant&#13;\npotential of rutin. Res J Life Sci&#13;\nBioinformatics Pharm Chem Sci, 4: 265-274&#13;\n10. Kim H, Kong H, Choi B, Yang Y, Kim Y,&#13;\nLim MJ, Neckers L, Jung Y (2005). Metabolic&#13;\nand pharmacological properties of rutin, a&#13;\ndietary quercetin glycoside, for treatment of&#13;\ninflammatory bowel disease. Pharm Res, 22:&#13;\n1499-1509&#13;\n11. Osman NI, Sidik NJ, Awal A, Adam NAM,&#13;\nRezali NI (2016). In vitro xanthine oxidase&#13;\nand albumin denaturation inhibition assay of&#13;\nBarringtonia racemosa L. and total phenolic&#13;\ncontent analysis for potential anti-infl&#13;\nammatory use in gouty arthritis. J Intercult&#13;\nEthnopharmacol, 5: 343-349.&#13;\n12. Kumari S, Yasmin N, Hussain MR,&#13;\nBabuselvam M (2015). In vitro&#13;\nantiinflammatory and anti-arthritic property&#13;\nof Rhizopora mucronata leaves. Internat J&#13;\nPharm Sci Res, 6: 482-485.&#13;\n13. Oyedepo OO and Femurewa AJ (1995).&#13;\nAnti‐protease and membrane stabilizing&#13;\nactivities of extracts of Fagra zanthoxiloides,&#13;\nOlax subscorpioides and Tetrapleura tetraptera.&#13;\nInternat J Pharmacog, 33: 65‐69.&#13;\n14. Sakat S, Juvekar AR, Gambhire MN (2010).&#13;\nIn vitro antioxidant and anti-inflammatory&#13;\nactivity of methanol extract of Oxalis&#13;\ncorniculata Linn. Internat J Pharma&#13;\nPharmacological Sc, 2: 146-155.&#13;\n15. Saso L, Valentini G, Casini ML, Grippa E,&#13;\nGatto MT, Leone MG (2001). Inhibition of&#13;\nheat-induced denaturation of albumin by&#13;\nnonsteroidal antiinflammatory drugs&#13;\n(NSAIDs): Pharmacological implications.&#13;\nArch Pharm Res, 24: 150-158.&#13;\n16. Opie EL (1962). On the relation of necrosis&#13;\nand inflammation to denaturation of proteins.&#13;\nJ Exp Med, 115: 597-608.&#13;\n17. Das S, Chatterjee S (1995). Long term toxicity&#13;\nstudy of ART-400. Indian Indg Med, 16: 117-&#13;\n123.&#13;\n18. Dai H, Korthuis RJ (2011). Mast cell&#13;\nproteases and inflammation. Drug Discov&#13;\nToday Dis Models, 8: 47-55.&#13;\ndoi: 10.1016/j.ddmod.2011.06.004\t\t\t\t\t</div>", "time": "2021-11-11T09:57:08.217Z", "slug": "evaluation-of-anti-inflammatory-potential-of-rutin", "authors": []}}, {"model": "artical.artical", "pk": 25, "fields": {"issue": 12, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAtishay Jain, Ayan Azam, Neelima Mishra , Usha Vishwakarma\t\t\t\t\t", "pdf": "achivesPdf/227-234-1_vfhFmCc.pdf", "heading": "Stem Cells: Boon for Mankind – A Review", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tIn recent years stem cell therapy has become a very promising advanced scientific research topic.&#13;\nThe development of treatment methods evoked great expectations. The paper is focused on&#13;\ndiscovery on different and potential therapy based on the cells. The genesis of stem cells is followed&#13;\nby laboratory steps of control stem cells culturing and derivations. Among many types of stem tissue&#13;\napplication and potential of these therapies require attention due to their versatility. This review is&#13;\nsummarized by challenges that stem cell therapy must overcome to be accepted worldwide and&#13;\nvariety of possibilities make this cutting edge a modern medicine, providing hope for untreatable&#13;\ndisease.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tStem cell, culturing, genesis, disease, therapy\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. https://www.isscr.org&#13;\n2. Pouton CW, Haymes JM. Embryonic stem&#13;\ncells as a 1 source of models for Drug&#13;\nDiscovery. Nature Reviews Drug Discovery&#13;\n2007; 6: 606-616.&#13;\n3. Seaberg RM, Van Dar Kooy D. Stem and&#13;\nprogenitre cells : The premature dissolution&#13;\nof rigorous definition Trends in&#13;\nNeurosciences 2003; 26: 125 131&#13;\n4. Tabar V, Panagiotakos G, Greenberg ED,&#13;\nChan BK, Sadelain M, et al. Migration and&#13;\ndifferentiation of neural precursors derived&#13;\nfrom human embryonic stem cells in the rat&#13;\nbrain. Nature Biotechnology 2005; 23: 601-&#13;\n606.&#13;\n5. Perrier AL, Tabar V, Barberi T, Rubio ME ,&#13;\nBruses J, et al. Derivation of Midbrain&#13;\ndopamine neurons from human embryonic&#13;\nstem cells Proceedings of National Academy&#13;\nof Sciences 2004; 101(34): 12543-12548&#13;\n6. Young HE, Black AC Jr. Adult stem cells.&#13;\nThe Anatomical Record Part A Discoveries&#13;\nin Molecular Cellular and Evolutionary&#13;\nBiology 2004; 276: 75-102&#13;\n7. Phinney DG, Prockop DJ. Concise review:&#13;\nmesenchymal stem multipotent stromal cells:&#13;\nthe state of transdifferentiation and modes of&#13;\ntissue repair-current reviews. Stem Cells 2007;&#13;\n25: 2896 -2902&#13;\n8. Ploemacher RE. Stem cells: characterization&#13;\nand measurement. Baillieres Clinical&#13;\nHematology 1997; 10(3): 429-444&#13;\n9. Domen J, Weissman IL. Self-renewal,&#13;\ndifferentiation or death: regulation and&#13;\nmanipulation of hematopoietic stem cell fate.&#13;\nMolecular Medicine Today 1999; 5: 201-208.&#13;\n&#13;\n10. Jaenisch R, Young R. Stem cells, the&#13;\nmolecular circuitry of pluripotency and&#13;\nnuclear reprogramming. Cell 2008; 132: 567-&#13;\n582&#13;\n11. Lindvall O, Kokaia Z. Recovery and&#13;\nRehabilitation in stroke: Stem cells. Stroke&#13;\n2004; 35: 2691- 2694.&#13;\n12. Patkar S, Tate R, Modo M, Plevin R, Carswell&#13;\nHV. Conditionally immortalised neural stem&#13;\ncells promote functional recovery and brain&#13;\nplasticity after transient focal cerebral&#13;\nischaemia in mice. Stem Cell Research 2012;&#13;\n8: 14-25.&#13;\n13. Tandon PN. Brain cell- recently unveiled&#13;\nsecrets; their clinical significance. Neurology&#13;\nIndia 2007; 55: 322-327&#13;\n14. Park CH , Minn YA, Lee JY, Choi DH ,&#13;\nChang MY, et al. In vitro and in vivo analysis of&#13;\nhuman embryonic stem cells-derived&#13;\ndopamine neurons, Journal of&#13;\nNeurochemistry 2005; 92: 1265-1276&#13;\n15. Yu G, Borlongan CV, Stahl CE, Hess DC,&#13;\nOu Y, et al. Systemic delivery of umbilical&#13;\ncord blood cells for stroke therapy: a review.&#13;\nRestorative Neurology and Neuroscience&#13;\n2009; 27: 41-54.&#13;\n16. Evans MJ, Kaufman MH. Establishment in&#13;\nculture of pluripotential cells from mouse&#13;\nembryos. Nature 1981; 292: 154-156.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:08.844Z", "slug": "stem-cells-boon-for-mankind-a-review", "authors": []}}, {"model": "artical.artical", "pk": 26, "fields": {"issue": 12, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tMeraj Khan*, Seerat Anwar\t\t\t\t\t", "pdf": "achivesPdf/218-226_eBHcyj1.pdf", "heading": "Nutraceuticals in the management of alzheimer’s disease", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe aim of this review is attempts to enlist and display the role of some nutraceuticals being used&#13;\nas in the prevention and management of Alzheimer's disease. Various cognitive enhancer are&#13;\nwidely used traditionally as medicine to prevent Alzheimer's disease. Nutraceuticals are food or&#13;\npart of a food including naturals (like plants, animals, minerals, or microbial sources) or&#13;\nchemical groups (like vitamins, antioxidants, amino acids and fatty acids) that promote wellness&#13;\nor health benefits including the prevention and/or treatment of a disease. One of the best benefits&#13;\nof nutraceuticals is that they provide a better therapeutic hope with lesser side effects compared&#13;\nto pharmaceutical agents or other conventional approach. Some of the herbal nutraceuticals like&#13;\nGingko Biloba, Huperzine Alpha are used in clinical practice to target the pathogenesis of&#13;\nAlzheimer's disease.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tNutraceuticals, Alzheimer's disease, Herbal Drugs, Gingko Biloba, Huperzine&#13;\nAlpha, Vitamins.\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Goodman Gilman A, Goodman LS, Rall TW,&#13;\nMurad F Eds. Goodman &amp; Gilman's The&#13;\nPharmacological Basis Of Therapeutics. New&#13;\nYork: Macmillan Publishing Company, 7th ed.&#13;\n1985; pp 560-62&#13;\n2. Dementia Fact Sheet, World Health&#13;\nOrganisation. 2016&#13;\n3. Levine DA, Langa KM. Vascular cognitive&#13;\nimpairment: disease mechanisms and&#13;\ntherapeutic implications. Neurotherapeutics&#13;\n2011; 8(3): 361–373&#13;\n4. Skoog I. Status of risk factors for vascular&#13;\ndementia. Neuroepidemiology 1998; 17(1):&#13;\n2–9&#13;\n5. Tiraboschi P, Hansen LA, Thal LJ, Corey-&#13;\nBloom J. The importance of neuritic plaques&#13;\nand tangles to the development and evolution&#13;\nof AD. Neurology 2004; 62(11): 1984-1989&#13;\n6. Wright CI, Geula C, Mesulam MM:&#13;\nNeurological cholinesterase in the normal&#13;\nbrain and in Alzheimer's disease: Relation to&#13;\nplaques, tangles, and patterns of selective&#13;\nvulnerability. Annals of Neurology 1993; 34:&#13;\n373-384.&#13;\n7. Francis PT, Palmer AM, Snape M, et al.,The&#13;\ncholinergic hypothesis of Alzheimer's disease:&#13;\nA review of progress. J Neurol ,neurosurg&#13;\nPsychiatry 1999; 54: 137-147.&#13;\n8. Brower V. Nutraceuticals: Poised for a&#13;\nhealthy slice of the healthcare market? Nature&#13;\nBiotechnology 1998; 16: 728-731&#13;\n9. Smith JV, Luo Y. Studies on molecular&#13;\nmechanisms of Ginkgo biloba extract.&#13;\nApplied Microbiology and Biotechnology&#13;\n2004; 64(4): 465–472&#13;\n10. http://www.herbal-supplement-resource.com&#13;\n11. http://www.richters.com&#13;\n12. Maurer K, Ihl R, Dierks T, Frolich L. Clinical&#13;\neﬃcacy of Ginkgo biloba special extract EGb&#13;\n761 in dementia of the Alzheimer type.&#13;\nJournal of Psychiatric Research 1997; 31(6):&#13;\n645–655&#13;\n13. Mazza M, Capuano A, Bria P, Mazza S.&#13;\nGinkgo biloba and donepezil: a comparison&#13;\nin the treatment of Alzheimer‟s dementia in a&#13;\nrandomized placebo-controlled double-blind&#13;\nstudy. European Journal of Neurology 2006;&#13;\n13(9): 981– 985&#13;\n14. Wang R, Xi CT. Neuroprotective eﬀects of&#13;\nhuperzine A: a natural cholinesterase&#13;\ninhibitor for the treatment of Alzheimer‟s&#13;\ndisease. NeuroSignals 2005; 14(1-2): 71-82&#13;\n15. http://www.holistictherapypractice.com&#13;\n16. Zhang Z, Wang X, Chen Q, Shu L, Wang J,&#13;\nShan G. Clinical efficacy and safety of&#13;\nhuperzine Alpha in treatment of mild to&#13;\nmoderate Alzheimer disease, a placebo-&#13;\ncontrolled, double-blind, randomized trial.&#13;\nZhonghua Yi Xue Za Zhi 2002; 82: 941-944&#13;\n17. Xu SS, Cai ZY, Qu ZW, Yang RM, Cai YL,&#13;\nWang GQ, Su XQ, Zhong XS, Cheng RY,&#13;\nXu WA, et al. Huperzine-A in capsules and&#13;\ntablets for treating patients with Alzheimer&#13;\ndisease. Zhongguo Yao Li Xue Bao 1999; 20:&#13;\n486-490.&#13;\n18. Perry EK, Pikering AT, Wang WW, et al.:&#13;\nMedicinal plants and Alzheimer's disease:&#13;\nIntegrating ethnobotanical and contemporary&#13;\nscientific evidence. Journal of Alternate and&#13;\nComplementary Medicine 1998; 4: 419-428.&#13;\n19. Kennedy DO, Scholey AB, Tildesley NTJ, et&#13;\nal.: Modulation of mood and cognitive&#13;\nperformance following acute administration&#13;\nof Melissa officinalis lemon balm. Pharmacol&#13;\nogy Biochemisty and Behavior 2002; 72: 953-&#13;\n964.&#13;\n20. Akhondzadeh S, Noroozian M, Mohammadi&#13;\nM, et al.: Melissa officinalis extract in the&#13;\ntreatment ofpatients with mild to moderate&#13;\nAlzheimer's disease: A double blind,&#13;\nrandomised, placebo controlled trial. Journal&#13;\nof Neurology, Neurosurgery and Psychiatry&#13;\n2003; 74: 863-866.&#13;\n21. Wake G, Court J, Pikering A, et al.: CNS&#13;\nacetylcholine receptor activity in European&#13;\nmedicinal plants traditionally used to improve&#13;\nfailing memory. Journal of&#13;\nEthnopharmacology 2000; 69: 105-114.&#13;\n22. Akhondzadeh S, Noroozian M, Mohammadi&#13;\nM, et al.: Salvia officinalis extract in the&#13;\ntreatment of patients with mild to moderate&#13;\nAlzheimer's disease: A double blind,&#13;\nrandomized and placebo-controlled trial.&#13;\nJournal of Clinical Pharmacy and&#13;\nTherapeutics 2003; 28: 53-59.&#13;\n23. Russo A, Borrelli F. Bacopa monniera, a&#13;\nreputed nootropic plant: an overview. Phyto&#13;\nmedicine 2005; 12(4): 305-317&#13;\n24. Bhattacharya SK, Bhattacharya A, Kumar A,&#13;\nGhosal S. Antioxidant activity of Bacopa&#13;\nmonniera in rat frontal cortex, striatum and&#13;\nhippocampus. Phytotherapy Research 2000;&#13;\n14(3): 174–179&#13;\n25. Russo A, Izzo AA, Borrelli F, Renis M,&#13;\nVanella A. Free radicalbscavenging capacity&#13;\nand protective effect of Bacopa monniera L.&#13;\non DNA damage. Phytotherapy Research&#13;\n2003; 17(8): 870-875&#13;\n26. Kamkaew N, Scholfield CN, Ingkaninan K,&#13;\nN. Taepavarapruk N, Chootip K. Bacopa&#13;\nmonnieri increases cerebral blood flow in rat&#13;\nindependent of blood pressure. Phytotherapy&#13;\nResearch 2013; 27(1): 135-138&#13;\n27. Kar Chowdhuri D, Parmar D, Kakkar P,&#13;\nShukla R, Seth PK, Srimal RC. Antistress&#13;\neffects of bacosides of Bacopa monnieri&#13;\nmodulation of Hsp70 expression, superoxide&#13;\ndismutase and cytochrome P450 activity in&#13;\nrat brain. Phytotherapy Research 2002; 16(7):&#13;\n639-645&#13;\n28. Kishore K, Singh M. Effect of bacosides,&#13;\nalcoholic extract of Bacopa monniera&#13;\nLinn.(brahmi) on experimental amnesia in&#13;\nmice. Indian Journal of Experimental Biology&#13;\n2005; 43(7): 640-645&#13;\n29. Goswami S, Saoji A, Kumar N, Thawani V,&#13;\nTiwari M, Thawani M. Effect of Bacopa&#13;\nmonnieri on Cognitive functions in&#13;\nAlzheimer‟s disease patients. International&#13;\nJournal of Collaborative Research in Internal&#13;\nMedicine and Public Health 2011; 3: 285-293.&#13;\n30. http://www.alz.org/research/science/alzhei&#13;\nmers treatment horizon.asp&#13;\n31. http://www.alz.org/research/clinical&#13;\ntrials/find clinical trials trialmatch.aspf\t\t\t\t\t</div>", "time": "2021-11-11T09:57:09.382Z", "slug": "nutraceuticals-in-the-management-of-alzheimers-dis", "authors": []}}, {"model": "artical.artical", "pk": 27, "fields": {"issue": 13, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAmbika, G.K.Pandey, B.K.Dubey\t\t\t\t\t", "pdf": "achivesPdf/259-267-1_VJ650kv.pdf", "heading": "Formulation and Characterization of Oxybenzone loaded liposomes", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tOxybenzone is a widely used sunscreen molecule incorporated in various sunscreen lotions and&#13;\ncreams. The objective of the present investigation was to formulate oxybenzone as liposomes and&#13;\nconvert them into the sunscreen creams or lotions to improve stability and enhance sunscreen&#13;\nefficiency and safety of the molecule. Liposomes of oxybenzone were prepared by dissolving varying&#13;\namounts of lecithin and drug (2: 0.1, 3.5: 0.1 and 6: 0.1). The liposomes were evaluated for particle&#13;\nsize, shape, zeta potential, entrapment efficiency and drug release. The liposomes were formulated as&#13;\nsunscreen cream and evaluated for various parameters and in vitro sunscreen efficacy. A maximum&#13;\nof 80.03% oxybenzone release was observed in the formulation OL3 at the end of 12th h while the&#13;\nlowest was observed for formulation OL5 (65.2%)\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tOxybenzone, sunscreen, liposomes, nitroprusside, cream, release\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Nicholas, J.L., Pathak, M. (1996). Sunscreens:&#13;\nDevelopment, Evaluation and Regulatory&#13;\nAspects, Cosmetic science technology series.&#13;\n2nd Edition. CRC press. p. 234-39.&#13;\n2. Gordan, V.C. (1993). Evaluation du facteur&#13;\nde protection solaire. Parfum. Cosmet. Arom.&#13;\nParis, 112: 62-65.&#13;\n3. Mansur, J.S., Breder, MNR., Mansur, MCA.,&#13;\nAzulay, RD. (1986). Deterninacao do fator de&#13;\nprotecao solar porEspectrofotometria, Bras.&#13;\nDermatol. Rio de Janeiro. 61: 121-124.&#13;\n4. Syre, R.M., Agin, P.P., Levee, G.J., Marlowe,&#13;\nE. (1979). Comparison of in-vivo and in-vitro&#13;\ntesting of Sunscreening formulas,&#13;\nPhotochem. Photobiol. Oxford. 29: 559-566.&#13;\n5. Afaq, F. and Mukhtar, H. (2006). Botanical&#13;\nantioxidants in the prevention of&#13;\nphotocarcinogenesis and photoaging. Exp.&#13;\nDermatol., 15: 678-684.&#13;\n6. Farhangi M, Dadshzadeh S, Bolourchian N&#13;\n(2017). Biodegradable Gelatin Microspheres&#13;\nas Controlled Release Intraarticular Delivery&#13;\nSystem: The Effect of Formulation Variables.&#13;\nIndian J Pharm Sci. 79(1): 105-112.&#13;\n7. Shaikh KS, Chellampillai B, Pawar AP (2010).&#13;\nStudies on nonionic surfactant bilayer vesicles&#13;\nof ciclopirox olamine. Drug Dev Ind&#13;\nPharmacy. 36(8): 946-953.&#13;\n8. Rekha U, Manjula BP (2011). Formulation&#13;\nand evaluation of microsponges for topical&#13;\n&#13;\ndrug delivery of Mometasone furoate.&#13;\nInternat J Pharmacy Pharm Sci. 3(4):133-137.&#13;\n9. Panda P, Ghosh A (2010). Formulation and&#13;\nEvaluation of Topical Dosage Form of&#13;\nEupatorium Odoratum Linn and Their&#13;\nWound Healing Activity. Internat J Pharm&#13;\nBioSci. 1(2): 201-203.&#13;\n10. Purushothamrao K, Khaliq K, Sagare P, Patil&#13;\nSK, Kharat SS, Alpana.K (2010). Formulation&#13;\n&#13;\nand evaluation of vanishing cream for scalp&#13;\npsoriasis. Internat J Pharm Sci Tech. 4(1): 33-&#13;\n41.&#13;\n11. Kaidbey KH, Kligman AM (1978).&#13;\nLaboratory methods for appraising the&#13;\nefﬁcacy of sunscreens. J Soc Cosmet Chem.&#13;\n29: 525–536.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:10.347Z", "slug": "formulation-and-characterization-of-oxybenzone-loa", "authors": []}}, {"model": "artical.artical", "pk": 28, "fields": {"issue": 13, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAzmi Abu Amama Jalis Ahmed, G.K.Pandey, B.K.Dubey\t\t\t\t\t", "pdf": "achivesPdf/249-258_G5XhPXb.pdf", "heading": "Formulation and evaluation of polyherbal capsules for the management of gout", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tTrigonella foenum-graecum (TF), Zingiber officinale (ZO) and Piper nigrum (PN) were extracted using ethanol&#13;\nand incorporated in to liposomes. These liposomes were formulated as capsule dosage form for the&#13;\nmanagement of gout. The extraction yield for TF, ZO and PN were found to be 38.9 41.6 and&#13;\n21.6% respectively respectively. The total phenolic content in TF, ZO and PN extracts were found&#13;\nto be 31.3 ± 1.367, 11.7 ± 2.896 and 8.7 ± 0.894 GAE mg/100g whereas it was found to be 49.8 ±&#13;\n0.735, 58.1 ± 1.721 and 69.06 ± 1.823 GAE mg/100g for 1:1:1, 1:2:1 and 2:1:1 mixture ratio of CQ&#13;\nand ZO respectively. The particle size of the liposomes was found to decrease with an increase in&#13;\nsonication time but the sonication time did not affect the total phenolic content of the liposomes.&#13;\nThe particle size of the liposome formulated using 5 min sonication time was considered optimum&#13;\nand was found to be 2.38 ± 0.0929 µm. The phenolic content in the liposomes was in accordance&#13;\nwith the extract mixture incorporated into the liposome with LF3 exhibiting the highest phenolics.&#13;\nThe liposomes were evaluated for stability for a period of 3 months at storage temperature of 4° and&#13;\n40°C. The liposomes were stable at both the temperature conditions and the particle size of the&#13;\nliposomes did not change considerably over a period of three months. The weight variation of&#13;\npolyherbal liposome filled capsules was between 3.5-4.1% whereas the disintegration time was found&#13;\nto be between 3.2 to 3.7 min.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tPolyherbal, liposomes, gout, stability, phenolics, prefill parameters\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Choi HK, Mount DB, Reginato AM.&#13;\nPathogenesis of gout. Annals of Internal&#13;\nMedicine 2005; 143(7): 499-516.&#13;\n&#13;\n2. Grosser T, Smyth EM, FitzGerald GA.&#13;\nPharmacotherapy of inflammation, fever,&#13;\npain and gout. In: Goodman and Gilman’s&#13;\nThe pharmacological basis of therapeutics.&#13;\n13th ed. McGraw Hill Education , New York,&#13;\n2016; pp 685-709&#13;\n3. Ehrlich SD. Herbal medicine. 2011. [Last&#13;\naccessed on 2019 November 1]. Available&#13;\nfrom: http://www.umm.edu/health/medical&#13;\n/altmed/treatment/herbal-medicine .&#13;\n4. What is Ayurveda. 2008. [Last accessed on&#13;\n2019 November 1]. Available&#13;\nfrom: http://www.ashtangayurveda.com/pag&#13;\nes/What-is-Ayurveda.asp .&#13;\n5. Oreagba IA, Oshikoya KA, Amachree M.&#13;\nHerbal medicine use among urban residents&#13;\nin Lagos, Nigeria. BMC Complementary and&#13;\nAlternative Medicine 2011; 11: 117.&#13;\nhttp://www.biomedcentral.com/1472-&#13;\n6882/11/117&#13;\n6. Kamboj VP. Herbal medicine. Current&#13;\nScience 2000; 78: 35–51.&#13;\n7. Yoganarsimhan SN. Medicinal plants of&#13;\nIndia. Cyber Media Bangalore 2, 2000; 2:136–&#13;\n137.&#13;\n8. Mishra G, Srivastava S, Nagori BP.&#13;\nPharmacological and therapeutic activity of&#13;\nCissus quadrangularis: An overview.&#13;\nInternational Journal of PharmTech Research&#13;\n2010; 2(2):1298-1310.&#13;\n9. Goyal S, Gupta N, Chatterjee S. Investigating&#13;\ntherapeutic potential of Trigonella foenum-&#13;\ngraecum L. as our defense mechanism against&#13;\n&#13;\nseveral human diseases. Journal of&#13;\nToxicology 2016;&#13;\nhttp://dx.doi.org/10.1155/2016/1250387&#13;\n10. Bang JS, Oh DH, Choi HM, Sur B-J, Lim S-J,&#13;\nKim JY, Yang H-I Yoo MC, Hahm D-H,&#13;\nKim KS. Anti-inflammatory and antiarthritic&#13;\neffects of piperine in human interleukin 1β-&#13;\nstimulated fibroblast-like synoviocytes and in&#13;\nrat arthritis models. Arthritis Research and&#13;\nTherapy 2009; 11: R46. doi:10.1186/ar2662&#13;\n11. Sahira Banu K, Cathrine L. General&#13;\nTechniques Involved in Phytochemical&#13;\nAnalysis. International Journal of Advances&#13;\nResearch in Chemical Sciences 2015; 2(4): 25-&#13;\n32&#13;\n12. Chanthasri W, Puangkeaw N, Kunworarath&#13;\nN, Jaisamut P, Limsuwan S, Maneenoon K,&#13;\nChoochana P, Chusri S. Antioxidant&#13;\ncapacities and total phenolic contents of 20&#13;\npolyherbal remedies used as tonics by folk&#13;\nhealers in Phatthalung and Songkhla&#13;\nprovinces, Thailand. BMC Complementary&#13;\nand Alternative Medicine 2018; 18:73.&#13;\nhttps://doi.org/10.1186/s12906-018-2131-y&#13;\n13. Armann C, Roding J, Ghyczy M, Pratzel HG.&#13;\nLiposomes from soya phospholipids as&#13;\npercutaneous drug carriers. Arzneim-Forsch/&#13;\nDrug Research 1990; 40: 1365-1368&#13;\n14. Jain S, Kale DP, Swami R, Katiyar SS.&#13;\nCodelivery of benzoyl peroxide &amp; adapalene&#13;\nusing modified liposomal gel for improved&#13;\nacne therapy. Nanomedicine 2018; 13(12):&#13;\n1481-1493&#13;\n&#13;\n15. Shanmuga PS, Muthusamy P, Vadivu R,&#13;\nRadha R, Vijaya Bharathi R, Kumudhaveni.&#13;\nDevelopment of polyherbal haematinic&#13;\ncapsules and its preformulation studies.&#13;\nInternational Journal of Innovative Research&#13;\nand Advance Studies 2017; 4(3): 192-195&#13;\n16. Jain CP, Naruka PS. Formulation and&#13;\nevaluation of fast dissolving tablets of&#13;\nvalsartan. International Journal of Pharmacy&#13;\nand Pharmaceutical Sciences 2009; 1(1): 219-&#13;\n226&#13;\n&#13;\n17. Prameela AR, Archana N, Siva PT, Mohan&#13;\nPV, Sudheer MK, Bala CK. Formulation and&#13;\nevaluation of orodispersible metformin&#13;\ntablets. International Journal of Applied&#13;\nPharmacy 2010; 2(3): 15-21.&#13;\n18. Dag D, Oztop MH. Formation and&#13;\nCharacterization of Green Tea Extract&#13;\nLoaded Liposomes. Journal of Food Science&#13;\n2017; doi: 10.1111/1750-3841.13615\t\t\t\t\t</div>", "time": "2021-11-11T09:57:11.372Z", "slug": "formulation-and-evaluation-of-polyherbal-capsules-", "authors": []}}, {"model": "artical.artical", "pk": 29, "fields": {"issue": 13, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAnkita Gupta*, Parul Mehta, Ashish Jain&#13;\n&#13;\nSchool of Pharmacy, LNCT University, Bhopal, Madhya Pradesh (India)\t\t\t\t\t", "pdf": "achivesPdf/242-248-1_d0M020i.pdf", "heading": "Formulation and evaluation of transdermal patches of Lamotrigine", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tLamotrigine is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. Existing approved formulations of lamotrigine present cyclical plasma concentration of drug with peaks occurring after administration followed by troughs occurring before the next administration. The objective of this study was to develop a transdermal patch of lamotrigine for the better&#13;\nmanagement of anti-convulsive therapy, alone or in combination. Transdermal patches were prepared by solvent casting method using HPMC, ethyl cellulose, and eudragit as the polymeric matrix. The patches were evaluated for thickness, folding endurance, % moisture content and uptake, drug content, tensile strength and in vitro permeation study. The thickness of the&#13;\ntransdermal patches F1-F6 for different polymer ratios varied from 0.070±0.008 mm to 0.083±0.005 mm. Formulation F4 contain minimum moisture contain 1.85±0.32% and minimum moisture uptake 2.14±0.32% with a folding endurance of 220±12, and 99.94±0.52% drug content.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tTransdermal, eudragit, HPMC, ethyl cellulose, Lamotrigine, release\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Soni M, Kumar S, Gupta GD. Transdermal&#13;\ndrug delivery: A novel approach to skin&#13;\npermeation. Journal of Pharmacy Research.&#13;\n2009; 2: 1184-1190.&#13;\n2. Naik A, Kalia YN, Guy RH. Transdermal&#13;\ndrug delivery: Overcoming the skin’s barrier&#13;\nfunction. Pharmaceutical Science Technology&#13;\nToday. 2009; 3: 318-326.&#13;\n3. Chandrashekhar NS, Shobha R.&#13;\nPhysicochemical and pharmacokinetic&#13;\nparameters in drug selection and loading for&#13;\ntransdermal drug delivery. Indian Journal of&#13;\nPharmaceutical Sciences. 2008; 70: 94-95.&#13;\n4. https://go.drugbank.com/drugs/DB00555;&#13;\nassessed on 27/12/2020&#13;\n5. Arora P, Mukherjee B. Design, development,&#13;\nphysicochemical, and in vitro and in vivo&#13;\nevaluation of transdermal patches containing&#13;\ndiclofenac diethylammonium salt. Journal of&#13;\nPharmaceutical Sciences. 2002; 91: 2076-&#13;\n2089.&#13;\n&#13;\n6. Dangi AA. Formulation &amp;Evalution of&#13;\nTransdermal Ondansetron hydrochloride&#13;\nMatrix Patch: In vitro Skin Permeation &amp;&#13;\nIrritation Study. International Journal of&#13;\nPharmaceutical Research and Allied Sciences.&#13;\n2012, 26-34.&#13;\n7. Chettupalli AK, Vasudha B, Krishna S.&#13;\nPreparation and In - Vitro Evaluation of&#13;\nGlyburide Fast Dissolving Tablets by Using&#13;\nSolid Dispersion Technique. International&#13;\nJournal of Pharmaceutical Sciences Reviews&#13;\nand Research. 2017; 44(1): 108-111.&#13;\n8. Chettupalli AK, Vasudha. B, Krishna S.&#13;\nEvaluation Of Anti Hyperlipidemic Activity&#13;\nOf Medicinal Plant, Argyreia Nervosa Burn.F&#13;\nIn Hyperlipidemic Rats. Journal of Global&#13;\nTrends in Pharmaceutical Sciences. 2017;&#13;\n8(1): 3577 – 3583.&#13;\n9. Ju RT, Nixon PR, Patel MV, Tong DM. Drug&#13;\nrelease from hydrophilic matrices. A&#13;\n&#13;\nmathematical model based on the polymer&#13;\ndisentanglement concentration and the&#13;\ndiffusion layer. Journal of Pharmaceutical&#13;\nSciences. 1995; 84: 1464-1477.&#13;\n10. Bhabani S, Ellaiah P, Das S. Formulation,&#13;\ndesign, preparation and in vitro&#13;\ncharacterization of nebivolol transdermal&#13;\npatches. Asian Journal of Pharmacy. 2011;&#13;\n5(3): 175-182.&#13;\n11. Crawford RR, Esmerian OK. Effect of&#13;\nplasticizers on some physical properties of&#13;\ncellulose acetate phthalate films. Journal of&#13;\nPharmaceutical Sciences. 1997; 60: 312- 314.&#13;\n12. Bhosale NR, Hardikar SR, Bhosale AV.&#13;\nFormulation and Evalution of Transdermal&#13;\npatches of Ropinirole hydrochloride.&#13;\nResearch Journal of Pharmaceutical&#13;\nBiological and Chemical Sciences. 2011; 2(1):&#13;\n140-145.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:12.120Z", "slug": "formulation-and-evaluation-of-transdermal-patches-", "authors": []}}, {"model": "artical.artical", "pk": 30, "fields": {"issue": 13, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tMeena Kumari Vaishya*, Virendra Sharma, J.P.Rai\t\t\t\t\t", "pdf": "achivesPdf/235-241-1_XBD5wzr.pdf", "heading": "Tazarotene loaded niosomal gel for effective acne treatment", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tNiosomes are the non-ionic surfactant-based vesicular system which may enhance anti-acne efficacy by improving bioavailability and intra-follicular penetration of the tazarotene. In the present study, we prepared tazarotene-loaded niosomes which were further incorporated in the carbopol 934 gel to&#13;\nalter the contact time to gain maximum benefits of the treatment. Prepared formulations of Niosome were optimized on basis of vesicle size, shape, surface charge and entrapment efficiency. % Entrapment efficiency and vesicle size of optimized Niosomes formulation (F-9) was found 78.85±0.25% and 212.4±0.32 nm respectively. Gel of F9 was formulated using carbopol 934 as the base. The in vitro anti acne activity of the niosomal gel was evaluated against Propionibacterium acnes using well diffusion method using clindamycin as the standard drug. The niosomal Gel NG-2 showed greater capacity (18.5±0.86, 19.0±0.7, 24.0±0.9) to inhibit bacterial growth than&#13;\ncorresponding to plain gel (10.0±0.5, 12.0±0.8, 14.0±0.7) at the concentration level of 10µg/ml, 20µg/ml and 30µg/ml respectively.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tTazarotene, noisome, gel, acne, stability, thin film hydration\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t1. Teixeira V, Vieira R, Figueiredo A. Impacto&#13;\npsicossocial da acne. Rev da Soc Port&#13;\nDermatol Venereol. 2012; 70(3): 291–296.&#13;\n2. Nast A, Dréno B, Bettoli V, et al. European&#13;\nevidence-based (S3) guidelines for the&#13;\ntreatment of acne. J Eur Acad Dermatol&#13;\nVenereol. 2012; 26 (S1): 1–29.&#13;\n3. Shah VP, Maibach HI, Topical Drug&#13;\nBioavailability, Bioequivalence, and&#13;\nPenetration, 1, Springer, USA, 1993, 369-391.&#13;\n4. Makeshwar K, Wasankar S. Niosomes: a&#13;\nnovel drug delivery system. Asian J. Pharm.&#13;\nRes. 2013; 3: 16-20.&#13;\n5. Goyal G, Garg T, Malik B, Chauhan G, Rath&#13;\nG, Goyal AK. Development and&#13;\ncharacterization of niosomal gel for topical&#13;\ndelivery of benzoyl peroxide, Drug Delivery,&#13;\n2015; 22(8): 1027–1042.&#13;\n6. Balakrishnan P, Shanmugam S, Lee WS et al.&#13;\nFormulation and in vitro assessment of&#13;\nminoxidil niosomes for enhanced skin&#13;\ndelivery. International Journal of&#13;\nPharmaceutics. 2009; 377 (1-2), 1–8.&#13;\n7. Firthouse PUM, Halith SM, Wahab SU,&#13;\nSirajudeen M, Mohideen SK. Formulation&#13;\nand evaluation of miconazole niosomes.&#13;\nInternational Journal of PharmTech&#13;\nResearch. 2011; 3 (2): 1019–1022.&#13;\n&#13;\n8. Sathali AAH, Sangeetha T. Formulation and&#13;\nevaluation of ocular niosomal in situ gel of&#13;\nlevoﬂoxacin hemihydrates. Journal of&#13;\nPharmacy Research. 2011; 4: 4331–4337.&#13;\n9. Sathali AAH, Rajalakshmi G. Evaluation of&#13;\ntransdermal targeted niosomal drug delivery&#13;\nof terbinafne hydrochloride. International&#13;\nJournal of PharmTech Research. 2010; 2 (3):&#13;\n2081–2089.&#13;\n10. Solanki AB, Parikh JR, Parikh RH, Patel MR.&#13;\nEvaluation of di erent compositions of&#13;\nniosomes to optimize aceclofenac&#13;\ntransdermal delivery. Asian Journal of&#13;\nPharmaceutical Sciences. 2010; 5 (3): 87–95.&#13;\n11. Salih OS, Samein LH, Ali WK. Formulation&#13;\nand in vitro evaluation of rosuvastatin&#13;\ncalcium niosomes. International Journal of&#13;\nPharmacy and Pharmaceutical Sciences. 2013;&#13;\n5 (4): 525–535.&#13;\n12. Shinde UA, Kanojiya SS. Serratiopeptidase&#13;\nniosomal gel with potential in topical delivery.&#13;\nJournal of Pharmaceutics. 2014, Article ID&#13;\n382959.&#13;\n13. Nakatsuji T, Kao MC, Fang JY, et al. (2009).&#13;\nAntimicrobial property of lauric acid against&#13;\nPropionibacterium acnes: its therapeutic&#13;\npotential for inflammatory acne vulgaris. J&#13;\nInvest Dermatol 129: 2480–2488.\t\t\t\t\t</div>", "time": "2021-11-11T09:57:12.653Z", "slug": "tazarotene-loaded-niosomal-gel-for-effective-acne-", "authors": []}}, {"model": "artical.artical", "pk": 31, "fields": {"issue": 14, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tOmprakash Dipankar1*, B.K.Dubey2, Mansi Gupta2 ", "pdf": "achivesPdf/295-303_ki48aDT.pdf", "heading": "Formulation and evaluation of extended release microspheres loaded with labetalol", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tMicrospheres loaded with Labetalol were prepared using chitosan as the polymer and TPP as the crosslinking agent. The formulation of micropsheres was done at various concentrations of the polymer and TPP. All the microsphere formulations (F1 to F6) were characterized for yield, entrapment efficiency, rheological properties (angle of repose, bulk density, tapped density, Hausner’s ratio, Carr’s index), and in vitro drug release. The pharmacokinetic release profile of drug from all the formulations was determined using zero order, Higuchi equation and Korsemeyer-Peppas release model.The particles were found to be in the range of 600-1100 µm and the percentage yield varied from 64-83%.The drug entrapment efficiencies of different formulations were in the range of 64.26 to 86.00%. All the formulated microspheres exhibit good flow properties with a value of angle of repose between 21°32’ to 29°72’. The Carr’s index of all the formulations was found in the range 5.88 to 14.57 % indicating good flow ability. The Hausner’s ratio of the formulations was found in the range 1.062 to 1.170. The cumulative drug release was observed to be 61.774%, 63.061%, 36.035%, 34.380%, 60.855% and 57.178% for the formulations F1 to F6 respectively. Consequently, it can be concluded that the microspheres produced from chitosan and TPP using ion gelation method is an excellent delivery system that has good extended release behavior and this would be beneficial in decreasing the dosing frequency of Labetalol in treatment of hypertensive conditions.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tLabetalol, antihypertensive, extended release, microspheres, chitosan, TPP\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Bramhmankar DM, Jaiswal SB (2005) Biopharmaceutics and pharmacokinetics – A Vallabh prakashan, Delhi.1<sup>st</sup> Edition, p 335-338.</li>\n<li>Chein YW (2005) Concepts and system design for rate-controlled drug delivery in Swarbrick. J (Ed). Novel Drug Delivery System. New York: Marcel Dekker, Inc, p 1-39</li>\n<li>Chowdary KPR, Rao YS (2003) Mucoadhesive Microcapsules of Glipizide: Characterization, In Vitro and in Vitro Evaluation. Indian J Pharm Sci 65(3): 279-284.</li>\n<li><a href=\"https://www.drugbank.ca/drugs/DB00598\">https://www.drugbank.ca/drugs/DB00598</a>. Assessed on 12/04/2021.</li>\n<li>Jain H, Eldose A, Patel P, Upadhyay U (2016) Formulation and evaluation of floating tablet of labetalol hydrochloride. Mintage J Pharm Med Sci 5(4): 16-19.</li>\n<li>Klausnera EA, Lavyb E, Friedmana M, Hoffmana A (2003) Expandable Gastroretentive Dosage forms. J Control Rel 90: 143-162 .</li>\n<li>Martin A (Ed) (1995) Micromeritics. In Physical Pharmacy and Pharmaceutical Sciences: Physical Chemical and Biopharmaceutical Principles in the Pharmaceutical Sciences. 4th edition, p. 423-449.</li>\n<li>Shabaraya AR, Narayanacharyulu R (2003) Design and Evaluation of Chitosan Microspheres of Metoprolol Tartrate for Sustained Release, Indian J Pharm Sci 65(3): 250-252.</li>\n<li>Stithit S, Chen W, Price JC (1998) Development and characterization of buoyant theophyline microspheres with near zero order release kinetics, J Microencapsul 15(6): 725-737.</li>\n<li>Subhash Kumar V, Saranya Nair P, Vekariya H (2016) Formulation and evaluation of floating tablet of Labetalol hydrochloride. J Pharm Sci Bioscientific Res 6(4): 509-515.</li>\n<li>Sunil Kumar K, Avinash P, Penchalaiah C, Bhaskar K, Shirisha T (2020) Formulation and In-vitro Evaluation of Sodium alginate Floating Micro beads of Labetalol by using Emulsion Gelation method. Int J Chem Pharm Sci 8(5): 103-109</li>\n<li>Swathi KN, Ashok Kumar P, Kulkarni SV (2018) Development and Evaluation of Controlled Release Microspheres Containing Labetalol. Der Pharmacia Lettre 10(4): 86-99</li>\n</ol> </div>", "time": "2021-11-11T09:57:13.758Z", "slug": "formulation-and-evaluation-of-extended-release-mic", "authors": []}}, {"model": "artical.artical", "pk": 32, "fields": {"issue": 14, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tMonika Malviya1*, Brijeshkunvar Mishra2, Bhushan Korde3\n1Vivekanand Institute of Pharmacy, Bhopal, Madhya Pradesh, India\n2RB Science Research Lab, Bhopal, Madhya Pradesh, India\n3TIT-Pharmacy, Bhopal, Madhya Pradesh, India ", "pdf": "achivesPdf/286-294_jZfaeab.pdf", "heading": "Antidepressant molecules: Synthesis and evaluation of novel azetidinone compounds", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tIn the effort to develop new potential molecule for the betterment of the health condition, a few of novel substituted azetidinones were synthesized and characterized for antidepressant action. All the synthesized compounds were characterized for their structure elucidation. Antidepressant studies of these compounds indicated that the compounds were having significant antidepressant activity. The synthesis of the compounds was performed in three steps that utilized SN<sub>2</sub> type substitution. The IR spectra of all the compounds exhibited the stretching vibration peaks due to C-N, C=O, C=N at 1400-1000 cm<sup>-1</sup>, 1765-1645 cm<sup>-1</sup> and 1690-1520 cm<sup>-1</sup> (medium) respectively. The other vibrations that appeared in the spectra included those from aromatic C=C and C-H, C-H alkane, C-Cl <strong>(4e), </strong>C-O<strong> (4d), </strong>C-H (methoxy), C-C (cycobutyl) and C=O (cycobutyl). The <sup>1</sup>HNMR spectra obtained displayed the peaks of aliphatic CH and aromatic CH at 2-3.3, and 6.7-7.2 ppm respectively. The mass spectra displayed the molecular ion peak and the isotopic peaks as calculated. The reference drug fluoxetine and the test compounds <strong>4b, 4d</strong> and <strong>4e</strong> decreased the immobility of mice in FST whereas the swimming frequency was increased significantly. An activity profile similar to TST was seen and the compounds <strong>4a, 4c</strong> and <strong>4f</strong> did not give the expected results.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tAzetidinone, fluoxetine, CNS, depressant, FST, TST\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Deep A, Kumar P, Narasimhan B, Lim SM, Ramasamy K, Mishra RK, Mani V (2016) 2-Azetidinone derivatives: synthesis, antimicrobial, anticancer evaluation and qsar studies. Acta Pol Pharmaceutica 73(1): 65-78</li>\n<li>Dubey A, Tiwari A, Srivastava SK (2013) Synthesis, antimicrobial and antitubercular screening of new azetidinone derivatives. J Chem Pharm Res 5(10): 134-140</li>\n<li>Hsu L-C, Ko Y-J, Cheng H-Y, Chang C-W, Lin Y-C, Cheng Y-H, Hsieh M-T, Peng WH (2012) Antidepressant-Like Activity of the Ethanolic Extract from <em style=\"font-size: 1.5rem;\">Uncaria lanosa</em><span style=\"font-size: 1.5rem;\"> Wallich var. </span><em style=\"font-size: 1.5rem;\">appendiculata</em><span style=\"font-size: 1.5rem;\"> Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice. Evidence Based Complementary Alt Med Article ID 497302; </span><a style=\"font-size: 1.5rem;\" href=\"https://doi.org/10.1155/2012/497302\">https://doi.org/10.1155/2012/497302</a></li>\n</ol>\n<ol start=\"4\">\n<li>Kerzare DR, Menghani SS, Khedekar PB (2018) Synthesis, Characterization, Antidepressant Activity and Docking Studies of Some Novel Indole Bearing Azetidinone Derivatives. Indian J Pharm Edu Res 52(1): 110-121</li>\n<li>Khan T, Yadav R, Gound SS (2018) An Efﬁcient Synthesis and Antibacterial Activity of Some Novel 2-Azetidinone Derivatives of 4H-1,2,4-Triazoles Under Mild Conditions. J Heterocyclic Chem 55: 1042-1047</li>\n<li>Pandya KM, Desai PS (2013) Study on Synthesis of Some Novel Azetidinone Derivatives. Int J Pharm Res Scholars 2(4): 179-183</li>\n<li>Patel KH, Mehta AG (2006) Synthesis and Antifungal Activity of Azetidinone and Thiazolidinones Derivatives of  2-Amino-6-(2-naphthalenyl)thiazolo[3,2-d]thiadiazole. E J Chem 3(4): 267-273</li>\n<li>Rajasekaran A, Periasamy M, Venkatesan S (2010) Synthesis, characterization and biological activity of some novel azetidinones. J Dev Biol Tissue Eng 2(1): 5-13</li>\n<li>Thomas AB, Nanda RK, Kothapalli LP, Hamane SC (2016) Synthesis and biological evaluation of Schiff’s bases and 2-azetidinones of isonocotinyl hydrazone as potential antidepressant and nootropic agents. Arabian J Chem 9(S1): S79-S90</li>\n</ol> </div>", "time": "2021-11-11T09:57:14.342Z", "slug": "antidepressant-molecules-synthesis-and-evaluation-", "authors": []}}, {"model": "artical.artical", "pk": 33, "fields": {"issue": 14, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRamanand Gupta1, Ajay Kumar1*, Rishikesh Sharma1\n1Bhabha Pharmacy Research Institute, Bhopal, Madhya Pradesh, India ", "pdf": "achivesPdf/277-285_zIAKKY2.pdf", "heading": "Formulation and development of Sumatriptan loaded S-SMEDDS using piperine for synergistic effect on permeation", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe present investigation was undertaken with an objective to enhance the permeation of sumatriptan succinate from self microemulsifying drug delivery system (SMEDDS) using piperine as the permeation enhancer. On screening of SMEDDS componentsclove oil (Oil), Capmul MCM (Surfactant) and PEG 400 (co surfactant) showed highest solubility of Sumatriptan succinate.Optimization was carried out by mixture design and from that the best batch was SS7 having 28% oil, 25.5% surfactant and 26.5% co surfactant. This batch showed lowest globule size 156 and highest %T 99.1%.The optimized formulation was then solidified by using adsorbent neusiline US2 showed free flowing powder. The micromeritical properties showed good flowability and reconstitution study of the powder showed the prepared emulsion was showed milky emulsion appearance. In-vitro dissolution and permeation study of optimized formulation showed that piperine increase the bioavailability of drug as compare to S-SMEDDS loaded with drug and marketed formulation.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tSumatriptan, SMEDDS, Capmul, Neusiline, migraine, stability\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Agostoni EC, Barbanti P, Calabresi P (2019) Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain20 (1):<strong> </strong>92 https://doi.org/10.1186/s10194-019-1038-4</li>\n<li>Azmi AAJA, Pandey GK, Dubey BK (2021) Formulation and evaluation of polyherbal capsules for the management of gout. J Pharmacol Biomed 5(1): 249-258</li>\n<li>Dokania S, Joshi AK (2015) Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead. Drug Deliv 22 (6): 675-690; doi: 10.3109/10717544.2014.896058.</li>\n<li>https://www.healthline.com › health › migraine assessed on 22/03/2021</li>\n<li>Kadu PJ, Kushare SS, Thacker DD, Gattani SG (2011) Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). <em>Pharm Dev Technol</em> 16: 65–74. doi:10.3109/10837450903499333</li>\n<li>Kim DS, Cho JH, Park JH, Kim JS, Song ES, Kwon J, Giri BR, Jin SG, Kim KS, Choi HG, Kim DW (2019) Self-microemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate. <em>Int J Nanomedicine </em>14: 4949-4960; <a href=\"https://doi.org/10.2147/IJN.S211014\">https://doi.org/10.2147/IJN.S211014</a></li>\n<li>Prajapati ST, Joshi HA, Patel CN (2013) Preparation and Characterization of Self-Microemulsifying Drug Delivery System of Olmesartan Medoxomil for Bioavailability Improvement. J Pharmaceut 728425; <a href=\"https://doi.org/10.1155/2013/728425\">https://doi.org/10.1155/2013/728425</a></li>\n<li>Silva LAD, Almeida SL, Alonso ECP, Rocha PBR, Martins FT, Taveira SF, Cunha-Filho MSS (2018) Preparation of a solid self-microemulsifying drug delivery system by hot-melt extrusion. Int J Pharmaceut 541 (1-2): 1-10; https://doi.org/10.1016/j.ijpharm.2018.02.020.</li>\n</ol> </div>", "time": "2021-11-11T09:57:15.394Z", "slug": "formulation-and-development-of-sumatriptan-loaded-", "authors": []}}, {"model": "artical.artical", "pk": 34, "fields": {"issue": 14, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tTripti Pandey1, Ajay Kumar1*, Rishikesh Sharma1\n1Bhabha Pharmacy Research Institute, Bhopal, Madhya Pradesh, India ", "pdf": "achivesPdf/268-276_hSqCqC5.pdf", "heading": "Effect of essential oils as penetration enhancers for ibuprofen loaded transdermal gel formulations", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe aim of the present study was to evaluate essential oils as penetration enhancers for transdermal gels using Ibuprofen as a model drug. Ibuprofen was formulated as a 5% carbopol gel. The amount of co-solvent (ethanol and propylene glycol) was optimized so as to obtain a homogenous gel. The prepared gels were evaluated for pH, spreading and homogeneity. Gel containing 5% drug, 0:15 proportion of ethanol: water and 1.5% carbopol was selected as base gel. The penetration of the gel was studied through cellulose membrane, egg shell membrane and rat skin. The gels containing different penetration enhancers were compared using various parameters like transdermal flux, permeability coefficient, and enhancement ratio and lag time. Anise oil was selected as the optimized essential oil for the gel formulations. The gel prepared using anise oil was studied for drug release kinetics and occlusivity. The gel was further studied for skin irritation in rat i.e. the formation of erythema and edema and compared with placebo gel and marketed formulation. The anise oil containing gel can be used to deliver therapeutically relevant doses of ibuprofen-like drugs.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tEssential oil, penetration enhancer, transdermal, gel, ibuprofen, ex vivo\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Abdul Rasool BK, Abu-Gharbieh EF, Fahmy SA, Saad HS, Khan SA (2010) Development and Evaluation of Ibuprofen Transdermal Gel Formulations. Trop J Pharm Res 9(4): 355-363</li>\n<li>Chandrashekhar NS, Shobha R (2008) Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci 70: 94-95</li>\n<li>Gupta A, Mehta P, Jain A (2021) Formulation and evaluation of transdermal patches of Lamotrigine. J Pharmacol Biomed 5(1): 242-248</li>\n<li>Herman, Anna, and Andrzej P. Herman (2015) Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol 67(4): 473-485</li>\n<li>Kashyap A, Das A, Ahmad AB (2020) Formulation and Evaluation of Transdermal Topical Gel of Ibuprofen. J Drug Del Ther 10(2): 20-25</li>\n<li>Kushwaha R, Malviya K, Omray LK (2018) Formulation development of herbal anti acne gel. J Pharmacol Biomed 2(4): 199-210</li>\n<li>Singh AP, Mishra B (2020) Evaluation of anti-inflammatory potential of Rutin using in vitro models. J Pharmacol Biomed 4(1): 211-217</li>\n</ol>&#13;\nSyed SM, Gaikwad SS, Wagh S (2020) Formulation and evaluation of gel containing fluconazole microsponges. Asian J Pharm Res Dev 8(4): 231-239\t\t\t\t\t</div>", "time": "2021-11-11T09:57:16.254Z", "slug": "effect-of-essential-oils-as-penetration-enhancers-", "authors": []}}, {"model": "artical.artical", "pk": 35, "fields": {"issue": 15, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRahul Khanna*, Pradeep Chauhan&#13;\n&#13;\n \t\t\t\t\t", "pdf": "achivesPdf/342-351_o36r7Bu.pdf", "heading": "Formulation and evaluation of Annona squamosa hydroalcoholic extract loaded phytosomes", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the present study was to prepare phytosomal formulation loaded with hydroalcoholic extract of <em>Annona squamosa</em> leaf. The extraction of leaf powder was done by maceration technique using 10:90, water: ethanol mixture with an extraction yield of 11.3%.  The extract was found to contain alkaloids, glycosides, proteins, phenols, flavonoids and triterpenes. Phytosomes of the extract were prepared by solvent evaporation method using lecithin as the lipid molecule. The particle size of the phytosomes was from 678 nm to 2617 nm in size with a polydispersity index varying between 0.368 - 0.718. The phytosomes were visible as rigid, spherical vesicles in SEM image. The surface of the phytosome vesicles was found to be regular and smooth. Sharp and distinct endothermic peaks in DSC revealed the formulation of stable phytosomes due to molecular interactions between the extract and lecithin. The phytosomes exhibited anti-inflammatory action in the <em>in vitro</em> assays by inhibiting albumin denaturation and protease activity. The phytosomes were found to be stable under the storage conditions. The best formulation with respect to particle size and anti-inflammatory action was ASP 4 that contained 2:0.5 ratio of lecithin: extract.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tPhytosome, Annona squamosa, extract, lecithin, anti-inflammatory\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Ahmad S. 2007. Pharmacognosy-Introduction of Plant Constituents and their Tests. 1-40. (Available at http://nsdl.niscair.res.in/handle/123456789/708 Accessed on 18 May 2021).</li>\n<li>Bombardelli E. P. Complexes Between Phospholipids and Vegetal Derivatives of Biological Interest. Fitoterapia. 1989; 60:1-9.</li>\n<li>Dhase AS, Saboo SS. Preparation and Evaluation of Phytosomes Containing Methanolic Extract of Leaves of Aegle Marmelos (Bael). International Journal of PharmTech Research 2015; 8(6): 231-240</li>\n<li>Govt. of India, Ministry of Health &amp; Family Welfare. Indian Pharmacopoeia. Ghaziabad: The Indian Pharmacopoeial Commission, 2007.</li>\n<li>Karole S, Gautam GK, Gutpa S. Preparation and evaluation of phytosomes containing ethanolic extract of leaves of Bombax ceiba for hepatoprotective activity. The Pharma Innovation Journal 2019; 8(2): 22-26</li>\n<li>Khandelwal, K.R., 2005. Practical Pharmacognosy-Techniques and Experiments, 14th ed. NiraliPrakashan, Pune, pp. 153</li>\n<li>Kidd P, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosomes: a Silybin phosphatidylcholine complex. Alternative Medicine Reviews. 2005; 10(3): 193-203.</li>\n<li>Kidd PM, Phytosomes, Highly Bioavailable Plant Extracts.[Online].[Cited 2008 Dec 12]. Available from://www.dockidd.com /pdf/ 2Links PhytosomeInd ,5_10_04.pdfstifolia</li>\n<li>Kumari S, Yasmin N, Hussain MR, Babuselvam M (2015). In vitro antiinflammatory and anti-arthritic property of Rhizopora mucronata leaves. <em>International J Pharm Sci Res</em> 2015, 6, 482-485.</li>\n<li>Nadkarni KM, Nadkarni AK. Indian Materia Medica. Bombay: Popular Prakashan Private Ltd; 1976.</li>\n<li>Oyedepo OO and Femurewa AJ. Anti‐protease and membrane stabilizing activities of extracts of Fagra zanthoxiloides, Olax subscorpioides and Tetrapleura tetraptera. <em>International J Pharmacogn </em>1995, 33, 65‐69.</li>\n<li>Patwardhan B., Vaidya A.D.B and Chorghade M (2004) “Ayurveda and Natural Products Drug Discovery” Current Science 86(6):789-799.</li>\n<li>Sakat S, Juvekar AR, Gambhire MN. <em>In vitro</em> antioxidant and anti-inflammatory activity of methanol extract of <em>Oxalis corniculata</em> Linn. <em>International J Pharma Pharmacological Sci</em> 2010, 2, 146-155.</li>\n<li>Singh AP, Mishra B. Evaluation of anti-inflammatory potential of Rutin using in vitro models. <em>J Pharmacol Biomed,</em> 2020, 4(1), 211-217</li>\n</ol> </div>", "time": "2021-11-11T09:57:17.062Z", "slug": "formulation-and-evaluation-of-annona-squamosa-hydr", "authors": []}}, {"model": "artical.artical", "pk": 36, "fields": {"issue": 15, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tShreya Mishra*, Sandeep Jain\t\t\t\t\t", "pdf": "achivesPdf/326-333_iaRisBZ.pdf", "heading": "Hepatoprotective and antioxidant effect of Delonix regia leaf extract against D-Galactosamine induced oxidative stress in rats", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the present study was to investigate and establish the hepatoprotective and antioxidant potential of <em>Delonix regia</em> leaves. In order to accomplish the objective, the leaf powder of the plant was extracted with 80% ethanol using soxhlet apparatus. The extract was found to contain alkaloids, phenols, tannins, flavonoids and triterpenoids. The total phenolic content of the extract was found to be 63.27±0.59 GAE mg/g. Hepatoprotective activity of the extract was determined in D-Galactosamine induced hepatotoxicity model at two doses (200 mg/kg and 400 mg/kg). Treatment with both doses of the extract of <em>Delonix regia</em> leaves decreased the D-Galactosamine induced alteration in SGOT, SGPT, ALP, ACP, total bilirubin and direct bilirubin in blood. It was also found that the <em>Delonix regia</em> leaf extract counteracted the D-Galactosamine-induced free radical activity that is equivalent to that of Vitamin E. SOD, GPx and CAT enzyme levels are statistically significant increased, whereas lipid peroxidation is decreased, when compared to D-galactosamine treated animals (P &lt; 0.05).\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>\n<em>Delonix</em> <em>regia</em>, D-Galactosamine, oxidative stress, hepatoprotective, antioxidant, extract\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Wang Lung-Shuo. Lee Chun-Ting, Su Wei-Lieh, Huang Shih-Che, Wang Shu-Chi. Delonixregia Leaf Extract (DRLE): A Potential Therapeutic Agent for Cardioprotection. PLoS ONE 11(12): e0167768. doi:10.1371/journal.pone.0167768</li>\n<li>Rahman MM, Hasan MN, Das AK, Hossain MT, Jahan R, Khatun MA, Rahmatullah M. Effect of delonixregia leaf extract on glucose tolerance in glucose-induced hyperglycemic mice. Afr JTradit Complement Altern Med 2011, 8(1):34-36</li>\n<li>SenthilVelan S, JeevaPrakash G, Sindhan V, Somasekhar E, Bharathi S, Rajani B. Evaluation of diuretic activity of Delonixregia (Gulmohr) flowers in albino rats. Int J Res Pharm Sci 2012, 3(3): 369-372</li>\n<li>Vivek MN, SachidanandaSwamy HC, Manasa M, Pallavi S, YashodaKambar, Asha MM, Chaithra M, PrashithKekuda TR, Mallikarjun N, Onkarappa R. Antimicrobial and Antioxidant activity of leaf and flower extract of Caesalpiniapulcherrima, Delonixregia and Peltaphorumferrugineum. JAppl Pharm Sci2013, 3(08): 064-071</li>\n<li>Aloh GS, Ifeanyi OE, Emeka OC, Uzoma OG, Ezechukwu OK, Ngozika KS. Effect of methanol extract of Delonixregia on free radical scavengers and lipid profile of wistar albino rats european journal of pharmaceutical and medical research. Eur J Pharm Med Res 2015, 2(2): 95-123</li>\n<li>Patil DD, Mhaske DK, Patare MA, Wadhawa GC. Antibacterial and Antioxidant, Anti-Inflammatory Study of Leaves and Root Delonixregia. Int J Pharm ChemSci 2014, 3(1): 131-135</li>\n<li>Tura AM, Kebede BH,H/mariam M. Physiochemical Characterization and Evaluation of Insecticidal Activities of Delonixregia Seed oil against Termite, Ticks and Cockroach. Int J Chemical Biochemical Sci 2015, 8: 28-34</li>\n<li>Parul R, Alam MJ, Rana MS. Antinociceptive and cytotoxic potential of ethanolic extract of Delonixregia (Leaves). Indian J Pharm Biological Res 2014, 2(1): 55-61</li>\n<li>Ansari AQ, Ahmed SA, Waheed MA, Sayyed JA. Extraction and determination of antioxidant activity of Withania somnifera Dunal. Eur J Experimental Biol 2013, 3(5): 502-507</li>\n<li>Sharma M, Abid R, Ahmad Y, Nabi NG. Protective Effect of Leaves of Ficus carica Against Carbon Tetrachloride-Induced hepatic Damage in Rats.UK Journal of Pharmaceutical and Biosciences. 2017; 5(1): 06-11.</li>\n<li>Pareek A, Godavarthi A, Issarani R, Nagori BP. Antioxidant and hepatoprotective activity of Fagonia schweinfurthii (Hadidi) Hadidi extract in carbon tetrachloride induced hepatotoxicity in HepG2 cell line and rats. J Ethnopharmacol. 2013; 150(3):973-981.</li>\n<li>Ganie SA, Zargar BA, Masood A, Zargar MA. Hepatoprotective and antioxidant activity of rhizome of Podophyllum hexandrum against carbon tetra chloride induced hepatotoxicity in rats. Biomed Environ Sci. 2013; 26(3):209-221.</li>\n<li>Gulcin I. Antioxidant activity of food constituents: an overview. Arch. Toxicol. 2012; 86: 345-391.</li>\n<li>Tapas AR, Sakarkar DM, Kakde RB. Flavonoids as Nutraceuticals: A Review: Tropical Journal of Pharmaceutical Research. 2008; 7(3): 1089-1099.</li>\n<li>Ghasemnezhad M, Sherafati M, Payvast GA. Variation in phenolic compounds, ascorbic acid and antioxidant activity of five coloured bell pepper Capsicum annum fruits at two different harvest times. Journal of functional foods. 2011; 3: 44-49.</li>\n<li>Milo KV, Kuli M, Jukic M. Screening of 70 medicinal plant extracts for antioxidant capacity and total phenols. Food Chem. 2004; 94: 550-557.</li>\n<li>Stankovic MS, Topuzovic M, Solujic S, Mihailovic V. Antioxidant activity and concentration of phenols and flavonoids in the whole plant and plant parts of Teucrium chamaedrys L. var. glanduliferum Haussk. J. Med. Plant Res. 2010; 4: 2092-2098.</li>\n<li>Alvarez-Jubete L, Wijngaard H, Arendt EK, Gallagher E. Polyphenol composition and in vitro antioxidant activity of amaranth, quinoa, buckwheat and wheat as affected by sprouting and baking. Food Chemistry. 2009; 119(2): 770-778.</li>\n<li>Tanaka K, Lizuka Y. Suppression of enzyme release from isolated rat liver lysosomes by non- steroidal anti-inflammatory drugs. Biochem Pharmacol. 1968; 17: 2023.</li>\n</ol> </div>", "time": "2021-11-11T09:57:17.756Z", "slug": "hepatoprotective-and-antioxidant-effect-of-delonix", "authors": []}}, {"model": "artical.artical", "pk": 37, "fields": {"issue": 15, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRavi Kumar*, Amit Jain\t\t\t\t\t", "pdf": "achivesPdf/334-341_8gBfsVB.pdf", "heading": "Formulation and evaluation of salicylic acid loaded ethosomes", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tEthosomes entrapping salicylic acid were prepared using cold method and the effect of varying concentration of ethanol was considered for obtaining an optimized formulation. Lecithin (2%w/w) was used as the phospholipid to provide the structure to the vesicles and propylene glycol (10%) was used as the permeating agent. The vesicles were found to be of spherical to irregular shape ranged from 1.4 µm to 1.8 µm in size. The drug entrapment in the ethosomes was studied by analyzing the unentrapped drug using UV spectrophotometry at 310.4 nm and it was found that the maximum entrapment efficiency was found to be 92.07% for formulation ET3 and minimum 58.68% for formulation ET5, respectively. The <em>in vitro</em> permeation study suggested that the maximum permeation in the egg membrane occurred in ET3 (0.38 mg/cm<sup>2</sup>) with 30% ethanol concentration while ET5 exhibited the minimum permeation (0.28 mg/cm<sup>2</sup>). It was observed that only about 2% degradation occurred at room temperature and all formulations were almost stable at 8° and 4° with only 1.3% degradation of SA thereby proving the stability of the developed system. The best ethosomal formulation (ET3) was incorporated into gel base to obtain gel formulations and the results revealed a good protection of the ethosomal gel when 2% carbopol was used as the gelling base.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tEthosome, salicylic acid, gel, stability, lecithin, propylene glycol\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\t, Naik S, Misra AN. Ethosomes: A novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exper Biol. 2009; 47:368-375.&#13;\n&#13;\nChandra A, Aggarwal G, Manchanda S, Narula A. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis. Pharm Nanotech. 2019; 7(5): 362-374&#13;\n&#13;\nEl-Shenawy AA, Abdelhafez WA, Ismail A, Kassem AA. Formulation and Characterization of Nanosized Ethosomal Formulations of Antigout Model Drug (Febuxostat) Prepared by Cold Method: In Vitro/Ex Vivo and In Vivo Assessment. AAPS PharmSciTech. 2020; 21: 31-43&#13;\n&#13;\nFathalla D, Youssef EMK, Soliman GM. Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients. Pharmaceutics. 2020; 12: 446; doi:10.3390/pharmaceutics12050446&#13;\n&#13;\nGupta A, Singh S, Kotla NG, Webster TJ. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomedicine 2014; 10: 171-182.&#13;\n&#13;\nIngebrigtsen SG, Škalko-Basnet N, de Albuquerque Cavalcanti Jacobsen C, Holsæter AM. Successful co-encapsulation of benzoyl peroxide and chloramphenicol in liposomes by a novel manufacturing method - dual asymmetric centrifugation. Eur J Pharm Sci 2017; 97: 192-199&#13;\n&#13;\nJain S, Kale DP, Swami R, Katiyar SS. Codelivery of benzoyl peroxide &amp; adapalene using modified liposomal gel for improved acne therapy. Nanomedicine 2018; 13(12): 1481-1493&#13;\n&#13;\nJani DA, Patel SA. Spectrophotometric determination of salicylic acid from single as well as combined dosage form. World Journal of Pharmaceutical Research. 2018; 7(8): 938-947&#13;\n&#13;\nKumar KP, Radhika PR, Sivakumar T. Ethosomes-A Priority in Transdermal Drug Delivery. Int J Advances Pharm Sci. 2010; 1: 111-121.&#13;\n&#13;\nLimsuwan T, Boonme P, Khongkow P, Amnuaikit T. Ethosomes of Phenylethyl Resorcinol as Vesicular Delivery System for Skin Lightening Applications. BioMed Res Int. 2017; doi.org/10.1155/2017/8310979&#13;\n&#13;\nShatalebi MA, Roostaei M, Preparation and physical evaluation of benzoyl peroxide 5% foamable emu oil emulsion, Jundishapur Journal of Natural Pharmaceutical Products, 10 (3), 2015, e16229-e16234.&#13;\n&#13;\n \t\t\t\t\t</div>", "time": "2021-11-11T09:57:18.555Z", "slug": "formulation-and-evaluation-of-salicylic-acid-loade", "authors": []}}, {"model": "artical.artical", "pk": 38, "fields": {"issue": 15, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tJeetu Singh, Urvesh Singh Narwaria\t\t\t\t\t", "pdf": "achivesPdf/319-325_uGl5BP0.pdf", "heading": "Evaluation of anti-inflammatory action of Melaleuca bracteata F. Muell. leaf extract", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe present work focused on preparing ethanolic extract of <em>Melaleuca bracteata </em>F. Muell. and evaluating its anti-inflammatory potential using <em>in vitro</em> and <em>in vivo</em> models. The ethanolic extract was dark brown in color and had an yield of 46.3% with respect to the weight of the leaf powder used for extraction. The total phenolic content in the ethanolic extract, expressed as gallic acid equivalents was found to be 74.27±0.59 GAE mg/g. The ethanolic extract of <em>Melaleuca Bracteata</em> exhibited the inhibition of albumin denaturation at all doses in a dose dependent manner. The 500 µg/mL concentration of the extract had shown the greatest inhibition capacity (58.9±2.869%) whereas the lowest inhibition capacity was exhibited by concentration 100 µg/mL (11.52±3.291%). MBE at dose level of 200 mg/Kg exhibited maximum reduction in edema after 3h with 27.74% reduction whereas the change decreased at the 4<sup>th</sup> hour to 16.57%. MBE dose of 400 mg/Kg exhibited 42.77% reduction after 3h. The results obtained led to the conclusion that <em>Melaleuca bracteata </em>leaves are a rich source of potential phytochemicals and exhibits anti-inflammatory action.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tAntiinflammatory, <em>Melaleuca bracteata</em>, albumin denaturation, carageenan, edema, extract\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Ghasemian M, Owlia S, Owlia MB (2016) Review of anti-inflammatory herbal medicines. Advances Pharmacol Sci. <a href=\"http://dx.doi.org/10.1155/2016/9130979\">http://dx.doi.org/10.1155/2016/9130979</a></li>\n<li>Uttara B, Singh AV, Zamboni P, Mahajan RT (2009) Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7: 65-74.</li>\n</ol>\n<ol start=\"3\">\n<li>Siddique S, Parveen Z, Firdaus-e-Bareen, Sania Mazhar (2020). Chemical composition, antibacterial and antioxidant activities of essential oils from leaves of three <em>Melaleuca</em> species of Pakistani ﬂora. Arabian Journal of Chemistry 13: 67-74</li>\n<li>Sharifi-Rad J, Salehi B, Varoni EM, Sharopov F, Yousaf Z, Ayatollahi SA, Kobarfard F, Sharifi-Rad M, Afdjei MH, Sharifi-Rad M, Iriti M (2017). Plants of the <em>Melaleuca</em> genus as antimicrobial Agents: From farm to pharmacy. Phytotherapy Research DOI: 10.1002/ptr.5880</li>\n<li>Goswami P, Verma SK, Chauhan A, Venkatesha KT, Verma RS, Singh VR, Darokar MP, Chanotiya CS, Padalia RC (2017). Chemical composition and antibacterial activity of <em>Melaleuca bracteata</em> essential oil from India: A natural source of methyl eugenol. Natural Product Communication 12(6): 965-968</li>\n<li>Cock IE, Winnett V, Sirdaarta J, Matthews B (2015). The potential of selected Australian medicinal plants with anti‑Proteus activity for the treatment and prevention of rheumatoid arthritis. Pharmacognosy Magazine 11(42, S1): S190-S208</li>\n<li>Adesanwo KJ, Shode FO, Aiyelaagbe OO, Rabiu OO, Oyede RT, Oluwole FS (2009). Antisecretory and antiulcerogenic activities of the stem bark extract of <em>Melaleuca bracteata</em> and isolation of principles. Journal of Medicinal Plants Research 3(10): 822-824</li>\n</ol>\n<ol>\n<li>Singh AP, Mishra B (2020). Evaluation of anti-inflammatory potential of Rutin using in vitro models. Journal of Pharmacology and Biomedicine 4(1): 211-217</li>\n<li>Amdekar S, Roy P, Singh V, Kumar A, Singh R, Sharma P (2012). Anti-Inflammatory Activity of Lactobacillus on Carrageenan-Induced Paw Edema in Male Wistar Rats. International Journal of Inflammation doi:10.1155/2012/752015</li>\n</ol>\n<ol start=\"10\">\n<li>Saso L, Valentini G, Casini ML, Grippa E, Gatto MT, Leone MG (2001). Inhibition of heat-induced denaturation of albumin by nonsteroidal antiinflammatory drugs (NSAIDs): Pharmacological implications. Archives of Pharmacal Research 24(2): 150-158.</li>\n<li>Opie EL (1962). On the relation of necrosis and inflammation to denaturation of proteins. Journal of Experimental Medicine 115: 597-608</li>\n</ol> </div>", "time": "2021-11-11T09:57:19.312Z", "slug": "evaluation-of-anti-inflammatory-action-of-melaleuc", "authors": []}}, {"model": "artical.artical", "pk": 39, "fields": {"issue": 15, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRuksar Amreen&#13;\n&#13;\nMayur Chaurey\t\t\t\t\t", "pdf": "achivesPdf/312-318_ysMKH8S.pdf", "heading": "Evaluation of estrogenic potential of ethanolic and aqueous extract of Pitunia hybrida", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the present study was to assess the estrogenic potential of different leaf extract of <em>Petunia hybrida</em> using the animal model. The extraction ability of different solvents for recovering extractable components from leaves followed the order: ethanol&gt;chloroform&gt;aqueous&gt;pet ether. The findings of preliminary phytochemical analysis suggest the presence of alkaloids, saponin glycosides, phenolics, terpenoids, sterols, and flavonoids in the leaf of the plant. The total phenolic content of pet ether, chloroform, ethanol and aqueous extracts of <em>Petunia hybrida</em> were 16.18±0.89, 23.97±0.61, 71.77±0.59 and 31.38±0.36 GAE mg/g, respectively. All the extracts were subjected to <em>in vitro</em> determination of antioxidant potential by DPPH method. The IC<sub>50</sub> value of the DPPH scavenging potential for the chlorofom, ethanol and aqueous extracts was found to be 245.9, 115.2 and 181.3µg/mL respectively whereas the IC<sub>50</sub> value of the pet ether extract was more than 250µg/mL. The ethanolic and aqueous extracts exhibited higher antioxidant potential as well as phenolic content and were evaluated for estrogenic potential in rats by uterine weight assay method. It was found that the extracts exhibited significant estrogenic activity but not comparable to the standard drug ethinyl estradiol. The results obtained led to the conclusion that <em>Petunia hybrida</em> leaves are a rich source of potential antioxidants and also possess the capacity to increase the estrogen level in animal. Estrogen receptor binding assays may be further carried out using the extracts to confirm the estrogenic mechanism of <em>Petunia hybrida</em> extracts.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>\n<em>Petunia hybrida</em>, estrogenic, antioxidant, phenolic content, anthocyanin, DPPH\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Mandal A. <a href=\"https://www.news-medical.net/health/What-are-Hormones.aspx;%20assessed%20on%2019/04/2020\">https://www.news-medical.net/health/What-are-Hormones.aspx; assessed on 19/04/2020</a></li>\n<li>Holt LH. <a href=\"https://health.howstuffworks.com/wellness/women/menopause/how-menopause-works2.html;%20assessed%20on%2019/04/2020\">https://health.howstuffworks.com/wellness/women/menopause/how-menopause-works2.html; assessed on 19/04/2020</a></li>\n<li>Kalita JC, Milligan SR (2010) In vitro estrogenic potency of phytoestrogen-glycosides and some plant flavanoids. Indian J Sci Tech 3(12): 1142-1147</li>\n<li>Shailajan S, Kumaria S, Pednekar S, Menon S, Choudhury H, Matani A (2016) Estrogenic Potential of Flemingia vestita Benth Tubers in Ovariectomized Rat Model. Pharmacogn J 8(1): 44-49</li>\n<li>An Trinh T, Park E-J, Lee D, Song JH, Lee HL, Kim KH, Kim Y, Jung K, Kang KS, Yoo J-E (2019) Estrogenic Activity of Sanguiin H-6 through Activation of Estrogen Receptor α Coactivator-binding Site. Nat Prod Sci 25(1): 28-33</li>\n<li>Hidalgo M, Martin-Santamaria S, Recio I, Sanchez-Moreno C, de Pascual-Teresa B, Rimbach G, de Pascual-Teresa S (2012) Potential anti-inﬂammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. Genes &amp; Nutrition 7: 259-306</li>\n<li>Schmitt E, Stopper H (2001) Estrogenic activity of naturally occurring anthocyanidins. Nutrition and Cancer 41(1&amp;2): 145-149</li>\n<li>Nanashima N, Horie K, Maeda H (2018) Phytoestrogenic activity of blackcurrant anthocyanins is partially mediated through estrogen receptor beta. Molecules 23:74; doi:10.3390/molecules23010074</li>\n<li>El-Alfy TS, Hetta MH, Yassin NZ, Abdel Rahman RF, Kadry EM (2012) Estrogenic activity of <em>Citrus medica</em> leaves growing in Egypt. J Appl Pharm Sci 2(8): 180-185</li>\n<li>Lee S-J, Chung H-Y, Maier CG-A, Wood AR, Dixon RA, Mabry TJ (1998) Estrogenic flavonoids from <em>Artemisia vulgaris</em> J Agr Food Chem 46(8): 3325-3329</li>\n<li>Song TT, Hendrich S, Murphy PA (1999) Estrogenic activity of Glycitein, a soy isoflavone. J Agr Food Chem 47(4): 1607-1610</li>\n<li><a href=\"https://en.wikipedia.org/wiki/Petunia_%C3%97_atkinsiana\">https://en.wikipedia.org/wiki/Petunia_%C3%97_atkinsiana</a>; assessed on 19/04/2020</li>\n<li>Griesbach RJ, Asen S, Leonnarat BA (1991) <em>Petunia hybrida</em> anthocyanins acylated with caffeic acid. Phytochemistry 30(5): 1729-1731</li>\n<li>Sahira Banu K, Cathrine L (2015) General Techniques Involved in Phytochemical Analysis. Internat J Adv Res Chemical Sci 2(4): 25-32</li>\n<li>Arora P, Arora V (2019) Preliminary phytochemical screening of crude drugs In: A Textbook of Herbal Drug Technology, Pee Vee Books, Punjab; pp 179-180</li>\n<li>Ansari AQ, Ahmed SA, Waheed MA, Sayyed JA (2013) Extraction and determination of antioxidant activity of <em>Withania somnifera</em> Eur J Experimental Biol 3(5): 502-507</li>\n</ol> </div>", "time": "2021-11-11T09:57:19.911Z", "slug": "evaluation-of-estrogenic-potential-of-ethanolic-an", "authors": []}}, {"model": "artical.artical", "pk": 40, "fields": {"issue": 15, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tSunil Ahirwar&#13;\n&#13;\nAjay Kumar&#13;\n&#13;\nRishikesh Sharma\t\t\t\t\t", "pdf": "achivesPdf/304-311_24QEEaR.pdf", "heading": "Formulation development and in vitro evaluation of oral dispersible tablets of Olanzapine by direct compression", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the present work was to formulate mouth dissolving tablet enriched with taste masking agent to provide rapid onset of action of olanzapine increasing its therapeutic efficacy and also increase the compliance amongst geriatric, pediatric and uncooperative patients. Precompression blends of the ODTs were prepared and evaluated for its micromeritic properties. Total four formulations of ODTs were prepared using direct compression (OLODT1 to OLODT4) method. The concentration of the super-disintegrant was varied for formulating the blends. Mannitol was used as the binder as well as sweetener while saccharin sodium was used as the additional taste masking agent in the formulations.  All the formulations were subjected to post compression evaluation test and the results indicate that the formulation had hardness of 3 Kg/cm<sup>2</sup>, thickness of 3 mm, weight variation in the range of 4.1-5.3 %, friability of less than 1 %, drug content in the range of 97.8 to 98.8 %, wetting time from 28 to 47 seconds with water absorption ratio of more than 75 %, disintegration time of less than 30 seconds and a drug release of more than 80 % over a period of 5 minutes.  The formulations were found to be stable under accelerated conditions for a period of 3 months with almost negligible change in the critical parameters.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tOlanzapine, oral dispersible, tablets, direct compression, formulation, Mannitol\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Tanaka W, Akito E, Yoshida K, Terada T, Ninomiya H (1977) Pharmaceutical preparation for oral cavity administration. United States Patent,<a href=\"https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US5073374\">US 4059686</a></li>\n<li>Wehling F, Schuehle S, Madamala N (1993) Pediatric effervescent dosage form. United States Patent,<a href=\"https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US5073374\">US 4755386</a></li>\n<li>Zade PS, Kawtikwar PS, Sakarkar DM (2009) Formulation, evaluation and optimization of fast dissolving tablet containing tizanidine hydrochloride. Int J PharmTech Res 1(1): 34-42.</li>\n<li>Doijad R, Manvi F, Khalandar K (2007) <a href=\"http://ispub.com/IJPHARM/5/2/12261\">A comparative study on mouth dissolving tablets of Granisetron with different super disintegrants: Formulation and Evaluation</a>. The Internet J Pharmacol 5(2)</li>\n<li>Nandare DS, Mandlik SK, Khiste SK, Mohite YD (2011) Formulation and optimization of mouth dissolving tablets of olanzapine by using 3<sup>2</sup> factorial design. Res J Pharm Technol 4(8): 1265-1268</li>\n<li>Raja Sridhar Rao P, G Chandrasekara Rao (2013) Optimization of olanzapine mouth dissolving tablets using micronization. Int J Pharm Biol Sci 3(2): 384-389</li>\n<li>Naik SBT, Venkateswarlu K, Chandrasekhar KB (2016) Formulation and in vitro evaluation of orodispersible tablets of olanzapine for the improvement of dissolution rate. J Chem Pharm Res 8(1): 177-181</li>\n<li>Maheswarappa MK, Desai PD (2011) Design and in vitro evaluation of mouth dissolving tablets of olanzapine. Asian J Pharmaceut 5: 107-113</li>\n<li>Mundhe V, Burande S, Kondapure A, Arsul V, Zarekar S (2013) Formulation and evaluation of mouth dissolving tablet of olanzapine by coprocessing supedisintegrants. Asian J Pharm Tech Innovation 1(1): 1-20</li>\n<li>https://www.drugbank.ca/drugs/DB00334 assessed on 24/03/20201</li>\n<li>Jain CP, Naruka PS (2009) Formulation and evaluation of fast dissolving tablets of valsartan. Int J Pharmacy Pharm Sci 1(1): 219-226</li>\n<li>Prameela AR, Archana N, Siva PT, Mohan PV, Sudheer MK, Bala CK (2010) Formulation and evaluation of orodispersible metformin tablets. Int J Appl Pharm 2(3): 15-21.</li>\n</ol> </div>", "time": "2021-11-11T09:57:20.402Z", "slug": "formulation-development-and-in-vitro-evaluation-of", "authors": []}}, {"model": "artical.artical", "pk": 41, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tAkash Kushwah, Sandeep Jain\t\t\t\t\t", "pdf": "achivesPdf/466-472_t63sNFu.pdf", "heading": "Evaluation of anti-inflammatory activity of leaf extract fractions of Alangium salvifolium", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of this study was  to evaluate the anti-inflammatory activity of active fractions of <em>Alangium salvifolium </em>leaf extract.From results, it has been inferred that the methanol and aqueous extracts of <em>Alangium salvifolium </em>contain the maximum number of phytoconstituents like alkaloids, glycosides, carbohydrates, flavonoids, tannins and polyphenol. While the alkaloids were absent in aqueous extracts of <em>Alangium salvifolium</em>. Based on the qualitative chemical test, it has been observed that chemically therapeutic compounds were present in sufficient amounts in methanolic and aqueous extracts of <em>Alangium salvifolium</em>. By the help of column chromatography the bioactive fractions were isolated which might be responsible for the therapeutic activity. The eight fractions (F1 to F8) were isolated from the methanol extract of <em>Alangium salvifolium</em>. The F6 and F7 indicate the presence of phenolic compounds and flavonoids. It is scientifically documented that flavonoid molecules possess anti-inflammatory activity on various animal models of inflammation. The isolated compound namely F6 and F7 exhibited anti-inflammatory effect on carrageenan-induced paw oedema. The F6 isolated from <em>Alangium salvifolium </em>produces maximum anti-inflammatory effect compared to F7. This study confirmed that flavonoid fraction obtained from <em>Alangium salvifolium </em>leaves extract are responsible for its anti inflammatory activity and the effects observed are attributable due to the presence of flavonoids in the plant.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>\n<em>Alangium salvifolium</em>, anti-inflammatory, extract, column chromatography, flavonoids\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants. New Delhi, India CSIR. 1956.</li>\n<li>Harbone JB. Phytochemical Methods-a guide to modern techniques of plant analysis. 3<sup>rd</sup> ed. Springer, New Delhi. 2005; 1-32.</li>\n<li>Howcroft KT, Campisi J, Louis GB, Smith MT, Wise B, Wyss-Coray T, Augustine AD, McElhaney JE, Kohanski R, Felipe S. The role of inflammation in age-related disease. Aging. 2013; 5(1):84-93.</li>\n<li>Jain VC, Patel NM, Shah DP, Patel PK, Joshi BH. Antioxidant and Antimicrobial Activities of <em>Alangium salvifolium </em>(L.F) Wang Root. Global Journal of Pharmacology. 2010; 4(1): 13-18.</li>\n<li>Kandelwal KR, Pawar AP, Kokate CK, Gokhale SB. Practical Pharmacognosy Technique and Experiments, 3<sup>rd</sup> edition, Nirali Prakashan. 1996; 2-4.</li>\n<li>Kokate CK, Purohit AP, Gokhale SB. Practical Pharmacognocy, 4<sup>th</sup> edition, Vallabh Prakashan. 2000; 107-111, 123-125, 130.</li>\n<li>Kumar PP, Prabhakara MC, Satyavathi K, Anil Kumar S. Evaluation of cardiac activity of some traditionally used backyard Indian medicinal plants. Research J of Pharmaceutical, Biological and Chemical sciences. 2010; 1(4): 641-654.</li>\n<li>Madhava Shetty K. Flowering plants of chittoor district, 1 edition, and students offset printers, Tirupati, AP., 2003; 150.</li>\n<li>Oyanagui Y. Anti-inflammatory effects of polyamines in serotonin and carrageenin paw edemata-possible mechanisms to increase vascular permeability inhibitory protein level which is regulated by glucocorticoids and superoxide radical. Agents Actions 1984;14:228-37.</li>\n<li>Rajeshwari C, Andallu S. Antioxidant and antiarthritis potential of coriander (<em>Coriandrum sativum </em>L.) leaves. e-Spen Journal. 2012; 7: 223-228.</li>\n<li>Skoog DA, Holler FJ, Nieman TA. Principles of Instrumental Analysis. 5<sup>th</sup> ed. Thomson Brooks/Cole Publishing, Belmont. 2004; 673-796.</li>\n<li>Xavier A, Kalaiselvi TF, Kandhasamy VM, Rajakumari MP, Srinivasan K, Natarajan D. Antifungal activity of leaf extracts of <em>Alangium salvifolium . </em>J of Tropical Med Plants. 2005; 6(2): 179–182.</li>\n</ol> </div>", "time": "2021-11-11T09:57:21.118Z", "slug": "evaluation-of-anti-inflammatory-activity-of-leaf-e", "authors": []}}, {"model": "artical.artical", "pk": 42, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tDeepak Atal, Atul Kaushik\t\t\t\t\t", "pdf": "achivesPdf/459-465_nLta1j7.pdf", "heading": "Probiotic Assisted Colon Specific Delivery of Ciprofloxacin", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tMatrix tablets of Ciprofloxacin were prepared using guar gum as the matrix forming polymer and incorporating Sporlac and Vivaflora probiotics in varying quantity to assist the targeted release of the drug in the colonic microflora. The angle of repose was found to be in the range of 26°32’ to 28°52’. The bulk density value ranged from 0.360 to 0.45 g/cm<sup>3</sup> while the tapped density value ranged from 0.50 to 0.54 g/cm<sup>3</sup>. The granules prepared in the present work were found to have the Carr’s Index between 15.68 to 18.51 % and the Hausner’s ratio was found to be ranging from 1.186 to 1.227. The thickness of all the tablets was found to be 6 mm while the hardness ranged from 5.2-5.3 kg/cm<sup>2</sup>. The friability and weight variation were found to be less than 0.3% and the drug content in each tablet was found to be 98 - 99%. The matrix tablets were also investigated for the in vitro drug release in absence and presence of rat caecal content and it was found that the release of drug from the tablets was affected by the presence of probiotics. The rat caecal content was able to increase the drug release from all the formulation. The drug release was highest from the formulation MT4 which exhibited 98.78% and 99.84 %cumulative release in absence and presence of rat caecal content respectively.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tCiprofloxacin, probiotic, colon, microflora, matrix tablet, release\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Ahmed IS, Ayres JW (2011). Comparison of in vitro and in vivo performance of a colonic delivery system. International Journal of Pharmaceutics, 409 (1-2), 169-177</li>\n<li>Ahuja V, Tandon RK (2010). Inflammatory bowel disease in the Asia–Pacific area: A comparison with developed countries and regional differences<strong>. </strong>Journal of Digestive Diseases, 11, 134-147</li>\n<li>Ghosh PK, Gupta VB, Gondoliya B, Rathore MS. (2010). Probiotic-assisted colon-specific delivery of diclofenac sodium from guar gum matrix tablets: In vitro evaluation. Asian Journal of Pharmaceutics, 4(4): 173-178</li>\n<li>Goindi S, Mann K, Aggarwal N (2011). Gastro-retentive floating beads of curcumin β-cyclodextrin complex to treat stomach tumors. Alternative Medicine Studies, 1 (e12), 49-53</li>\n<li>Libo Y, Chu JS, Fix JA (2002). Colon-speciﬁc drug delivery: new approaches and in vitro/in vivo evaluation. International Journal of Pharmaceutics, 235, 1-15</li>\n<li>Radhika PR, Pal TK, Sivakumar T (2009). Formulation and evaluation of sustained release matrix tablets of glipizide. Iranian Journal of Pharmaceutical Sciences, 5(4), 205-214</li>\n<li>Tomlin J, Read NW, Edwards CA, Duerden BI (1986). The degradation of guar gum by a faecal incubation system. British Journal of Nutrition, 55, 481-486.</li>\n<li>Jalonya R, Soni P, Malviya K, Omray LK (2018). Formulation and evaluation of bilayer tablets of diltiazem HCl. Journal of Pharmacology and Biomedicine, 2(3), 189-198</li>\n</ol> </div>", "time": "2021-11-11T09:57:21.739Z", "slug": "probiotic-assisted-colon-specific-delivery-of-cipr", "authors": []}}, {"model": "artical.artical", "pk": 43, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tShivam Jha*, Sandeep Jain\t\t\t\t\t", "pdf": "achivesPdf/450-458_pF5r8OY.pdf", "heading": "Standardization of marketed formulation Glucomap for antidiabetic action", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe primary objective of the current investigation was to standardize the formulation Glucomap Tablet, marketed as an effective treatment for management of diabetes. The procured tablets of GMT were brownish green in color, with no odor and a bitter taste. They were available as rough textured tablets with no coating, stored free from moisture. GMT exhibited 8.3% total ash with 2.05% acid insoluble ash and 5.75% water soluble ash. The water soluble and alcohol soluble extractives were 1.14% and 1.22% respectively suggesting the formulation to be suitable for human use. The results of preliminary qualitative phytochemical screening revealed that the classes of phytochemicals were present in GMT. TLC analysis of GMT was done using charantin as the marker using methanol: benzene (2:8) as the solvent system. Charantin appeared at Rf value of 0.56 on the TLC plate. The quantitation of the charantin was done by HPLC method and it was found that GMT contained 8.6 mg charantin per 500 mg of GMT (1.72 %). The antidiabetic potential of the GMT tablet was determined by extracting the tablets with ethanol and administering at a dose of 200mg/kg to alloxan induced diabetic rats. GMTEE was able to decrease blood sugar by 23.62% while the standard drug glibenclamide could reduce it by 28.12% on the 15<sup>th</sup> day.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tStandardization, herbal, glucomap, charantin, antidiabetic, WHO\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Anonymous. Quality Control Methods for Medicinal Plant Materials. World Health Organisation. Geneva, (1998) 25-28</li>\n<li>Chandana M. Puttaraju, Manorama Eti<em>. </em>WHO 75 gram OGTT-A single step procedure for screening and diagnosis of gestational diabetes mellitus. Int J Reproduction Contraception Obstetrics and Gynecology. 2015, 4(6). DOI: <a href=\"https://dx.doi.org/10.18203/2320-1770.ijrcog20151307\">http://dx.doi.org/10.18203/2320-1770.ijrcog20151307</a></li>\n<li>https://maharishiayurvedaindia.com/products/glucomap; assessed on 13/01/2021</li>\n<li>Mehta S, Singh RP, Saklani P. Phytochemical screening and TLC profiling of various extracts of Reinwardtia indica. Int J Pharmacogn Phytochem Res, 2017; 9(4): 523-527.</li>\n<li>Patel S, Patel T, Parmar K, Bhatt Y, Patel Y, Patel NM. Isolation, characterization and antimicrobial activity of charantin from Momordica charantia Linn. fruit, Int J Drug Dev Res, 2010; 2(3): 629-634.</li>\n<li>Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B-cells of the rat pancreas. Physiol. Res. 50, 536.</li>\n<li>Zold EL, Horvath A, Bacsadi B, Csupor D. Development and validation of a HPLC-UV method for quantification of charantin in momordica charantia products. 2019; DOI: 10.14232/tnpr.2019.af</li>\n</ol> </div>", "time": "2021-11-11T09:57:22.235Z", "slug": "standardization-of-marketed-formulation-glucomap-f", "authors": []}}, {"model": "artical.artical", "pk": 44, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tDheersingh*, Atul Kaushik\t\t\t\t\t", "pdf": "achivesPdf/441-449_BkokOxu.pdf", "heading": "Formulation of liposome incorporated polyherbal gel for management of gout", "abstract": "<div style=\"text-align: justify;\">\n<p></p>\n<em>Trigonella foenum-graecum,</em> <em>Zingiber</em> <em>officinale</em> and <em>Piper nigrum </em>were extracted using ethanol and incorporated in to liposomes. These liposomes were formulated as gel formulation for topical application for management of gout pain. The extraction yield for TF, ZO and PN were found to be 28.7, 37.4 and 21.1% respectively respectively. The total phenolic content in TF, ZO and PN extracts were found to be 28.3 ± 1.301, 13.2 ± 1.196 and 9.8 ± 0.894 GAE mg/100g whereas it was found to be 38.6 ± 0.735, 51.4 ± 0.721 and 63.08 ± 0.823 GAE mg/100g for 1:1:1, 1:2:1 and 2:1:1 mixture ratio of TF, ZO and PN respectively. The particle size of the liposomes was found to decrease with an increase in sonication time but the sonication time did not affect the total phenolic content of the liposomes. The particle size of the liposome formulated using 5 min sonication time was considered optimum and was found to be 4.27 ± 0.033µm. The liposomes were stable at both the temperature conditions and the particle size of the liposomes did not change considerably over a period of three months. ELF3 loaded gel formulations were prepared with different ratio of ELF3 using carbopol 934. The pH of all the formulations was in the range of the pH of the skin (5.0-5.5) and they exhibited optimum viscosity. The pH, viscosity and spreadability of PHLG3 was 5.3, 1694 cp &amp; 62 mm respectively.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tLiposome, polyherbal, carbopol, gout, pain, extract, phenolic\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Appendix 13.1 Buffers, In: Indian Pharmacopoeia, 1996, The Indian Pharmacopoeia Commission, Ghaziabad</li>\n<li>Armann C, Roding J, Ghyczy M, Pratzel HG. Liposomes from soya phospholipids as percutaneous drug carriers. Arzneim-Forsch/ Drug Research 1990; 40: 1365-1368</li>\n<li>Bang JS, Oh DH, Choi HM, Sur B-J, Lim S-J, Kim JY, Yang H-I Yoo MC, Hahm D-H, Kim KS. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Research and Therapy 2009; 11: R46. doi:10.1186/ar2662</li>\n<li>Chanthasri W, Puangkeaw N, Kunworarath N, Jaisamut P, Limsuwan S, Maneenoon K, Choochana P, Chusri S. Antioxidant capacities and total phenolic contents of 20 polyherbal remedies used as tonics by folk healers in Phatthalung and Songkhla provinces, Thailand. BMC Complementary and Alternative Medicine 2018; 18:73. https://doi.org/10.1186/s12906-018-2131-y</li>\n<li>Dag D, Oztop MH. Formation and Characterization of Green Tea Extract Loaded Liposomes. Journal of Food Science 2017; doi: 10.1111/1750-3841.13615</li>\n<li>Ehrlich SD. Herbal medicine. 2011. [Last accessed on 2019 November 1]. Available from: <a href=\"http://www.umm.edu/health/medical/altmed/treatment/herbal-medicine\">http://www.umm.edu/health/medical/altmed/treatment/herbal-medicine</a> .</li>\n<li>Goyal S, Gupta N, Chatterjee S. Investigating therapeutic potential of <em>Trigonella foenum-graecum</em> L. as our defense mechanism against several human diseases. Journal of Toxicology 2016; <a href=\"http://dx.doi.org/10.1155/2016/1250387\">http://dx.doi.org/10.1155/2016/1250387</a></li>\n<li><a href=\"https://en.wikipedia.org/wiki/Ginger\">https://en.wikipedia.org/wiki/Ginger</a>;  assessed on 2 November 2019</li>\n<li>Jain S, Kale DP, Swami R, Katiyar SS. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29972675\">Codelivery of benzoyl peroxide &amp; adapalene using modified liposomal gel for improved acne therapy.</a> Nanomedicine 2018; 13(12): 1481-1493</li>\n<li>Kamboj VP. Herbal medicine. Current Science 2000; 78: 35–51.</li>\n</ol> </div>", "time": "2021-11-11T09:57:23.336Z", "slug": "formulation-of-liposome-incorporated-polyherbal-ge", "authors": []}}, {"model": "artical.artical", "pk": 45, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tShubham Sharma*, Naveen Tripathi\t\t\t\t\t", "pdf": "achivesPdf/432-440_H9c4g6P.pdf", "heading": "Formulation and characterization of oxybenzone loaded liposomes", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tIn the present study it was attempted to develop liposomal dosage form of oxybenzone and formulate it into cream for topical application with an aim to improvise the sunscreen efficacy of oxybenzone. Ethanol injection method was used formulating the liposomes with varying ratio of lecithin and cholesterol. Surface smoothness of the liposomes was enhanced by an increase in the lecithin concentration, as evident from the TEM photomicrographs. The particle size was found to be reduced with the increasing ratio of lecithin to cholesterol. The drug loading, encapsulation efficiency and drug release from the liposomes followed the similar trend and F1 was found to be having the smallest particle size, highest drug loading and encapsulation efficiency as well as the highest drug released over 8 h. The cream formulations made from the liposomes (F1) and pure drug was found to possess all the physicochemical evaluation parameters within acceptable limits. The sunscreen efficacy of the cream formulations was tested using sodium nitroprusside absorbance method at 395 nm, and it revealed that the liposome loaded formulations had better sunscreen efficiency as compared to the plain drug loaded formulations.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tOxybenzone, liposome, cream, sunscreen, ethanol injection\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Ambika, Pandey GK, Dubey BK. Formulation and Characterization of Oxybenzone loaded liposomes. J. Pharmacol. Biomed 2021; 5(1): 259-267.</li>\n<li>Barry, B.W., William, A.C. (1995). Dermatological Formulation, Marcel Dekker Inc. New York, p. 14.</li>\n<li>Farhangi M, Dadshzadeh S, Bolourchian N (2017). Biodegradable Gelatin Microspheres as Controlled Release Intraarticular Delivery System: The Effect of Formulation Variables. Indian J Pharm Sci. 79(1): 105-112.</li>\n<li>Gordan, V.C. (1993). Evaluation du facteur de protection solaire. Parfum. Cosmet. Arom. Paris, 112: 62-65.</li>\n<li><a href=\"https://www.drugbank.ca/drugs/DB01428\">https://www.drugbank.ca/drugs/DB01428</a>; assessed on 22/12/2020.</li>\n<li>Kaidbey KH, Kligman AM (1978). Laboratory methods for appraising the efﬁcacy of sunscreens. J Soc Cosmet Chem. 29: 525–536.</li>\n<li>King A, Young G. (1999). Characteristics and occurrence of phenolics phytochemicals. J. Am Diet Assoc. 99: 213-8.</li>\n<li>Nicholas, J.L., Pathak, M. (1996). Sunscreens: Development, Evaluation and Regulatory Aspects, Cosmetic science technology series. 2nd Edition. CRC press. p. 234-39.</li>\n<li>Pierre MBR, Costa IdSM. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Archives in Dermatology Asia 2011; 303: 607-621.</li>\n<li>Purushothamrao K, Khaliq K, Sagare P, Patil SK, Kharat SS, Alpana.K (2010). Formulation and evaluation of vanishing cream for scalp psoriasis. Internat J Pharm Sci Tech. 4(1): 33-41.</li>\n<li>Rekha U, Manjula BP (2011). Formulation and evaluation of microsponges for topical drug delivery of Mometasone furoate. Internat J Pharmacy Pharm Sci. 3(4):133-137.</li>\n<li>Shaikh KS, Chellampillai B, Pawar AP (2010). Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Drug Dev Ind Pharmacy. 36(8): 946-953.</li>\n</ol> </div>", "time": "2021-11-11T09:57:24.153Z", "slug": "formulation-and-characterization-of-oxybenzonerge5", "authors": []}}, {"model": "artical.artical", "pk": 46, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tPradeep Baraiya*, Pradeep Chauhan\t\t\t\t\t", "pdf": "achivesPdf/415-421_vcS2Kob.pdf", "heading": "Investigation of antioxidant potential of Petunia hybrida leaf extracts", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the present study was to assess the antioxidant potential of different leaf extract of <em>Petunia hybrida</em> using the in vitro model. The extraction ability of different solvents for recovering extractable components from leaves followed the order: ethanol&gt;chloroform&gt;aqueous&gt;pet ether. The findings of preliminary phytochemical analysis suggest the presence of alkaloids, saponin glycosides, phenolics, terpenoids, sterols, and flavonoids in the leaf of the plant. The total phenolic content of pet ether, chloroform, ethanol and aqueous extracts of <em>Petunia hybrida</em> were 16.18±0.89, 23.97±0.61, 71.77±0.59 and 31.38±0.36 GAE mg/g, respectively. All the extracts were subjected to <em>in vitro</em> determination of antioxidant potential by DPPH method. The IC<sub>50</sub> value of the DPPH scavenging potential for the chloroform, ethanol and aqueous extracts was found to be 163.3, 96.1 and 153.2 µg/mL respectively. The reducing potential was found to be dose dependent and the followed the order ethanolic&gt;aqueous&gt;chloroform. The IC<sub>50</sub> value of the percent HRSA for the chloroform, ethanol and aqueous extracts was found to be 225.90, 172.02, and 177.7 µg/mL respectively. The IC<sub>50</sub> value of the percent PRP for the chloroform, ethanol and aqueous extracts was found to be 226.17, 172.72, and 223.14 µg/mL respectively. It was found that the chloroform fraction was best able to inhibit the phosphomolybdenum complex.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>\n<em>Petunia hybrida, </em>DPPH, antioxidant, phosphomolybdenum, extract, hydroxyl, scavenging\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Ansari AQ, Ahmed SA, Waheed MA, Sayyed JA. Extraction and determination of antioxidant activity of <em>Withania somnifera</em> Dunal. Eur J Experimental Biol 2013, 3(5): 502-507</li>\n<li>Griesbach RJ, Asen S, Leonnarat BA. <em>Petunia hybrida</em> anthocyanins acylated with caffeic acid. Phytochemistry. 1991; 30(5): 1729-1731</li>\n<li><a href=\"https://en.wikipedia.org/wiki/Petunia_%C3%97_atkinsiana\">https://en.wikipedia.org/wiki/Petunia_%C3%97_atkinsiana</a>; assessed on 19/07/2021</li>\n<li>Kalita JC, Milligan SR. In vitro estrogenic potency of phytoestrogen-glycosides and some plant flavanoids. Indian Journal of Science and Techology. 2010; 3(12): 1142-1147</li>\n<li>Sas K, Robotka H, Toldi J, Vecsei L. Mitochondrial, metabolic disturbances, oxidative stress and kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007, 257: 221–239.</li>\n<li>Schram AW, Jonsson LMV, de Vlaming P. Identification of Anthocyanins and Intermediates of Anthocyanin Biosynthesis from Petunia hybrida Using High Performance Liquid Chromatography. Z Naturforsch. 1983; 38c: 342-345</li>\n<li>Thenmozhi M, Sivaraj R. <em>In Vitro</em> evaluation of the antibacterial activity of Petunia leaf and callus extracts. Journal of Agriculture Techology. 2011; 7(2): 321-330</li>\n<li>Vogel GH (Ed). Endorinology. In: Drug Discovery and Evaluation: Pharmacological Assays. Springer-Verlag, Berlin, Heidelberg; 2002</li>\n</ol> </div>", "time": "2021-11-11T09:57:24.803Z", "slug": "investigation-of-antioxidant-potential-of-petunia-", "authors": []}}, {"model": "artical.artical", "pk": 47, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tChirayu Bhugra, Bharat Tyagi\t\t\t\t\t", "pdf": "achivesPdf/408-414_yUfbsES.pdf", "heading": "Study of synergistic antiinflammatory action of Murraya koenigii and Ocimum sanctum leaf extract", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe present work was undertaken with an aim to determined the effect of combined extract of <em>Murraya koenigii</em> and <em>Ocimum sanctum</em>.  The extraction yield in the solvent mixture was found to be 39.6 % for <em>Murraya koenigii</em> and 43.7 % for <em>Ocimum sanctum</em> The findings of preliminary phytochemical analysis suggest the presence of alkaloids, saponin glycosides, phenolics, terpenoids, and flavonoids in the leaf of the <em>Murraya koenigii</em> while alkaloids were not found to be present in <em>Ocimum sanctum. </em>The total phenolic content of the hydroalcoholic extracts of <em>M. koenigii</em> and <em>O. sanctum</em> were 38.31±1.7 and 54.27±2.1GAE mg/g, respectively. The phenolic content was highest in the combined extract (MSE:OSE, 1:2) of all the three combinations with total phenolics 63.9±3.8 GAE mg/g. The extracts were individually and in combination (1:1, 1:2 &amp; 2:1) subjected to determination of anti-inflammatory potential by carrageenan induced rat paw edema method using ibuprofen as the standard drug. Ibuprofen at dose of 10 mg/Kg inhibited 69.23% edema after 4h of administration whereas the maximum edema inhibition exhibited by the combined extracts was 52.47% (MKE:OSE, 1:2)  at the end of 4h.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>\n<em>Murraya koenigii</em>, <em>Ocimum sanctum</em>, carrageenan, anti-inflammatory, Ibuprofen, combined extracts\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Agati G, Azzarello E, Pollastri S, Tattini M. Flavonoids as antioxidants in plants: location and functional signiﬁcance. Plant Science. 2012; 196: 67–76.</li>\n<li>Ansari AQ, Ahmed SA, Waheed MA, Sayyed JA. Extraction and determination of antioxidant activity of Withania somnifera Dunal. Eur J Experimental Biol 2013, 3(5): 502-507.</li>\n<li>Bravo L. Polyphenols: chemistry, dietary sources, metabolism and nutritional signiﬁcance. Nutrition Reviews. 1998; 56: 317–333.</li>\n<li>George B, Corina B, Gheorghe C. Antioxidant activity of <em>Humulus lupulus</em> and <em>Vaccinium myrtillus</em> individual and combined extracts. Romanian Biotechnological Letters. 2015; 20(2): 1027-10286</li>\n<li>Goldyne ME, Burrish GF, Poubelle P and Borgeat P (1984). Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenaserelated pathways, J Biol Chem., 259: 8815-8819.</li>\n<li>Gupta S, George M, Singhal M, Sharma GN, Garg V (2010). Leaves extract of Murraya koenigii for anti-inflammatory and analgesic activity in animal models, J Aadv Pharm Tech Res, 1: 68-77.</li>\n<li>Jain M, Gilhotra R, Singh RP, et al. Curry leaf (MurrayaKoenigii): a spice with medicinal property. MOJ Biol Med. 2017;2(3):236–256. DOI: <a href=\"https://doi.org/10.15406/mojbm.2017.02.00050\">10.15406/mojbm.2017.02.00050</a></li>\n<li>Kemisetti D, Manda S. Synthesis and comparison of peg-ibuprofen and peg-ketoprofen prodrugs by <em>in vitro </em>and <em>in vivo </em>evaluation. J Drug Del Ther, 2018; 8(4): 145-154.</li>\n<li>Komape NPM, Bagla VP, Kabongo-Kayoka P, Masoko P. Anti-mycobacteria potential and synergistic effects of combined crude extracts of selected medicinal plants used by Bapedi traditional healers to treat tuberculosis related symptoms in Limpopo Province, South Africa. BMC Complementary and Alternative Medicine. 2017; 17: 128. DOI 10.1186/s12906-016-1521-2</li>\n<li>Mirje MM, Zaman SU, Ramabhimaiah S (2014). Evaluation of the anti-inflammatory activity of Ocimum sanctum Linn (Tulsi) in albino rats, Int J Curr Microbiol App Sci., 3(1): 198-205.</li>\n<li>Pattanayak P, Behera P, Das D, Panda SK (2010). Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview. Pharmacognosy Review, 4 (7): 95-105.</li>\n<li>Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Nat Acad Sci, 1994; 91:12013–12017.</li>\n</ol> </div>", "time": "2021-11-11T09:57:25.557Z", "slug": "study-of-synergistic-antiinflammatory-action-of-mu", "authors": []}}, {"model": "artical.artical", "pk": 48, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tBasant Rathore, Sandeep Jain\t\t\t\t\t", "pdf": "achivesPdf/422-431_xfXTNpM.pdf", "heading": "Standardization of marketed preparation GH Pain Nil Powder for antiinflammatory and analgesic action", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe primary objective of the current investigation was to standardize the formulation GH Pain Nil Powder, marketed for management of joint pain according to the WHO guidelines for establishing scientific evidence for applicability of the formulation for human use. The procured pouches of GHPN were yellowish-brown in color, with characteristic odor and bitter taste. They were available as granular powder (Churna). GHPN exhibited 8.9% total ash with 2.65% acid insoluble ash and 5.1% water soluble ash. The water soluble and alcohol soluble extractives were 1.48% and 1.4% respectively suggesting the formulation to be suitable for human use.The results of preliminary qualitative phytochemical screening revealed that except proteins and amino acids all the classes of phytochemicals were present in GHPN. TLC analysis of GHPN was done using Allicin as the marker using ethylacetate: chloroform: water (5:3:1) as the solvent system. Allicin appeared at Rf value of 0.61 on the TLC plate as bluish-green spot. The quantitation of the Allicin was done by HPLC method and it was found that GHPN contained 4.12 µg Allicin per 5 g of GHPN. The anti-inflammatory activity was evaluated using carrageenan induced rat paw edema method and it was seen that GHPN was able to inhibit only 28.27% edema formation in rat paws. The analgesic action of GHPN was evaluated using tail flick method and the response time pain stimulus (thermal) was observed. The highest reaction time for GHPN was 6.26 ± 0.053 sec at 60 min post administration while it was 3.48 ± 0.079 sec and 7.23 ± 0.151 sec for saline and Ibuprofen respectively at the same time duration.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tStandardization, herbal, Allicin, anti-inflammatory, analgesic, extractives\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Batiha GE-S, Beshbishy AM, Wasef LG, Elewa YHA, Al-Sagan AA, Abd El-Hack ME, Taha AE, Abd-Elhakim YM, Devkota HP. Chemical constituents and pharmacological activities of Garlic (Allium sativum L.): A review. Nutrients, 2020; 12(3): 872. doi:10.3390/nu12030872</li>\n<li>Chong K, Zamora MP, Dileshni A, Tilakawardane Nancy EB, James AR, Liu Y. Investigation of allicin stability in aqueous garlic extract by high performance liquid chromatography method. J Scientific Res reports, 20156; 4: 590-598.</li>\n<li>Fan S-H, Ali NA, Basri DF. Evaluation of Analgesic Activity of the Methanol Extract from the Galls of Quercus infectoria (Olivier) in Rats. Evidence-Based Complementary and Alternative Medicine, 2014;  <a href=\"http://dx.doi.org/10.1155/2014/976764\">http://dx.doi.org/10.1155/2014/976764</a></li>\n<li>Gautam V, Raman RMV and Ashish K. Exporting Indian healthcare (Export potential of Ayurveda and Siddha products and services) Road beyond boundaries (The case of selected Indian healthcare systems). Export-Import Bank of India, Mumbai, 2003; 4–54.</li>\n<li>Kemisetti D, Manda S. Synthesis and comparison of peg-ibuprofen and peg-ketoprofen prodrugs by <em>in vitro </em>and <em>in vivo </em>evaluation. J Drug Del Ther, 2018; 8(4): 145-154.</li>\n<li>Kochhar SL. 1981. Tropical crops: A textbook of economy botany. London: Macmillan Pub Ltd.268–71.</li>\n<li>Mathialagan R, Mansor N, Shamsuddin MR, Uemura Y, Majeed Z. Optimisation of Ultrasonic-Assisted Extraction (UAE) of Allicin from Garlic (Allium sativum L.). Chemical Engineering Transactions, 2017; 56: 1747-1752</li>\n<li>Meena AK et al. Standardisation of Ayurvedic polyherbal formulation, Pancasama Churna. International Journal of Pharmacognosy and Phytochemical Research, 2010; 1: 11-14.</li>\n<li>Mehta S, Singh RP, Saklani P. Phytochemical screening and TLC profiling of various extracts of Reinwardtia indica. Int J Pharmacogn Phytochem Res, 2017; 9(4): 523-527.</li>\n<li>Mukerjee PK. Quality control of herbal drugs, Business horizons Pharmaceutical publisher, New Delhi, 2002.</li>\n<li>Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Nat Acad Sci, 1994; 91:12013–12017.</li>\n<li>Vaidya ADB and Devasagayam TPA. Current status of herbal drugs in India: An overview. J Clin Biochem, 2007; 41(1):1–11.</li>\n<li>Wani MS. Herbal medicine and its standardization. Pharmaceutical Reviews, 2007; 5(6).</li>\n<li>WHO (1998). Quality Control Methods for Medicinal Plant Materials, World Health Organization, Geneva.</li>\n<li>Yadav NP and Dixit VK. Recent approaches in herbal drug standardization. Int J Integr Biol, 2008; 2:195-203.</li>\n<li>Zafar R, Panwar R and SagarBhanu PS. Herbal drug standardization. The Indian Pharmacist, 2005; 4(36):21-25.</li>\n</ol> </div>", "time": "2021-11-11T09:57:26.181Z", "slug": "standardization-of-marketed-preparation-gh-pain-ni", "authors": []}}, {"model": "artical.artical", "pk": 49, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRavi, Sandeep Jain\t\t\t\t\t", "pdf": "achivesPdf/398-407_EyHkxa2.pdf", "heading": "Formulation and evaluation of Labetalol mouth dissolving tablets", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the present work was to formulate mouth dissolving tablet enriched with taste masking agent to provide rapid onset of action of Labetalol increasing its therapeutic efficacy and also increase the compliance amongst geriatric, pediatric and uncooperative patients. Total seven formulations of MDTs were prepared using direct compression (LODT1 to LODT4) and sublimation method (LODT5 to LODT7). The concentration of the super-disintegrant or the sublimating agent was varied depending on the method. Mannitol/Lactose was used as the binder as well as sweetener while saccharin sodium was used as the additional taste masking agent in the formulations. All the formulations were subjected to post compression evaluation test and the results indicate that the formulation had hardness of 3 Kg/cm<sup>2</sup>, thickness of 3 mm, weight variation in the range of 2.7-3.3 %, friability of less than 1 %, drug content in the range of 97.2 to 98.9 %, wetting time from 17 to 49 seconds with water absorption ratio of more than 75 %, disintegration time of less than 30 seconds and a drug release of more than 80 % over a period of 5 minutes. The formulations were found to be stable under accelerated conditions for a period of 3 months with almost negligible change in the critical parameters.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tLabetalol, hypertension, mannitol, lactose, mouth dissolving, tablet\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n</div>", "time": "2021-11-11T09:57:27.296Z", "slug": "formulation-and-evaluation-of-labetalol-mouth-diss", "authors": []}}, {"model": "artical.artical", "pk": 50, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tPankaj Pal, Pradeep Chauhan\t\t\t\t\t", "pdf": "achivesPdf/390-397_mb6gmjs.pdf", "heading": "Formulation and evaluation of intranasal mucoadhesive gel of Ibuprofen", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the investigation was to improvise the bioavailability of ibuprofen by formulating it as in situ intranasal gel delivery system thereby bettering the management of migraine. The <em>in situ</em> intranasal gel delivery system loaded with ibuprofen was prepared using cold stirring method and evaluated for various parameters. The concentration of poloxamer 407 to be used was optimized by gellation temperature study and it was found that 18% w/v of the same was able to gellify at temperature equivalent to the nasal temperature. The higher concentration of carbopol 934 increased the gel characteristics so much that they may not be pleasant for adminstration. The pH of all the formulations was found to be between 5.9 to 6.3, viscosity of the sol formulation ranged between 27 to 77 cps while that of the <em>in situ </em>gel ranged between 108 to 201 cps. The drug content ranged from 91.3 to 95.6 %. The <em>in vitro </em>release studies of different formulations of drug loaded <em>in situ </em>gels were carried out for 20 min in PBS pH 6.8. The maximum drug release from the formulations ranged from 76.7 to 101.2 % over the duration of in vitro release study.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tIntranasal, mucoadhesive, poloxamer, ibuprofen, migraine\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Jansson B, Hägerström H, Fransén N, Edsman K,Björk E.The influence of gellan gum on the transfer of fluorescein dextran across rat nasal epithelium in vivo. EurJPharmaceutBiopharmaceut. 2005; 59(3): 557-564.</li>\n<li>Chavan Jyotsna D, Doijad Rajendra C. Formulation and evaluation of chitosan based microparticulate nasal drug delivery system of rizatriptan benzoate. Internat J PharmTech Res. 2010; 2(4): p 2391-2402</li>\n<li>Butani S, Shah T, Parmar K, Rajput A. Development ofrizatriptan benzoate microspheres for nose to brain targeting. Internat J ApplPharmaceut. 2016; 8(4): p 69-74</li>\n<li>Kalita B, Saikia K, Kalita B. Development and characterization of mucoadhesive microsphere-loaded intranasal gel of venlafaxine hydrochloride. Asian J Pharm Clin Res. 2016; 9(S3): 139-144</li>\n<li>Paul A, Fathima KM, Nair SC. Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer. The Open Med Chem J. 2017; 11: 222-244</li>\n<li>Thakkar HP, Patel AA, Chauhan NP. Formulation and optimization of mucoadhesive microemulsion containing mirtazapine for intranasal delivery. Chronicles Young Scientists. 2014; 5(1): 25-32</li>\n<li><a href=\"https://www.drugbank.ca/drugs/DB01050\">https://www.drugbank.ca/drugs/DB01050</a>assessed on 10/01/2021</li>\n<li>Kempwade, K., Taranalli, A (2014) Formulation and evaluation of thermoreversible, mucoadhesive in situ intranasal gel of rizatriptan benzoate. Journal of Sol-Gel Science and Technology. 72:43-48.</li>\n<li>Schmolka, I.R (1972) Artificial skin I. Preparation and properties of pluronic F‐127 gels for treatment of burns. Journal of Biomedical Materials Research. 6:571-582.</li>\n<li>Guideline, ICH Harmonised Tripartite. \"Stability testing of new drug substances and products.\" Q1A (R2), Current Step 4 (2003).</li>\n</ol> </div>", "time": "2021-11-11T09:57:28.236Z", "slug": "formulation-and-evaluation-of-intranasal-mucoadhes", "authors": []}}, {"model": "artical.artical", "pk": 51, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tRoshani Khan, Urvesh Narwariya\t\t\t\t\t", "pdf": "achivesPdf/383-389_6WN6VSp.pdf", "heading": "Formulation and Evaluation of Sustained Release Matrix Tablets of Ciprofloxacin", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the current investigation was to formulate matrix tablets of ciprofloxacin with an ability to sustain the release of the drug for a period of 12 h. The objective was accomplished by preparation of the matrix tablets employing wet granulation method for formulating the tablets using HPMC and sodium CMC as the matrix forming polymers. The angle of repose for all formulations was found to be within the range from 25°64’ to 27°54’ indicating good flow property of powder blend. The bulk density and tapped density values were found to be within the range from 0.366 to 0.404 and 0.404 to 0.436 respectively.  The Hausner’s ratio values were found to be within the range from 1.02 to 1.12. The thickness of all formulation was ranged in between 4.1 to 4.2 mm while the hardness of the formulations ranged from 6.1 to 6.6 Kg/cm<sup>2</sup>. The friability of all formulation was in the range of 0.23% to 0.61% and the weight variation was in the range of 1.2 to 4.4 %. Swelling study was performed on all the formulation for 9 h. All formulation was in the range of 2.06 to 6.21.  The highest degree of swelling was achieved by F7.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tCiprofloxacin, sustained release, matrix tablets, swelling, HPMC, CMC\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Gupta PK, Robinson JR. (1992) Oral controlled release delivery. Treatise on controlled drug delivery. 93(2): 545-555</li>\n<li>Jantzen GM, Robinson JR. (1995) Sustained and Controlled- Release Drug Delivery systems. Modern Pharmaceutics 121(4): 501-502.</li>\n<li>Altaf AS, Friend DR. (2003) Sustained-Release Technology in Rathbone MJ, Hadgraft J, Robert MS, Modified Release Drug Delivery Technology, Marcell Dekker Inc., New York.</li>\n<li>Vidyadhara S, Rao PR, Prasad JA. (2004) Formulation And Evaluation Of Propranolol Hydrochloride Oral Controlled Release Matrix Tablets. Indian Journal of Pharmaceutical Sciences 66: 188-192.</li>\n<li>Reddy KR, Mutalik S, Reddy S. (2003) Once-daily sustained release matrix tablets of Nicorandil: Formulation and in vitro evaluation. AAPS PharmSciTech 4: 1-9.</li>\n<li>Mohammed AD, James LF, Michael HR, John EH, Rajabi-Siahboomi AR. (1999) Release of Propranolol hydrochloride from matrix tablets containing sodium carboxy methylcellulose and Hydroxy propyl methyl cellulose. Pharmaceutical Development Technology 4: 313-24.</li>\n<li>Lee BJ, Ryu SG, Cui JH. (1995) Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Development and Industrial Pharmacy 25: 493-501.</li>\n<li>en.wikipedia.org/wiki/Ciprofloxacin hydrochloride; last assessed 16/06/2021</li>\n<li>Soumya P, Raghavendra Rao NG, Revathi K, Chawda B. (2013) Design and development of oral sustained release matrix tablets of didanosine using natural polymer blend. Journal of Chemical and Pharmaceutical Research. 5(12): 1398-1408.</li>\n<li>Jalonya R, Soni P, Malviya K, Omray LK. (2018) Formulation and evaluation of bilayer tablets of diltiazem HCl. Journal of Pharmacology and Biomedicine 2(3): 189-198.</li>\n</ol> </div>", "time": "2021-11-11T09:57:28.888Z", "slug": "formulation-and-evaluation-of-sustained-release-ma", "authors": []}}, {"model": "artical.artical", "pk": 52, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tBeerendra Singh*, Amit Jain\t\t\t\t\t", "pdf": "achivesPdf/374-382-1_jRSCPnE.pdf", "heading": "Evaluation of wound healing action of Delonix regia leaf extract in rats", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the present investigation was to evaluate the wound healing action of <em>Delonix regia</em> leaf extract in rats. Successive solvent extraction of the leaves of Delonix regia was perfomed using soxhlet method and the extraction abilities of different solvents for recovering extractable components from leaves followed the order: methanol&gt;ethylacetate&gt;water&gt;pet ether. The findings of preliminary phytochemical screening suggest the presence of alkaloids, saponins, phenolics, tannins, terpenoids, sterols, and flavonoids in the leaf of the plant. The acute toxicity study reveals a LD<sub>50</sub> of more than 2000 mg/Kg for tannin rich ethyl acetate extract of the plant. The ethyl acetate extract of <em>Delonix regia</em> leaves were evaluated for the <em>in vivo</em> wound healing effect by the excision model. The topical application of 5 % w/w of the <em>Delonix regia </em>resulted in an enhanced and statistically significant (p &lt; 0.001) wound healing activity <em>in vivo</em>. The plant extract exhibited 78.47 ± 5.86 % contraction of wound on the 20<sup>th</sup> day whereas only 52.07 ± 5.46 % contraction of wound was found in the control animals.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tWound healing, <em>Delonix regia</em>, flavonoids, extract, in vivo, excision model\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Parul R, Alam MJ, Rana MS. (2014) Antinociceptive and cytotoxic potential of ethanolic extract of Delonixregia (Leaves). Indian Journal of Pharmaceutical and Biological Research. 2(1): 55-61</li>\n<li>Fatmawaty, Fadilah, Astuti H. (2013) Antimalarial activity of Delonixregia on mice with Plasmodium berghei. Journal of Natural Products. 6: 61-66</li>\n<li>Shiramane RS, Biradar KV, Chivde BV, Shambhulingayya HM, Goud V. (2011) In-Vivo antidiarrhoeal activity of ethanolic extract of delonixregia flowers in experimental induced diarrhoea in wistar albino rats. International Journal of Research in Pharmacy and Chemistry. 1(3): 442-447</li>\n<li>Chhabra D, Gupta RK. (2015) Fortification of curd using Delonixregia flower petal extract and estimation of its phytochemical, antibacterial &amp; antioxidant activity. Journal of Pharmacognosy and Phytochemistry. 4(3): 299-307</li>\n<li>SeetharamanYN, Vijay, Sharanabasappa G, Srinivas Murthy N, Sangamma VR. (2002) Antimicrobial and analgesic activities of DelonixElata gamble and Delonix regia Raf. Aryavaidyan. 16(1): 51-53</li>\n<li>Tiwari P, Joshi A, Dubey BK. (2017) Total phenolic content, flavonoid concentration, antimicrobial and insecticidal screening of aqueous extracts of Annona squamosa (seeds), Azadirachta indica (leaves) and Lavandula angustifolia (flower). Journal of Pharmacology and Biomedicine. 1(1): 30-43.</li>\n<li>Arora P, Arora V. (2019) Preliminary phytochemical screening of crude drugs In: A Textbook of Herbal Drug Technology, Pee Vee Books, Punjab, pp 179-180</li>\n<li><a href=\"https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd_gl423.pdf\">https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd_gl423.pdf</a>; assessed on 17/05/2021</li>\n<li>Gaur R, Azizi M, Gan J, Hansal P, Harper K, Mannan R,  Panchal A, Patel K, Patel MK, Patel N, Rana J, Rogowska A. (2009). Simple ointment: Formulated preparations. British Pharmacopoeia. 3.</li>\n<li>Morton JJP, Malone MH. (1972) Evaluation of vulnerary activity by an open wound procedure in rats. <a href=\"https://www.researchgate.net/journal/Archives-Internationales-de-Pharmacodynamie-et-de-Therapie-0301-4533\"> Archives Internationales de Pharmacodynamie et de Thérapie </a> 196: 117-126.</li>\n<li>Shabir G, Anwar F, Sultana B, Khalid ZM, Afzal M, Khan QM, Ashrafuzzaman M. (2011) Antioxidant and Antimicrobial Attributes and Phenolics of Different Solvent Extracts from Leaves, Flowers and Bark of Gold Mohar [Delonixregia (Bojer ex Hook.) Raf.]. Molecules 7302-7319. doi:10.3390/molecules16097302</li>\n<li>Singh S, Kumar SN. (2014) A Review: Introduction to Genus Delonix. World Journal of Pharmaceutical Pharmaceutical Sciences 3(6): 2042-2055</li>\n</ol> </div>", "time": "2021-11-11T09:57:29.621Z", "slug": "evaluation-of-wound-healing-action-of-delonix-regi", "authors": []}}, {"model": "artical.artical", "pk": 53, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tKanchan Kushwah*, Atul Kaushik\t\t\t\t\t", "pdf": "achivesPdf/366-373-13_OnjdApU.pdf", "heading": "Formulation and evaluation of matrix tablets of Norfloxacin", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe objective of the current investigation was to formulate matrix tablets of norfloxacin that could control the release of the drug thereby reducing its dosing frequency and improving the bioavailability. The objective was accomplished by preparation of the matrix tablets using HPMC and xanthan gum as the matrix forming polymers. The angle of repose for all formulations was found to be within the range from 24°22 to 26°18. The bulk density and tapped density values were found to be within the range from 0.42 to 0.58 and 0.53 to 0.67 respectively.  The Hausner’s ratio values were found to be within the range from 1.06 to 1.21.The thickness of all formulation was ranged in between 4.1 to 4.3 mm while the hardness of the formulations ranged from 4.1 to 4.6 Kg/cm<sup>2</sup>. The friability of all formulation was in the range of 0.23% to 0.61% and the weight variation was in the range of 0.48 to 0.56 %. Swelling study was performed on all the formulation for 9 h. The results of swelling index were shown in table. All formulation was in the range of 1.37 to 5.31.  The highest degree of swelling was achieved by F9 that contained highest concentration of HPMC and xanthan gum.  The formulation F7-F9 were able to release almost 100% of the drug at the end of 12 h duration.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>&#13;\n\t\t\t\t\t\tNorfloxacin, controlled release, matrix tablet, xanthan gum, HPMC, precompression\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Vyas SP and Khar RK. (2002) Controlled drug delivery concepts and advances. Vallabh prakashan, New Delhi; 1<sup>st</sup> edition.</li>\n<li>Chien YW. (1982) Novel drug delivery systems. 2nd edition, Marcel dekker, New York.</li>\n<li>Xiaoling Li, Jasti BR. (2005) Design of Controlled Release Drug  Delivery Systems. McGraw-Hill Professional; 1<sup>st</sup> edition.</li>\n<li>Jantzen GM, Robinson JR. (1995) Sustained and Controlled- Release Drug Delivery systems. Modern Pharmaceutics. 121(4): 501-502.</li>\n<li>Chugh I, Seth N, Rana AC, Gupta S. (2012) Oral sustain release drug delivery system: an overview, International research journal of pharmacy. 3(5):57-62.</li>\n<li><a href=\"https://www.drugbank.ca/drugs/DB01059\">https://www.drugbank.ca/drugs/DB01059</a> assessed on 07/06/2021</li>\n<li>Suja C, Sismy C. (2018) Formulation and Evaluation of Sustained Release Dosage Forms of Norfloxacin. International Journal of Pharmaceutical Sciences and Nanotechnology 11(6). <a href=\"https://doi.org/10.37285/ijpsn.2018.11.6.6\">DOI 10.37285/ijpsn.2018.11.6.6</a></li>\n<li>Oliveira PR, Mendes C, Klein L, da Silva Sangoi M, Bernardi LS, Silva MAS. (2013) Formulation Development and Stability Studies of Norfloxacin Extended-Release Matrix Tablets. BioMed Research International. 2013. <a href=\"http://dx.doi.org/10.1155/2013/716736\">http://dx.doi.org/10.1155/2013/716736</a></li>\n<li>Bomma R, Naidu RAS, Yamsani YR, Veerabrahma K. (2009) Development and evaluation of gastroretentive norfloxacin floating tablets. Acta Pharmaceutica. 59: 211-221.</li>\n<li>Karthik M, Swetha P, Balaji A. (2018) Development of gastroretentive floating matrix tablets of norfloxacin. World Journal of Pharmacy and Pharmaceutical Sciences. 8(1): 920-978.</li>\n<li>Gul S, Sajid S. (2015) Formulation of Improved Norfloxacin HCl Tablets: Quality Control Assessment and Comparison Study of Acidic and Basic Form of Norfloxacin in Tablet Formulation. Journal of Developing Drugs. 5(1): 145. DOI: 10.4172/2329-6631.1000145</li>\n<li>Madhuri M, Nagendra Babu B, Jeevan Mani Babu D. (2017) Formulation and evaluation of matrix floating tablets of Norfloxacin and Tinidazole combination. Indian Journal of Research in Pharmacy and Biotechnology. 5(2): 119-123.</li>\n<li>Al-Dhubiab BE. (2018) Development and in vitro assessment of Norfloxacin nanoparticles. Journal of Pharmaceutical Sciences and Research. 10(8): 1876-1880.</li>\n<li>Gadade DD, Sarda K, Shahi SR. (2016) Investigation and Optimization of the Effect of Polymers on Drug Release of Norfloxacin from Floating Tablets. Polymers in Medicine 46(2): 117-127.</li>\n<li>Radhika PR, Pal TK, Sivakumar T. (2009) Formulation and Evaluation of Sustained ReleaseMatrix Tablets of Glipizide. Iranian Journal of Pharmaceutical Sciences. 5(4): 205-214.</li>\n</ol> </div>", "time": "2021-11-11T09:57:30.348Z", "slug": "formulation-and-evaluation-of-matrix-tablets-of-no", "authors": []}}, {"model": "artical.artical", "pk": 54, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tYogesh Mathur, Amit Jain\t\t\t\t\t", "pdf": "achivesPdf/360-365_6Xhryj5.pdf", "heading": "Screening of antidepressant potential of leaves of Araucaria columaris", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tThe present work was undertaken with an objective to establish the anti-depressant action of ethanolic leaf extract of <em>Araucaria columnaris</em>. The yield of the ethanolic extract was found to be 36.9% and the extract was black in color. The preliminary phytochemical analysis suggests the presence of cardiac glycosides, phenolics, terpenoids, sterols, and flavonoids in the leaves. The antidepressant action of the extract (EEAC) was tested using two animal models at two dose levels (200 and 400 mg/kg) using forced swim test (FST) and tail suspension test (TST) models. The immobility time in the TST for EEAC (400 mg/kg) was found to be 18.33 ± 1.994 sec and was significantly comparable (<em>p</em>&lt;0.0001) to that of fluoxetine at a dose on 10mg/kg (9.67 ± 0.667 sec). The swimming frequency in the FST increased significantly at both the dose levels of EEAC and it surpassed fluoxetine (43.00 ± 1.211) at 400 mg/kg dose of EEAC (44.00 ± 1.317).\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>\n<em>Araucaria columnaris, </em>extract, forced swim test, tail suspension test, antidepressant, fluoxetine\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Aslam MS, Choudhary BA, Ijaz AS, Uzair M, Ahmad MS, Mamat AS (2015) Biological screening of Araucaria columnaris. International Journal of Pharmacy and Pharmaceutical Sciences. 7(4): 313-315</li>\n<li>Aslam MS, Choudhary BA, Uzair M, Ijaz AS (2013) Phytochemical and ethno-pharmacological review of the genus Araucaria-review. Tropical Journal of Pharmaceutical Research. 12(4): 651-659</li>\n<li>Aslam MS, Choudhary BA, Uzair M, Ijaz AS (2014) Phytochemistry of aerial parts of araucaria columnaris. Journal of Applied Pharmacy. 6(1): 114-120</li>\n<li>de Oliveira KN, Costa P, Santin JR, Mazzambani L, Bürger C, Mora C, Nunes RJ, de Souza MM (2011) Synthesis and antidepressant-like activity evaluation of sulphonamides and sulphonyl-hydrazones. Bioorganic &amp; Medicinal Chemistry. 19: 4295-4306</li>\n<li>Guan LP, Zhao D-H, Chang Y, Wen Z-S, Tang L-M, Huang F-F (2013) Synthesis of 2,4-dihydroxychalcone derivatives as potential antidepressant eﬀect. Drug Research. 63: 46-51</li>\n<li><a href=\"https://www.gardenia.net/plant/araucaria-columnaris?\">https://www.gardenia.net/plant/araucaria-columnaris?</a>; assessed on 22/04/2021</li>\n<li>Malviya M, Mishra B, Korde B (2021) Antidepressant molecules: Synthesis and evaluation of novel azetidinone compounds. Journal of Pharmacology and Biomedicine. 5(2): 286-294.</li>\n<li>Saranya Devi K, Rathinamala J, Jayashree S (2014) Phytochemical and therapeutic effect of araucaria columnaris resin extracts on clinical pathogens. European Journal of Molecular Biology and Biochemistry. 1(5): 182-185</li>\n<li>Scapagnini G, Davinelli S, Drago F, De Lorenzo A, Oriani G (2012) Antioxidants as antidepressants: fact or fiction? CNS Drugs. 26(6): 477-490. doi: 10.2165/11633190-000000000-00000. PMID: 22668245.</li>\n<li>Schmeda-Hirschmann G, Astudillo L, Sepulveda B, Rodrıguez JA, Theoduloz C, Yanez T, Palenzuela JA (2005) Gastroprotective effect and cytotoxicity of natural and semisynthetic labdane diterpenes from araucaria araucana resin. Zeitschrift für Naturforschung C. 60(7-8): 511-522</li>\n<li>Shabir G, Anwar F, Sultana B, Khalid ZM, Afzal M, Khan QM, Ashrafuzzaman M (2011) Antioxidant and Antimicrobial Attributes and Phenolics of Different Solvent Extracts from Leaves, Flowers and Bark of Gold Mohar [Delonix regia (Bojer ex Hook.) Raf.]. Molecules. 7302-7319. doi:10.3390/molecules16097302</li>\n<li>Tiwari P, Joshi A, Dubey BK (2017) Total phenolic content, flavonoid concentration, antimicrobial and insecticidal screening of aqueous extracts of Annona squamosa (seeds), Azadirachta indica (leaves) and Lavandula angustifolia (flower). Journal of pharmacology and Biomedicine. 1(1): 30-43</li>\n<li>Zaffar M, Munis MFH, Rasul F, Masood S, Hassan SW, Imran M, Nasim W, Zakir A, Quraishi UM, Chaudhary HJ (2014) Biological assays of plant extracts from Araucaria columnaris and Cycas revoluta. Journal of Food, Agriculture &amp; Environment.  12(1): 128-131</li>\n</ol> </div>", "time": "2021-11-11T09:57:31.501Z", "slug": "screening-of-antidepressant-potential-of-leaves-of", "authors": []}}, {"model": "artical.artical", "pk": 55, "fields": {"issue": 16, "boardimg": "default.jpg", "otherauthors": "&#13;\n\t\t\t\t\t\tPriyanka Ojha, Sandeep Jain\t\t\t\t\t", "pdf": "achivesPdf/352-359_50SzXGv.pdf", "heading": "Evaluation of wound healing action of Annona squamosa bark extract", "abstract": "<div style=\"text-align: justify;\">\n<p></p>&#13;\n\t\t\t\t\t\tSuccessive solvent extraction of the defatted bark of <em>Annona squamosa</em> was perfomed using soxhlet method and the extraction abilities of different solvents for recovering extractable components from leaves followed the order: ethanol&gt;ethylacetate&gt;water. The findings of preliminary phytochemical screening suggest the presence of alkaloids, saponins, phenolics, tannins, terpenoids, sterols, and flavonoids in the bark of the plant. The acute toxicity study reveals a LD<sub>50</sub> of more than 2000 mg/Kg for the phytochemical rich ethanolic extract of the bark of AS. The ethanolic extract of <em>Annona squamosa</em> bark was evaluated for the <em>in vivo</em> wound healing effect by the excision model. The topical application of 1 and 2 % w/w of the <em>Annona squamosa</em> extract resulted in an accelerated wound healing capability.  The plant extract (ASBE 2%) exhibited 86.15 % contraction of wound on the 15<sup>th</sup> day which was more than the povidone iodine used as the standard that exhibited 78.1% contraction of the wound. The control animals with ointment base were found to contraction 69.42 % while ASBE 1% healed 78.1% of wound by the 15<sup>th</sup> day.\t\t\t\t\t</div>", "keywords": "<div>\n<span></span>\n<em>Annona squamosa</em>, wound, bark extract, phytochemical, phenolics, extraction\t\t\t\t\t</div>", "doi": "<div>\n<span></span>\n</div>", "references": "<div style=\"text-align: justify;\">\n<p></p>\n<ol>\n<li>Gajalakshmi S, Divya R, Divya Deepika V, Mythili S, Sathiavelu A. (2011) Pharmacological activities of Annona squamosa: A review. International Journal of Pharmaceutical Sciences Review and Research 10(2): 24-29.</li>\n<li>Gaur R, Azizi M, Gan J., Hansal P, Harper K, Mannan R,  Panchal A, Patel K, Patel MK, Patel N, Rana J, Rogowska A. (2009). Simple ointment: Formulated preparations. British Pharmacopoeia. 3.</li>\n<li>Gulcin, I. (2012) Antioxidant activity of food constituents : An overview, Arch Toxicol, 86, 345-391.</li>\n<li>Kodati, DR, Burra S, Goud PK. (2011) Evaluation of wound healing activity of methanolic root extract of Plumbago zeylanica L. in Wistar albino rats. Asian Journal of Plant Sciences and Research 1: 26-34.</li>\n<li>Lakshmi MS, Rani KS, Reddy TU. (2012) A review on diabetes mellitus and the herbal plants used for its treatment, Asian Journal of Pharmacy and Clinical Research 5: 15-21.</li>\n<li>Ma C, Chen Y, Chen J, Li X, Chen Y. (2017) A Review on Annona squamosa L.: Phytochemicals and Biological Activities. The American Journal of Chinese Medicine 45 (5):  1–32</li>\n<li>Mittal AS. (2016) Phytochemical Investigation Of Annona Squamosa Bark. Bulletin of Environment, Pharmacology and Life Sciences 5(11)</li>\n<li>Samanta R, Pattnaik AK, Pradhan KK, Mehta BK, Pattanayak SP, Banerjee S. (2016) Wound healing activity of Silibinin in mice. Pharmacognosy Research 8(4): 298-302.</li>\n<li>Shabbir M, Khan MR, Saeed N (2013) Assessment of phytochemicals, antioxidant, anti-lipid peroxidation and anti-hemolytic activity of extract and various fractions of Maytenus royleanus leaves, BMC Complementary and Alternative Medicine doi:10.1186/1472-6882-13-143.</li>\n<li>Singh N, Singh M. (2017) An Evaluation of Phytochemicals in Maceration and Infusion Extracts of Cyperus rotundus Linn Leaves in Two Different Solvents. Journal of Pharmacology and Biomedicine 1(2): 77-84</li>\n<li>Talekar YP, Das B, Paul T, Talekar DY, Apte KG, Parab PB. (2012) Evaluation of wound healing potential of aqueous and ethanolic extracts of Tridax procumbens Linn. in Wistar rats. Asian Journal of Pharmaceutical and Clinical Research 5: 141-145.</li>\n</ol> </div>", "time": "2021-11-11T09:57:32.221Z", "slug": "evaluation-of-wound-healing-action-of-annona-squam", "authors": []}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "54.36.148.167"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "54.36.149.41"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "54.36.148.91"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "54.36.149.77"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "54.36.149.93"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "54.36.148.228"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "54.36.148.13"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "54.36.148.48"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "54.36.148.59"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "54.36.149.36"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "54.36.148.175"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "54.36.148.215"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 43, "ip": "54.36.148.192"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 48, "ip": "54.36.148.154"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "54.36.148.46"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 10, "ip": "54.36.148.54"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "54.36.149.69"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 23, "ip": "54.36.148.104"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 15, "ip": "54.36.149.92"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 16, "ip": "54.36.148.180"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 14, "ip": "54.36.148.21"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 13, "ip": "54.36.149.69"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 12, "ip": "54.36.149.61"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 19, "ip": "54.36.148.18"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 18, "ip": "54.36.148.51"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 17, "ip": "54.36.148.27"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 11, "ip": "54.36.148.185"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 26, "ip": "54.36.148.148"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 25, "ip": "54.36.148.231"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 8, "ip": "54.36.149.86"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "54.36.149.67"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 20, "ip": "54.36.148.104"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 9, "ip": "54.36.149.9"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "54.36.148.126"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 22, "ip": "54.36.148.35"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "54.36.149.34"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 34, "ip": "54.36.148.199"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 27, "ip": "54.36.149.20"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "54.36.149.107"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 31, "ip": "54.36.148.102"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 28, "ip": "54.36.148.214"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "54.36.149.18"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 30, "ip": "54.36.148.242"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "54.36.148.82"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "54.36.148.123"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 39, "ip": "54.36.149.24"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "54.36.148.168"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 37, "ip": "54.36.148.178"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 40, "ip": "54.36.148.141"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 36, "ip": "54.36.148.190"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "54.36.148.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "54.36.148.178"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 6, "ip": "54.36.148.103"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "54.36.148.104"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "54.36.148.76"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "117.217.83.250"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 16, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 17, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 6, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 22, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 48, "ip": "207.46.13.139"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "207.46.13.215"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "40.77.167.17"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "157.55.39.152"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "157.55.39.152"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "40.77.167.17"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "40.77.167.63"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "40.77.167.63"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "40.77.167.17"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "207.46.13.215"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "207.46.13.215"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "207.46.13.215"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "157.55.39.152"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "40.77.167.63"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 40, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 13, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 23, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 37, "ip": "117.217.43.61"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 36, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "27.7.251.113"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "27.7.251.113"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 14, "ip": "27.7.251.113"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 13, "ip": "27.7.251.113"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 12, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 43, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 48, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 20, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 25, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 16, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 25, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 23, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 8, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 14, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 10, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 13, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 12, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 34, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 39, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 27, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 20, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 31, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 28, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 37, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 19, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 18, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 40, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 17, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 36, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 9, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 11, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 15, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 26, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 6, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 30, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 22, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "173.231.60.194"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 37, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 19, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 34, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 26, "ip": "106.206.196.1"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 18, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 28, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 26, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 30, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 6, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 27, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 10, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 6, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 17, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 48, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 8, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 13, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 22, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 15, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "51.222.253.6"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "51.222.253.5"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "51.222.253.15"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "51.222.253.6"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "51.222.253.15"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "51.222.253.14"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "51.222.253.1"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "51.222.253.18"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "51.222.253.20"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "51.222.253.13"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "51.222.253.5"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "51.222.253.16"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 43, "ip": "51.222.253.20"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 48, "ip": "51.222.253.16"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "51.222.253.4"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 10, "ip": "51.222.253.11"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "51.222.253.20"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 23, "ip": "51.222.253.9"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 15, "ip": "51.222.253.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 16, "ip": "51.222.253.4"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 14, "ip": "51.222.253.11"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 13, "ip": "51.222.253.20"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 12, "ip": "51.222.253.7"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 19, "ip": "51.222.253.3"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 18, "ip": "51.222.253.7"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 17, "ip": "51.222.253.14"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 11, "ip": "51.222.253.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 26, "ip": "51.222.253.11"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 25, "ip": "51.222.253.16"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 8, "ip": "51.222.253.11"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "51.222.253.10"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 20, "ip": "51.222.253.3"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 9, "ip": "51.222.253.1"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 34, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "51.222.253.20"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 22, "ip": "51.222.253.19"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "51.222.253.10"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 9, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 34, "ip": "51.222.253.18"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 27, "ip": "51.222.253.17"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "51.222.253.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 31, "ip": "51.222.253.3"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 14, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 28, "ip": "51.222.253.20"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "51.222.253.17"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 30, "ip": "51.222.253.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 14, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "51.222.253.5"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "51.222.253.3"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 39, "ip": "51.222.253.3"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "51.222.253.3"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 37, "ip": "51.222.253.17"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 40, "ip": "51.222.253.14"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 36, "ip": "51.222.253.5"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "51.222.253.7"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "51.222.253.8"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 6, "ip": "51.222.253.3"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 20, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "51.222.253.18"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "51.222.253.17"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 48, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 31, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 37, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 43, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 9, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 31, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 15, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 11, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 10, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 26, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 8, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 39, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 16, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 39, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 40, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "49.36.44.198"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 18, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 40, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 23, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 30, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 25, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 16, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 18, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 8, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 13, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 19, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 27, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 20, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 43, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 37, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 31, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 34, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 25, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 9, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 12, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 39, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 27, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "54.36.148.237"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "54.36.148.209"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "54.36.148.141"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "54.36.149.87"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "54.36.148.53"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "54.36.148.180"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "54.36.149.43"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "54.36.148.171"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "54.36.149.69"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "54.36.148.64"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "54.36.148.218"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "54.36.148.203"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 43, "ip": "54.36.149.99"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 48, "ip": "54.36.149.100"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "54.36.148.243"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 10, "ip": "54.36.148.163"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "54.36.148.29"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 23, "ip": "54.36.149.6"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 15, "ip": "54.36.148.118"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 16, "ip": "54.36.149.30"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 14, "ip": "54.36.148.119"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 13, "ip": "54.36.149.85"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 12, "ip": "54.36.148.175"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 19, "ip": "54.36.148.150"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 18, "ip": "54.36.148.88"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 17, "ip": "54.36.149.72"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 11, "ip": "54.36.148.171"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 26, "ip": "54.36.148.163"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 25, "ip": "54.36.149.8"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 8, "ip": "54.36.148.43"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "54.36.148.207"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 20, "ip": "54.36.148.200"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 9, "ip": "54.36.148.51"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "54.36.149.19"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 22, "ip": "54.36.148.212"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "54.36.149.31"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 34, "ip": "54.36.148.157"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 27, "ip": "54.36.148.76"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "54.36.148.56"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 31, "ip": "54.36.149.86"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 28, "ip": "54.36.148.117"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "54.36.148.133"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 30, "ip": "54.36.148.21"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "54.36.148.96"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "54.36.148.199"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 39, "ip": "54.36.149.15"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 35, "ip": "54.36.149.38"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 37, "ip": "54.36.149.6"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 40, "ip": "54.36.149.48"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 36, "ip": "54.36.149.56"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "54.36.148.215"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "54.36.148.242"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 6, "ip": "54.36.149.10"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 3, "ip": "54.36.148.23"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "54.36.149.9"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 22, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 2, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 11, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 10, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 4, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "223.181.137.21"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 23, "ip": "223.181.137.21"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 26, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 32, "ip": "117.217.80.238"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 27, "ip": "117.217.80.238"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 24, "ip": "117.217.80.238"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 6, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 10, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 21, "ip": "117.217.80.121"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 22, "ip": "117.217.80.121"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 36, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 5, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 28, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 1, "ip": "49.36.46.248"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 40, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 39, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 38, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 16, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 18, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "157.55.39.91"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 8, "ip": "114.119.135.186"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 43, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 17, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 9, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 29, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 34, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 14, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 11, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "114.119.147.2"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 33, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 15, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 20, "ip": "114.119.135.181"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 7, "ip": "114.119.135.172"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 12, "ip": "114.119.135.193"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 23, "ip": "114.119.135.174"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "114.119.135.187"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "207.46.13.176"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 41, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 55, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 52, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 45, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 50, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 49, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 53, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 51, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 44, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 46, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 42, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 54, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 43, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 48, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 0, "fields": {"articalid": 47, "ip": "144.76.96.236"}}, {"model": "artical.blogviews", "pk": 1, "fields": {"articalid": 1, "ip": "127.0.0.1"}}, {"model": "artical.blogviews", "pk": 2, "fields": {"articalid": 3, "ip": "127.0.0.1"}}, {"model": "artical.blogviews", "pk": 3, "fields": {"articalid": 41, "ip": "127.0.0.1"}}, {"model": "artical.downloadcount", "pk": 1, "fields": {"articalid": 2, "dcount": 10}}, {"model": "artical.downloadcount", "pk": 2, "fields": {"articalid": 1, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 3, "fields": {"articalid": 4, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 4, "fields": {"articalid": 21, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 5, "fields": {"articalid": 25, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 6, "fields": {"articalid": 41, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 7, "fields": {"articalid": 55, "dcount": 11}}, {"model": "artical.downloadcount", "pk": 8, "fields": {"articalid": 52, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 9, "fields": {"articalid": 45, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 10, "fields": {"articalid": 50, "dcount": 11}}, {"model": "artical.downloadcount", "pk": 11, "fields": {"articalid": 49, "dcount": 12}}, {"model": "artical.downloadcount", "pk": 12, "fields": {"articalid": 53, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 13, "fields": {"articalid": 51, "dcount": 10}}, {"model": "artical.downloadcount", "pk": 14, "fields": {"articalid": 44, "dcount": 10}}, {"model": "artical.downloadcount", "pk": 15, "fields": {"articalid": 46, "dcount": 10}}, {"model": "artical.downloadcount", "pk": 16, "fields": {"articalid": 42, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 17, "fields": {"articalid": 54, "dcount": 10}}, {"model": "artical.downloadcount", "pk": 18, "fields": {"articalid": 43, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 19, "fields": {"articalid": 48, "dcount": 11}}, {"model": "artical.downloadcount", "pk": 20, "fields": {"articalid": 47, "dcount": 10}}, {"model": "artical.downloadcount", "pk": 21, "fields": {"articalid": 16, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 22, "fields": {"articalid": 23, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 23, "fields": {"articalid": 8, "dcount": 10}}, {"model": "artical.downloadcount", "pk": 24, "fields": {"articalid": 32, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 25, "fields": {"articalid": 14, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 26, "fields": {"articalid": 10, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 27, "fields": {"articalid": 13, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 28, "fields": {"articalid": 12, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 29, "fields": {"articalid": 34, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 30, "fields": {"articalid": 7, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 31, "fields": {"articalid": 38, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 32, "fields": {"articalid": 24, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 33, "fields": {"articalid": 39, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 34, "fields": {"articalid": 27, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 35, "fields": {"articalid": 33, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 36, "fields": {"articalid": 35, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 37, "fields": {"articalid": 20, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 38, "fields": {"articalid": 31, "dcount": 6}}, {"model": "artical.downloadcount", "pk": 39, "fields": {"articalid": 28, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 40, "fields": {"articalid": 37, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 41, "fields": {"articalid": 19, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 42, "fields": {"articalid": 36, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 43, "fields": {"articalid": 18, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 44, "fields": {"articalid": 29, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 45, "fields": {"articalid": 40, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 46, "fields": {"articalid": 17, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 47, "fields": {"articalid": 9, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 48, "fields": {"articalid": 11, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 49, "fields": {"articalid": 15, "dcount": 8}}, {"model": "artical.downloadcount", "pk": 50, "fields": {"articalid": 26, "dcount": 6}}, {"model": "artical.downloadcount", "pk": 51, "fields": {"articalid": 6, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 52, "fields": {"articalid": 30, "dcount": 7}}, {"model": "artical.downloadcount", "pk": 53, "fields": {"articalid": 3, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 54, "fields": {"articalid": 22, "dcount": 9}}, {"model": "artical.downloadcount", "pk": 55, "fields": {"articalid": 5, "dcount": 6}}, {"model": "blogs.category", "pk": 1, "fields": {"cat": "Chemistry", "slug": "Chemistry"}}, {"model": "blogs.category", "pk": 2, "fields": {"cat": "Forensic science", "slug": "forensic-science"}}, {"model": "blogs.category", "pk": 3, "fields": {"cat": "Gemological", "slug": "Gemological"}}, {"model": "blogs.category", "pk": 7, "fields": {"cat": "Calorimetry.", "slug": "calorimetry"}}, {"model": "blogs.category", "pk": 8, "fields": {"cat": "chromatography", "slug": "chromatography"}}, {"model": "blogs.category", "pk": 9, "fields": {"cat": "pharmaceutical", "slug": "pharmaceutical"}}, {"model": "blogs.category", "pk": 10, "fields": {"cat": "Testing", "slug": "testing"}}, {"model": "blogs.category", "pk": 11, "fields": {"cat": "Microbiological", "slug": "microbiological"}}, {"model": "blogs.category", "pk": 12, "fields": {"cat": "chemical synthesis", "slug": "chemical-synthesis"}}, {"model": "blogs.blogs", "pk": 2, "fields": {"category": 3, "title": "Testing Food quality and safety", "blog_des": "Laboratories used for scientific research take many forms because of the differing requirements of specialists in the various fields of science and engineering, allowing them to accomplish their desir", "blog_detail": "<p>Testing Food quality and safety Laboratories used for scientific research take many forms because of the differing requirements of specialists in the various fields of science and engineering, allowing them to accomplish their desired goals. Fusce libero velit, tristique eu mauris vitae, convallis facilisis sapien. Demanding applications require engineered solutions.Demanding applications require engineered solutions. Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don&rsquo;t look even slightly believable. Lorem Ipsum is simply dummy text of the printing and typesetting industry. Welcome to Laboratory Laboratories used for scientific research take many lorem. Maecenas in posuere justo. Quisque non condimentum augue, ac luctus diam. Integer semper, lectus at ornare euismod, purus est placerat nisi, quis vehicula mi urna sed orci. Etiam lacinia aliquet augue vitae auctor. Curabitur in blandit leo. Pellentesque pell</p>", "date": "2021-10-28T07:05:44.029Z", "img": "img/blog-new-01_FFRNDl4.jpg", "slug": "testing-food-quality-and-safety"}}, {"model": "blogs.comment", "pk": 0, "fields": {"blog": 2, "name": "Lloydhycle", "email": "test@tesst.com", "website": "https://devpost.com/batespehrson947", "body": "Heya i am for thee first time here. I came across this board and I find It really useful & it helped me out a lot. \r\n \r\n<a href=\"https://manchesterclopedia.win/wiki/1xbet_trkiye_bahis_ve_casino_siteleri_1\">manchesterclopedia.win</a>", "date": "2021-12-11T21:19:47.262Z"}}, {"model": "services.services", "pk": 4, "fields": {"category": 7, "type": "training", "title": "Ipqc of solid dosage form", "img1": "services/Solid-Dosage-Forms-Tablets.jpg", "img2": "services/bg1.png", "tagline": "IPQC of solid dosage forms", "details": "<table border=\"0\" cellpadding=\"2\" cellspacing=\"2\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td>Duration</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>02 Days</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Number of hours</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>10 (Theory 02, Practical 08)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Course content</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>All practical aspects of in process quality control parameters of solid dosage forms (powder, capsules, tablets)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Outcome</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>The candidate will be able to perform specification testing of raw materials and finished products (tablets, capsules)</td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>", "ourresearch": "<p><span style=\"color:#1c1d1f\">Learning of IPQC Tests</span></p>\r\n\r\n<ol>\r\n\t<li style=\"list-style-type:decimal\"><span style=\"color:#1c1d1f\">Tablet Dosage quality control</span></li>\r\n\t<li style=\"list-style-type:decimal\"><span style=\"color:#1c1d1f\">Hadling of Equipments</span></li>\r\n\t<li style=\"list-style-type:decimal\"><span style=\"color:#1c1d1f\">Theory &amp; Practical demonstration</span></li>\r\n\t<li style=\"list-style-type:decimal\"><span style=\"color:#1c1d1f\">Certificate of completion</span></li>\r\n</ol>", "slug": "ipqc-of-solid-dosage-form", "associatedfaculty": [1]}}, {"model": "services.services", "pk": 5, "fields": {"category": 8, "type": "training", "title": "One month complete training", "img1": "services/home-about.jpg", "img2": "services/hands-with-egg-in-glass-e1538272117565.jpg", "tagline": "One month complete training", "details": "<table border=\"0\" cellpadding=\"2\" cellspacing=\"2\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td>Duration</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>25 days</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Number of hours</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>125 (Theory 35, Practical 90)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Course content</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>All practical aspects preformulation study, tablet formulation, IPQC of solid dosage form, handling of UV and HPLC, microbiological training, extraction of phytoconstituents from plants, TLC, preparation for job interview</td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>", "ourresearch": "", "slug": "hands-on-hplc", "associatedfaculty": [2]}}, {"model": "services.services", "pk": 7, "fields": {"category": 9, "type": "training", "title": "Formulation and IPQC testing of tablets", "img1": "services/ipqc-tests-1-638.webp", "img2": "services/manufacturing-term-analysis-how-to-distinguish-qc--iqc--ipqc--qa.jpg", "tagline": "Formulation and IPQC testing of tablets", "details": "<table border=\"0\" cellpadding=\"2\" cellspacing=\"2\" style=\"width:100%\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td><span style=\"color:#000000\">Duration</span></td>\r\n\t\t\t<td><span style=\"color:#000000\">-</span></td>\r\n\t\t\t<td><span style=\"color:#000000\">02 Days</span></td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td><span style=\"color:#000000\">Number of hours</span></td>\r\n\t\t\t<td><span style=\"color:#000000\">-</span></td>\r\n\t\t\t<td><span style=\"color:#000000\">10 (Theory 02, Practical 08)</span></td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td><span style=\"color:#000000\">Course content</span></td>\r\n\t\t\t<td><span style=\"color:#000000\">-</span></td>\r\n\t\t\t<td><span style=\"color:#000000\">All practical aspects of formulating granules, punching of tablets and in process quality checks of tablets</span></td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td><span style=\"color:#000000\">Outcome</span></td>\r\n\t\t\t<td><span style=\"color:#000000\">-</span></td>\r\n\t\t\t<td><span style=\"color:#000000\">The candidate will be able to formulate tablet dosage form effectively and would be able to talk confidently in interview about tablet manufacturing</span></td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>", "ourresearch": "<p>-</p>", "slug": "ipqc-of-solid-dosage-forms", "associatedfaculty": [1, 2]}}, {"model": "services.services", "pk": 9, "fields": {"category": 10, "type": "training", "title": "15 Day training", "img1": "services/Quality-control-tests-for-tablets.jpg", "img2": "services/Disintegration-test-apparatus.jpg", "tagline": "15 Day training", "details": "<table border=\"0\" cellpadding=\"2\" cellspacing=\"2\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td>Duration</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>12 working days</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Number of hours</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>60 (Theory 20, Practical 40)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Course content</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>All practical aspects tablet formulation, IPQC of solid dosage form, handling of UV and HPLC, microbiological training.</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Outcome</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>The candidate will be able to have a sound practical knowledge of all testing of tablets and basic microbiological techniques</td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>\r\n\r\n<p>&nbsp;</p>", "ourresearch": "", "slug": "manufacture-and-testing-of-tablets", "associatedfaculty": [1, 2]}}, {"model": "services.services", "pk": 10, "fields": {"category": 11, "type": "training", "title": "Practical Aspects of Microbiology", "img1": "services/basic-microbiological-techniques-1-638.webp", "img2": "services/General-Aseptic-Techniques-in-Microbiology-Laboratory.webp", "tagline": "Practical Aspects of Microbiology", "details": "<table border=\"0\" cellpadding=\"2\" cellspacing=\"2\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td>Duration</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>02 Days</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Number of hours</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>10 (Theory 02, Practical 08)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Course content</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>- Preparation of broth, plate, culturing of microorganism</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Outcome</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>The candidate will be able to perform microbiological testing which is required in quality control of parenteral products</td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>", "ourresearch": "<h2><span style=\"color:#000000\"><strong>Microbiology Training</strong></span></h2>\r\n\r\n<p><span style=\"color:#444444\">Microbial testing is important in many industries worldwide like water, food, detergents, pharma and cosmetics, where human health is at risk of being adversely affected by disease-causing microorganisms. The microbiological investigation is necessary and required to detect contamination, maintain high quality standards and to ensure safety and efficacy of the products.</span></p>\r\n\r\n<p><span style=\"color:#444444\"><span style=\"background-color:#ffffff\">The Center of Training and Skill Development, Mohali provides Microbiology summer/winter training to Life sciences students. This is an industry oriented program to provide a thorough knowledge on the test methods and precautions to be taken for carrying out microbiological test of various samples. The trainee practices solid and liquid media preparation, identification of different microorganisms, their isolation and culture maintenance. Hands-on practice on various equipments used during the test is also provided</span></span><span style=\"color:#444444\"><span style=\"background-color:#ffffff\">.</span></span></p>\r\n\r\n<p><span style=\"color:#000000\"><strong>Advanced Microbiology Training</strong></span></p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Introduction to Good Laboratory Practices</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Basics of Calculations; Buffers and Reagent Preparation</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Various Media (Solid/Liquid) preparation and Its Sterilization</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Various methods of Inoculation of Cultures( Streaking, spreading)</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Microbial Enumeration (TAMC and TCYM)</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Antimicrobial Susceptibility test( Kirby-Bauer test)</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Isolation and Culturing of microbes from Soil, Water, Air Samples</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Isolation of pure bacterial colonies from mixed population</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Identification of microorganisms by Biochemical testing</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Various staining techniques</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">CFU ( Colony Forming Unit) Count</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Pyrogen Testing</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Sterility test</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Bacterial Motility Test</span></li>\r\n\t<li style=\"list-style-type:disc\"><span style=\"color:#444444\">Water portability or MPN test</span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"color:#000000\">Extraction of phytoconstituents from plants</span></p>\r\n\r\n<p><span style=\"color:#000000\">Many antioxidant compounds can be found in fruits and vegetables including phenolics, carotenoids, anthocyanins, and tocopherols</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B1-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>1</u></strong></span></a><span style=\"color:#000000\">]. Approximately 20% of known plants have been used in pharmaceutical studies, impacting the healthcare system in positive ways such as treating cancer and harmful diseases&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B2-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>2</u></strong></span></a><span style=\"color:#000000\">]. Plants are able to produce a large number of diverse bioactive compounds. High concentrations of phytochemicals, which may protect against free radical damage, accumulate in fruits and vegetables&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B3-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>3</u></strong></span></a><span style=\"color:#000000\">]. Plants containing beneficial phytochemicals may supplement the needs of the human body by acting as natural antioxidants</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B4-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>4</u></strong></span></a><span style=\"color:#000000\">]. Various studies have shown that many plants are rich source of antioxidants. For instance, vitamins A, C, E, and phenolic compounds such as flavonoids, tannins, and lignins, found in plants, all act as antioxidants&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B3-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>3</u></strong></span></a><span style=\"color:#000000\">]. The consumption of fruits and vegetables has been linked with several health benefits, a result of medicinal properties and high nutritional value&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B5-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>5</u></strong></span></a><span style=\"color:#000000\">]. Antioxidants control and reduce the oxidative damage in foods by delaying or inhibiting oxidation caused by reactive oxygen species (ROS), ultimately increasing the shelf-life and quality of these foods</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B6-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>6</u></strong></span></a><span style=\"color:#000000\">]. Beta carotene, ascorbic acid, and many phenolics play dynamic roles in delaying aging, reducing inflammation, and preventing certain cancers</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B7-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>7</u></strong></span></a><span style=\"color:#000000\">]. Increasing the consumption of fruits and vegetables has been recommended by many agencies and health care systems throughout the world</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;[</span><a href=\"https://www.mdpi.com/2223-7747/6/4/42/htm#B8-plants-06-00042\" style=\"text-decoration:none\"><span style=\"color:#3156a2\"><strong><u>8</u></strong></span></a><span style=\"color:#000000\">].</span></p>\r\n\r\n<p><span style=\"color:#000000\">The objective of this paper is to provide a review of phytochemical studies that have addressed extracting, measuring and identifying bioactive compounds of plants. This review includes an overview of the lipid oxidation process, details of plants known to be antioxidant and antimicrobial sources, phenolic compounds, antioxidants from vegetables and fruits, cancer prevention, extraction techniques for phenolic compounds, isolation and purification of bioactive molecules, and techniques for structural classification of bioactive molecules.</span></p>", "slug": "practical-aspects-of-microbiology", "associatedfaculty": [1, 2]}}, {"model": "services.services", "pk": 11, "fields": {"category": 8, "type": "training", "title": "(HPLC) instrument", "img1": "services/primer_F_AllianceHPLCSystem.jpg", "img2": "services/Functional-schematic-of-a-modern-HPLC-instrument.png", "tagline": "High Performance Liquid Chromatography (HPLC) instrument", "details": "<table border=\"0\" cellpadding=\"2\" cellspacing=\"2\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td>Duration</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>02 Days</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Number of hours</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>10 (Theory 02, Practical 08)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Course content</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>All practical aspects of HPLC (method setup, column washing, stock solution, sample solution preparation, working standard and unknown sample analysis)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Outcome</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>The candidate will be able to perform analytical operations involving HPLC (an essential instrument in Quality Control of Pharmaceuticals)</td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>\r\n\r\n<p>&nbsp;</p>", "ourresearch": "", "slug": "hplc-instrument", "associatedfaculty": [2]}}, {"model": "services.services", "pk": 12, "fields": {"category": 10, "type": "training", "title": "UV Spectrophotometer", "img1": "services/DU640_spectrophotometer.jpg", "img2": "services/uv-vis-faq-instrument-design-spectrophotometer-function.png", "tagline": "UV Spectrophotometer", "details": "<table border=\"0\" cellpadding=\"2\" cellspacing=\"2\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td>Duration</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>02 Days</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Number of hours</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>10 (Theory 02, Practical 08)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Course content</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>All practical aspects of UV spectrophotometry (stock solution, sample solution preparation, working standard and unknown sample analysis)</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td>Outcome</td>\r\n\t\t\t<td>-</td>\r\n\t\t\t<td>The candidate will be able to perform analytical operations involving UV spectrophotometer (an essential instrument in Quality Control of Pharmaceuticals)</td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>", "ourresearch": "", "slug": "antibiotic-assay", "associatedfaculty": []}}, {"model": "services.services", "pk": 13, "fields": {"category": 12, "type": "service", "title": "Synthesis of molecules", "img1": "services/shutterstock_1645313347.webp", "img2": "services/new-framework-designed-to-enable-efficient-synthesis-of-complex-molecules-34195_1Nr8V4b.jpg", "tagline": "Synthesis of molecules", "details": "<p>A chemical synthesis usually involves the breaking of existing bonds and the formation of new ones. Synthesis of a complex molecule may involve a considerable number of individual reactions leading in sequence from available starting materials to the desired end product. Each step usually involves reaction at only one chemical bond in the molecule.</p>\r\n\r\n<p>In planning the route of chemical synthesis, chemists usually visualize the end product and work backward toward increasingly simpler compounds. For many compounds, it is possible to establish alternative synthetic routes. The ones actually used depend on many factors, such as cost and availability of starting materials, the amount of energy needed to make the reaction proceed at a satisfactory rate, and the cost of separating and purifying the end products. Moreover, knowledge of the reaction mechanism and the function of the chemical structure (or behavior of the functional groups) helps to accurately determine the most-favored pathway that leads to the desired reaction product.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>A goal in planning a chemical synthesis is to find reactions that will affect only one part of the molecule, leaving other parts unchanged. Another goal is to produce high yields of the desired product in as short a time as possible. Often, reactions in a synthesis compete, reducing the yield of a desired product. Competition can also lead to the formation of side products which can be difficult to separate from the main one. In some industrial syntheses, by-product formation can be welcome if the by-products are commercially useful. Diethyl ether, for example, is a by-product of the large-scale synthesis of ethanol (ethyl alcohol) from ethylene. Both the alcohol and ether are valuable and can be separated easily.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>The reactions involved in chemical syntheses usually, but not always, involve at least two different substances. Some molecules will change into others solely under the effect of heat, for example, while others react on exposure to radiation (e.g., ultraviolet light) or to electric current. However, where two or more different substances interact, they need to be brought into close proximity with one another. This is usually done by carrying out the syntheses with the elements or compounds in their liquid or gaseous states. Where the reactants are in volatile solids, reaction is often carried out in solution.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>The rate of a chemical reaction generally increases with temperature; chemical syntheses are thus often carried out at elevated temperatures. The industrial synthesis of nitric acid from ammonia and oxygen, for instance, is carried out at about 900 &deg;C (1,650 &deg;F). Frequently, heating will increase the rate of a reaction insufficiently or the instability of one or more reactants prevents application. In such cases catalysts&mdash;substances that speed up or slow down a reaction&mdash;are used. Most industrial processes involve the use of catalysts.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>Some substances react so rapidly and violently that only careful control of the conditions will lead to the desired product. When ethylene gas is synthesized to polyethylene, one of the most common plastics, a</p>\r\n\r\n<p>large amount of heat is released. If this release is not controlled in some way&mdash;e.g., by cooling the reactor vessel&mdash;the ethylene molecules decompose to carbon and hydrogen.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>Many techniques have been developed to separate the products of chemical synthesis. These often involve a phase change. For example, the product of a synthetic reaction may not dissolve in a particular solvent, while the starting materials do. In this case, the product will precipitate out as a solid and can be separated from the mixture by filtration. Alternatively, if both starting materials and products are volatile, it may be possible to separate them by distillation.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>Certain chemical syntheses lend themselves readily to the use of automated techniques. Automatic DNA (deoxyribonucleic acid) synthesizers, for example, are widely used to produce specific protein sequences.</p>", "ourresearch": "", "slug": "synthesis-of-molecules", "associatedfaculty": [1, 2]}}, {"model": "services.services", "pk": 14, "fields": {"category": 8, "type": "service", "title": "Extraction and isolation of phytoconstituents", "img1": "services/Phytochemistry-Lab_-How-to-Identify-the-Phytoconstituents.jpg", "img2": "services/visuel-principes-actifs-totum.jpg", "tagline": "Extraction and isolation of phytoconstituents", "details": "<p>Natural medicines were the only option for the prevention and treatment of human diseases for thousands of years. Natural products are important sources for drug development. The amounts of bioactive natural products in natural medicines are always fairly low. Today, it is very crucial to develop effective and selective methods for the extraction and isolation of those bioactive natural products. This paper intends to provide a comprehensive view of a variety of methods used in the extraction and isolation of natural products. This paper also presents the advantage, disadvantage and practical examples of conventional and modern techniques involved in natural products research.</p>\r\n\r\n<p>The selection of the solvent is crucial for solvent extraction. Selectivity, solubility, cost and safety should be considered in selection of solvents. Based on the law of similarity and intermiscibility (like dissolves like), solvents with a polarity value near to the polarity of the solute are likely to perform better and vice versa. Alcohols (EtOH and MeOH) are universal solvents in solvent extraction for phytochemical investigation.</p>\r\n\r\n<p>Generally, the finer the particle size is, the better result the extraction achieves. The extraction efficiency will be enhanced by the small particle size due to the enhanced penetration of solvents and diffusion of solutes. Too fine particle size, however, will cost the excessive absorption of solute in solid and difficulty in subsequent filtration.</p>\r\n\r\n<p>High temperatures increase the solubility and diffusion. Temperatures that too high, however, may cause solvents to be lost, leading to extracts of undesirable impurities and the decomposition of thermo labile components.</p>\r\n\r\n<p>The extraction efficiency increases with the increase in extraction duration in a certain time range. Increasing time will not affect the extraction after the equilibrium of the solute is reached inside and outside the solid material.</p>\r\n\r\n<p>The greater the solvent-to-solid ratio is, the higher the extraction yield is; however, a solvent-to-solid ratio that is too high will cause excessive extraction solvent and requires a long time for concentration.</p>", "ourresearch": "", "slug": "extraction-and-isolation-of-phytoconstituents", "associatedfaculty": [1, 2]}}, {"model": "services.services", "pk": 15, "fields": {"category": 1, "type": "service", "title": "Drug Design", "img1": "services/4982936d-0d3c-474f-8d5c-e51d61e8cf43.jpg", "img2": "services/Platform-designed-to-accelerate-drug-discovery-development_wrbm_large.jpg", "tagline": "Drug Design. And Novel drug", "details": "<p>Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target.</p>\r\n\r\n<p>The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques.</p>\r\n\r\n<p>This type of modeling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the bimolecular target is known as structure-based drug design.</p>\r\n\r\n<p>In addition to small molecules, biopharmaceuticals including peptides and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of these protein-based therapeutics have also been developed.</p>\r\n\r\n<p>The phrase &quot;drug design&quot; is to some extent a misnomer. A more accurate term is ligand design (i.e., design of a molecule that will bind tightly to its target).</p>\r\n\r\n<p>Although design techniques for prediction of binding affinity are reasonably successful, there are many other properties, such as bioavailability, metabolic half-life, side effects, etc., that first must be optimized before a ligand can become a safe and efficacious drug. These other characteristics are often difficult to predict with rational design techniques. Nevertheless, due to high attrition rates, especially during clinical phases of drug development, more attention is being focused early in the drug design process on selecting candidate drugs whose physicochemical properties are predicted to result in fewer complications during development and hence more likely to lead to an approved, marketed drug.</p>\r\n\r\n<p>Furthermore, in vitro experiments complemented with computation methods are increasingly used in early drug discovery to select compounds with more favorable ADME (absorption, distribution, metabolism, and excretion) and toxicological profiles.</p>\r\n\r\n<p>Novel drug delivery system is a novel approach to drug delivery that addresses the limitations of the traditional drug delivery systems. Our country has a vast knowledge base of Ayurveda whose potential is only being realized in the recent years. However, the drug delivery system used for administering the herbal medicine to the patient is traditional and out-of-date, resulting in reduced efficacy of the drug. If the novel drug delivery technology is applied in herbal medicine, it may help in increasing the efficacy and reducing the side effects of various herbal compounds and herbs.</p>\r\n\r\n<p>This is the basic idea behind incorporating novel method of drug delivery in herbal medicines. Thus it is important to integrate novel drug delivery system and Indian Ayurveda medicines to combat more serious diseases.</p>\r\n\r\n<p>For a long time herbal medicines were not considered for development as novel formulations owing to lack of scientific justification and processing difficulties, such as standardization, extraction and identification of individual drug components in complex polyhedral systems.</p>\r\n\r\n<p>However, modern phytopharmaceutical research can solve the scientific needs (such as determination of pharmacokinetics, mechanism of action, site of action, accurate dose required etc.) of herbal medicines to be incorporated in novel drug delivery system, such as nanoparticles, micro emulsions, matrix systems, solid dispersions, liposomes, solid lipid nanoparticles and so on.</p>\r\n\r\n<p>This article summarizes various drug delivery technologies, which can be used for herbal actives together with some examples.</p>\r\n\r\n<p>Keywords: Herbal medicines, herbs, novel drug delivery system, phytopharmaceuticals</p>\r\n\r\n<p>The future of medicine is rooted in the past, before chemists undertook to synthesize synthetic silver bullets for all that ailments, and before pharmaceutical companies hitched our collective health to what has become for them a multibillion-dollar wagon. In the past, almost all the medicines were from the plants; the plant being man&#39;s only chemist for ages.</p>\r\n\r\n<p>Herbs are staging a comeback, herbal &lsquo;renaissance&rsquo; is happening all over the globe and more and more people are taking note of herbal therapies to treat various kinds of ailments in place of mainstream medicine. There are three main reasons for the popularity of herbal medicines:</p>\r\n\r\n<p>There is a growing concern over the reliance and safety of drugs and surgery.</p>\r\n\r\n<p>Modern medicine is failing to effectively treat many of the most common health conditions.</p>\r\n\r\n<p>Many natural measures are being shown to produce better results than drugs or surgery without the side effects.</p>\r\n\r\n<p>Also there is increasing evidence that many current drug therapies simply suppress symptoms and ignore the underlying disease processes. In contrast, many natural products appear to address the cause of many diseases and yield superior clinical results. Unfortunately, most physicians and patients are not aware that these natural alternatives exist. But research in this field is a never ending process.</p>\r\n\r\n<p>The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all.</p>\r\n\r\n<p>On the other hand, the very slow progress in the efficacy of the treatment of severe diseases has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues.</p>\r\n\r\n<p>From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, bio-recognition and efficacy of drugs were generated.</p>\r\n\r\n<p>These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bio conjugate chemistry and molecular biology.</p>", "ourresearch": "", "slug": "drug-design", "associatedfaculty": []}}, {"model": "services.services", "pk": 16, "fields": {"category": 1, "type": "service", "title": "Pharmacological Screening", "img1": "services/shutterstock_heart-675x380.jpg", "img2": "services/7e76d828c980ed9db3eb4827d4fd7122.jpg", "tagline": "Pharmacological Screening (in vitro and in vivo)", "details": "<p><span style=\"color:#000000\">Safety-related drug failures remain a major challenge for the pharmaceutical industry. One approach to ensuring drug safety involves assessing small molecule drug specificity by examining the ability of a drug candidate to interact with a panel of &ldquo;off-target&rdquo; proteins, referred to as secondary pharmacology screening. Information from human genetics and pharmacology can be used to select proteins associated with adverse effects for such screening. In an analysis of marketed drugs, we found a clear relationship between the genetic and pharmacological phenotypes of a drug&rsquo;s off-target proteins and the observed drug side effects. In addition to using this phenotypic information for the selection of secondary pharmacology screens, we also show that it can be used to help identify drug off-target protein interactions responsible for drug-related adverse events. We anticipate that this phenotype-driven approach to secondary pharmacology screening will help to reduce safety-related drug failures due to drug off-target protein interactions.</span></p>\r\n\r\n<p><span style=\"color:#000000\">Enrichment Analysis</span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"color:#000000\">We annotated phenotype matches (as defined above) between drug side effects and off-target phenotypes obtained from genetics, pharmacology, or both.&nbsp;</span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"color:#000000\">To test for which phenotypes off-target genetics/pharmacology tended to reflect drug side effects we performed an enrichment analysis using 230 MedDRA HLGT terms (ie, all HLGT terms for which there were side effects in our dataset).&nbsp;</span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"color:#000000\">First, we removed all side effect terms that mapped to the same SOC term as the drug indication to avoid side effects likely to represent exaggerated pharmacology (eg, drugs with cardiac indications were removed when we considered cardiac arrhythmia as a side effect). Second, we excluded drugs where the intended target had genetic or pharmacological evidence for the phenotype reasoning that such effects were more likely to be modulated by the intended target rather than an off-target interaction.&nbsp;</span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"color:#000000\">We then recorded the number of drugs that had a matching side effect and off-target phenotype (ie, the drug side effect matched the phenotype of at least one of the drug&rsquo;s off-targets), absence of the side effect and absence of a matching off-target phenotype, presence of side effect but absence of a matching off-target phenotype, and absence of a side effect but presence of an off-target phenotype. Drugs with phenotype matches with the intended target were removed from the analysis.&nbsp;</span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"color:#000000\">We constructed 2 &times; 2 contingency tables containing the number of drugs fulfilling each of these criteria and calculated an odds ratio and p value for each HLGT term using a two-sided Fisher&rsquo;s exact test (Agresti, 2002; Fisher, 1935) &ldquo;fisher.test&rdquo; in the R &ldquo;stats&rdquo; package (R version 3.4.2). Fisher&rsquo;s exact test was chosen to be robust to small sample sizes in certain contingency tables (Kim, 2017; Ludbrook, 2008). For instances where there were zero values in the contingency table (ie, when no drugs matched the criteria) these were assigned a pseudocount of one to avoid infinite or zero odds ratio values.&nbsp;</span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"color:#000000\">We corrected our significance threshold for multiple testing using the Bonferroni method which adjusts the p value based on the number of tests performed (Bland and Altman, 1995). In this instance, we examined 618 drugs over each of 230 phenotypes giving a total of 1.4 &times; 105 tests performed</span></p>", "ourresearch": "", "slug": "pharmacological-screening-in-vitro-and-in-vivo", "associatedfaculty": [1]}}, {"model": "services.services", "pk": 17, "fields": {"category": 8, "type": "service", "title": "Novel Drug Delivery Systems", "img1": "services/1-s2.0-S0367326X10000912-fx1.jpg", "img2": "services/T601921815_g.jpg", "tagline": "Novel Drug Delivery Systems", "details": "<p><span style=\"color:#000000\">Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target.</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques.</span></p>\r\n\r\n<p><span style=\"color:#000000\">This type of modeling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the bimolecular target is known as structure-based drug design.</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;In addition to small molecules, biopharmaceuticals including peptides and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of these protein-based therapeutics have also been developed.</span></p>\r\n\r\n<p><span style=\"color:#000000\">The phrase &quot;drug design&quot; is to some extent a misnomer. A more accurate term is ligand design (i.e., design of a molecule that will bind tightly to its target).</span></p>\r\n\r\n<p><span style=\"color:#000000\">Although design techniques for prediction of binding affinity are reasonably successful, there are many other properties, such as bioavailability, metabolic half-life, side effects, etc., that first must be optimized before a ligand can become a safe and efficacious drug. These other characteristics are often difficult to predict with rational design techniques. Nevertheless, due to high attrition rates, especially during clinical phases of drug development, more attention is being focused early in the drug design process on selecting candidate drugs whose physicochemical properties are predicted to result in fewer complications during development and hence more likely to lead to an approved, marketed drug.</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;Furthermore, in vitro experiments complemented with computation methods are increasingly used in early drug discovery to select compounds with more favorable ADME (absorption, distribution, metabolism, and excretion) and toxicological profiles.</span></p>\r\n\r\n<p><span style=\"color:#000000\">Novel drug delivery system is a novel approach to drug delivery that addresses the limitations of the traditional drug delivery systems. Our country has a vast knowledge base of Ayurveda whose potential is only being realized in the recent years. However, the drug delivery system used for administering the herbal medicine to the patient is traditional and out-of-date, resulting in reduced efficacy of the drug. If the novel drug delivery technology is applied in herbal medicine, it may help in increasing the efficacy and reducing the side effects of various herbal compounds and herbs.</span></p>\r\n\r\n<p><span style=\"color:#000000\">This is the basic idea behind incorporating novel method of drug delivery in herbal medicines. Thus it is important to integrate novel drug delivery system and Indian Ayurveda medicines to combat more serious diseases.&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">For a long time herbal medicines were not considered for development as novel formulations owing to lack of scientific justification and processing difficulties, such as standardization, extraction and identification of individual drug components in complex polyhedral systems.</span></p>\r\n\r\n<p><span style=\"color:#000000\">&nbsp;However, modern phytopharmaceutical research can solve the scientific needs (such as determination of pharmacokinetics, mechanism of action, site of action, accurate dose required etc.) of herbal medicines to be incorporated in novel drug delivery system, such as nanoparticles, micro emulsions, matrix systems, solid dispersions, liposomes, solid lipid nanoparticles and so on.</span></p>\r\n\r\n<p><span style=\"color:#000000\">This article summarizes various drug delivery technologies, which can be used for herbal actives together with some examples.</span></p>\r\n\r\n<p><span style=\"color:#000000\"><strong>Keywords:&nbsp;</strong></span><span style=\"color:#000000\">Herbal medicines, herbs, novel drug delivery system, phytopharmaceuticals</span></p>\r\n\r\n<p><span style=\"color:#000000\">The future of medicine is rooted in the past, before chemists undertook to synthesize synthetic silver bullets for all that ailments, and before pharmaceutical companies hitched our collective health to what has become for them a multibillion-dollar wagon. In the past, almost all the medicines were from the plants; the plant being man&#39;s only chemist for ages.&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">Herbs are staging a comeback, herbal &lsquo;renaissance&rsquo; is happening all over the globe and more and more people are taking note of herbal therapies to treat various kinds of ailments in place of mainstream medicine. There are three main reasons for the popularity of herbal medicines:</span></p>\r\n\r\n<p><span style=\"color:#000000\">There is a growing concern over the reliance and safety of drugs and surgery.</span></p>\r\n\r\n<p><span style=\"color:#000000\">Modern medicine is failing to effectively treat many of the most common health conditions.</span></p>\r\n\r\n<p><span style=\"color:#000000\">Many natural measures are being shown to produce better results than drugs or surgery without the side effects.</span></p>\r\n\r\n<p><span style=\"color:#000000\">Also there is increasing evidence that many current drug therapies simply suppress symptoms and ignore the underlying disease processes. In contrast, many natural products appear to address the cause of many diseases and yield superior clinical results. Unfortunately, most physicians and patients are not aware that these natural alternatives exist. But research in this field is a never ending process.</span></p>\r\n\r\n<p><span style=\"color:#000000\">The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all.&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">On the other hand, the very slow progress in the efficacy of the treatment of severe diseases has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues.&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, bio-recognition and efficacy of drugs were generated.&nbsp;</span></p>\r\n\r\n<p><span style=\"color:#000000\">These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bio conjugate chemistry and molecular biology.</span></p>\r\n\r\n<p>&nbsp;</p>", "ourresearch": "", "slug": "novel-drug-delivery-systems", "associatedfaculty": [1, 2]}}, {"model": "team.teammodel", "pk": 1, "fields": {"name": "Brijeshkunvar Mishra", "position": "Head Research and Development", "twiter": "https://twitter.com/", "facebook": "https://www.facebook.com/", "google": "https://www.google.com/", "linkedin": "https://www.linkedin.com/", "profile": "teamprofile/download.jpg", "phone": "123456789", "email": "lab@rbscience.com", "website": "www.yoursite.com", "address": "4578 Marmora Road, Glasgow", "education": "Doctor of Philosophy", "slug": "samantha-wood", "experience": "<p>Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, aliquam quaerat voluptatem.</p>\r\n\r\n<p>Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem.</p>"}}, {"model": "team.teammodel", "pk": 2, "fields": {"name": "Richa Mishra", "position": "Head Planning and Finance", "twiter": "#", "facebook": "#", "google": "#", "linkedin": "#", "profile": "teamprofile/download_CkVWne8.jpg", "phone": "123456789", "email": "Alex@gmail.com", "website": "www.yoursite.com", "address": "4578 Marmora Road, Glasgow", "education": "4578 Marmora Road, Glasgow", "slug": "alex-mitchell", "experience": "<p>Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, aliquam quaerat voluptatem.</p>\r\n\r\n<p>Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem.</p>"}}, {"model": "team.teammodel", "pk": 3, "fields": {"name": "Faizan Ali", "position": "Head of Training, Senior Scientist", "twiter": "#", "facebook": "#", "google": "#", "linkedin": "#", "profile": "teamprofile/download_wDKDnPo.jpg", "phone": "1234567890", "email": "faizel@gmail.com", "website": "#", "address": "4578 Marmora Road, Glasgo", "education": "Doctor of Philosophy", "slug": "faizan-ali", "experience": "<p>Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, aliquam quaerat voluptatem.</p>\r\n\r\n<p>Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem.</p>"}}, {"model": "research.category", "pk": 1, "fields": {"name": "VACCINES", "slug": "vaccines"}}, {"model": "research.category", "pk": 2, "fields": {"name": "PATHOLOGY", "slug": "pathology"}}, {"model": "research.category", "pk": 3, "fields": {"name": "ONCOLOGY", "slug": "oncology"}}, {"model": "research.category", "pk": 5, "fields": {"name": "BIOSAFETY", "slug": "biosafety"}}, {"model": "research.category", "pk": 6, "fields": {"name": "INCUBATOR", "slug": "incubator"}}, {"model": "research.researchmodel", "pk": 1, "fields": {"category": 3, "heading": "NANOSTRUCTURED MATERIALS", "projectDetails": "<p><strong>RESEARCH NAME</strong> : Nuclear Micro-Reactors</p>\r\n\r\n<p><strong>CLIENT </strong>: Envato Pvt Ltd</p>\r\n\r\n<p><strong>CATEGORY :</strong>&nbsp;Biosafety, Incubator</p>\r\n\r\n<p><strong>DELIVERY MODE :</strong>&nbsp;Stipulated Price</p>\r\n\r\n<p><strong>LOCATION :</strong>&nbsp;USA</p>", "overview": "'When faced with a supply chain disruption, proactive and reactive supply chain risk management can in fact make or break a company’s existence. One of the most famous (or rather infamous) cases is the fire at the Philips microchip plant in Albuquerque, New Mexico, in 2000, which simultaneously affected both Nokia and Ericsson. However, both companies took a very different approach toward the incident, and in hindsight, clearly displayed how to and how not to handle supply chain disruptions. New Mexico, in 2000, which simultaneously affected both Nokia and Ericsson", "content": "<p>&#39;&#39;</p>", "processOverview": "<p>dsd</p>", "time": "2021-10-28T07:09:40.443Z", "img": "research/research-new-01-800x650.jpg", "slug": "nanostructured-materials"}}, {"model": "research.researchmodel", "pk": 2, "fields": {"category": 2, "heading": "ORGANIC SYNTHESIS", "projectDetails": "<p><strong>RESEARCH NAME</strong> : Nuclear Micro-Reactors</p>\r\n\r\n<p><strong>CLIENT </strong>: Envato Pvt Ltd</p>\r\n\r\n<p><strong>CATEGORY :</strong>&nbsp;Biosafety, Incubator</p>\r\n\r\n<p><strong>DELIVERY MODE :</strong>&nbsp;Stipulated Price</p>\r\n\r\n<p><strong>LOCATION :</strong>&nbsp;USA</p>", "overview": "When faced with a supply chain disruption, proactive and reactive supply chain risk management can in fact make or break a company’s existence. One of the most famous (or rather infamous) cases is the fire at the Philips microchip plant in Albuquerque, New Mexico, in 2000, which simultaneously affected both Nokia and Ericsson. However, both companies took a very different approach toward the incident, and in hindsight, clearly displayed how to and how not to handle supply chain disruptions. New Mexico, in 2000, which simultaneously affected both Nokia and Ericsson", "content": "<h4>Challenge &amp; Solution</h4>\r\n\r\n<p>Being a top us private facility for any kind of scientific research, we are proud of the overall amount of work we`ve done so far. Excepteur sint occaecat cupidatat non dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p>\r\n\r\n<h6>Exerci tation ullamcorper suscipit lobortis</h6>\r\n\r\n<p>Exerci tation ullamcorper suscipitorens lobortis nisl ut aliquip ex ea commodo. Exerci tation ullamcorper suscipitorens. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.</p>\r\n\r\n<h6>Occaecat sint occaecat suscipit dolore</h6>\r\n\r\n<p>Exerci tation ullamcorper suscipitorens lobortis nisl ut aliquip ex ea commodo. Exerci tation ullamcorper suscipitorens. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.</p>\r\n\r\n<h6>Being a top us private facility for any kind</h6>\r\n\r\n<p>Exerci tation ullamcorper suscipitorens lobortis nisl ut aliquip ex ea commodo. Exerci tation ullamcorper suscipitorens. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.</p>", "processOverview": "<p>Being a top us private facility for any kind of&nbsp; scientific research, we are proud of the overall amount of work we`ve done so far. Excepteur sint occaecat cupidatat non dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p>", "time": "2021-10-28T07:09:19.445Z", "img": "research/research-new-02-800x650.jpg", "slug": "organic-synthesis"}}, {"model": "research.process", "pk": 1, "fields": {"researchModel": 2, "title": "LAB TECHNICIANS", "content": "This is a case of a patient with a history of dementia, worsened with an agitation."}}, {"model": "research.process", "pk": 2, "fields": {"researchModel": 2, "title": "RESEARCH CENTER", "content": "This is a case of a patient with a history of dementia, worsened with an agitation."}}, {"model": "research.process", "pk": 3, "fields": {"researchModel": 2, "title": "OUR EXPERIENCE", "content": "This is a case of a patient with a history of dementia, worsened with an agitation."}}, {"model": "superuser.aboutcontact", "pk": 1, "fields": {"logo": "logo/logo-b-01_NQ83pUj.png", "phone": "+919406974835", "email": "rbsciencebhopal@gmail.com", "workingHours": "Mon to Fri: 9am to 8pm", "country": "india", "state": "Madhya Pradesh", "city": "BHOPAL", "BuildingNo": "D-424,", "address": "NEW MINAL RESIDENCY, GOVINDPURA, JK ROAD 462023", "facebook": "https://www.facebook.com/rbsciencebhopal", "twiter": "", "linkedin": "https://www.linkedin.com/in/rb-science-28376b1a4/?originalSubdomain=in", "instagram": "https://www.instagram.com/rbscience/?hl=en", "fliker": ""}}]